Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

2583 470697 25 None 6 4 Human 9.0 pAC50 = 9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1038/s41467-023-40064-9
520 470697 25 None 6 4 Human 9.0 pAC50 = 9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1038/s41467-023-40064-9
CHEMBL839 470697 25 None 6 4 Human 9.0 pAC50 = 9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1038/s41467-023-40064-9
DB00521 470697 25 None 6 4 Human 9.0 pAC50 = 9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1038/s41467-023-40064-9
1978 515 40 None 24 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
40 515 40 None 24 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
7107 515 40 None 24 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
CHEMBL642 515 40 None 24 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
DB01193 515 40 None 24 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
10184665 8655 40 None -1737 9 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
4799 8655 40 None -1737 9 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
7353 8655 40 None -1737 9 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
CHEMBL1198857 8655 40 None -1737 9 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
DB09082 8655 40 None -1737 9 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
216416 221077 40 None -117 23 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL328190 221077 40 None -117 23 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
DB06202 221077 40 None -117 23 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
1865 384925 34 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
4411 384925 34 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
CHEMBL521606 384925 34 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
DB01203 384925 34 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
72093 78550 5 None -10 28 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 78550 5 None -10 28 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
DB13500 78550 5 None -10 28 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
1873 77714 61 None -10 16 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
4418 77714 61 None -10 16 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 77714 61 None -10 16 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
DB12092 77714 61 None -10 16 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
12582 1957 29 None -3 5 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
2783 1957 29 None -3 5 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
673 1957 29 None -3 5 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
CHEMBL49080 1957 29 None -3 5 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
DB01407 1957 29 None -3 5 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
3083544 57618 28 None -30 4 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
4943 57618 28 None -30 4 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 57618 28 None -30 4 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
DB00983 57618 28 None -30 4 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
DB01274 57618 28 None -30 4 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
100 8289 46 None -144 23 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 8289 46 None -144 23 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 8289 46 None -144 23 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 8289 46 None -144 23 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 8289 46 None -144 23 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
11980903 38402 12 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 38402 12 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 38402 12 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 38402 12 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
DB06816 38402 12 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
2713 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
DB00878 470127 64 None -5 26 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
6436135 199770 30 None -1 2 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 9 2 4 5.8 CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O 10.1038/s41467-023-40064-9
648 199770 30 None -1 2 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 9 2 4 5.8 CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL283754 199770 30 None -1 2 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 9 2 4 5.8 CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O 10.1038/s41467-023-40064-9
DB00587 199770 30 None -1 2 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 9 2 4 5.8 CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O 10.1038/s41467-023-40064-9
5906 38405 15 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
CHEMBL1201319 38405 15 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
DB00610 38405 15 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
202 3105 49 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 3105 49 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 3105 49 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 3105 49 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 3105 49 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3191 202914 68 None -95 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
977 202914 68 None -95 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
CHEMBL305660 202914 68 None -95 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
DB11742 202914 68 None -95 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
1786 5120 49 None 4 3 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
4171 5120 49 None 4 3 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
553 5120 49 None 4 3 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL13 5120 49 None 4 3 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00264 5120 49 None 4 3 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
6436173 117955 32 None -4 22 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 117955 32 None -4 22 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
DB01220 117955 32 None -4 22 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
2274 6448 36 None -363 20 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 6448 36 None -363 20 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 6448 36 None -363 20 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 6448 36 None -363 20 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 6448 36 None -363 20 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3464 6446 11 None -85 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
4916 6446 11 None -85 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
CHEMBL160519 6446 11 None -85 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
DB01366 6446 11 None -85 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
31729 461868 6 None -5 5 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 461868 6 None -5 5 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3926 474146 33 None -27 18 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL92870 474146 33 None -27 18 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
DB13766 474146 33 None -27 18 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
1016 8173 46 None -19 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
2561 8173 46 None -19 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
2733526 8173 46 None -19 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL83 8173 46 None -19 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
DB00675 8173 46 None -19 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
2267 1156 50 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
271 1156 50 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
7121 1156 50 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL639 1156 50 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00972 1156 50 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2435 7298 64 None -208 19 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 7298 64 None -208 19 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 7298 64 None -208 19 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 7298 64 None -208 19 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 7298 64 None -208 19 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2540 18749 72 None -1148 26 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
475 18749 72 None -1148 26 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 18749 72 None -1148 26 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
DB00796 18749 72 None -1148 26 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
64139 175742 64 None -3 8 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 0 1 2 4.1 O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1 10.1038/s41467-023-40064-9
CHEMBL223228 175742 64 None -3 8 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 0 1 2 4.1 O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1 10.1038/s41467-023-40064-9
DB00625 175742 64 None -3 8 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 0 1 2 4.1 O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1 10.1038/s41467-023-40064-9
451668 38370 64 None None None Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 228 2 3 8 -2.1 Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 10.1038/s41467-023-40064-9
CHEMBL1201129 38370 64 None None None Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 228 2 3 8 -2.1 Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 10.1038/s41467-023-40064-9
DB01262 38370 64 None None None Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 228 2 3 8 -2.1 Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 10.1038/s41467-023-40064-9
33624 8322 24 None -1 3 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
4061 8322 24 None -1 3 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
565 8322 24 None -1 3 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL499 8322 24 None -1 3 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
DB00373 8322 24 None -1 3 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
1222 3419 44 None -467 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 3419 44 None -467 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 3419 44 None -467 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 3419 44 None -467 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 3419 44 None -467 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
1836 5276 50 None -6 5 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
3340 5276 50 None -6 5 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
5281040 5276 50 None -6 5 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
CHEMBL787 5276 50 None -6 5 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
DB00471 5276 50 None -6 5 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
2767 313429 63 None -10 17 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
5591 313429 63 None -10 17 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 313429 63 None -10 17 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
DB00197 313429 63 None -10 17 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
3151 3013 70 None -3388 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 3013 70 None -3388 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 3013 70 None -3388 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 3013 70 None -3388 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 3013 70 None -3388 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2303 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
4946 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
564 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
63 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
91536 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL27 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL452861 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
DB00571 6476 48 None -4 14 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
5282219 79340 49 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 79340 49 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
DB05197 79340 49 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
105 7039 60 None -19 2 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
2083 7039 60 None -19 2 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
558 7039 60 None -19 2 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
CHEMBL714 7039 60 None -19 2 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
DB01001 7039 60 None -19 2 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
11976 1897 43 None -7244 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
623 1897 43 None -7244 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667466 1897 43 None -7244 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 1897 43 None -7244 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 1897 43 None -7244 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 1897 43 None -7244 14 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
155774 8875 30 None 28 2 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
2848 8875 30 None 28 2 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
538 8875 30 None 28 2 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL75753 8875 30 None 28 2 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
DB13781 8875 30 None 28 2 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
180 829 44 None -1778 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 829 44 None -1778 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 829 44 None -1778 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 829 44 None -1778 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 829 44 None -1778 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1419 193823 38 None -52 12 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
3689 193823 38 None -52 12 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL305187 193823 38 None -52 12 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
DB08954 193823 38 None -52 12 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
1971 5840 38 None -1348 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 5840 38 None -1348 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 5840 38 None -1348 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 5840 38 None -1348 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 5840 38 None -1348 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
5482 38332 59 None -13 13 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 38332 59 None -13 13 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
DB01007 38332 59 None -13 13 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2419 7043 56 None -162 10 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 7043 56 None -162 10 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 7043 56 None -162 10 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 7043 56 None -162 10 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 7043 56 None -162 10 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
129211 8177 49 None -1479 12 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
2562 8177 49 None -1479 12 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
488 8177 49 None -1479 12 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
CHEMBL836 8177 49 None -1479 12 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
DB00706 8177 49 None -1479 12 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
26987 1955 32 None -7762 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 1955 32 None -7762 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 1955 32 None -7762 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 1955 32 None -7762 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 1955 32 None -7762 22 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
4640 159843 24 None -218 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2107011 159843 24 None -218 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
DB13403 159843 24 None -218 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
4486 241544 23 None None None Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 11 2 9 0.3 Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O 10.1038/s41467-023-40064-9
CHEMBL360861 241544 23 None None None Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 11 2 9 0.3 Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O 10.1038/s41467-023-40064-9
DB16008 241544 23 None None None Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 11 2 9 0.3 Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O 10.1038/s41467-023-40064-9
1549120 393450 55 None -17 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 393450 55 None -17 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
DB15293 393450 55 None -17 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
2372 216137 33 None 12 6 Human 7.6 pAC50 = 7.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 216137 33 None 12 6 Human 7.6 pAC50 = 7.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
DB01295 216137 33 None 12 6 Human 7.6 pAC50 = 7.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
2782 24492 43 None -3 2 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 227 3 2 2 2.8 CC(C)(C)NCC(O)c1ccccc1Cl 10.1038/s41467-023-40064-9
5606 24492 43 None -3 2 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 227 3 2 2 2.8 CC(C)(C)NCC(O)c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1159717 24492 43 None -3 2 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 227 3 2 2 2.8 CC(C)(C)NCC(O)c1ccccc1Cl 10.1038/s41467-023-40064-9
DB12248 24492 43 None -3 2 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 227 3 2 2 2.8 CC(C)(C)NCC(O)c1ccccc1Cl 10.1038/s41467-023-40064-9
65948 42417 69 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
CHEMBL1275868 42417 69 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
DB09230 42417 69 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
4908 371987 57 None -5 7 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 4 2.8 COc1cc(NC(C)CCCN)c2ncccc2c1 10.1038/s41467-023-40064-9
CHEMBL506 371987 57 None -5 7 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 4 2.8 COc1cc(NC(C)CCCN)c2ncccc2c1 10.1038/s41467-023-40064-9
DB01087 371987 57 None -5 7 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 4 2.8 COc1cc(NC(C)CCCN)c2ncccc2c1 10.1038/s41467-023-40064-9
4452 5640 12 None -8912 18 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
983 5640 12 None -8912 18 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
CHEMBL20734 5640 12 None -8912 18 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
2470 8060 43 None -7079 15 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 8060 43 None -7079 15 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 8060 43 None -7079 15 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 8060 43 None -7079 15 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
216239 47615 74 None -15 9 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
2459 47615 74 None -15 9 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 47615 74 None -15 9 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
DB00398 47615 74 None -15 9 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
3760 97073 29 None -3 5 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1571863 97073 29 None -3 5 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
DB08943 97073 29 None -3 5 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
30323 125224 40 None -7 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL178 125224 40 None -7 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
DB00694 125224 40 None -7 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
135398735 270475 30 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 270475 30 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
5381226 270475 30 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 270475 30 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
DB01045 270475 30 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
176 823 54 None -16 21 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2157 823 54 None -16 21 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2566 823 54 None -16 21 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
CHEMBL633 823 54 None -16 21 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
DB01118 823 54 None -16 21 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2333 279489 72 None -25 13 Human 4.5 pAC50 = 4.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
318 279489 72 None -25 13 Human 4.5 pAC50 = 4.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 279489 72 None -25 13 Human 4.5 pAC50 = 4.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
DB12319 279489 72 None -25 13 Human 4.5 pAC50 = 4.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
1887 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
189562 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
71301 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
7246 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
9844194 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL2365658 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL3526436 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL434394 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
DB04861 5630 45 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
2585 1662 62 None 1 28 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 1662 62 None 1 28 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 1662 62 None 1 28 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 1662 62 None 1 28 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 1662 62 None 1 28 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
3149 26881 13 None -8 26 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1187011 26881 13 None -8 26 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
DB11594 26881 13 None -8 26 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
2601 8241 23 None -1023 14 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
443951 8241 23 None -1023 14 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
56 8241 23 None -1023 14 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL73151 8241 23 None -1023 14 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB13399 8241 23 None -1023 14 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
5311064 2816 32 None -3 5 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
534 2816 32 None -3 5 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
806 2816 32 None -3 5 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
CHEMBL493682 2816 32 None -3 5 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
150 5099 16 None -1174 13 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 5099 16 None -1174 13 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 5099 16 None -1174 13 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 5099 16 None -1174 13 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 5099 16 None -1174 13 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
2291 6470 51 None 10 6 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2561 6470 51 None 10 6 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
4932 6470 51 None 10 6 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL631 6470 51 None 10 6 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
DB01182 6470 51 None 10 6 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2464 7398 37 None -3 2 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
5253 7398 37 None -3 2 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
7297 7398 37 None -3 2 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
CHEMBL471 7398 37 None -3 2 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
DB00489 7398 37 None -3 2 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
1976 24250 34 None -72 12 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
4567 24250 34 None -72 12 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 24250 34 None -72 12 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
DB06152 24250 34 None -72 12 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
2176 6361 47 None 1 5 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
4828 6361 47 None 1 5 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
91 6361 47 None 1 5 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL500 6361 47 None 1 5 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
DB00960 6361 47 None 1 5 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
389 239896 36 None 1 10 Human 8.3 pAC50 = 8.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 10.1038/s41467-023-40064-9
44112 239896 36 None 1 10 Human 8.3 pAC50 = 8.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 10.1038/s41467-023-40064-9
CHEMBL357995 239896 36 None 1 10 Human 8.3 pAC50 = 8.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 10.1038/s41467-023-40064-9
DB08807 239896 36 None 1 10 Human 8.3 pAC50 = 8.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 10.1038/s41467-023-40064-9
9931954 25215 63 None -3 2 Human 4.4 pAC50 = 4.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1173055 25215 63 None -3 2 Human 4.4 pAC50 = 4.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
DB12332 25215 63 None -3 2 Human 4.4 pAC50 = 4.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
3486 6418 47 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
4883 6418 47 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
555 6418 47 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL6995 6418 47 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
DB01297 6418 47 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
25382 23462 27 None -141 21 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL110094 23462 27 None -141 21 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
DB13384 23462 27 None -141 21 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
36811 2998 34 None -123 14 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 2998 34 None -123 14 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 2998 34 None -123 14 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 2998 34 None -123 14 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 2998 34 None -123 14 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
16362 6358 55 None -616 31 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 6358 55 None -616 31 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 6358 55 None -616 31 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 6358 55 None -616 31 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 6358 55 None -616 31 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2318 310871 17 None -8 15 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL400599 310871 17 None -8 15 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
DB09022 310871 17 None -8 15 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
11504295 5953 40 None -338 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
4814 5953 40 None -338 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
7543 5953 40 None -338 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
CHEMBL605846 5953 40 None -338 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
DB09080 5953 40 None -338 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
2398 1965 48 None -89 25 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 1965 48 None -89 25 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 1965 48 None -89 25 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 1965 48 None -89 25 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 1965 48 None -89 25 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
1499 4274 42 None -4 4 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 4274 42 None -4 4 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 4274 42 None -4 4 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 4274 42 None -4 4 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 4274 42 None -4 4 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
137 765 35 None -5 7 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
2119 765 35 None -5 7 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
563 765 35 None -5 7 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
66368 765 35 None -5 7 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL266195 765 35 None -5 7 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00866 765 35 None -5 7 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
2027 389514 22 None -1 5 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
4631 389514 22 None -1 5 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 389514 22 None -1 5 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
DB01580 389514 22 None -1 5 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
123707 98133 32 None 1 12 Human 7.2 pAC50 = 7.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
2169 98133 32 None 1 12 Human 7.2 pAC50 = 7.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 98133 32 None 1 12 Human 7.2 pAC50 = 7.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
1155 3351 39 None -79 8 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 3351 39 None -79 8 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 3351 39 None -79 8 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 3351 39 None -79 8 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 3351 39 None -79 8 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
5329102 387203 55 None -54 37 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 387203 55 None -54 37 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
DB01268 387203 55 None -54 37 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
2249 1058 67 None 7 3 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
255 1058 67 None 7 3 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
548 1058 67 None 7 3 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL24 1058 67 None 7 3 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
DB00335 1058 67 None 7 3 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
9801 174427 27 None -17 16 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL24072 174427 27 None -17 16 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB04825 174427 27 None -17 16 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
135409453 8225 26 None -85 33 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 8225 26 None -85 33 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
2579 8225 26 None -85 33 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
5362436 8225 26 None -85 33 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 8225 26 None -85 33 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
DB01079 8225 26 None -85 33 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
242 971 74 None -63 29 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 971 74 None -63 29 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 971 74 None -63 29 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 971 74 None -63 29 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 971 74 None -63 29 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2663 199008 20 None 60 2 Human 7.1 pAC50 = 7.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 10.1038/s41467-023-40064-9
569 199008 20 None 60 2 Human 7.1 pAC50 = 7.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 10.1038/s41467-023-40064-9
CHEMBL27810 199008 20 None 60 2 Human 7.1 pAC50 = 7.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 10.1038/s41467-023-40064-9
DB04846 199008 20 None 60 2 Human 7.1 pAC50 = 7.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 10.1038/s41467-023-40064-9
2335 26122 15 None -9 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
3018 26122 15 None -9 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 26122 15 None -9 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
DB11125 26122 15 None -9 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
56959 65183 65 None -5 8 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 65183 65 None -5 8 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
DB00243 65183 65 None -5 8 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
2796 199133 56 None -15 11 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
5639 199133 56 None -15 11 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 199133 56 None -15 11 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
DB12661 199133 56 None -15 11 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
2351 18649 37 None -3 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 18649 37 None -3 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
DB01244 18649 37 None -3 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
11658860 4776 23 None -39 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
2941 4776 23 None -39 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
4374 4776 23 None -39 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
CHEMBL360328 4776 23 None -39 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
DB04871 4776 23 None -39 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
119607 473188 71 None 1 6 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
2799 473188 71 None 1 6 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL865 473188 71 None 1 6 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
DB00580 473188 71 None 1 6 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
2436 470362 35 None -23 24 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
68617 470362 35 None -23 24 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 470362 35 None -23 24 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
DB01104 470362 35 None -23 24 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
16363 1232 41 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
312 1232 41 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
9215 1232 41 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL297302 1232 41 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB12867 1232 41 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
1054 3263 41 None 31 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
59768 3263 41 None 31 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
7178 3263 41 None 31 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL768 3263 41 None 31 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00187 3263 41 None 31 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
275196 251180 36 None -26 5 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 4 0 8 2.9 COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C 10.1038/s41467-023-40064-9
CHEMBL364713 251180 36 None -26 5 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 4 0 8 2.9 COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C 10.1038/s41467-023-40064-9
DB06174 251180 36 None -26 5 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 4 0 8 2.9 COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C 10.1038/s41467-023-40064-9
156419 1933 51 None -12 14 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
3308 1933 51 None -12 14 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
647 1933 51 None -12 14 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1201284 1933 51 None -12 14 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
DB01012 1933 51 None -12 14 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
41684 64851 70 None -19 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 64851 70 None -19 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
DB00507 64851 70 None -19 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
1673 1981 14 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
5284371 1981 14 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
725 1981 14 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
CHEMBL485 1981 14 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
DB00318 1981 14 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
31101 1504 27 None -331 22 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 1504 27 None -331 22 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 1504 27 None -331 22 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 1504 27 None -331 22 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 1504 27 None -331 22 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
135564886 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
DB16024 38403 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
1028 599 43 None -204 9 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 599 43 None -204 9 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 599 43 None -204 9 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 599 43 None -204 9 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 599 43 None -204 9 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2405 1368 47 None 17 3 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
380 1368 47 None 17 3 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
7129 1368 47 None 17 3 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL645 1368 47 None 17 3 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
DB00612 1368 47 None 17 3 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
9849126 26707 0 None 3 4 Guinea pig 10.4 pEC50 = 10.4 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
CHEMBL1185969 26707 0 None 3 4 Guinea pig 10.4 pEC50 = 10.4 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
1499 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
3779 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
536 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
CHEMBL434 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
DB01064 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
1499 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
3779 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
536 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
CHEMBL434 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
DB01064 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
1499 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
3779 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
536 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
CHEMBL434 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
DB01064 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
1499 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
3779 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
536 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
CHEMBL434 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
DB01064 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
1499 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
3779 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
536 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
CHEMBL434 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
DB01064 4274 42 None 2 31 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
177641039 465244 0 None None None Human 10.0 pEC50 = 10.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 378 7 4 5 2.3 O=C1COc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070273 465244 0 None None None Human 10.0 pEC50 = 10.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 378 7 4 5 2.3 O=C1COc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177640581 465234 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 5 6 1.7 O=C1COc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070231 465234 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 5 6 1.7 O=C1COc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177641044 465264 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 5 6 1.7 O=C1COc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070455 465264 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 5 6 1.7 O=C1COc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
11268355 196741 0 None 1 3 Human 9.9 pEC50 = 9.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
CHEMBL26183 196741 0 None 1 3 Human 9.9 pEC50 = 9.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
177640004 465226 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 5 6 1.7 O=C1COc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070181 465226 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 5 6 1.7 O=C1COc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177640792 465196 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 360 7 4 5 2.1 O=C1COc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069944 465196 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 360 7 4 5 2.1 O=C1COc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177641048 465289 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 360 7 4 5 2.1 O=C1COc2c(C(O)CNCCCc3ccccc3F)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070679 465289 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 360 7 4 5 2.1 O=C1COc2c(C(O)CNCCCc3ccccc3F)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177640810 465262 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 372 8 4 6 2.0 COc1ccccc1CCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6070433 465262 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 372 8 4 6 2.0 COc1ccccc1CCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
177640798 465215 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 376 7 4 5 2.6 O=C1COc2c(C(O)CNCCCc3ccc(Cl)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070117 465215 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 376 7 4 5 2.6 O=C1COc2c(C(O)CNCCCc3ccc(Cl)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177640841 465129 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 7 4 5 2.3 Cc1cccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1021/acs.jmedchem.3c02074
CHEMBL6069070 465129 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 7 4 5 2.3 Cc1cccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1021/acs.jmedchem.3c02074
177640489 465254 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 360 7 4 5 2.1 O=C1COc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070374 465254 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 360 7 4 5 2.1 O=C1COc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177639998 465205 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 342 7 4 5 2.0 O=C1COc2c(C(O)CNCCCc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070012 465205 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 342 7 4 5 2.0 O=C1COc2c(C(O)CNCCCc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
69648727 465238 0 None -13 2 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 8 4 5 2.4 O=C1COc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070244 465238 0 None -13 2 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 8 4 5 2.4 O=C1COc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
1239 3447 41 None 2 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3410 3447 41 None 2 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3465 3447 41 None 2 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
CHEMBL1256786 3447 41 None 2 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
DB00983 3447 41 None 2 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
177640896 465240 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 7 4 5 2.3 Cc1ccccc1CCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6070256 465240 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 7 4 5 2.3 Cc1ccccc1CCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
177639954 465266 0 None None None Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 372 8 4 6 2.0 COc1cccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1021/acs.jmedchem.3c02074
CHEMBL6070486 465266 0 None None None Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 372 8 4 6 2.0 COc1cccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1021/acs.jmedchem.3c02074
177640418 465126 0 None -16 2 Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 410 7 4 5 3.0 O=C1COc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069056 465126 0 None -16 2 Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 410 7 4 5 3.0 O=C1COc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
69648731 465269 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 372 8 4 6 2.0 COc1ccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
CHEMBL6070493 465269 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 372 8 4 6 2.0 COc1ccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
24936881 41387 0 None 1 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1257913 41387 0 None 1 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
12065 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 10.1016/j.bmcl.2009.10.013
45483813 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 10.1016/j.bmcl.2009.10.013
CHEMBL579394 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 10.1016/j.bmcl.2009.10.013
164622827 371763 0 None -26 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028721 371763 0 None -26 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
177641031 465201 0 None None None Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 7 4 5 2.3 Cc1ccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
CHEMBL6069965 465201 0 None None None Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 356 7 4 5 2.3 Cc1ccc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
9891927 365841 9 None -5 4 Guinea pig 9.1 pEC50 = 9.1 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483201 365841 9 None -5 4 Guinea pig 9.1 pEC50 = 9.1 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
45483810 394238 1 None -3 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL567863 394238 1 None -3 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
123686 4050 42 None 74 3 Human 9.1 pEC50 = 9.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
12581 4050 42 None 74 3 Human 9.1 pEC50 = 9.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
CHEMBL11268 4050 42 None 74 3 Human 9.1 pEC50 = 9.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
1499 4274 42 None 2 31 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
3779 4274 42 None 2 31 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
536 4274 42 None 2 31 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
CHEMBL434 4274 42 None 2 31 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
DB01064 4274 42 None 2 31 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
164623105 371766 0 None -47 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028738 371766 0 None -47 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
13345218 394313 0 None -8 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 372 6 5 6 2.1 CC(C)(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL568272 394313 0 None -8 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 372 6 5 6 2.1 CC(C)(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44392175 259676 0 None 1 2 Human 9.1 pEC50 = 9.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 480 12 5 7 3.2 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2004.11.001
CHEMBL369346 259676 0 None 1 2 Human 9.1 pEC50 = 9.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 480 12 5 7 3.2 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2004.11.001
177640528 465115 0 None -32 2 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 342 6 4 5 1.9 Cc1ccccc1CCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6068972 465115 0 None -32 2 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 342 6 4 5 1.9 Cc1ccccc1CCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
1499 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
3779 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
536 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
CHEMBL434 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
DB01064 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
1499 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
3779 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
536 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
CHEMBL434 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
DB01064 4274 42 None 2 31 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
177640481 465231 0 None None None Human 9.0 pEC50 = 9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 292 4 4 5 1.3 O=C1COc2c(C(O)CNC3CCCC3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070223 465231 0 None None None Human 9.0 pEC50 = 9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 292 4 4 5 1.3 O=C1COc2c(C(O)CNC3CCCC3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177640332 465296 0 None None None Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 410 7 4 5 3.0 O=C1COc2c(C(O)CNCCCc3ccc(C(F)(F)F)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070795 465296 0 None None None Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 410 7 4 5 3.0 O=C1COc2c(C(O)CNCCCc3ccc(C(F)(F)F)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
1499 4274 42 None 2 31 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
3779 4274 42 None 2 31 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
536 4274 42 None 2 31 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
CHEMBL434 4274 42 None 2 31 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
DB01064 4274 42 None 2 31 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
44392230 137896 1 None 1 2 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 479 12 6 6 3.0 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc(C(=O)O)c1 10.1016/j.bmcl.2004.11.001
CHEMBL183283 137896 1 None 1 2 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 479 12 6 6 3.0 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc(C(=O)O)c1 10.1016/j.bmcl.2004.11.001
177640726 465195 0 None -58 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 264 4 4 5 0.5 O=C1COc2c(C(O)CNC3CC3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069933 465195 0 None -58 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 264 4 4 5 0.5 O=C1COc2c(C(O)CNC3CC3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177639808 465203 0 None -57 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 346 6 4 5 1.7 O=C1COc2c(C(O)CNCCc3cccc(F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069982 465203 0 None -57 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 346 6 4 5 1.7 O=C1COc2c(C(O)CNCCc3cccc(F)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
24822304 198165 0 None 6 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 412 9 3 5 4.1 O=C(O)c1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
CHEMBL272234 198165 0 None 6 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 412 9 3 5 4.1 O=C(O)c1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
105 7039 60 None -4 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
2083 7039 60 None -4 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
558 7039 60 None -4 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
CHEMBL714 7039 60 None -4 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
DB01001 7039 60 None -4 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
164615126 371708 0 None -104 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028293 371708 0 None -104 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
90645347 221997 0 None -7 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 12 6 7 5.6 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298987 221997 0 None -7 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 12 6 7 5.6 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
177640071 465249 0 None -29 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 432 10 4 8 2.0 COc1cc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc(OC)c1OC 10.1021/acs.jmedchem.3c02074
CHEMBL6070309 465249 0 None -29 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 432 10 4 8 2.0 COc1cc(CCCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc(OC)c1OC 10.1021/acs.jmedchem.3c02074
171037899 465186 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 4 6 1.6 COc1ccccc1CCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6069893 465186 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 4 6 1.6 COc1ccccc1CCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
177640169 465207 0 None -107 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 344 7 4 6 1.4 O=C1COc2c(C(O)CNCCOc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070033 465207 0 None -107 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 344 7 4 6 1.4 O=C1COc2c(C(O)CNCCOc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
164618895 371738 0 None -95 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028525 371738 0 None -95 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
1499 4274 42 None 2 31 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/acs.jmedchem.3c02074
3779 4274 42 None 2 31 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/acs.jmedchem.3c02074
536 4274 42 None 2 31 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/acs.jmedchem.3c02074
CHEMBL434 4274 42 None 2 31 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/acs.jmedchem.3c02074
DB01064 4274 42 None 2 31 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/acs.jmedchem.3c02074
45101519 408796 0 None -1 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL577917 408796 0 None -1 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
24936492 41419 0 None -1 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258026 41419 0 None -1 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
177640379 465210 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 266 4 4 5 0.8 CC(C)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6070071 465210 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 266 4 4 5 0.8 CC(C)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
164612078 371682 0 None -64 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028119 371682 0 None -64 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
9927453 197018 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL26393 197018 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
177640375 465191 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 328 6 4 5 1.6 O=C1COc2c(C(O)CNCCc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069904 465191 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 328 6 4 5 1.6 O=C1COc2c(C(O)CNCCc3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
42625513 26827 0 None -3 4 Guinea pig 8.7 pEC50 = 8.7 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
CHEMBL1186722 26827 0 None -3 4 Guinea pig 8.7 pEC50 = 8.7 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
90645346 221979 0 None -2 3 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 13 6 7 4.7 O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298762 221979 0 None -2 3 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 13 6 7 4.7 O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1 10.1016/j.bmcl.2014.04.095
177640239 465294 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 4 6 1.6 COc1cccc(CCNCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1021/acs.jmedchem.3c02074
CHEMBL6070774 465294 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 4 6 1.6 COc1cccc(CCNCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1021/acs.jmedchem.3c02074
42625517 26987 0 None -19 4 Guinea pig 8.0 pEC50 = 8 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187654 26987 0 None -19 4 Guinea pig 8.0 pEC50 = 8 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
11180293 221992 0 None -22 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 543 12 6 8 3.1 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
CHEMBL3298897 221992 0 None -22 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 543 12 6 8 3.1 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
56668796 138892 0 None -31 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 598 20 7 7 4.3 O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1 10.1016/j.bmc.2011.08.043
CHEMBL1852632 138892 0 None -31 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 598 20 7 7 4.3 O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1 10.1016/j.bmc.2011.08.043
45273268 391063 0 None 194 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 362 10 3 4 4.0 O[C@@H](CNCCc1ccc(Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL556274 391063 0 None 194 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 362 10 3 4 4.0 O[C@@H](CNCCc1ccc(Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10217757 221757 0 None -31 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 497 12 5 6 5.2 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290998 221757 0 None -31 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 497 12 5 6 5.2 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
164614147 371696 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028233 371696 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164618813 371737 0 None -275 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028523 371737 0 None -275 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
164619360 371741 0 None -371 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028547 371741 0 None -371 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
1155 3351 39 None -2 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1016/j.ejmech.2022.114961
3343 3351 39 None -2 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1016/j.ejmech.2022.114961
557 3351 39 None -2 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1016/j.ejmech.2022.114961
CHEMBL32800 3351 39 None -2 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1016/j.ejmech.2022.114961
DB01288 3351 39 None -2 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1016/j.ejmech.2022.114961
155774 8875 30 None 64 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
2848 8875 30 None 64 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
538 8875 30 None 64 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
CHEMBL75753 8875 30 None 64 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
DB13781 8875 30 None 64 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
10863093 103562 0 None -19 3 Human 7.0 pEC50 = 7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 439 10 4 6 2.1 C[C@H](CNc1ccc(CC(=O)NS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL157210 103562 0 None -19 3 Human 7.0 pEC50 = 7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 439 10 4 6 2.1 C[C@H](CNc1ccc(CC(=O)NS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
16049450 136425 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807827 136425 0 None -100 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
16049234 136426 0 None -158 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807828 136426 0 None -158 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049448 136427 0 None -63 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807829 136427 0 None -63 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049374 136431 0 None -79 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807869 136431 0 None -79 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
1499 4274 42 None 2 31 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
3779 4274 42 None 2 31 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
536 4274 42 None 2 31 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
CHEMBL434 4274 42 None 2 31 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
DB01064 4274 42 None 2 31 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
9888047 184174 0 None -398 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1cccc(-c2occc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245673 184174 0 None -398 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1cccc(-c2occc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441231 294745 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2csc(C(=O)O)n2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL393470 294745 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2csc(C(=O)O)n2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441235 297645 0 None -251 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1ccc(-c2sccc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL395834 297645 0 None -251 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1ccc(-c2sccc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
45271523 389873 0 None -10 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 10 4 4 4.4 Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550096 389873 0 None -10 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 10 4 4 4.4 Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
45272417 390283 0 None -1 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL552368 390283 0 None -1 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
42625823 26945 0 None -501 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 576 19 5 7 4.7 O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187371 26945 0 None -501 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 576 19 5 7 4.7 O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
46832804 21315 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm100326d
CHEMBL1084655 21315 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm100326d
10553603 199889 0 None 1 3 Human 7.0 pEC50 = 7 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 1.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(NC(=O)CC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL284612 199889 0 None 1 3 Human 7.0 pEC50 = 7 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 1.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(NC(=O)CC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
177640834 465108 0 None -758 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 362 6 4 5 2.2 O=C1COc2c(C(O)CNCCc3ccc(Cl)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6068908 465108 0 None -758 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 362 6 4 5 2.2 O=C1COc2c(C(O)CNCCc3ccc(Cl)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
42625517 26987 0 None -1995 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187654 26987 0 None -1995 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625588 354303 0 None -630 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 2.9 NS(=O)(=O)Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL475237 354303 0 None -630 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 2.9 NS(=O)(=O)Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
10121328 18786 0 None -100 3 Human 6.0 pEC50 = 6 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 593 11 5 10 1.4 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(C(=O)O)cn4)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL101606 18786 0 None -100 3 Human 6.0 pEC50 = 6 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 593 11 5 10 1.4 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(C(=O)O)cn4)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
11575154 158852 0 None -100000 2 Human 5.0 pEC50 = 5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1ccncc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
CHEMBL207943 158852 0 None -100000 2 Human 5.0 pEC50 = 5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1ccncc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
44237766 121029 0 None -10000 2 Rat 5.0 pEC50 = 5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 550 10 6 6 5.5 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1cccc(Oc2ccccc2)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682221 121029 0 None -10000 2 Rat 5.0 pEC50 = 5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 550 10 6 6 5.5 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1cccc(Oc2ccccc2)c1 10.1016/j.bmcl.2010.12.096
155517986 334765 0 None -478630 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 366 7 4 4 3.3 CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4445289 334765 0 None -478630 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 366 7 4 4 3.3 CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
164622775 371762 0 None -120226 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 428 10 4 7 2.5 COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
CHEMBL5028718 371762 0 None -120226 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 428 10 4 7 2.5 COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
44313150 213500 0 None -27 3 Human 5.0 pEC50 = 5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308868 213500 0 None -27 3 Human 5.0 pEC50 = 5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
1960 5823 49 None -741 15 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
439260 5823 49 None -741 15 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
505 5823 49 None -741 15 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
6921840 5823 49 None -741 15 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL1437 5823 49 None -741 15 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00368 5823 49 None -741 15 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
10301101 203010 0 None -1659 2 Human 4.0 pEC50 = 4 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 509 9 3 6 3.5 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL306423 203010 0 None -1659 2 Human 4.0 pEC50 = 4 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 509 9 3 6 3.5 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/s0960-894x(03)00387-1
145984792 330598 0 None -12882 3 Human 4.0 pEC50 = 4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 461 12 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)c3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4246134 330598 0 None -12882 3 Human 4.0 pEC50 = 4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 461 12 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)c3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
45483848 394234 0 None None None Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 394 7 3 3 5.3 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL567843 394234 0 None None None Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 394 7 3 3 5.3 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
11567751 449377 0 None -29 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 374 6 4 5 2.5 CC(C)(Cc1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600401 449377 0 None -29 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 374 6 4 5 2.5 CC(C)(Cc1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
10145482 18519 0 None -34 2 Human 6.0 pEC50 = 6 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 604 12 5 7 3.4 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL100057 18519 0 None -34 2 Human 6.0 pEC50 = 6 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 604 12 5 7 3.4 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
10281165 18761 0 None -16 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 560 11 5 7 3.3 O=C(Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1)NC1CCCCC1 10.1016/s0960-894x(02)00607-8
CHEMBL101485 18761 0 None -16 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 560 11 5 7 3.3 O=C(Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1)NC1CCCCC1 10.1016/s0960-894x(02)00607-8
11539348 449618 0 None -9 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 434 6 4 5 3.1 CC(C)(Cc1ccc(Br)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600616 449618 0 None -9 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 434 6 4 5 3.1 CC(C)(Cc1ccc(Br)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
44309649 469211 0 None -186 2 Human 5.0 pEC50 = 5.0 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 436 9 3 7 1.6 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL71348 469211 0 None -186 2 Human 5.0 pEC50 = 5.0 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 436 9 3 7 1.6 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(03)00387-1
3083544 57618 28 None -138 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
4943 57618 28 None -138 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
CHEMBL1363 57618 28 None -138 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
DB00983 57618 28 None -138 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
DB01274 57618 28 None -138 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
10280301 219297 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccc(F)cc1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL322973 219297 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccc(F)cc1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
177640476 465211 0 None -1258 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 306 4 4 5 1.7 O=C1COc2c(C(O)CNC3CCCCC3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070078 465211 0 None -1258 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 306 4 4 5 1.7 O=C1COc2c(C(O)CNC3CCCCC3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
10231394 332578 0 None -190 2 Human 5.0 pEC50 = 5.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 562 15 5 7 3.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL430662 332578 0 None -190 2 Human 5.0 pEC50 = 5.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 562 15 5 7 3.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
24823782 198343 0 None 3 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 396 8 3 4 4.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
CHEMBL273097 198343 0 None 3 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 396 8 3 4 4.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
45484646 394381 0 None -1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL568667 394381 0 None -1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
24894323 350425 0 None -52 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 468 12 4 5 5.2 CCCOc1cc(-c2ccc(NCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL459645 350425 0 None -52 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 468 12 4 5 5.2 CCCOc1cc(-c2ccc(NCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
155536813 336730 0 None -263 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4473790 336730 0 None -263 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
45270680 389583 0 None 5 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 421 10 4 4 4.1 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL549421 389583 0 None 5 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 421 10 4 4 4.1 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
45269853 393541 0 None -4 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL563872 393541 0 None -4 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
52943968 41662 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258824 41662 0 None 1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
16222840 391658 0 None -316 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 566 11 4 7 4.7 C[C@H](NCCc1ccc(-c2ccc(C(=O)NS(C)(=O)=O)c(OC3CCCCC3)c2)cc1)[C@H](O)c1ccc(O)cc1 10.1016/j.bmcl.2009.06.083
CHEMBL557253 391658 0 None -316 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 566 11 4 7 4.7 C[C@H](NCCc1ccc(-c2ccc(C(=O)NS(C)(=O)=O)c(OC3CCCCC3)c2)cc1)[C@H](O)c1ccc(O)cc1 10.1016/j.bmcl.2009.06.083
24895559 347214 0 None -338 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 483 12 3 5 5.4 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL452034 347214 0 None -338 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 483 12 3 5 5.4 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
105 7039 60 None -4 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
2083 7039 60 None -4 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
558 7039 60 None -4 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
CHEMBL714 7039 60 None -4 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
DB01001 7039 60 None -4 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
44377726 119616 0 None -389 2 Human 5.9 pEC50 = 5.9 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 550 10 5 10 1.6 CS(=O)(=O)Nc1cc(O[C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
CHEMBL164378 119616 0 None -389 2 Human 5.9 pEC50 = 5.9 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 550 10 5 10 1.6 CS(=O)(=O)Nc1cc(O[C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
1499 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
3779 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
536 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
CHEMBL434 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
DB01064 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
1499 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
3779 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
536 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
CHEMBL434 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
DB01064 4274 42 None 2 31 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
16223251 350426 0 None -204 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 11 4 6 3.9 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL459646 350426 0 None -204 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 11 4 6 3.9 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24895787 369958 0 None -1 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
CHEMBL488431 369958 0 None -1 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
44309272 468855 0 None -2 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 611 14 6 8 2.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL68766 468855 0 None -2 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 611 14 6 8 2.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(03)00387-1
44392181 138365 0 None -10 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccccc1NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183744 138365 0 None -10 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccccc1NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44441230 194204 0 None -7 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2csc(C(=O)O)n2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247518 194204 0 None -7 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2csc(C(=O)O)n2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
2687 7894 12 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
5387 7894 12 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
CHEMBL420746 7894 12 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
44441226 194085 0 None 1 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2nc(C(=O)O)co2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL246908 194085 0 None 1 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2nc(C(=O)O)co2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
1239 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
3410 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
3465 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
CHEMBL1256786 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
DB00983 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
90645345 221963 0 None -11 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 574 12 6 8 4.7 CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298692 221963 0 None -11 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 574 12 6 8 4.7 CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943485 221987 0 None -12 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 544 12 5 8 3.6 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
CHEMBL3298831 221987 0 None -12 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 544 12 5 8 3.6 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
46832798 38120 1 None -31 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O 10.1021/jm100326d
CHEMBL1198879 38120 1 None -31 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O 10.1021/jm100326d
46832509 38129 0 None -50 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 510 18 5 8 2.7 CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198908 38129 0 None -50 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 510 18 5 8 2.7 CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
46832232 38132 0 None -100 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 467 16 4 6 4.5 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O 10.1021/jm100326d
CHEMBL1198923 38132 0 None -100 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 467 16 4 6 4.5 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O 10.1021/jm100326d
1239 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3410 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3465 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
CHEMBL1256786 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
DB00983 3447 41 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
24895557 347213 0 None -575 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 12 3 5 5.2 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL452033 347213 0 None -575 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 12 3 5 5.2 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44392490 137543 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
CHEMBL182708 137543 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
44268327 198581 0 None 1 2 Human 5.9 pEC50 = 5.9 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
CHEMBL274807 198581 0 None 1 2 Human 5.9 pEC50 = 5.9 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
10575455 200158 1 None -60 3 Human 5.9 pEC50 = 5.9 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 448 8 5 7 1.2 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(N)=O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL286574 200158 1 None -60 3 Human 5.9 pEC50 = 5.9 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 448 8 5 7 1.2 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(N)=O)cc3)CC2)ccc1O 10.1021/jm000544b
11504295 5953 40 None -870 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
4814 5953 40 None -870 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
7543 5953 40 None -870 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
CHEMBL605846 5953 40 None -870 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
DB09080 5953 40 None -870 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
145982668 330776 0 None -15 3 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 418 11 3 4 4.1 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4250215 330776 0 None -15 3 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 418 11 3 4 4.1 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
2419 7043 56 None -1445 5 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
5152 7043 56 None -1445 5 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
559 7043 56 None -1445 5 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
CHEMBL1263 7043 56 None -1445 5 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
DB00938 7043 56 None -1445 5 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
53357711 136815 0 None -125 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 531 19 7 7 3.3 O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814279 136815 0 None -125 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 531 19 7 7 3.3 O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
56675511 138701 0 None -100 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1851850 138701 0 None -100 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
42625587 26966 0 None -125 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 562 18 4 7 4.3 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1 10.1021/jm801016j
CHEMBL1187520 26966 0 None -125 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 562 18 4 7 4.3 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1 10.1021/jm801016j
9845280 158958 0 None -7 3 Human 5.9 pEC50 = 5.9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 3 5 4.5 COC(=O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
CHEMBL208352 158958 0 None -7 3 Human 5.9 pEC50 = 5.9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 3 5 4.5 COC(=O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
23661589 193840 0 None -19952 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1cccc(-c2sccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245873 193840 0 None -19952 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1cccc(-c2sccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
10289065 26813 0 None -501 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625898 26813 0 None -501 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186683 26813 0 None -501 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL485847 26813 0 None -501 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625741 26867 0 None -158 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186940 26867 0 None -158 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
145983711 330265 0 None -2691 3 Human 4.9 pEC50 = 4.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 476 12 5 5 3.5 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4237802 330265 0 None -2691 3 Human 4.9 pEC50 = 4.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 476 12 5 5 3.5 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
24895265 369957 0 None -70 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
CHEMBL488430 369957 0 None -70 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
44392552 136843 0 None -23 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
CHEMBL181440 136843 0 None -23 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
155564340 349426 0 None -263 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 493 11 5 5 4.9 CC(CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)CC(C)(C)C 10.1016/j.bmc.2018.10.043
CHEMBL4576089 349426 0 None -263 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 493 11 5 5 4.9 CC(CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)CC(C)(C)C 10.1016/j.bmc.2018.10.043
44574826 352511 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1cn(Cc2ccccc2)cn1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467301 352511 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1cn(Cc2ccccc2)cn1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
45270697 389914 0 None -20 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550444 389914 0 None -20 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
44580039 370207 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O)c1ccccc1 10.1016/j.bmcl.2008.08.009
CHEMBL490222 370207 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O)c1ccccc1 10.1016/j.bmcl.2008.08.009
45271036 389990 0 None -2951 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL550871 389990 0 None -2951 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
24895363 347683 0 None -3162 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 11 3 4 5.3 CC(C)COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453322 347683 0 None -3162 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 11 3 4 5.3 CC(C)COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24895261 369929 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL488223 369929 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
42639967 26780 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 497 11 3 7 3.1 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186557 26780 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 497 11 3 7 3.1 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
44591506 353225 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL473495 353225 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
11152564 200194 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
CHEMBL286818 200194 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
44574651 352430 0 None None None Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 444 11 4 5 3.3 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466704 352430 0 None None None Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 444 11 4 5 3.3 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.bmc.2009.03.044
213051 183387 0 None -4 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL24350 183387 0 None -4 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
2723 123170 6 None -8 5 Human 7.9 pEC50 = 7.9 Functional
Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorCompound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptor
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
65772 123170 6 None -8 5 Human 7.9 pEC50 = 7.9 Functional
Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorCompound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptor
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL174984 123170 6 None -8 5 Human 7.9 pEC50 = 7.9 Functional
Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorCompound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptor
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
DB13692 123170 6 None -8 5 Human 7.9 pEC50 = 7.9 Functional
Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorCompound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptor
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
177640872 465182 0 None -457 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 266 5 4 5 0.8 CCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6069823 465182 0 None -457 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 266 5 4 5 0.8 CCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
164623433 371770 0 None -380 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028756 371770 0 None -380 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
9804536 330568 0 None -7 3 Human 7.8 pEC50 = 7.8 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 465 11 4 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
CHEMBL4245391 330568 0 None -7 3 Human 7.8 pEC50 = 7.8 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 465 11 4 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
44574825 352509 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nc2ccccc2n1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467298 352509 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nc2ccccc2n1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
45273276 391327 0 None -2 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL556689 391327 0 None -2 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
44579966 385169 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 429 9 3 4 4.8 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
CHEMBL521611 385169 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 429 9 3 4 4.8 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
24949572 350980 0 None -34 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)c1 10.1021/jm800222k
CHEMBL463182 350980 0 None -34 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)c1 10.1021/jm800222k
44565931 26713 0 None -4677 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 4 8 3.6 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL1186040 26713 0 None -4677 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 4 8 3.6 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1 10.1021/jm9000709
11381882 199514 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL282039 199514 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
155515718 334526 0 None -2884 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
CHEMBL4441752 334526 0 None -2884 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
24894317 347784 0 None -22 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 11 3 4 5.6 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453575 347784 0 None -22 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 11 3 4 5.6 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44392228 137176 0 None -7 2 Human 7.8 pEC50 = 7.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 441 11 5 5 3.1 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)NC1CCCCC1 10.1016/j.bmcl.2004.11.001
CHEMBL182127 137176 0 None -7 2 Human 7.8 pEC50 = 7.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 441 11 5 5 3.1 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)NC1CCCCC1 10.1016/j.bmcl.2004.11.001
1028 599 43 None -21 11 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
479 599 43 None -21 11 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
5816 599 43 None -21 11 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL679 599 43 None -21 11 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00668 599 43 None -21 11 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
155524038 335436 0 None -120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 414 8 4 4 4.2 O=c1ccc2c(C(O)CNCCCc3ccc(-c4ccccc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4454489 335436 0 None -120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 414 8 4 4 4.2 O=c1ccc2c(C(O)CNCCCc3ccc(-c4ccccc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
155550544 348365 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 388 7 4 4 3.6 O=c1ccc2c(C(O)CNCCCc3ccc4ccccc4c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4550290 348365 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 388 7 4 4 3.6 O=c1ccc2c(C(O)CNCCCc3ccc4ccccc4c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
44126933 392761 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561291 392761 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
45268516 392924 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 605 13 5 9 2.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL561743 392924 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 605 13 5 9 2.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
16222940 369742 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL487682 369742 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24895259 372432 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 528 12 5 7 3.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL512147 372432 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 528 12 5 7 3.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44591507 353251 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL473702 353251 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
9842600 371336 0 None -38 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 375 7 3 4 3.0 O=C(O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2 10.1021/jm800222k
CHEMBL498305 371336 0 None -38 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 375 7 3 4 3.0 O=C(O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2 10.1021/jm800222k
44377535 118244 0 None -117 2 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 508 8 4 9 2.8 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)Oc4cccc5nc(O)ccc45)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL161949 118244 0 None -117 2 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 508 8 4 9 2.8 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)Oc4cccc5nc(O)ccc45)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
56673609 136435 0 None -199 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807873 136435 0 None -199 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
56672116 138657 0 None -630 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 570 19 5 8 2.4 NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1851624 138657 0 None -630 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 570 19 5 8 2.4 NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
44441227 294740 0 None -10 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2nc(C(=O)O)co2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL393469 294740 0 None -10 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2nc(C(=O)O)co2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
145981079 331496 0 None -39 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3ccc(Cl)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4282047 331496 0 None -39 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3ccc(Cl)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
164626310 371791 0 None -346 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5028930 371791 0 None -346 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
177640957 465242 0 None -645 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 280 6 4 5 1.1 CCCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6070260 465242 0 None -645 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 280 6 4 5 1.1 CCCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
164614249 371698 0 None -295 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028241 371698 0 None -295 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
24949889 371374 0 None -35 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 451 7 3 4 5.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CCC3)c1 10.1021/jm800222k
CHEMBL498531 371374 0 None -35 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 451 7 3 4 5.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CCC3)c1 10.1021/jm800222k
42639311 26792 0 None -56 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 524 14 3 6 4.5 CCCCCOc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186600 26792 0 None -56 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 524 14 3 6 4.5 CCCCCOc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
44392558 137555 0 None -2 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
CHEMBL182770 137555 0 None -2 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
44237669 121025 0 None -7943 2 Rat 5.8 pEC50 = 5.8 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 540 9 6 5 4.7 O=C(NCc1c(Cl)cccc1Cl)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682217 121025 0 None -7943 2 Rat 5.8 pEC50 = 5.8 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 540 9 6 5 4.7 O=C(NCc1c(Cl)cccc1Cl)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
9933039 328052 0 None -28 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL417613 328052 0 None -28 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
9933039 328052 0 None -28 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL417613 328052 0 None -28 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
44309523 202279 0 None -52 3 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 420 10 3 6 2.3 CCCCOc1ccc(S(=O)(=O)N2CC(NC[C@H](O)c3ccc(O)cc3)C2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL302803 202279 0 None -52 3 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 420 10 3 6 2.3 CCCCOc1ccc(S(=O)(=O)N2CC(NC[C@H](O)c3ccc(O)cc3)C2)cc1 10.1016/s0960-894x(03)00387-1
10601234 221495 0 None -23 3 Human 5.8 pEC50 = 5.8 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 493 11 5 8 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(COCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL32888 221495 0 None -23 3 Human 5.8 pEC50 = 5.8 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 493 11 5 8 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(COCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
10140889 20396 0 None -4 2 Human 6.8 pEC50 = 6.8 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 484 12 4 6 3.3 CCN(CC)C(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL108061 20396 0 None -4 2 Human 6.8 pEC50 = 6.8 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 484 12 4 6 3.3 CCN(CC)C(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44574978 372426 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 524 12 2 6 4.0 O=C(Cc1nccn1Cc1ccccc1)N1CCCc2cc(CCNC[C@H](O)COc3ccccc3)ccc21 10.1016/j.bmc.2009.03.044
CHEMBL512099 372426 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 524 12 2 6 4.0 O=C(Cc1nccn1Cc1ccccc1)N1CCCc2cc(CCNC[C@H](O)COc3ccccc3)ccc21 10.1016/j.bmc.2009.03.044
24823464 197921 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL270964 197921 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm701324c
24823464 197921 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL270964 197921 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm9000709
44392457 330819 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
CHEMBL425161 330819 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
44127677 390222 0 None -2 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1ccc2ccccc2n1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL552089 390222 0 None -2 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1ccc2ccccc2n1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
567 1496 16 None -173 4 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(03)00073-8
9841972 1496 16 None -173 4 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(03)00073-8
CHEMBL284782 1496 16 None -173 4 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(03)00073-8
11703823 452093 0 None -131 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 390 6 4 5 3.0 CC(C)(Cc1ccc(Cl)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL603274 452093 0 None -131 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 390 6 4 5 3.0 CC(C)(Cc1ccc(Cl)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
24950234 349971 0 None -223 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 10 4 5 5.8 CCCNc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL458923 349971 0 None -223 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 10 4 5 5.8 CCCNc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
131487 19320 8 None None None Guinea pig 6.8 pEC50 = 6.8 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
CHEMBL10494 19320 8 None None None Guinea pig 6.8 pEC50 = 6.8 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
24822648 197910 0 None -28 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
CHEMBL270889 197910 0 None -28 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
45484558 393925 0 None -4 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL565770 393925 0 None -4 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
44574687 352434 0 None None None Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 406 11 3 6 2.2 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466713 352434 0 None None None Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 406 11 3 6 2.2 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1 10.1016/j.bmc.2009.03.044
44219629 352482 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1nccn1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467083 352482 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1nccn1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
44126931 390171 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 496 12 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL551831 390171 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 496 12 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
24895664 350656 0 None -251 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 12 3 4 5.8 CCCOc1cc(-c2ccc(CCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL459863 350656 0 None -251 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 12 3 4 5.8 CCCOc1cc(-c2ccc(CCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44396568 139569 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL188196 139569 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
9853471 469731 0 None -295 3 Human 5.8 pEC50 = 5.8 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL75604 469731 0 None -295 3 Human 5.8 pEC50 = 5.8 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
44331425 18793 0 None -186 3 Human 5.7 pEC50 = 5.7 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 576 13 6 8 2.5 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1016/s0960-894x(02)00608-x
CHEMBL101630 18793 0 None -186 3 Human 5.7 pEC50 = 5.7 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 576 13 6 8 2.5 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1016/s0960-894x(02)00608-x
45483838 394015 0 None -14 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 383 7 4 4 3.5 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
CHEMBL566352 394015 0 None -14 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 383 7 4 4 3.5 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
10302342 219344 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 538 14 5 6 4.5 O=C(NCCCC1CCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL323258 219344 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 538 14 5 6 4.5 O=C(NCCCC1CCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44396488 139018 0 None -14 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 556 12 4 7 3.8 C[C@H](Cc1c[nH]c2c(OCC(=O)N(C)C)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL185703 139018 0 None -14 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 556 12 4 7 3.8 C[C@H](Cc1c[nH]c2c(OCC(=O)N(C)C)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
9831168 469590 0 None 1 3 Human 7.7 pEC50 = 7.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL74085 469590 0 None 1 3 Human 7.7 pEC50 = 7.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
11005613 238515 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 12 4 5 4.3 Cc1ccc(S(=O)(=O)NCCc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL348269 238515 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 12 4 5 4.3 Cc1ccc(S(=O)(=O)NCCc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
44441234 194206 0 None -63 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1ccc(-c2occc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247520 194206 0 None -63 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1ccc(-c2occc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441228 332541 0 None -3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2nc(C(=O)O)cs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL430390 332541 0 None -3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2nc(C(=O)O)cs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
46832507 38131 0 None -12 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 475 17 6 7 2.8 NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198915 38131 0 None -12 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 475 17 6 7 2.8 NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
10203169 38153 0 None -25 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O 10.1021/jm100326d
CHEMBL1199300 38153 0 None -25 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O 10.1021/jm100326d
44574867 352484 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 562 13 3 6 4.4 O=C(Cc1nccn1Cc1ccc(Br)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467102 352484 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 562 13 3 6 4.4 O=C(Cc1nccn1Cc1ccc(Br)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
44579650 370406 0 None -15 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 10 4 6 3.4 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL492005 370406 0 None -15 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 10 4 6 3.4 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
44580041 385826 0 None -9 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(O)c1cc(NC(=O)c2ccccc2)cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1016/j.bmcl.2008.08.009
CHEMBL524145 385826 0 None -9 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(O)c1cc(NC(=O)c2ccccc2)cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1016/j.bmcl.2008.08.009
44127480 393530 0 None 6 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL563810 393530 0 None 6 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
44560793 372072 0 None -2951 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 11 3 5 4.5 CCCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL507506 372072 0 None -2951 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 11 3 5 4.5 CCCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
9873257 175899 15 None -147 3 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
CHEMBL22375 175899 15 None -147 3 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
155527926 335793 0 None -8709 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 451 11 5 5 3.9 CC(C)CCC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
CHEMBL4460095 335793 0 None -8709 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 451 11 5 5 3.9 CC(C)CCC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
164612026 368660 0 None -776 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assay
ChEMBL 237 4 3 4 1.3 CC(C)NC(CO)c1cc(F)c(N)c(C#N)c1 10.1021/acs.jmedchem.0c01195
CHEMBL4860455 368660 0 None -776 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assay
ChEMBL 237 4 3 4 1.3 CC(C)NC(CO)c1cc(F)c(N)c(C#N)c1 10.1021/acs.jmedchem.0c01195
56670092 136436 0 None -79 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807874 136436 0 None -79 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
56675509 136813 0 None -79 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814270 136813 0 None -79 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1016/j.bmc.2011.05.064
53357712 138699 0 None -251 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 5 7 3.9 CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1851848 138699 0 None -251 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 5 7 3.9 CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
56658244 138700 0 None -79 4 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
CHEMBL1851849 138700 0 None -79 4 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
9958539 203155 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
CHEMBL307647 203155 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
164615222 371709 0 None -91 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028301 371709 0 None -91 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
13121351 465259 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 280 3 4 5 1.1 CC(C)(C)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6070415 465259 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 280 3 4 5 1.1 CC(C)(C)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
164615492 371712 0 None -120 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028319 371712 0 None -120 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
177640293 465187 0 None -70 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 308 8 4 5 1.9 CCCCCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
CHEMBL6069894 465187 0 None -70 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 308 8 4 5 1.9 CCCCCCNCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1021/acs.jmedchem.3c02074
177640583 465235 0 None -165 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 4 6 1.6 COc1ccc(CCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
CHEMBL6070233 465235 0 None -165 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 358 7 4 6 1.6 COc1ccc(CCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
2388 18486 20 None -4 7 Guinea pig 8.7 pEC50 = 8.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
443372 18486 20 None -4 7 Guinea pig 8.7 pEC50 = 8.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
CHEMBL1160723 18486 20 None -4 7 Guinea pig 8.7 pEC50 = 8.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
44392215 137901 0 None 1 2 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183307 137901 0 None 1 2 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmcl.2004.11.001
177640576 465193 0 None -47 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 418 8 4 5 3.6 O=C1COc2c(C(O)CNCCC(c3ccccc3)c3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069914 465193 0 None -47 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 418 8 4 5 3.6 O=C1COc2c(C(O)CNCCC(c3ccccc3)c3ccccc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
5311116 4758 10 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
544 4758 10 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
CHEMBL207802 4758 10 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
56598832 179130 0 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348218 179130 0 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
164617772 371727 0 None -173 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028458 371727 0 None -173 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164611794 371679 0 None -131 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028104 371679 0 None -131 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
10289065 26813 0 None -1 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625898 26813 0 None -1 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186683 26813 0 None -1 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL485847 26813 0 None -1 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625511 27003 0 None -3 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
CHEMBL1187778 27003 0 None -3 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
90645344 221940 0 None -7 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN 10.1016/j.bmcl.2014.04.095
CHEMBL3298324 221940 0 None -7 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN 10.1016/j.bmcl.2014.04.095
10239722 221942 0 None -11 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298326 221942 0 None -11 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1 10.1016/j.bmcl.2014.04.095
164621302 371753 0 None -120 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028641 371753 0 None -120 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
164610792 371672 0 None -134 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028040 371672 0 None -134 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
145984584 330749 0 None -5 3 Human 8.5 pEC50 = 8.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 444 10 5 4 4.4 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4249564 330749 0 None -5 3 Human 8.5 pEC50 = 8.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 444 10 5 4 4.4 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
24822643 313548 0 None -4 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(F)c1 10.1021/jm701324c
CHEMBL408145 313548 0 None -4 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(F)c1 10.1021/jm701324c
44392212 333069 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL434524 333069 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
45271492 389996 0 None 16 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 390 10 3 4 3.5 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL550906 389996 0 None 16 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 390 10 3 4 3.5 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
10113837 137869 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 435 11 5 5 3.3 O=C(Nc1ccccc1)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183129 137869 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 435 11 5 5 3.3 O=C(Nc1ccccc1)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44396531 139122 0 None -38 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL186135 139122 0 None -38 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
24822469 198080 0 None -26 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 401 8 3 4 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)s1 10.1021/jm701324c
CHEMBL271765 198080 0 None -26 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 401 8 3 4 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)s1 10.1021/jm701324c
24950568 372877 0 None -234 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc1 10.1021/jm800222k
CHEMBL516002 372877 0 None -234 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc1 10.1021/jm800222k
11625493 449019 1 None -12 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 8 4 6 2.8 CCOc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL600007 449019 1 None -12 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 8 4 6 2.8 CCOc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
44565908 370375 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 512 11 4 8 2.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL491726 370375 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 512 11 4 8 2.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
10139127 120285 0 None -50 2 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 455 9 3 7 2.6 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccccc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL165893 120285 0 None -50 2 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 455 9 3 7 2.6 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccccc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
44589133 349823 0 None -2 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 354 8 2 4 3.4 CC(C)NCC(O)COc1ccc2c(c1)CCCN2Cc1ccccc1 10.1016/j.bmc.2008.11.030
CHEMBL458541 349823 0 None -2 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 354 8 2 4 3.4 CC(C)NCC(O)COc1ccc2c(c1)CCCN2Cc1ccccc1 10.1016/j.bmc.2008.11.030
10145446 18532 0 None -102 2 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 602 14 5 8 3.6 O=C(NCCCc1cccs1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL100124 18532 0 None -102 2 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 602 14 5 8 3.6 O=C(NCCCc1cccs1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
46232816 450765 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL601858 450765 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
11632691 463840 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL605372 463840 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
44377523 119039 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 509 9 3 8 1.0 O=C1N=c2cccc(OC[C@@H](O)CNC3CCN(c4ccc(CC5SC(=O)NC5=O)cc4)CC3)c2=N1 10.1016/s0960-894x(01)00063-4
CHEMBL162711 119039 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 509 9 3 8 1.0 O=C1N=c2cccc(OC[C@@H](O)CNC3CCN(c4ccc(CC5SC(=O)NC5=O)cc4)CC3)c2=N1 10.1016/s0960-894x(01)00063-4
9933039 328052 0 None -28 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL417613 328052 0 None -28 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
24895563 350698 0 None -173 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 12 3 5 4.5 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL460256 350698 0 None -173 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 12 3 5 4.5 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
11668125 451138 0 None -4 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL602258 451138 0 None -4 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
155536314 336700 0 None -6025 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4473515 336700 0 None -6025 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
24895789 372043 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 375 8 3 3 4.3 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
CHEMBL507003 372043 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 375 8 3 3 4.3 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
44396715 139734 0 None -20 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL189081 139734 0 None -20 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
155551006 348015 0 None -44 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
CHEMBL4541169 348015 0 None -44 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
164620585 371747 0 None -616 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028602 371747 0 None -616 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
56598833 179129 0 None 436 3 Human 7.6 pEC50 = 7.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
CHEMBL2348217 179129 0 None 436 3 Human 7.6 pEC50 = 7.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
42639314 26838 0 None -575 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 550 11 3 6 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCCC1 10.1021/jm9000709
CHEMBL1186804 26838 0 None -575 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 550 11 3 6 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCCC1 10.1021/jm9000709
2388 18486 20 None -4 7 Guinea pig 5.7 pEC50 = 5.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
443372 18486 20 None -4 7 Guinea pig 5.7 pEC50 = 5.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
CHEMBL1160723 18486 20 None -4 7 Guinea pig 5.7 pEC50 = 5.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
145983266 330405 0 None -66 3 Human 6.7 pEC50 = 6.7 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 512 14 5 6 2.7 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4241176 330405 0 None -66 3 Human 6.7 pEC50 = 6.7 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 512 14 5 6 2.7 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
319 7908 34 None -2290 5 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
444031 7908 34 None -2290 5 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
784 7908 34 None -2290 5 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
CHEMBL1346 7908 34 None -2290 5 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
155543518 349026 0 None -794 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 457 9 5 5 3.7 O=C(Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)c1ccccc1 10.1016/j.bmc.2018.10.043
CHEMBL4566727 349026 0 None -794 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 457 9 5 5 3.7 O=C(Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)c1ccccc1 10.1016/j.bmc.2018.10.043
45101521 393918 0 None -4 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 570 15 8 9 1.3 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C(N)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL565747 393918 0 None -4 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 570 15 8 9 1.3 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C(N)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
44560794 347594 0 None -346 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 474 10 3 5 5.4 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
CHEMBL453056 347594 0 None -346 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 474 10 3 5 5.4 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
164623230 371769 0 None -1479 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028744 371769 0 None -1479 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
44579940 374940 0 None -37 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc(C(=O)O)c1 10.1016/j.bmcl.2008.08.009
CHEMBL519985 374940 0 None -37 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc(C(=O)O)c1 10.1016/j.bmcl.2008.08.009
46232857 449376 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600400 449376 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
42639654 26906 0 None -1258 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 513 11 3 7 3.8 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1187156 26906 0 None -1258 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 513 11 3 7 3.8 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
164615990 368597 0 None -831 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassayAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassay
ChEMBL 427 9 5 6 1.6 CN(C)C(=O)CNc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2 10.1021/acs.jmedchem.0c01195
CHEMBL4859326 368597 0 None -831 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassayAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassay
ChEMBL 427 9 5 6 1.6 CN(C)C(=O)CNc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2 10.1021/acs.jmedchem.0c01195
9832011 215174 0 None -151 3 Human 5.6 pEC50 = 5.6 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL312074 215174 0 None -151 3 Human 5.6 pEC50 = 5.6 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
11091850 100497 0 None -25 3 Human 7.6 pEC50 = 7.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 465 11 4 4 4.6 Cc1ccc(CNC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL154370 100497 0 None -25 3 Human 7.6 pEC50 = 7.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 465 11 4 4 4.6 Cc1ccc(CNC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
44441232 194205 0 None -19 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2ocnc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247519 194205 0 None -19 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2ocnc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
9892481 142479 12 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.095
CHEMBL1940832 142479 12 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.095
9849126 26707 0 None -630 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
CHEMBL1185969 26707 0 None -630 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
9892481 142479 12 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
CHEMBL1940832 142479 12 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
44574720 352463 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 11 4 5 4.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c4ccccc4c23)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466923 352463 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 11 4 5 4.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c4ccccc4c23)cc1 10.1016/j.bmc.2009.03.044
49861320 117807 0 None -6 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1615579 117807 0 None -6 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
10048077 198194 15 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL272383 198194 15 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
44574757 352398 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 511 14 3 6 4.4 O=C(Cc1cccc(OCc2ccccc2)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466467 352398 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 511 14 3 6 4.4 O=C(Cc1cccc(OCc2ccccc2)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
10048077 198194 15 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL272383 198194 15 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
11003341 99569 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL153558 99569 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
56658246 136814 0 None -1258 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814277 136814 0 None -1258 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
11003341 99569 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL153558 99569 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
2419 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
5152 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
559 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
CHEMBL1263 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
DB00938 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
42625511 27003 0 None -316 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
CHEMBL1187778 27003 0 None -316 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
2419 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
5152 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
559 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
CHEMBL1263 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
DB00938 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
2419 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
5152 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
559 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
CHEMBL1263 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
DB00938 7043 56 None -1445 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
10180590 142477 0 None -707 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
CHEMBL1940830 142477 0 None -707 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
10202462 142478 0 None -223 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
CHEMBL1940831 142478 0 None -223 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
11669967 158174 0 None -12589 2 Human 5.6 pEC50 = 5.6 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 468 10 5 5 4.5 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL206002 158174 0 None -12589 2 Human 5.6 pEC50 = 5.6 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 468 10 5 5 4.5 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
45375919 394110 0 None -87 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL566973 394110 0 None -87 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
10232096 217298 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 586 12 5 6 5.1 O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL319041 217298 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 586 12 5 6 5.1 O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44396530 139375 0 None -23 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL187317 139375 0 None -23 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
44396798 333976 0 None -56 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL442225 333976 0 None -56 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
45483846 393902 0 None -1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL565685 393902 0 None -1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44574868 352485 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nccn1Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467103 352485 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nccn1Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24823131 197708 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1Cl 10.1021/jm701324c
CHEMBL269823 197708 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1Cl 10.1021/jm701324c
24823294 314922 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
CHEMBL409718 314922 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
44127374 392915 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccncc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561693 392915 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccncc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24823294 314922 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL409718 314922 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
11420551 26787 0 None -436 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 4 6 3.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186589 26787 0 None -436 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 4 6 3.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
24823294 314922 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL409718 314922 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
1028 599 43 None -21 11 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 599 43 None -21 11 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 599 43 None -21 11 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 599 43 None -21 11 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 599 43 None -21 11 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
10119515 217999 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL319840 217999 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
11758172 201076 0 None -371 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL293994 201076 0 None -371 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
44336319 20693 0 None -524 2 Human 5.6 pEC50 = 5.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 617 12 6 7 3.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
CHEMBL108214 20693 0 None -524 2 Human 5.6 pEC50 = 5.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 617 12 6 7 3.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
46232973 449619 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccccc1C(F)(F)F)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600617 449619 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccccc1C(F)(F)F)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
44392255 330823 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 11 5 5 2.1 CC(C)NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL425173 330823 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 11 5 5 2.1 CC(C)NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44574827 352543 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 518 13 3 6 4.3 O=C(Cc1nccn1Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467502 352543 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 518 13 3 6 4.3 O=C(Cc1nccn1Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24950401 350979 0 None -147 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 481 8 3 6 4.5 CN(C)c1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL463181 350979 0 None -147 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 481 8 3 6 4.5 CN(C)c1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
44127171 352431 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL466705 352431 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
10722793 232396 0 None -630 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL331744 232396 0 None -630 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
9871800 119287 0 None -269 3 Human 5.6 pEC50 = 5.6 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 534 9 5 9 2.0 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
CHEMBL163262 119287 0 None -269 3 Human 5.6 pEC50 = 5.6 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 534 9 5 9 2.0 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
46232974 442974 11 None -27 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NC[C@@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL600817 442974 11 None -27 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NC[C@@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
46233013 462578 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
CHEMBL604125 462578 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
45484538 38017 0 None -2 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL1197779 38017 0 None -2 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
44579651 370407 0 None -14 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.1 C[C@H](Cc1cccc(Oc2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.08.009
CHEMBL492006 370407 0 None -14 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.1 C[C@H](Cc1cccc(Oc2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.08.009
24894202 372184 0 None -676 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 473 10 3 4 6.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
CHEMBL509156 372184 0 None -676 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 473 10 3 4 6.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
44574688 352401 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 461 11 5 6 2.0 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466519 352401 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 461 11 5 6 2.0 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1016/j.bmc.2009.03.044
44574722 352465 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 433 11 3 5 3.5 Cc1cc(C)nc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.03.044
CHEMBL466925 352465 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 433 11 3 5 3.5 Cc1cc(C)nc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.03.044
44219630 352486 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 2 6 3.7 CN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467116 352486 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 2 6 3.7 CN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24822310 198044 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL271576 198044 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
24822310 198044 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1016/j.bmcl.2008.08.009
CHEMBL271576 198044 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1016/j.bmcl.2008.08.009
44127054 390060 0 None 6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL551350 390060 0 None 6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/j.ejmech.2009.01.022
24822310 198044 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm800222k
CHEMBL271576 198044 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm800222k
24895365 347684 0 None -309 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 10 3 4 5.5 CC(C)Oc1cc(-c2ccc(CC(C)(C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453323 347684 0 None -309 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 10 3 4 5.5 CC(C)Oc1cc(-c2ccc(CC(C)(C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
10298968 120302 0 None -239 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 471 9 4 8 2.3 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccc(O)cc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL166085 120302 0 None -239 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 471 9 4 8 2.3 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccc(O)cc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
44396596 251381 0 None -25 3 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL361505 251381 0 None -25 3 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
44396521 251752 0 None -6 2 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 514 12 5 7 3.6 C[C@H](Cc1c[nH]c2c(OCCN)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL362136 251752 0 None -6 2 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 514 12 5 7 3.6 C[C@H](Cc1c[nH]c2c(OCCN)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
2419 7043 56 None -1445 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.3c02074
5152 7043 56 None -1445 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.3c02074
559 7043 56 None -1445 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.3c02074
CHEMBL1263 7043 56 None -1445 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.3c02074
DB00938 7043 56 None -1445 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.3c02074
44127171 352431 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466705 352431 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.bmc.2009.03.044
1028 599 43 None -15 11 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
479 599 43 None -15 11 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
5816 599 43 None -15 11 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
CHEMBL679 599 43 None -15 11 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
DB00668 599 43 None -15 11 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
45101537 390048 0 None -1819 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL551272 390048 0 None -1819 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
45483830 394095 0 None -14 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 329 7 4 4 2.8 Cc1ccccc1CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
CHEMBL566777 394095 0 None -14 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 329 7 4 4 2.8 Cc1ccccc1CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
44237720 121028 0 None -91 2 Rat 6.5 pEC50 = 6.5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 530 9 6 5 4.4 O=C(NCC12CC3CC(CC(C3)C1)C2)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682220 121028 0 None -91 2 Rat 6.5 pEC50 = 6.5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 530 9 6 5 4.4 O=C(NCC12CC3CC(CC(C3)C1)C2)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
145983355 330667 0 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 454 12 3 5 3.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NS(=O)(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4248093 330667 0 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 454 12 3 5 3.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NS(=O)(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
44268273 197402 0 None 17 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nMAgonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nM
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
CHEMBL267306 197402 0 None 17 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nMAgonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nM
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
44392190 137883 0 None 4 2 Human 8.5 pEC50 = 8.5 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 421 10 5 5 3.2 O=C(Nc1ccccc1)Nc1ccc(C[C@H](O)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183211 137883 0 None 4 2 Human 8.5 pEC50 = 8.5 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 421 10 5 5 3.2 O=C(Nc1ccccc1)Nc1ccc(C[C@H](O)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
9896742 469811 0 None 12 3 Human 8.5 pEC50 = 8.5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmCompound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nm
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL76403 469811 0 None 12 3 Human 8.5 pEC50 = 8.5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmCompound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nm
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
66653268 179113 0 None 3311 3 Human 8.5 pEC50 = 8.5 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
CHEMBL2348201 179113 0 None 3311 3 Human 8.5 pEC50 = 8.5 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
164622954 371765 0 None -245 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028726 371765 0 None -245 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164624634 371782 0 None -131 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028836 371782 0 None -131 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
24822971 195816 0 None 3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2Cl)cc1 10.1021/jm701324c
CHEMBL257106 195816 0 None 3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2Cl)cc1 10.1021/jm701324c
11134054 100251 0 None -2 3 Human 8.5 pEC50 = 8.5 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 444 10 4 6 4.1 C[C@H](CNc1ccc(CC(=O)Nc2nccs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154150 100251 0 None -2 3 Human 8.5 pEC50 = 8.5 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 444 10 4 6 4.1 C[C@H](CNc1ccc(CC(=O)Nc2nccs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
1499 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
1499 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
3779 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
3779 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
536 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
536 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
CHEMBL434 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
CHEMBL434 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
DB01064 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
DB01064 4274 42 None 2 31 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
45484583 408587 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL577702 408587 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
45484585 38018 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL1197807 38018 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
24936626 41281 0 None -173 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257555 41281 0 None -173 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
45483814 394360 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL568531 394360 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44392212 333069 0 None 12 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL434524 333069 0 None 12 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
56597179 179131 0 None 2754 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348219 179131 0 None 2754 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
45483868 394314 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL568273 394314 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
45483864 424631 0 None -9 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL584498 424631 0 None -9 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
177640936 465149 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 346 6 4 5 1.7 O=C1COc2c(C(O)CNCCc3ccc(F)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6069307 465149 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 346 6 4 5 1.7 O=C1COc2c(C(O)CNCCc3ccc(F)cc3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
177640579 465232 0 None -138 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 362 6 4 5 2.2 O=C1COc2c(C(O)CNCCc3cccc(Cl)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070225 465232 0 None -138 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 362 6 4 5 2.2 O=C1COc2c(C(O)CNCCc3cccc(Cl)c3)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
24823624 315014 0 None 1 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL409827 315014 0 None 1 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
16049028 136417 0 None -50 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807819 136417 0 None -50 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
11592062 221941 0 None -25 3 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1 10.1016/j.bmcl.2014.04.095
CHEMBL3298325 221941 0 None -25 3 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1 10.1016/j.bmcl.2014.04.095
24822645 195860 0 None -15 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(Cl)c1 10.1021/jm701324c
CHEMBL257297 195860 0 None -15 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(Cl)c1 10.1021/jm701324c
45269866 390068 0 None 1 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL551389 390068 0 None 1 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
45269025 392682 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 500 11 5 6 2.7 NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL561173 392682 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 500 11 5 6 2.7 NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
45267257 393722 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 449 12 4 4 3.8 O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL564648 393722 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 449 12 4 4 3.8 O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10283146 216906 0 None -2 3 Human 7.5 pEC50 = 7.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL317003 216906 0 None -2 3 Human 7.5 pEC50 = 7.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
1960 5823 49 None -741 15 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
439260 5823 49 None -741 15 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
505 5823 49 None -741 15 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
6921840 5823 49 None -741 15 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL1437 5823 49 None -741 15 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00368 5823 49 None -741 15 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
164623583 371773 0 None -316 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028767 371773 0 None -316 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
24822970 314000 0 None -9 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 9 3 3 4.5 O=C(O)Cc1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL408694 314000 0 None -9 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 9 3 3 4.5 O=C(O)Cc1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
11224220 347085 0 None -2137 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 431 10 3 3 5.5 CC(C)Cc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL451760 347085 0 None -2137 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 431 10 3 3 5.5 CC(C)Cc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
172745 200298 2 None 234 2 Guinea pig 6.5 pEC50 = 6.5 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 200298 2 None 234 2 Guinea pig 6.5 pEC50 = 6.5 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
44268268 42512 1 None -234 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
CHEMBL12769 42512 1 None -234 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
172462257 389030 0 None -2 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 459 10 2 5 5.0 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCCC(c3ccccc3)c3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5430355 389030 0 None -2 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 459 10 2 5 5.0 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCCC(c3ccccc3)c3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
172446785 387485 0 None -2 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 389 11 2 3 4.8 CCc1ccccc1OC[C@@H](O)CNCCC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2022.114961
CHEMBL5397120 387485 0 None -2 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 389 11 2 3 4.8 CCc1ccccc1OC[C@@H](O)CNCCC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2022.114961
16049377 136430 0 None -63 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807832 136430 0 None -63 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
56665368 138751 0 None -31 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852119 138751 0 None -31 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
56672271 138831 0 None -125 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 19 7 7 2.7 NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852407 138831 0 None -125 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 19 7 7 2.7 NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
56672269 138877 0 None -50 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 515 19 6 6 3.9 CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852564 138877 0 None -50 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 515 19 6 6 3.9 CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
56658405 138878 0 None -63 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1852565 138878 0 None -63 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.08.043
46832505 38150 1 None -12 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 417 16 4 6 3.3 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O 10.1021/jm100326d
CHEMBL1199261 38150 1 None -12 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 417 16 4 6 3.3 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O 10.1021/jm100326d
46889854 21628 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086077 21628 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
24949728 349254 0 None -436 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 479 8 3 4 5.7 CC(C)Oc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
CHEMBL457199 349254 0 None -436 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 479 8 3 4 5.7 CC(C)Oc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
44127679 390304 0 None -37 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 422 11 4 7 1.9 O=C(Cc1cnccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL552497 390304 0 None -37 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 422 11 4 7 1.9 O=C(Cc1cnccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
172454272 388351 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 359 7 2 7 1.6 O[C@@H](CNCC1COc2ccccc2O1)COc1ccc2c(c1)OCO2 10.1016/j.ejmech.2022.114961
CHEMBL5415148 388351 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 359 7 2 7 1.6 O[C@@H](CNCC1COc2ccccc2O1)COc1ccc2c(c1)OCO2 10.1016/j.ejmech.2022.114961
9891927 365841 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483201 365841 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
9891927 365841 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL483201 365841 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
44331302 475154 0 None -630 3 Human 5.5 pEC50 = 5.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 667 12 6 8 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL99219 475154 0 None -630 3 Human 5.5 pEC50 = 5.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 667 12 6 8 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
11661536 157635 0 None -50 3 Human 5.5 pEC50 = 5.5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cncc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
CHEMBL205389 157635 0 None -50 3 Human 5.5 pEC50 = 5.5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cncc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
145987415 332040 0 None -1258 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3cccc(Cl)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4292648 332040 0 None -1258 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3cccc(Cl)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
24895192 372969 0 None -151 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 437 10 3 4 4.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(F)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL516804 372969 0 None -151 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 437 10 3 4 4.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(F)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
42639969 26840 0 None -1584 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 496 11 4 7 3.1 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186809 26840 0 None -1584 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 496 11 4 7 3.1 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
16118894 4572 6 None -199 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
3467 4572 6 None -199 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
CHEMBL276257 4572 6 None -199 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
45483815 408174 0 None -11 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1ccc(C(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL577289 408174 0 None -11 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1ccc(C(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
11504295 5953 40 None -870 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1021/acs.jmedchem.3c02074
4814 5953 40 None -870 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1021/acs.jmedchem.3c02074
7543 5953 40 None -870 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1021/acs.jmedchem.3c02074
CHEMBL605846 5953 40 None -870 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1021/acs.jmedchem.3c02074
DB09080 5953 40 None -870 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1021/acs.jmedchem.3c02074
44574721 352464 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 419 11 3 5 3.1 Cc1cccnc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466924 352464 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 419 11 3 5 3.1 Cc1cccnc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24950238 348984 0 None -69 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 437 7 3 4 5.0 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm800222k
CHEMBL456578 348984 0 None -69 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 437 7 3 4 5.0 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm800222k
45270697 389914 0 None -20 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550444 389914 0 None -20 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
24949568 372801 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 536 9 4 6 5.6 O=C(O)c1cc(NC2CCOCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
CHEMBL515349 372801 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 536 9 4 6 5.6 O=C(O)c1cc(NC2CCOCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
10075383 197425 0 None -436 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL267545 197425 0 None -436 2 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
46232768 432532 0 None -14 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL592879 432532 0 None -14 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
164624092 371778 0 None -794 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 442 10 4 7 2.9 COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
CHEMBL5028807 371778 0 None -794 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 442 10 4 7 2.9 COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
145986105 330253 0 None -25 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 429 10 4 4 4.0 O=C(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
CHEMBL4237453 330253 0 None -25 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 429 10 4 4 4.0 O=C(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
44219641 352353 0 None -5 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
CHEMBL466088 352353 0 None -5 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
24822815 198241 0 None -588 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 467 11 3 4 5.6 CC(C)COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL272583 198241 0 None -588 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 467 11 3 4 5.6 CC(C)COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
44127678 393085 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1cc2ccccc2cn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL562153 393085 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1cc2ccccc2cn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
1960 5823 49 None -741 15 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 5823 49 None -741 15 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 5823 49 None -741 15 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
6921840 5823 49 None -741 15 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 5823 49 None -741 15 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 5823 49 None -741 15 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
10275157 19713 0 None -7 2 Human 6.5 pEC50 = 6.5 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 442 10 5 6 2.2 CNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107012 19713 0 None -7 2 Human 6.5 pEC50 = 6.5 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 442 10 5 6 2.2 CNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
10283539 332625 0 None -354 3 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
CHEMBL431048 332625 0 None -354 3 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
9800339 443169 9 None -251 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL603271 443169 9 None -251 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
24823626 198344 0 None -6 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1cccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c1 10.1021/jm701324c
CHEMBL273098 198344 0 None -6 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1cccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c1 10.1021/jm701324c
155557083 348588 0 None -724 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4556022 348588 0 None -724 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
145982607 330589 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 432 12 3 4 4.0 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)Cc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4245968 330589 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 432 12 3 4 4.0 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)Cc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
24949566 348903 1 None -281 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 8 4 5 5.0 CC(=O)Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL456353 348903 1 None -281 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 8 4 5 5.0 CC(=O)Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
1862 329 10 None None None Guinea pig 4.4 pEC50 = 4.4 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
510 329 10 None None None Guinea pig 4.4 pEC50 = 4.4 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
CHEMBL281232 329 10 None None None Guinea pig 4.4 pEC50 = 4.4 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
24824079 27156 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 441 11 3 5 4.5 O=C(O)COc1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL1188934 27156 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 441 11 3 5 4.5 O=C(O)COc1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
24895357 369567 0 None -194 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 10 3 4 5.7 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL487443 369567 0 None -194 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 10 3 4 5.7 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
42639965 26984 0 None -691 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 534 11 3 5 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1CC1CCCCC1 10.1021/jm9000709
CHEMBL1187643 26984 0 None -691 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 534 11 3 5 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1CC1CCCCC1 10.1021/jm9000709
44457929 175734 0 None -58 2 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
CHEMBL22318 175734 0 None -58 2 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
2419 7043 56 None -1445 5 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
5152 7043 56 None -1445 5 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
559 7043 56 None -1445 5 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
CHEMBL1263 7043 56 None -1445 5 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
DB00938 7043 56 None -1445 5 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
24823130 198007 0 None -38 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1F 10.1021/jm701324c
CHEMBL271367 198007 0 None -38 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1F 10.1021/jm701324c
44580011 370063 0 None -52 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL489200 370063 0 None -52 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
10028830 7965 32 None -79 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2022.114961
13196 7965 32 None -79 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2022.114961
CHEMBL4238084 7965 32 None -79 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2022.114961
9997789 369573 1 None -107 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at beta1 adrenoceptor (unknown origin)Agonist activity at beta1 adrenoceptor (unknown origin)
ChEMBL 310 3 3 3 3.4 CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1 10.1021/acs.jmedchem.0c01195
CHEMBL4874511 369573 1 None -107 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at beta1 adrenoceptor (unknown origin)Agonist activity at beta1 adrenoceptor (unknown origin)
ChEMBL 310 3 3 3 3.4 CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1 10.1021/acs.jmedchem.0c01195
24895263 387029 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 10 4 6 4.6 Nc1ccc([C@@H](O)CNCCc2ccc(-c3ccc(C(=O)O)c(OC4CCCCC4)c3)cc2)cn1 10.1021/jm8000345
CHEMBL529659 387029 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 10 4 6 4.6 Nc1ccc([C@@H](O)CNCCc2ccc(-c3ccc(C(=O)O)c(OC4CCCCC4)c3)cc2)cn1 10.1021/jm8000345
44591508 352895 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 475 10 4 6 4.6 Nc1ccncc1[C@@H](O)CNCCc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1 10.1021/jm9000709
CHEMBL470857 352895 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 475 10 4 6 4.6 Nc1ccncc1[C@@H](O)CNCCc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1 10.1021/jm9000709
319 7908 34 None -39 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
444031 7908 34 None -39 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
784 7908 34 None -39 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
CHEMBL1346 7908 34 None -39 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
56670158 136428 0 None -7 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807830 136428 0 None -7 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
16049309 136432 0 None -100 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807870 136432 0 None -100 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
56663238 136434 0 None -199 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807872 136434 0 None -199 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
1239 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
3410 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
3465 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
CHEMBL1256786 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
DB00983 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
3083544 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
4943 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1363 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
DB00983 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
DB01274 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
10288976 138870 0 None -251 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 17 6 6 3.9 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852543 138870 0 None -251 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 17 6 6 3.9 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1 10.1016/j.bmc.2011.08.043
1239 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3410 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3465 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
CHEMBL1256786 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
DB00983 3447 41 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3083544 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
4943 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
CHEMBL1363 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
DB00983 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
DB01274 57618 28 None -138 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
49861320 117807 0 None -6 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1615579 117807 0 None -6 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
44565932 370266 0 None -4897 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 528 11 4 8 3.4 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL490733 370266 0 None -4897 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 528 11 4 8 3.4 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
10305108 220945 0 None -77 3 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 659 17 6 8 4.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL327519 220945 0 None -77 3 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 659 17 6 8 4.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)CC2)cc1 10.1016/s0960-894x(02)00607-8
44441233 294747 0 None -100 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2ocnc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL393471 294747 0 None -100 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2ocnc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
10184665 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
4799 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
7353 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
CHEMBL1198857 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
DB09082 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
10184665 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
4799 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
7353 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
CHEMBL1198857 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
DB09082 8655 40 None -44 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
11038599 101128 0 None -25 3 Human 6.4 pEC50 = 6.4 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 516 11 5 6 3.7 C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154906 101128 0 None -25 3 Human 6.4 pEC50 = 6.4 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 516 11 5 6 3.7 C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
9512 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
9887812 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
CHEMBL208427 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
DB06190 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
44441236 193842 0 None -3162 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 416 9 4 5 4.5 O=C(O)c1ccsc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245875 193842 0 None -3162 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 416 9 4 5 4.5 O=C(O)c1ccsc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
10298567 138247 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1cccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmcl.2004.11.001
CHEMBL183611 138247 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1cccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmcl.2004.11.001
177640897 465241 0 None -354 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 346 6 4 5 1.7 O=C1COc2c(C(O)CNCCc3ccccc3F)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070257 465241 0 None -354 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 346 6 4 5 1.7 O=C1COc2c(C(O)CNCCc3ccccc3F)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
164625303 371785 0 None -316 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028871 371785 0 None -316 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
164623918 371775 0 None -199 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 374 7 4 4 2.8 O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5028793 371775 0 None -199 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 374 7 4 4 2.8 O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
164608750 371662 0 None -181 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5027923 371662 0 None -181 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
164615474 371711 0 None -61 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028315 371711 0 None -61 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164617688 371725 0 None -416 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028449 371725 0 None -416 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
56598967 179123 0 None 2238 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
CHEMBL2348211 179123 0 None 2238 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
45101520 413681 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 513 12 7 8 1.2 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL583235 413681 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 513 12 7 8 1.2 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
46232769 450013 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL601036 450013 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
164614743 371703 0 None -134 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028269 371703 0 None -134 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
45484536 394306 0 None -5 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 527 13 7 8 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL568239 394306 0 None -5 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 527 13 7 8 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
559926 197330 2 None 27 2 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
CHEMBL266619 197330 2 None 27 2 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
45270673 390241 0 None 58 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 406 10 3 5 3.9 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)Oc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL552253 390241 0 None 58 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 406 10 3 5 3.9 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)Oc1ccccc1 10.1016/j.bmc.2009.06.031
45273280 391562 0 None -1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 11 4 4 3.7 O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL557095 391562 0 None -1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 11 4 4 3.7 O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
44396513 139010 0 None -30 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL185660 139010 0 None -30 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
10420352 327758 5 None 83 2 Guinea pig 7.4 pEC50 = 7.4 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 327758 5 None 83 2 Guinea pig 7.4 pEC50 = 7.4 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
10076548 328257 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 13 5 8 2.7 CCCCN(C(=O)CC(=O)O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
CHEMBL418600 328257 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 13 5 8 2.7 CCCCN(C(=O)CC(=O)O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
24893966 350699 0 None -724 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 12 3 5 4.8 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL460257 350699 0 None -724 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 12 3 5 4.8 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
44331766 19001 0 None -2 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 449 9 3 4 4.3 O[C@@H](CNCC1CCN(CCC(F)(F)F)CC1)COc1cccc2[nH]c3ccccc3c12 10.1016/s0960-894x(02)00607-8
CHEMBL103137 19001 0 None -2 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 449 9 3 4 4.3 O[C@@H](CNCC1CCN(CCC(F)(F)F)CC1)COc1cccc2[nH]c3ccccc3c12 10.1016/s0960-894x(02)00607-8
22063464 451136 0 None -10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
CHEMBL602257 451136 0 None -10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
10189730 19614 0 None -426 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 647 14 6 8 3.4 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
CHEMBL106511 19614 0 None -426 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 647 14 6 8 3.4 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
145984324 330704 0 None -7 3 Human 6.4 pEC50 = 6.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 449 11 4 4 4.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=S)Nc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4248727 330704 0 None -7 3 Human 6.4 pEC50 = 6.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 449 11 4 4 4.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=S)Nc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
44574723 352436 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 11 3 5 3.5 O=C(Cc1cccc(Cl)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466726 352436 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 11 3 5 3.5 O=C(Cc1cccc(Cl)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
155567283 349945 0 None -588 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
CHEMBL4588479 349945 0 None -588 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
44377771 330423 0 None -70 3 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 596 10 5 9 3.4 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)c4ccc(O)c(NS(=O)(=O)c5ccccc5)c4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL424167 330423 0 None -70 3 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 596 10 5 9 3.4 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)c4ccc(O)c(NS(=O)(=O)c5ccccc5)c4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
1028 599 43 None -21 11 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
479 599 43 None -21 11 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
5816 599 43 None -21 11 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL679 599 43 None -21 11 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00668 599 43 None -21 11 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
46232856 462780 0 None -128 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL604333 462780 0 None -128 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
10651147 220205 0 None -10964 3 Human 4.4 pEC50 = 4.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 596 12 6 8 2.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL32599 220205 0 None -10964 3 Human 4.4 pEC50 = 4.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 596 12 6 8 2.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
44392542 138156 0 None -6 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1016/j.bmcl.2004.12.033
CHEMBL183552 138156 0 None -6 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1016/j.bmcl.2004.12.033
11432806 138490 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
11432806 138490 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL184407 138490 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL184407 138490 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
164612025 371681 0 None -2454 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028117 371681 0 None -2454 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
24895669 373751 0 None -7079 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 5 4.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL518168 373751 0 None -7079 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 5 4.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44392575 136701 0 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
CHEMBL181300 136701 0 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
52949489 41417 0 None -21 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258024 41417 0 None -21 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
44268324 40668 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12450 40668 0 None -93 2 Human 6.4 pEC50 = 6.4 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
10626150 200205 0 None -295 3 Human 5.4 pEC50 = 5.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 534 11 5 9 1.3 CCOC(=O)CNC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
CHEMBL286868 200205 0 None -295 3 Human 5.4 pEC50 = 5.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 534 11 5 9 1.3 CCOC(=O)CNC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
44336180 20799 0 None -15 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1ccc(F)cc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL108263 20799 0 None -15 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1ccc(F)cc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
11270071 199224 0 None 1 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL279931 199224 0 None 1 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
5311452 7458 12 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10.1016/j.ejmech.2022.114961
547 7458 12 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10.1016/j.ejmech.2022.114961
CHEMBL1326499 7458 12 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10.1016/j.ejmech.2022.114961
24949564 372646 0 None -147 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 452 7 4 5 4.6 Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL514094 372646 0 None -147 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 452 7 4 5 4.6 Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
24893964 369930 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL488224 369930 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
24893964 369930 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL488224 369930 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
3038500 23645 11 None -1778 6 Human 5.3 pEC50 = 5.3 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL111201 23645 11 None -1778 6 Human 5.3 pEC50 = 5.3 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
10187653 18684 0 None -3 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 554 11 5 7 3.5 O=C(Nc1ccccc1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL100970 18684 0 None -3 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 554 11 5 7 3.5 O=C(Nc1ccccc1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
44396736 139155 0 None -11 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL186271 139155 0 None -11 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
44127056 390182 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1ccsc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL551892 390182 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1ccsc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24949420 371335 1 None -51 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
CHEMBL498304 371335 1 None -51 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
42639652 26997 0 None -1513 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 3 6 3.5 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1187716 26997 0 None -1513 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 3 6 3.5 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
45483847 393903 0 None -2 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL565686 393903 0 None -2 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
45483816 394231 0 None -12 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.10.013
CHEMBL567833 394231 0 None -12 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.10.013
52947562 41556 0 None 3 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258486 41556 0 None 3 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
11026016 99969 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 411 10 4 5 2.5 C[C@H](CNc1ccc(CNS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL153916 99969 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 411 10 4 5 2.5 C[C@H](CNc1ccc(CNS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
10902809 101337 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 304 7 3 3 3.5 C[C@H](CNc1ccccc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL155072 101337 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 304 7 3 3 3.5 C[C@H](CNc1ccccc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
2419 7043 56 None -21 5 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
5152 7043 56 None -21 5 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
559 7043 56 None -21 5 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
CHEMBL1263 7043 56 None -21 5 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
DB00938 7043 56 None -21 5 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
155543358 348810 0 None -102 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4561253 348810 0 None -102 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
177640523 465097 0 None -120 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 342 6 4 5 1.9 Cc1ccc(CCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
CHEMBL6068791 465097 0 None -120 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 342 6 4 5 1.9 Cc1ccc(CCNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1021/acs.jmedchem.3c02074
45484568 407314 0 None -10 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 541 13 6 8 1.8 CN(C)CC(=O)NCCCC(=O)Nc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.06.104
CHEMBL576428 407314 0 None -10 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 541 13 6 8 1.8 CN(C)CC(=O)NCCCC(=O)Nc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.06.104
177640171 465208 0 None -407 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 362 6 4 5 2.2 O=C1COc2c(C(O)CNCCc3ccccc3Cl)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
CHEMBL6070035 465208 0 None -407 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as induction of accumulation of cAMP by HTRF assay
ChEMBL 362 6 4 5 2.2 O=C1COc2c(C(O)CNCCc3ccccc3Cl)ccc(O)c2N1 10.1021/acs.jmedchem.3c02074
45483843 394133 0 None -9 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL567192 394133 0 None -9 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
45484569 394717 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 596 13 6 9 1.5 CN1CCN(CC(=O)NCCCC(=O)Nc2ccc(CC(C)(C)NCC(O)c3ccc(O)c4c3OCC(=O)N4)cc2)CC1 10.1016/j.bmcl.2009.06.104
CHEMBL570834 394717 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 596 13 6 9 1.5 CN1CCN(CC(=O)NCCCC(=O)Nc2ccc(CC(C)(C)NCC(O)c3ccc(O)c4c3OCC(=O)N4)cc2)CC1 10.1016/j.bmcl.2009.06.104
45268128 393105 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 427 10 4 4 3.9 O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL562315 393105 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 427 10 4 4 3.9 O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10233153 18578 0 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 642 11 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4ccc5c(C(=O)O)cccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL100351 18578 0 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 642 11 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4ccc5c(C(=O)O)cccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
10553602 255118 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 0.9 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)NCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL36568 255118 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 0.9 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)NCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
9893058 138674 0 None -39 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1 10.1016/j.bmc.2011.05.064
CHEMBL1851721 138674 0 None -39 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1 10.1016/j.bmc.2011.05.064
56678849 138916 0 None -63 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 18 5 8 2.7 O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1852744 138916 0 None -63 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 18 5 8 2.7 O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
56675663 138879 0 None -50 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 6 6 4.6 NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852575 138879 0 None -50 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 6 6 4.6 NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1 10.1016/j.bmc.2011.08.043
46833102 38123 0 None -31 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198882 38123 0 None -31 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
44574913 352487 0 None None None Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 526 15 2 6 4.5 CCCN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467117 352487 0 None None None Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 526 15 2 6 4.5 CCCN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24895667 350809 0 None -208 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(Cl)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL461282 350809 0 None -208 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(Cl)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
10003858 372253 1 None -3548 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 10 4 5 4.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL510100 372253 1 None -3548 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 10 4 5 4.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
42625513 26827 0 None -1000 4 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
CHEMBL1186722 26827 0 None -1000 4 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
42625515 26996 0 None -794 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 3.0 CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187711 26996 0 None -794 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 3.0 CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
11718543 330698 0 None -125 3 Human 5.3 pEC50 = 5.3 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)n1 10.1021/jm0509445
CHEMBL424866 330698 0 None -125 3 Human 5.3 pEC50 = 5.3 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)n1 10.1021/jm0509445
9801145 193841 0 None -630 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 9 4 5 4.0 O=C(O)c1ccoc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245874 193841 0 None -630 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 9 4 5 4.0 O=C(O)c1ccoc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
11605652 26823 0 None -501 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186715 26823 0 None -501 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
44392240 136649 0 None -6 2 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 12 5 5 2.2 CCCNC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL181115 136649 0 None -6 2 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 12 5 5 2.2 CCCNC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44580010 370062 0 None -46 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 441 10 3 5 4.7 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL489199 370062 0 None -46 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 441 10 3 5 4.7 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
24894319 372964 0 None -213 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 11 3 5 4.5 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL516785 372964 0 None -213 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 11 3 5 4.5 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
10202842 329111 0 None -16 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 428 10 5 6 1.9 NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL421030 329111 0 None -16 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 428 10 5 6 1.9 NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
24895561 350811 0 None -194 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 509 11 3 5 6.1 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL461301 350811 0 None -194 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 509 11 3 5 6.1 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
44331443 18797 0 None -26 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 689 14 7 9 2.3 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL101674 18797 0 None -26 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 689 14 7 9 2.3 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
44331351 474986 0 None -16 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 610 13 6 8 2.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL98088 474986 0 None -16 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 610 13 6 8 2.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
10209574 19774 0 None -22 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1cc(F)ccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107382 19774 0 None -22 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1cc(F)ccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
10304565 217001 0 None -11 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 622 12 5 7 3.6 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c(F)c3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL317809 217001 0 None -11 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 622 12 5 7 3.6 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c(F)c3)CC2)cc1 10.1016/s0960-894x(02)00607-8
44396577 139240 0 None -25 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL186676 139240 0 None -25 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
24822817 195667 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
CHEMBL256418 195667 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
24822817 195667 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL256418 195667 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
24822817 195667 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL256418 195667 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
44237613 121023 0 None -2754 2 Rat 6.3 pEC50 = 6.3 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 502 10 6 6 3.4 COc1ccccc1CNC(=O)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682215 121023 0 None -2754 2 Rat 6.3 pEC50 = 6.3 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 502 10 6 6 3.4 COc1ccccc1CNC(=O)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
44580009 370064 0 None -42 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.0 Cc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL489201 370064 0 None -42 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.0 Cc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
44127575 387299 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1cccs1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL539226 387299 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1cccs1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
45270391 390296 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 459 11 4 6 3.8 O=C(CC1C=Nc2ccccc21)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL552434 390296 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 459 11 4 6 3.8 O=C(CC1C=Nc2ccccc21)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
45273276 391327 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL556689 391327 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
24822472 197720 0 None -38 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL269920 197720 0 None -38 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
44237670 121027 0 None -8128 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 534 9 6 5 5.4 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.12.096
CHEMBL1682219 121027 0 None -8128 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 534 9 6 5 5.4 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.12.096
44396737 139145 0 None -47 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 683 14 4 10 5.2 CCOC(=O)c1ccc(S(=O)(=O)Oc2cccc3c(C[C@@H](C)NC[C@H](O)c4cccc(NS(=O)(=O)c5cccs5)c4)c[nH]c23)cc1 10.1016/j.bmcl.2004.10.035
CHEMBL186236 139145 0 None -47 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 683 14 4 10 5.2 CCOC(=O)c1ccc(S(=O)(=O)Oc2cccc3c(C[C@@H](C)NC[C@H](O)c4cccc(NS(=O)(=O)c5cccs5)c4)c[nH]c23)cc1 10.1016/j.bmcl.2004.10.035
44444173 194396 0 None -8 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level
ChEMBL 516 11 4 7 3.3 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2c1C1(CC1)C(=O)N2 10.1016/j.bmcl.2007.09.011
CHEMBL248547 194396 0 None -8 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level
ChEMBL 516 11 4 7 3.3 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2c1C1(CC1)C(=O)N2 10.1016/j.bmcl.2007.09.011
44331426 18771 0 None -114 3 Human 6.2 pEC50 = 6.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 578 13 7 9 1.0 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL101521 18771 0 None -114 3 Human 6.2 pEC50 = 6.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 578 13 7 9 1.0 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
44127048 390172 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 436 11 5 6 2.6 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(O)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL551832 390172 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 436 11 5 6 2.6 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(O)c1ccccc1 10.1016/j.ejmech.2009.01.022
1499 4274 42 None -2 31 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
3779 4274 42 None -2 31 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
536 4274 42 None -2 31 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
CHEMBL434 4274 42 None -2 31 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
DB01064 4274 42 None -2 31 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
24936491 41390 0 None -2 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257916 41390 0 None -2 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
9845282 157612 0 None -63 3 Human 8.2 pEC50 = 8.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL205224 157612 0 None -63 3 Human 8.2 pEC50 = 8.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
155564079 346697 0 None -97 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 442 8 4 4 4.9 CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4575759 346697 0 None -97 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 442 8 4 4 4.9 CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
56943515 221928 0 None -7 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 478 13 6 7 3.7 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298213 221928 0 None -7 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 478 13 6 7 3.7 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1 10.1016/j.bmcl.2014.04.095
11169365 221996 0 None -22 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 11 6 7 4.0 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298986 221996 0 None -22 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 11 6 7 4.0 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
164612262 371683 0 None -190 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028127 371683 0 None -190 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
5493324 193703 28 None -208 3 Human 8.2 pEC50 = 8.2 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL279260 193703 28 None -208 3 Human 8.2 pEC50 = 8.2 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
24822972 197834 0 None 1 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(CCNC[C@H](O)c2cccc(Cl)c2)ccc1-c1ccc(C(=O)O)cc1 10.1021/jm701324c
CHEMBL270460 197834 0 None 1 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(CCNC[C@H](O)c2cccc(Cl)c2)ccc1-c1ccc(C(=O)O)cc1 10.1021/jm701324c
52948056 41389 0 None 1 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257915 41389 0 None 1 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
45483844 407750 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL576848 407750 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
155513474 334309 0 None -83 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 478 8 4 4 5.1 CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4438531 334309 0 None -83 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 478 8 4 4 5.1 CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
164618278 371730 0 None -389 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028489 371730 0 None -389 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
45271518 389627 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 479 11 4 6 3.9 COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL549689 389627 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 479 11 4 6 3.9 COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
45270690 389866 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550037 389866 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
45273281 391681 0 None -1 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL557295 391681 0 None -1 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10008017 200057 12 None -7 3 Human 7.2 pEC50 = 7.2 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 12 6 8 2.3 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1021/jm000544b
CHEMBL285881 200057 12 None -7 3 Human 7.2 pEC50 = 7.2 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 12 6 8 2.3 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1021/jm000544b
44127782 393711 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL564556 393711 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
52944986 41482 0 None -72 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
CHEMBL1258257 41482 0 None -72 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
10187201 19520 0 None -77 2 Human 6.2 pEC50 = 6.2 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 540 17 5 6 4.9 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL106022 19520 0 None -77 2 Human 6.2 pEC50 = 6.2 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 540 17 5 6 4.9 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44312924 329746 0 None -229 3 Human 5.2 pEC50 = 5.2 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL421871 329746 0 None -229 3 Human 5.2 pEC50 = 5.2 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
44219641 352353 0 None -5 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
CHEMBL466088 352353 0 None -5 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
24895791 369906 0 None -199 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 419 10 3 4 4.7 CCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL488051 369906 0 None -199 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 419 10 3 4 4.7 CCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
44580040 370371 0 None -389 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 510 10 4 5 5.7 CC(C)(C)C(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL491645 370371 0 None -389 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 510 10 4 5 5.7 CC(C)(C)C(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
24950560 346876 0 None -16 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccccc2Cl)CC3)cc1 10.1021/jm800222k
CHEMBL450842 346876 0 None -16 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccccc2Cl)CC3)cc1 10.1021/jm800222k
145984042 330547 0 None -1348 3 Human 5.2 pEC50 = 5.2 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 475 13 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Cc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4244929 330547 0 None -1348 3 Human 5.2 pEC50 = 5.2 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 475 13 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Cc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
24824225 27087 0 None None None Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 454 11 3 5 4.4 CN(c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1)c1ccc(OCC(=O)O)cc1 10.1021/jm701324c
CHEMBL1188359 27087 0 None None None Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 454 11 3 5 4.4 CN(c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1)c1ccc(OCC(=O)O)cc1 10.1021/jm701324c
10092953 198333 0 None -34 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
CHEMBL273028 198333 0 None -34 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
16049376 136433 0 None -39 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807871 136433 0 None -39 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
10238776 138767 0 None -79 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 473 17 6 6 3.6 NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852214 138767 0 None -79 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 473 17 6 6 3.6 NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
24900689 142607 0 None -125 5 Human 7.2 pEC50 = 7.2 Functional
Binding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assayBinding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assay
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945039 142607 0 None -125 5 Human 7.2 pEC50 = 7.2 Functional
Binding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assayBinding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assay
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
11002571 101359 0 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 348 8 4 4 3.2 C[C@H](CNc1ccc(C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL155092 101359 0 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 348 8 4 4 3.2 C[C@H](CNc1ccc(C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
10346448 238543 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL348501 238543 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
11647543 275612 0 None -2511 3 Human 6.2 pEC50 = 6.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL377028 275612 0 None -2511 3 Human 6.2 pEC50 = 6.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
145987168 332007 0 None -316 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 4 5 2.1 COc1cccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2018.04.041
CHEMBL4291941 332007 0 None -316 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 4 5 2.1 COc1cccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2018.04.041
42625897 26744 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 564 18 4 8 3.1 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1 10.1021/jm801016j
CHEMBL1186265 26744 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 564 18 4 8 3.1 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1 10.1021/jm801016j
42625821 26812 0 None -630 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 522 18 4 7 3.4 CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186678 26812 0 None -630 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 522 18 4 7 3.4 CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
44237614 121024 0 None -31622 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 490 9 6 5 3.6 O=C(NCc1ccc(F)cc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682216 121024 0 None -31622 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 490 9 6 5 3.6 O=C(NCc1ccc(F)cc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
44331444 18619 0 None -524 3 Human 5.2 pEC50 = 5.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 709 13 5 8 4.2 CC(C)N(Cc1cc(F)ccc1F)C(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
CHEMBL100589 18619 0 None -524 3 Human 5.2 pEC50 = 5.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 709 13 5 8 4.2 CC(C)N(Cc1cc(F)ccc1F)C(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
24824226 197748 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 439 11 3 4 4.3 O=C(O)COc1ccc(Cc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL270027 197748 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 439 11 3 4 4.3 O=C(O)COc1ccc(Cc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
44579925 367640 0 None -6 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 445 9 3 4 5.4 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1Cl 10.1016/j.bmcl.2008.08.009
CHEMBL484265 367640 0 None -6 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 445 9 3 4 5.4 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1Cl 10.1016/j.bmcl.2008.08.009
45483849 394270 0 None None None Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 388 6 3 3 4.5 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1cc(Cl)c(N)c(Cl)c1 10.1016/j.bmcl.2009.10.013
CHEMBL568060 394270 0 None None None Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 388 6 3 3 4.5 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1cc(Cl)c(N)c(Cl)c1 10.1016/j.bmcl.2009.10.013
24936488 41518 0 None -3 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258373 41518 0 None -3 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
44574759 352481 0 None None None Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 470 12 3 6 3.6 O=C(Cc1nccn1-c1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467082 352481 0 None None None Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 470 12 3 6 3.6 O=C(Cc1nccn1-c1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24950570 349432 0 None -794 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1F 10.1021/jm800222k
CHEMBL457629 349432 0 None -794 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1F 10.1021/jm800222k
44396532 139043 0 None -42 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL185836 139043 0 None -42 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
44127478 389976 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 435 11 5 6 2.6 NC(C(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL550743 389976 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 435 11 5 6 2.6 NC(C(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
2419 7043 56 None -1445 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
5152 7043 56 None -1445 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
559 7043 56 None -1445 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
CHEMBL1263 7043 56 None -1445 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
DB00938 7043 56 None -1445 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
24950053 371208 0 None -117 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 443 7 3 5 5.1 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)s1 10.1021/jm800222k
CHEMBL497280 371208 0 None -117 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 443 7 3 5 5.1 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)s1 10.1021/jm800222k
24950236 372230 0 None -89 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 9 4 5 6.8 O=C(O)c1cc(NC2CCCCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
CHEMBL509729 372230 0 None -89 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 9 4 5 6.8 O=C(O)c1cc(NC2CCCCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
44579649 370224 0 None -12 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 408 10 3 6 3.4 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL490415 370224 0 None -12 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 408 10 3 6 3.4 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
11224275 347589 0 None -1621 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 11 3 4 5.1 CCCOc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453048 347589 0 None -1621 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 11 3 4 5.1 CCCOc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
45483839 394016 0 None None None Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 380 7 3 3 4.8 CCc1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL566353 394016 0 None None None Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 380 7 3 3 4.8 CCc1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
45483852 393849 0 None -14 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 392 6 4 5 2.6 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL565267 393849 0 None -14 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 392 6 4 5 2.6 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
155564766 349484 0 None -181 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
CHEMBL4577508 349484 0 None -181 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
12578 1929 47 None 154 3 Human 8.1 pEC50 = 8.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.1021/jm400348g
2755 1929 47 None 154 3 Human 8.1 pEC50 = 8.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.1021/jm400348g
CHEMBL1374751 1929 47 None 154 3 Human 8.1 pEC50 = 8.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.1021/jm400348g
164620479 371746 0 None -288 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028596 371746 0 None -288 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
145985242 330421 0 None -6 3 Human 8.1 pEC50 = 8.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 443 11 4 4 3.9 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4241613 330421 0 None -6 3 Human 8.1 pEC50 = 8.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 443 11 4 4 3.9 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
164617235 371722 0 None -251 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028422 371722 0 None -251 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
11810896 238234 0 None -2 3 Human 8.1 pEC50 = 8.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 375 9 4 4 3.1 CC(=O)NCc1ccc(NC[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm0101500
CHEMBL345304 238234 0 None -2 3 Human 8.1 pEC50 = 8.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 375 9 4 4 3.1 CC(=O)NCc1ccc(NC[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm0101500
1499 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
3779 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
536 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
CHEMBL434 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
DB01064 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
9871386 221758 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
CHEMBL3290999 221758 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
66796015 221944 0 None -35 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 474 11 6 7 3.2 NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298328 221944 0 None -35 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 474 11 6 7 3.2 NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943518 221945 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 488 12 6 7 3.6 NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298329 221945 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 488 12 6 7 3.6 NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943545 221946 0 None -28 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 13 6 7 4.0 NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298330 221946 0 None -28 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 13 6 7 4.0 NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943546 221962 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 518 14 6 8 3.2 NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298691 221962 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 518 14 6 8 3.2 NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943517 221988 0 None -3 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 621 13 5 9 2.8 CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1 10.1016/j.bmcl.2014.04.095
CHEMBL3298832 221988 0 None -3 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 621 13 5 9 2.8 CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1 10.1016/j.bmcl.2014.04.095
1499 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
3779 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
536 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
CHEMBL434 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
DB01064 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
56678973 138869 0 None -7 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 555 18 6 6 5.6 O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1 10.1016/j.bmc.2011.08.043
CHEMBL1852541 138869 0 None -7 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 555 18 6 6 5.6 O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1 10.1016/j.bmc.2011.08.043
56658407 138928 0 None -15 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 18 6 6 3.3 NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852796 138928 0 None -15 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 18 6 6 3.3 NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
1499 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
3779 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
536 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
CHEMBL434 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
DB01064 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
1499 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
3779 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
536 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
CHEMBL434 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
DB01064 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
10225563 38126 0 None -19 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 445 16 4 6 3.9 Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198889 38126 0 None -19 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 445 16 4 6 3.9 Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
9871386 221758 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290999 221758 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
45271517 389596 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 499 10 4 4 4.8 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL549487 389596 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 499 10 4 4 4.8 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
45272431 389776 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 547 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL549960 389776 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 547 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
44517694 389915 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
CHEMBL550445 389915 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
44517696 391867 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL557705 391867 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
24949891 371387 0 None -46 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
CHEMBL498703 371387 0 None -46 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
24937269 41516 0 None -2 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258371 41516 0 None -2 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
44127481 392699 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)c1 10.1016/j.ejmech.2009.01.022
CHEMBL561211 392699 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)c1 10.1016/j.ejmech.2009.01.022
11189433 450351 0 None -57 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL601430 450351 0 None -57 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
44396779 139348 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL187209 139348 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
155551133 348064 0 None -446 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 340 7 4 5 1.9 O=c1ccc2c(C(O)CNCCOc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4542430 348064 0 None -446 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 340 7 4 5 1.9 O=c1ccc2c(C(O)CNCCOc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
24823127 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL272584 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
24823127 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL272584 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1016/j.bmcl.2008.08.009
44127050 393709 0 None 1 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccccc1Cl)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL564544 393709 0 None 1 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccccc1Cl)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24823127 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL272584 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
24823127 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL272584 198242 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
44589400 387056 0 None -1 3 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 446 11 2 5 4.2 COc1ccc(CCNCC(O)COc2ccc3c(c2)CCCN3Cc2ccccc2)cc1 10.1016/j.bmc.2008.11.030
CHEMBL530556 387056 0 None -1 3 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 446 11 2 5 4.2 COc1ccc(CCNCC(O)COc2ccc3c(c2)CCCN3Cc2ccccc2)cc1 10.1016/j.bmc.2008.11.030
45271886 390089 0 None -724 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 508 11 3 5 4.5 CC(C)Cc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL551532 390089 0 None -724 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 508 11 3 5 4.5 CC(C)Cc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
42639806 26786 0 None -40 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 468 10 3 6 2.9 COc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186584 26786 0 None -40 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 468 10 3 6 2.9 COc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
44331346 475209 0 None -120 3 Human 6.1 pEC50 = 6.1 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
CHEMBL99599 475209 0 None -120 3 Human 6.1 pEC50 = 6.1 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
172461665 388926 0 None 134 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 366 7 2 6 2.4 O[C@@H](CNCC1COc2ccccc2O1)COc1cccc2cnccc12 10.1016/j.ejmech.2022.114961
CHEMBL5427527 388926 0 None 134 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubationAgonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation
ChEMBL 366 7 2 6 2.4 O[C@@H](CNCC1COc2ccccc2O1)COc1cccc2cnccc12 10.1016/j.ejmech.2022.114961
44560791 372254 0 None -154 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 376 8 3 4 3.7 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
CHEMBL510102 372254 0 None -154 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 376 8 3 4 3.7 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
42639808 26793 0 None -1230 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 522 11 3 6 4.2 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCC1 10.1021/jm9000709
CHEMBL1186601 26793 0 None -1230 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 522 11 3 6 4.2 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCC1 10.1021/jm9000709
10302915 19684 0 None -23 2 Human 6.1 pEC50 = 6.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1c(F)cccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL106884 19684 0 None -23 2 Human 6.1 pEC50 = 6.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1c(F)cccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44127681 389978 0 None 2 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 420 11 4 5 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL550746 389978 0 None 2 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 420 11 4 5 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
164623544 371771 0 None -2754 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 406 7 4 4 3.5 O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5028764 371771 0 None -2754 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 406 7 4 4 3.5 O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
24949722 349526 0 None -223 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 455 6 3 3 5.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(C(F)(F)F)cc2)CC3)cc1 10.1021/jm800222k
CHEMBL457839 349526 0 None -223 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 455 6 3 3 5.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(C(F)(F)F)cc2)CC3)cc1 10.1021/jm800222k
11476004 347588 0 None -954 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453047 347588 0 None -954 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
45269853 393541 0 None -4 2 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL563872 393541 0 None -4 2 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
9799092 100572 0 None -5 3 Human 7.1 pEC50 = 7.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154419 100572 0 None -5 3 Human 7.1 pEC50 = 7.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
9799092 100572 0 None -5 3 Human 7.1 pEC50 = 7.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL154419 100572 0 None -5 3 Human 7.1 pEC50 = 7.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
56678847 138669 0 None -125 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
CHEMBL1851691 138669 0 None -125 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
56678845 138698 0 None -39 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.05.064
CHEMBL1851839 138698 0 None -39 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.05.064
9871096 138940 0 None -125 4 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1852860 138940 0 None -125 4 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
9799092 100572 0 None -5 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL154419 100572 0 None -5 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441229 194166 0 None -100 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2nc(C(=O)O)cs2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247315 194166 0 None -100 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2nc(C(=O)O)cs2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
46833103 21733 0 None -10 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(O)cc2)ccc1O 10.1021/jm100326d
CHEMBL1086535 21733 0 None -10 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(O)cc2)ccc1O 10.1021/jm100326d
11060184 238449 0 None -1000 3 Human 6.1 pEC50 = 6.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 11 4 6 3.5 C[C@H](CNc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL347616 238449 0 None -1000 3 Human 6.1 pEC50 = 6.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 11 4 6 3.5 C[C@H](CNc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
9823696 157440 0 None -501 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.7 Cc1ccc(C(=O)O)cc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
CHEMBL204827 157440 0 None -501 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.7 Cc1ccc(C(=O)O)cc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
11495581 158954 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 425 9 4 5 4.2 C[C@H](CNc1cccc(-c2ncccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL208328 158954 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 425 9 4 5 4.2 C[C@H](CNc1cccc(-c2ncccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
11546349 278566 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL383511 278566 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
2419 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
5152 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
559 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
CHEMBL1263 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
DB00938 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
2419 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
5152 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
559 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
CHEMBL1263 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
DB00938 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
2419 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
5152 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
559 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
CHEMBL1263 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
DB00938 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
2419 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
5152 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
559 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
CHEMBL1263 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
DB00938 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
2419 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
5152 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
559 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
CHEMBL1263 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
DB00938 7043 56 None -1445 5 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
10940242 330098 0 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 515 12 4 6 3.8 C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL422876 330098 0 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 515 12 4 6 3.8 C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
42625743 26869 0 None -39 3 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186943 26869 0 None -39 3 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
559929 19239 7 None 4 2 Guinea pig 8.1 pEC50 = 8.1 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
CHEMBL10453 19239 7 None 4 2 Guinea pig 8.1 pEC50 = 8.1 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
44419332 278956 0 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelsAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels
ChEMBL 505 11 4 8 2.5 Cn1c(=O)[nH]c2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(C(N)=O)cn4)cc3)c21 10.1016/j.bmcl.2006.08.010
CHEMBL386016 278956 0 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelsAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels
ChEMBL 505 11 4 8 2.5 Cn1c(=O)[nH]c2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(C(N)=O)cn4)cc3)c21 10.1016/j.bmcl.2006.08.010
46889771 21323 0 None 2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084706 21323 0 None 2 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
45268136 393190 0 None -2 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
CHEMBL562669 393190 0 None -2 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
44560792 347485 0 None -794 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 10 3 5 4.5 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL452798 347485 0 None -794 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 10 3 5 4.5 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24950718 349972 0 None -398 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(C(=O)O)ccc1-c1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(Cl)cc1)CC2 10.1021/jm800222k
CHEMBL458927 349972 0 None -398 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(C(=O)O)ccc1-c1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(Cl)cc1)CC2 10.1021/jm800222k
11272641 26711 0 None -6165 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 537 11 3 7 4.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL1186009 26711 0 None -6165 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 537 11 3 7 4.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
25071020 385714 0 None -251 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 469 11 3 5 5.5 CC(C)Oc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL523265 385714 0 None -251 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 469 11 3 5 5.5 CC(C)Oc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
24949726 372665 0 None -457 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
CHEMBL514265 372665 0 None -457 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
44127479 392807 0 None 10 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1cccc(Cl)c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561348 392807 0 None 10 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1cccc(Cl)c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24895359 375521 0 None -104 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 405 9 3 4 4.3 COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL520903 375521 0 None -104 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 405 9 3 4 4.3 COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
145989075 331891 0 None -524 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 324 6 4 4 2.1 O=c1ccc2c(C(CO)NCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4289813 331891 0 None -524 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 324 6 4 4 2.1 O=c1ccc2c(C(CO)NCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
145994130 332166 0 None -83 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(CO)NCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4294937 332166 0 None -83 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(CO)NCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
24894315 347090 0 None -165 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 11 3 5 5.2 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL451772 347090 0 None -165 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 11 3 5 5.2 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44580042 385639 0 None -26 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 396 9 3 5 3.6 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
CHEMBL522641 385639 0 None -26 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 396 9 3 5 3.6 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
42639491 26839 0 None -1659 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 3 6 5.3 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1SC1CCCCC1 10.1021/jm9000709
CHEMBL1186805 26839 0 None -1659 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 3 6 5.3 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1SC1CCCCC1 10.1021/jm9000709
44396738 251939 0 None -77 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 655 13 5 9 4.8 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccc(C(=O)O)cc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL362763 251939 0 None -77 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 655 13 5 9 4.8 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccc(C(=O)O)cc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
10142284 19228 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 510 11 5 6 3.9 O=C(NC1CCCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL104481 19228 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 510 11 5 6 3.9 O=C(NC1CCCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
1239 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
3410 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
3465 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
CHEMBL1256786 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
DB00983 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
1239 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
3410 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
3465 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
CHEMBL1256786 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
DB00983 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
1239 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
3410 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
3465 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
CHEMBL1256786 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
DB00983 3447 41 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
24895361 368665 0 None -933 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL486051 368665 0 None -933 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
155550964 348019 0 None -575 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 352 8 4 4 2.9 O=c1ccc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4541263 348019 0 None -575 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 352 8 4 4 2.9 O=c1ccc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
10232593 19733 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 609 17 6 7 4.8 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107129 19733 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 609 17 6 7 4.8 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)cc2)CC1 10.1016/s0960-894x(01)00645-x
9873245 18862 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL102194 18862 0 None -18 2 Human 6.1 pEC50 = 6.1 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
10028830 7965 32 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2018.03.032
13196 7965 32 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2018.03.032
CHEMBL4238084 7965 32 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2018.03.032
44237666 121026 0 None -44668 2 Rat 5.1 pEC50 = 5.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 548 10 6 5 5.0 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)NC(c1ccccc1)c1ccccc1 10.1016/j.bmcl.2010.12.096
CHEMBL1682218 121026 0 None -44668 2 Rat 5.1 pEC50 = 5.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 548 10 6 5 5.0 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)NC(c1ccccc1)c1ccccc1 10.1016/j.bmcl.2010.12.096
24950059 348901 0 None -169 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 467 8 3 5 5.0 COc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL456352 348901 0 None -169 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 467 8 3 5 5.0 COc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
24823466 27095 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 440 11 4 5 4.4 O=C(O)COc1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL1188436 27095 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 440 11 4 5 4.4 O=C(O)COc1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
11270069 196063 0 None 6 2 Human 8.0 pEC50 = 8.0 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL25823 196063 0 None 6 2 Human 8.0 pEC50 = 8.0 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
52949488 41416 0 None -3 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258023 41416 0 None -3 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
155548071 347830 0 None -131 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(O)CNCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4536813 347830 0 None -131 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(O)CNCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
56598831 180000 0 None 1023 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2365796 180000 0 None 1023 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
45101522 425772 0 None -5 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 578 15 7 9 2.0 CC(C)(Cc1ccc(NC(=O)CCCNCCCS(=O)(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL585751 425772 0 None -5 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 578 15 7 9 2.0 CC(C)(Cc1ccc(NC(=O)CCCNCCCS(=O)(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
45272430 390286 0 None -8 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 439 10 4 4 4.2 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL552374 390286 0 None -8 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 439 10 4 4 4.2 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
44517692 393705 0 None -4 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL564516 393705 0 None -4 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
44237612 121019 0 None -4466 2 Rat 6.1 pEC50 = 6.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 472 9 6 5 3.4 O=C(NCc1ccccc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682211 121019 0 None -4466 2 Rat 6.1 pEC50 = 6.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 472 9 6 5 3.4 O=C(NCc1ccccc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
11398536 26743 0 None -6309 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 535 11 4 6 4.7 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1NC1CCCCC1 10.1021/jm9000709
CHEMBL1186241 26743 0 None -6309 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 535 11 4 6 4.7 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1NC1CCCCC1 10.1021/jm9000709
24895565 350655 0 None -575 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 11 3 5 5.5 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL459862 350655 0 None -575 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 11 3 5 5.5 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
44127167 392940 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1cccnc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561818 392940 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1cccnc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24949720 372647 0 None -2398 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1 10.1021/jm800222k
CHEMBL514102 372647 0 None -2398 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1 10.1021/jm800222k
44565907 385701 0 None -138 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 498 11 4 8 2.3 CCOc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL523149 385701 0 None -138 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 498 11 4 8 2.3 CCOc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
10205463 19837 0 None -10 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 470 11 5 6 3.0 CC(C)NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107633 19837 0 None -10 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 470 11 5 6 3.0 CC(C)NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44127052 391669 0 None -2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccccc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL557269 391669 0 None -2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccccc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
44574758 352456 0 None -18 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 394 11 4 5 2.2 O=C(Cc1ncc[nH]1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466879 352456 0 None -18 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 394 11 4 5 2.2 O=C(Cc1ncc[nH]1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
9896817 202940 0 None -6 3 Human 6.0 pEC50 = 6.0 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL305891 202940 0 None -6 3 Human 6.0 pEC50 = 6.0 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
24823296 198330 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm701324c
CHEMBL273006 198330 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm701324c
24949883 350068 0 None -691 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c(F)c1 10.1021/jm800222k
CHEMBL459133 350068 0 None -691 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c(F)c1 10.1021/jm800222k
24823296 198330 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm9000709
CHEMBL273006 198330 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm9000709
10648298 199908 0 None -251 3 Human 5.0 pEC50 = 5.0 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 477 10 5 7 2.1 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL284788 199908 0 None -251 3 Human 5.0 pEC50 = 5.0 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 477 10 5 7 2.1 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
46232815 464627 0 None 5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL606208 464627 0 None 5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
9896817 202940 0 None 3 2 Human 5.0 pIC50 = 5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL305891 202940 0 None 3 2 Human 5.0 pIC50 = 5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
9962058 469664 0 None 1 2 Human 4.0 pIC50 = 4 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL74860 469664 0 None 1 2 Human 4.0 pIC50 = 4 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)cc2)cc1 10.1016/s0960-894x(00)00459-5
53318280 121442 0 None -1 2 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 623 11 3 6 7.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684578 121442 0 None -1 2 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 623 11 3 6 7.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
11722516 181707 0 None None None Guinea pig 5.9 pIC50 = 5.9 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
CHEMBL23929 181707 0 None None None Guinea pig 5.9 pIC50 = 5.9 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
44268214 42430 0 None 4 2 Human 7.8 pIC50 = 7.8 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 331 10 3 5 2.4 COc1ccc(CCCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12762 42430 0 None 4 2 Human 7.8 pIC50 = 7.8 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 331 10 3 5 2.4 COc1ccc(CCCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
53319639 121445 0 None 1 2 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684582 121445 0 None 1 2 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
145990586 331653 0 None -1 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assayAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 331653 0 None -1 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assayAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
53326196 121443 0 None 1 2 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684580 121443 0 None 1 2 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
567 1496 16 None -87 5 Rat 6.7 pIC50 = 6.7 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
9841972 1496 16 None -87 5 Rat 6.7 pIC50 = 6.7 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
CHEMBL284782 1496 16 None -87 5 Rat 6.7 pIC50 = 6.7 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
1786 5120 49 None -1 3 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
4171 5120 49 None -1 3 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
553 5120 49 None -1 3 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
CHEMBL13 5120 49 None -1 3 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
DB00264 5120 49 None -1 3 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
127034967 273926 0 None -1 3 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1 10.1021/acs.jmedchem.5b01088
CHEMBL3736156 273926 0 None -1 3 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1 10.1021/acs.jmedchem.5b01088
53326839 121444 0 None 1 2 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684581 121444 0 None 1 2 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
11722516 181707 0 None None None Guinea pig 5.7 pIC50 = 5.7 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
CHEMBL23929 181707 0 None None None Guinea pig 5.7 pIC50 = 5.7 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
51346867 121446 0 None 1 2 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684583 121446 0 None 1 2 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
53326197 121447 0 None 1 2 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684584 121447 0 None 1 2 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
2303 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
4946 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
564 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
63 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
91536 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
CHEMBL27 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
CHEMBL452861 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
DB00571 6476 48 None -8 12 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
9873245 18862 0 None -6 2 Human 7.6 pIC50 = 7.6 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL102194 18862 0 None -6 2 Human 7.6 pIC50 = 7.6 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
14739907 329085 0 None 1 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 367 10 2 6 2.6 Cc1cccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)c1 10.1021/jm00172a033
CHEMBL421005 329085 0 None 1 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 367 10 2 6 2.6 Cc1cccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)c1 10.1021/jm00172a033
14739906 474565 0 None 16 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 411 13 2 7 2.5 COCCc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL95457 474565 0 None 16 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 411 13 2 7 2.5 COCCc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
53326195 121441 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684577 121441 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
9853471 469731 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL75604 469731 0 None 1 2 Human 5.5 pIC50 = 5.5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
3462 1951 13 None -3 2 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
5486546 1951 13 None -3 2 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
CHEMBL1204876 1951 13 None -3 2 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
1786 5120 49 None -1 3 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
4171 5120 49 None -1 3 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
553 5120 49 None -1 3 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
CHEMBL13 5120 49 None -1 3 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
DB00264 5120 49 None -1 3 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
3687256 21163 5 None 3 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assayAntagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assay
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1083994 21163 5 None 3 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assayAntagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assay
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
14739905 475113 0 None 7 2 Human 7.4 pIC50 = 7.4 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 353 10 2 6 2.3 OC(CNCCOc1ccc(-n2ccnc2)cc1)COc1ccccc1 10.1021/jm00172a033
CHEMBL98975 475113 0 None 7 2 Human 7.4 pIC50 = 7.4 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 353 10 2 6 2.3 OC(CNCCOc1ccc(-n2ccnc2)cc1)COc1ccccc1 10.1021/jm00172a033
1499 4274 42 None -269 5 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
3779 4274 42 None -269 5 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
536 4274 42 None -269 5 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
CHEMBL434 4274 42 None -269 5 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
DB01064 4274 42 None -269 5 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
14823035 270609 1 None -5 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
CHEMBL38486 270609 1 None -5 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
14739908 216882 0 None 1 2 Human 5.3 pIC50 = 5.3 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.9 CS(=O)(=O)Nc1ccc(C(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL316868 216882 0 None 1 2 Human 5.3 pIC50 = 5.3 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.9 CS(=O)(=O)Nc1ccc(C(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44313150 213500 0 None 1 2 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308868 213500 0 None 1 2 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
2723 123170 6 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
65772 123170 6 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL174984 123170 6 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
DB13692 123170 6 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
10283539 332625 0 None -22 2 Human 5.2 pIC50 = 5.2 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
CHEMBL431048 332625 0 None -22 2 Human 5.2 pIC50 = 5.2 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
127034966 273962 0 None -1 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1 10.1021/acs.jmedchem.5b01088
CHEMBL3736433 273962 0 None -1 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1 10.1021/acs.jmedchem.5b01088
187238 159697 5 None None None Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 159697 5 None None None Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
187238 159697 5 None None None Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 159697 5 None None None Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
187238 159697 5 None None None Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 159697 5 None None None Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
187238 159697 5 None None None Rat 10.1 pKd = 10.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 159697 5 None None None Rat 10.1 pKd = 10.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
13040915 202982 0 None None None Guinea pig 10.0 pKd = 10 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL30622 202982 0 None None None Guinea pig 10.0 pKd = 10 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
3047497 27654 4 None None None Rat 9.6 pKd = 9.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192675 27654 4 None None None Rat 9.6 pKd = 9.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
3047497 27654 4 None None None Rat 9.6 pKd = 9.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192675 27654 4 None None None Rat 9.6 pKd = 9.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
187238 159697 5 None None None Rat 9.5 pKd = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 159697 5 None None None Rat 9.5 pKd = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
2685 1837 22 None None None Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
541 1837 22 None None None Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
CHEMBL280822 1837 22 None None None Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
123686 4050 42 None None None Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
12581 4050 42 None None None Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
CHEMBL11268 4050 42 None None None Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
33624 8322 24 None None None Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
4061 8322 24 None None None Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
565 8322 24 None None None Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
CHEMBL499 8322 24 None None None Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
DB00373 8322 24 None None None Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
13187527 197411 0 None None None Rat 9.3 pKd = 9.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL267375 197411 0 None None None Rat 9.3 pKd = 9.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
56598832 179130 0 None None None Human 9.0 pKd = 9 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348218 179130 0 None None None Human 9.0 pKd = 9 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
2685 1837 22 None None None Human 9.0 pKd = 9.0 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.ejmech.2022.114961
541 1837 22 None None None Human 9.0 pKd = 9.0 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.ejmech.2022.114961
CHEMBL280822 1837 22 None None None Human 9.0 pKd = 9.0 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.ejmech.2022.114961
66653268 179113 0 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
CHEMBL2348201 179113 0 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
5311116 4758 10 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
544 4758 10 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
CHEMBL207802 4758 10 None None None Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
2303 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
4946 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
564 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
63 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
91536 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL27 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL452861 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
DB00571 6476 48 None None None Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
12733305 123154 0 None None None Guinea pig 8.7 pKd = 8.7 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 357 8 2 6 2.5 COc1ccc(CCNCC(O)C2=COc3ccccc3O2)cc1OC 10.1021/jm00140a015
CHEMBL174853 123154 0 None None None Guinea pig 8.7 pKd = 8.7 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 357 8 2 6 2.5 COc1ccc(CCNCC(O)C2=COc3ccccc3O2)cc1OC 10.1021/jm00140a015
13187527 197411 0 None None None Rat 8.7 pKd = 8.7 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL267375 197411 0 None None None Rat 8.7 pKd = 8.7 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
44288749 329218 0 None None None Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL42117 329218 0 None None None Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
44288749 329218 0 None None None Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL42117 329218 0 None None None Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
11722868 214097 0 None None None Guinea pig 7.0 pKd = 7 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 minAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 min
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
CHEMBL31025 214097 0 None None None Guinea pig 7.0 pKd = 7 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 minAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 min
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
13040919 215751 0 None None None Guinea pig 5.0 pKd = 5 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL31335 215751 0 None None None Guinea pig 5.0 pKd = 5 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
172461665 388926 0 None None None Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 366 7 2 6 2.4 O[C@@H](CNCC1COc2ccccc2O1)COc1cccc2cnccc12 10.1016/j.ejmech.2022.114961
CHEMBL5427527 388926 0 None None None Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 366 7 2 6 2.4 O[C@@H](CNCC1COc2ccccc2O1)COc1cccc2cnccc12 10.1016/j.ejmech.2022.114961
44371562 102959 0 None None None Guinea pig 5.0 pKd = 5.0 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 7 2 5 1.2 CC(C)NCC(O)COC(=O)Cc1cccs1 10.1021/jm00387a006
CHEMBL156683 102959 0 None None None Guinea pig 5.0 pKd = 5.0 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 7 2 5 1.2 CC(C)NCC(O)COC(=O)Cc1cccs1 10.1021/jm00387a006
20554487 27556 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 369 11 2 5 2.2 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1191855 27556 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 369 11 2 5 2.2 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCC2)cc1 10.1021/jm00389a008
54757126 137793 0 None None None Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830492 137793 0 None None None Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
14856222 337161 0 None None None Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 217 5 2 4 0.9 CC(C)C(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
CHEMBL449651 337161 0 None None None Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 217 5 2 4 0.9 CC(C)C(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
12733304 256177 0 None None None Guinea pig 5.9 pKd = 5.9 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 275 3 1 4 2.5 OC(CN1CCCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL366558 256177 0 None None None Guinea pig 5.9 pKd = 5.9 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 275 3 1 4 2.5 OC(CN1CCCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
44288217 311145 0 None None None Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL40217 311145 0 None None None Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
2303 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
4946 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
564 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
63 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
91536 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL27 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL452861 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
DB00571 6476 48 None None None Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
44371486 38160 0 None None None Guinea pig 6.9 pKd = 6.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 230 7 2 4 1.9 CCC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1199437 38160 0 None None None Guinea pig 6.9 pKd = 6.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 230 7 2 4 1.9 CCC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
54757229 137815 0 None None None Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830617 137815 0 None None None Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
3682 365954 13 None None None Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.ejmech.2022.114961
CHEMBL513389 365954 13 None None None Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.ejmech.2022.114961
44371537 103905 0 None None None Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 4 1.5 CC(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
CHEMBL157557 103905 0 None None None Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 4 1.5 CC(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
12348305 197320 0 None None None Guinea pig 6.9 pKd = 6.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 281 6 2 6 0.9 CC(C)NCC(O)COC(=O)c1ccc2c(c1)OCO2 10.1021/jm00387a006
CHEMBL266548 197320 0 None None None Guinea pig 6.9 pKd = 6.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 281 6 2 6 0.9 CC(C)NCC(O)COC(=O)c1ccc2c(c1)OCO2 10.1021/jm00387a006
2369 1284 48 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 1284 48 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 1284 48 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 1284 48 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 1284 48 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
12606708 27340 0 None None None Guinea pig 5.9 pKd = 5.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 282 6 2 4 2.6 CC(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
CHEMBL1190195 27340 0 None None None Guinea pig 5.9 pKd = 5.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 282 6 2 4 2.6 CC(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
44287476 26284 0 None None None Guinea pig 5.9 pKd = 5.9 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 230 7 2 4 1.9 CCC(CC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
CHEMBL1183311 26284 0 None None None Guinea pig 5.9 pKd = 5.9 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 230 7 2 4 1.9 CCC(CC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
3047527 468622 0 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 11 2 4 3.2 CC(C)NCC(O)COc1ccc(CCOCC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL6712 468622 0 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 11 2 4 3.2 CC(C)NCC(O)COc1ccc(CCOCC2CCCC2)cc1 10.1021/jm00389a008
2447486 125781 0 None None None Guinea pig 7.9 pKd = 7.9 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL1788270 125781 0 None None None Guinea pig 7.9 pKd = 7.9 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
54756927 137787 0 None None None Human 7.9 pKd = 7.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830486 137787 0 None None None Human 7.9 pKd = 7.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44288217 311145 0 None None None Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL40217 311145 0 None None None Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
172446785 387485 0 None None None Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 389 11 2 3 4.8 CCc1ccccc1OC[C@@H](O)CNCCC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2022.114961
CHEMBL5397120 387485 0 None None None Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 389 11 2 3 4.8 CCc1ccccc1OC[C@@H](O)CNCCC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2022.114961
12606686 183668 0 None None None Guinea pig 4.9 pKd = 4.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL24391 183668 0 None None None Guinea pig 4.9 pKd = 4.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00180a007
1786 5120 49 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
4171 5120 49 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
553 5120 49 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
CHEMBL13 5120 49 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
DB00264 5120 49 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
12733308 241124 0 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 393 4 2 7 3.1 Oc1nc2ccccc2n1C1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
CHEMBL360139 241124 0 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 393 4 2 7 3.1 Oc1nc2ccccc2n1C1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
3047500 27534 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1191645 27534 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
3047500 27534 0 None None None Rat 6.8 pKd = 6.8 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1191645 27534 0 None None None Rat 6.8 pKd = 6.8 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
44287622 26274 0 None None None Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 7 2 4 2.4 CC(C)C(=NOCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00380a001
CHEMBL1183276 26274 0 None None None Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 7 2 4 2.4 CC(C)C(=NOCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00380a001
10403687 5103 2 None None None Guinea pig 4.8 pKd = 4.8 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 319 8 2 2 3.9 CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
1205 5103 2 None None None Guinea pig 4.8 pKd = 4.8 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 319 8 2 2 3.9 CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
CHEMBL275035 5103 2 None None None Guinea pig 4.8 pKd = 4.8 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 319 8 2 2 3.9 CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
12733301 123177 0 None None None Guinea pig 7.8 pKd = 7.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 235 4 2 4 1.7 CC(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL175010 123177 0 None None None Guinea pig 7.8 pKd = 7.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 235 4 2 4 1.7 CC(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
44371406 25940 0 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 278 9 2 4 2.4 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1181107 25940 0 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 278 9 2 4 2.4 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)C 10.1021/jm00180a007
44264144 27535 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 385 11 2 6 1.6 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCO2)cc1 10.1021/jm00389a008
CHEMBL1191646 27535 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 385 11 2 6 1.6 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCO2)cc1 10.1021/jm00389a008
361497 102324 0 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 5 1.3 CC(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
CHEMBL156147 102324 0 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 5 1.3 CC(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
172454272 388351 0 None None None Human 5.8 pKd = 5.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 359 7 2 7 1.6 O[C@@H](CNCC1COc2ccccc2O1)COc1ccc2c(c1)OCO2 10.1016/j.ejmech.2022.114961
CHEMBL5415148 388351 0 None None None Human 5.8 pKd = 5.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 359 7 2 7 1.6 O[C@@H](CNCC1COc2ccccc2O1)COc1ccc2c(c1)OCO2 10.1016/j.ejmech.2022.114961
12778441 155110 0 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL2110257 155110 0 None None None Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
3486 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
4883 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
555 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
CHEMBL6995 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
DB01297 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
172468087 388961 0 None None None Human 5.8 pKd = 5.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 459 10 2 5 5.0 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCCC(c3ccccc3)c3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5428413 388961 0 None None None Human 5.8 pKd = 5.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 459 10 2 5 5.0 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCCC(c3ccccc3)c3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
3486 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
4883 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
555 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
CHEMBL6995 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
DB01297 6418 47 None None None Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
12606710 27651 0 None None None Guinea pig 4.8 pKd = 4.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 204 6 3 4 0.7 CC(C)NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1192661 27651 0 None None None Guinea pig 4.8 pKd = 4.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 204 6 3 4 0.7 CC(C)NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
44287431 25508 0 None None None Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 8 2 4 2.0 CC(C)NCC(O)CON=C(C(C)C)C(C)C 10.1021/jm00380a001
CHEMBL1178793 25508 0 None None None Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 8 2 4 2.0 CC(C)NCC(O)CON=C(C(C)C)C(C)C 10.1021/jm00380a001
54757331 137817 0 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830619 137817 0 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
155774 8875 30 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
2848 8875 30 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
538 8875 30 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
CHEMBL75753 8875 30 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
DB13781 8875 30 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
56598831 180000 0 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2365796 180000 0 None None None Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
44264411 27655 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 443 15 2 6 3.6 COc1ccc(CCNCC(O)COc2ccc(CCOCC3CCC3)cc2)cc1OC 10.1021/jm00389a008
CHEMBL1192677 27655 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 443 15 2 6 3.6 COc1ccc(CCNCC(O)COc2ccc(CCOCC3CCC3)cc2)cc1OC 10.1021/jm00389a008
3486 6418 47 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
4883 6418 47 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
555 6418 47 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
CHEMBL6995 6418 47 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
DB01297 6418 47 None None None Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
172450718 388445 0 None None None Human 5.8 pKd = 5.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 426 9 3 6 3.0 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc3c(c2)OC(C)(C)CC3=O)cc1 10.1016/j.ejmech.2022.114961
CHEMBL5416996 388445 0 None None None Human 5.8 pKd = 5.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 426 9 3 6 3.0 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc3c(c2)OC(C)(C)CC3=O)cc1 10.1016/j.ejmech.2022.114961
137 765 35 None None None Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2119 765 35 None None None Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
563 765 35 None None None Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
66368 765 35 None None None Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
CHEMBL266195 765 35 None None None Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
DB00866 765 35 None None None Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
54756927 137787 0 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830486 137787 0 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
12606701 25507 0 None None None Guinea pig 5.7 pKd = 5.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL1178787 25507 0 None None None Guinea pig 5.7 pKd = 5.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
44371426 38220 0 None None None Guinea pig 6.7 pKd = 6.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 6 2 4 1.5 CC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1199902 38220 0 None None None Guinea pig 6.7 pKd = 6.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 6 2 4 1.5 CC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
2303 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
4946 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
564 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
63 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
91536 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL27 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL452861 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
DB00571 6476 48 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
11768868 27420 1 None None None Guinea pig 4.7 pKd = 4.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 161 4 2 3 0.4 COCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1190805 27420 1 None None None Guinea pig 4.7 pKd = 4.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 161 4 2 3 0.4 COCC(O)CNC(C)(C)C 10.1021/jm00180a007
12606701 25507 0 None None None Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL1178787 25507 0 None None None Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
2303 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
4946 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
564 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
63 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
91536 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
CHEMBL27 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
CHEMBL452861 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
DB00571 6476 48 None None None Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
2176 6361 47 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
4828 6361 47 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
91 6361 47 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
CHEMBL500 6361 47 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
DB00960 6361 47 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
2303 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
4946 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
564 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
63 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
91536 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL27 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL452861 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
DB00571 6476 48 None None None Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
56597179 179131 0 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348219 179131 0 None None None Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
2369 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
44264404 27679 0 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 319 11 2 4 2.5 OC(CNC1CC1)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192875 27679 0 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 319 11 2 4 2.5 OC(CNC1CC1)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
2369 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 1284 48 None None None Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
44287522 25504 0 None None None Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 10 2 4 2.3 CCCC(CCC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
CHEMBL1178778 25504 0 None None None Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 10 2 4 2.3 CCCC(CCC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
54757027 137791 0 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830490 137791 0 None None None Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
1786 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
4171 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
553 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
CHEMBL13 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
DB00264 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
1786 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
4171 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
553 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
CHEMBL13 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
DB00264 5120 49 None None None Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
172462381 389089 0 None None None Human 5.6 pKd = 5.6 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 9 2 5 3.4 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCCCc3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5431834 389089 0 None None None Human 5.6 pKd = 5.6 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 9 2 5 3.4 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCCCc3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
54757026 137790 0 None None None Human 6.6 pKd = 6.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830489 137790 0 None None None Human 6.6 pKd = 6.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
172455562 388694 0 None None None Human 5.6 pKd = 5.6 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 7 2 7 2.0 O=c1ccc2ccc(OC[C@@H](O)CNCC3COc4ccccc4O3)cc2o1 10.1016/j.ejmech.2022.114961
CHEMBL5422259 388694 0 None None None Human 5.6 pKd = 5.6 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 7 2 7 2.0 O=c1ccc2ccc(OC[C@@H](O)CNCC3COc4ccccc4O3)cc2o1 10.1016/j.ejmech.2022.114961
44287498 26672 0 None None None Guinea pig 4.6 pKd = 4.6 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 214 6 2 4 1.3 CC(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
CHEMBL1185760 26672 0 None None None Guinea pig 4.6 pKd = 4.6 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 214 6 2 4 1.3 CC(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
127940 469760 4 None None None Human 6.6 pKd = 6.6 Functional
The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
CHEMBL7585 469760 4 None None None Human 6.6 pKd = 6.6 Functional
The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
172462257 389030 0 None None None Human 6.6 pKd = 6.6 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 459 10 2 5 5.0 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCCC(c3ccccc3)c3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5430355 389030 0 None None None Human 6.6 pKd = 6.6 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 459 10 2 5 5.0 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCCC(c3ccccc3)c3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
56598833 179129 0 None None None Human 7.6 pKd = 7.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
CHEMBL2348217 179129 0 None None None Human 7.6 pKd = 7.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
168613 116545 17 None None None Guinea pig 7.6 pKd = 7.6 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1 10.1021/jm00350a009
CHEMBL1744069 116545 17 None None None Guinea pig 7.6 pKd = 7.6 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1 10.1021/jm00350a009
12733306 122857 0 None None None Guinea pig 6.6 pKd = 6.6 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 368 5 1 6 2.5 COc1ccccc1N1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
CHEMBL173882 122857 0 None None None Guinea pig 6.6 pKd = 6.6 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 368 5 1 6 2.5 COc1ccccc1N1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
2303 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
4946 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
564 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
63 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
91536 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL27 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL452861 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
DB00571 6476 48 None None None Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
10042467 2937 1 None None None Guinea pig 4.6 pKd = 4.6 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 333 8 1 2 4.3 CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C 10.1021/jm991056a
1203 2937 1 None None None Guinea pig 4.6 pKd = 4.6 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 333 8 1 2 4.3 CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C 10.1021/jm991056a
CHEMBL11553 2937 1 None None None Guinea pig 4.6 pKd = 4.6 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 333 8 1 2 4.3 CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C 10.1021/jm991056a
44371642 102460 0 None None None Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 6 2 4 0.5 CC(C)NCC(O)COC(=O)C(C)C 10.1021/jm00387a006
CHEMBL156271 102460 0 None None None Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 6 2 4 0.5 CC(C)NCC(O)COC(=O)C(C)C 10.1021/jm00387a006
12606702 26285 0 None None None Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL1183312 26285 0 None None None Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
12606704 38229 0 None None None Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 290 7 2 4 2.8 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1199951 38229 0 None None None Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 290 7 2 4 2.8 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
44371312 102500 0 None None None Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 5 2 4 0.7 CCC(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
CHEMBL156304 102500 0 None None None Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 5 2 4 0.7 CCC(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
44264509 468682 0 None None None Rat 5.5 pKd = 5.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 429 14 2 4 4.5 CC(CCc1ccc(F)cc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL6749 468682 0 None None None Rat 5.5 pKd = 5.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 429 14 2 4 4.5 CC(CCc1ccc(F)cc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
3047492 468929 4 None None None Guinea pig 5.5 pKd = 5.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
CHEMBL6939 468929 4 None None None Guinea pig 5.5 pKd = 5.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
2303 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
4946 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
564 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
63 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
91536 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
CHEMBL27 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
CHEMBL452861 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
DB00571 6476 48 None None None Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
54669764 137792 0 None None None Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830491 137792 0 None None None Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
56598967 179123 0 None None None Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
CHEMBL2348211 179123 0 None None None Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
54757026 137790 0 None None None Human 7.5 pKd = 7.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830489 137790 0 None None None Human 7.5 pKd = 7.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
54758320 137818 0 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830620 137818 0 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
12606706 184036 0 None None None Guinea pig 6.5 pKd = 6.5 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL24480 184036 0 None None None Guinea pig 6.5 pKd = 6.5 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
172445308 387418 0 None None None Human 5.5 pKd = 5.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 413 8 2 7 2.7 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCCc3ccc4c(c3)OCO4)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5395772 387418 0 None None None Human 5.5 pKd = 5.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 413 8 2 7 2.7 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCCc3ccc4c(c3)OCO4)cc2O1 10.1016/j.ejmech.2022.114961
1531 4617 40 None None None Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
3869 4617 40 None None None Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
7207 4617 40 None None None Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
CHEMBL429 4617 40 None None None Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
DB00598 4617 40 None None None Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
172461924 389127 0 None None None Human 5.5 pKd = 5.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 413 7 2 7 2.6 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCC3COc4ccccc4O3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5432691 389127 0 None None None Human 5.5 pKd = 5.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 413 7 2 7 2.6 CC1(C)CC(=O)c2ccc(OC[C@H](O)CNCC3COc4ccccc4O3)cc2O1 10.1016/j.ejmech.2022.114961
172470154 389354 0 None None None Human 5.5 pKd = 5.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 396 9 3 6 2.3 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc3ccc(=O)oc3c2)cc1 10.1016/j.ejmech.2022.114961
CHEMBL5437540 389354 0 None None None Human 5.5 pKd = 5.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 396 9 3 6 2.3 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc3ccc(=O)oc3c2)cc1 10.1016/j.ejmech.2022.114961
121848 251266 2 None None None Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL368457 251266 2 None None None Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
10028830 7965 32 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2022.114961
13196 7965 32 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2022.114961
CHEMBL4238084 7965 32 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 497 13 4 6 2.7 CC(=O)NCC1=CC(=CC=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O 10.1016/j.ejmech.2022.114961
44264298 27630 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 346 12 2 5 2.7 CC(CC#N)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192477 27630 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 346 12 2 5 2.7 CC(CC#N)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
12778440 122944 0 None None None Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL173976 122944 0 None None None Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
54756929 137789 0 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830488 137789 0 None None None Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
44263933 27910 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 10 2 4 2.7 CC(C)NCC(O)COc1ccc(COCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1194583 27910 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 10 2 4 2.7 CC(C)NCC(O)COc1ccc(COCC2CCC2)cc1 10.1021/jm00389a008
172455968 388746 0 None None None Human 5.4 pKd = 5.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 371 7 2 7 1.4 O=C1COc2cc(OC[C@@H](O)CNCC3COc4ccccc4O3)ccc21 10.1016/j.ejmech.2022.114961
CHEMBL5423415 388746 0 None None None Human 5.4 pKd = 5.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 371 7 2 7 1.4 O=C1COc2cc(OC[C@@H](O)CNCC3COc4ccccc4O3)ccc21 10.1016/j.ejmech.2022.114961
172461561 389141 0 None None None Human 5.4 pKd = 5.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 413 7 2 7 2.6 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCC3COc4ccccc4O3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5432967 389141 0 None None None Human 5.4 pKd = 5.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 413 7 2 7 2.6 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCC3COc4ccccc4O3)cc2O1 10.1016/j.ejmech.2022.114961
5311452 7458 12 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10.1016/j.ejmech.2022.114961
547 7458 12 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10.1016/j.ejmech.2022.114961
CHEMBL1326499 7458 12 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10.1016/j.ejmech.2022.114961
2447484 193822 0 None None None Guinea pig 7.4 pKd = 7.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL305153 193822 0 None None None Guinea pig 7.4 pKd = 7.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
54758415 137819 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830621 137819 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
12606709 38256 0 None None None Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 296 5 2 4 3.0 CC(C)(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
CHEMBL1200073 38256 0 None None None Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 296 5 2 4 3.0 CC(C)(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
3047500 27534 0 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1191645 27534 0 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
44371514 25977 0 None None None Guinea pig 6.4 pKd = 6.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 8 2 4 1.5 CCC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1181235 25977 0 None None None Guinea pig 6.4 pKd = 6.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 8 2 4 1.5 CCC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
172465355 388862 0 None None None Human 5.4 pKd = 5.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 9 2 5 3.4 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCCCc3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
CHEMBL5426087 388862 0 None None None Human 5.4 pKd = 5.4 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 9 2 5 3.4 CC1(C)CC(=O)c2ccc(OC[C@@H](O)CNCCCc3ccccc3)cc2O1 10.1016/j.ejmech.2022.114961
127940 469760 4 None None None Guinea pig 7.4 pKd = 7.4 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptorThe compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
CHEMBL7585 469760 4 None None None Guinea pig 7.4 pKd = 7.4 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptorThe compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
2369 1284 48 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 1284 48 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 1284 48 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 1284 48 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 1284 48 None None None Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
137 765 35 None None None Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2119 765 35 None None None Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
563 765 35 None None None Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
66368 765 35 None None None Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
CHEMBL266195 765 35 None None None Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
DB00866 765 35 None None None Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2303 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
4946 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
564 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
63 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
91536 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL27 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL452861 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
DB00571 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
2303 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
4946 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
564 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
63 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
91536 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL27 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL452861 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
DB00571 6476 48 None None None Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
54757232 137816 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830618 137816 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
54757126 137793 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830492 137793 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
44264188 468882 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 325 10 2 4 2.1 CC(C)NCC(O)COc1ccc(C[S+]([O-])CC2CC2)cc1 10.1021/jm00389a008
CHEMBL6902 468882 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 325 10 2 4 2.1 CC(C)NCC(O)COc1ccc(C[S+]([O-])CC2CC2)cc1 10.1021/jm00389a008
54757229 137815 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830617 137815 0 None None None Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
12606687 26491 0 None None None Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 175 6 2 3 0.8 CC(C)NCC(O)COC(C)C 10.1021/jm00180a007
CHEMBL1184385 26491 0 None None None Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 175 6 2 3 0.8 CC(C)NCC(O)COC(C)C 10.1021/jm00180a007
134495 1544 16 None None None Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
9809 1544 16 None None None Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
CHEMBL289093 1544 16 None None None Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
134495 1544 16 None None None Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
9809 1544 16 None None None Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
CHEMBL289093 1544 16 None None None Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
44371383 102855 1 None None None Guinea pig 6.3 pKd = 6.3 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 5 1.7 CC(C)(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
CHEMBL156603 102855 1 None None None Guinea pig 6.3 pKd = 6.3 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 5 1.7 CC(C)(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
10447834 3955 1 None None None Guinea pig 4.3 pKd = 4.3 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 305 7 2 2 3.7 NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
4026 3955 1 None None None Guinea pig 4.3 pKd = 4.3 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 305 7 2 2 3.7 NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
CHEMBL275507 3955 1 None None None Guinea pig 4.3 pKd = 4.3 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 305 7 2 2 3.7 NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
54757129 137794 0 None None None Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830493 137794 0 None None None Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
44287469 26270 0 None None None Guinea pig 5.3 pKd = 5.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 9 2 4 2.7 CCCC(CCC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
CHEMBL1183268 26270 0 None None None Guinea pig 5.3 pKd = 5.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 9 2 4 2.7 CCCC(CCC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
44288489 333540 0 None None None Rat 7.3 pKd = 7.3 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 314 8 3 5 2.5 OC(CNc1nc2ccccc2[nH]1)CON=C(C1CC1)C1CC1 10.1021/jm970338c
CHEMBL43850 333540 0 None None None Rat 7.3 pKd = 7.3 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 314 8 3 5 2.5 OC(CNc1nc2ccccc2[nH]1)CON=C(C1CC1)C1CC1 10.1021/jm970338c
12606684 196429 0 None None None Guinea pig 6.3 pKd = 6.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL26003 196429 0 None None None Guinea pig 6.3 pKd = 6.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00180a007
4752 37934 24 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 10.1021/jm00389a008
60657 37934 24 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 10.1021/jm00389a008
CHEMBL1201274 37934 24 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 10.1021/jm00389a008
DB09351 37934 24 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 10.1021/jm00389a008
44371512 25947 0 None None None Guinea pig 8.3 pKd = 8.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 292 8 2 4 2.8 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1181139 25947 0 None None None Guinea pig 8.3 pKd = 8.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 292 8 2 4 2.8 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00180a007
91565 24103 17 None None None Guinea pig 8.2 pKd = 8.2 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 275 6 3 4 2.3 CC(C)NCC(O)COc1ccc(O)c2ccccc12 10.1021/jm00373a008
CHEMBL1137 24103 17 None None None Guinea pig 8.2 pKd = 8.2 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 275 6 3 4 2.3 CC(C)NCC(O)COc1ccc(O)c2ccccc12 10.1021/jm00373a008
13187531 469393 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 10 2 4 3.3 CC(C)NCC(O)COc1ccc(CCOC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL7250 469393 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 10 2 4 3.3 CC(C)NCC(O)COc1ccc(CCOC2CCCCC2)cc1 10.1021/jm00389a008
44381395 122267 0 None None None Guinea pig 7.3 pKd = 7.3 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 289 6 2 5 1.2 CC(C)NCC(O)COC1=CC(=O)C(=O)c2ccccc21 10.1021/jm00373a008
CHEMBL171432 122267 0 None None None Guinea pig 7.3 pKd = 7.3 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 289 6 2 5 1.2 CC(C)NCC(O)COC1=CC(=O)C(=O)c2ccccc21 10.1021/jm00373a008
54756928 137788 0 None None None Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830487 137788 0 None None None Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44287620 25505 0 None None None Guinea pig 4.3 pKd = 4.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 5 2 4 1.7 CC(C)(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
CHEMBL1178780 25505 0 None None None Guinea pig 4.3 pKd = 4.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 5 2 4 1.7 CC(C)(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
172461757 389020 0 None None None Human 5.3 pKd = 5.3 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 8 2 7 2.1 O=c1ccc2ccc(OC[C@@H](O)CNCCc3ccc4c(c3)OCO4)cc2o1 10.1016/j.ejmech.2022.114961
CHEMBL5430136 389020 0 None None None Human 5.3 pKd = 5.3 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 383 8 2 7 2.1 O=c1ccc2ccc(OC[C@@H](O)CNCCc3ccc4c(c3)OCO4)cc2o1 10.1016/j.ejmech.2022.114961
12606705 26204 0 None None None Guinea pig 6.2 pKd = 6.2 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 188 6 2 4 0.8 CC(C)=NOCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1182729 26204 0 None None None Guinea pig 6.2 pKd = 6.2 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 188 6 2 4 0.8 CC(C)=NOCC(O)CNC(C)C 10.1021/jm00180a007
2685 1837 22 None None None Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulationAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
541 1837 22 None None None Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulationAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
CHEMBL280822 1837 22 None None None Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulationAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
172442898 387738 0 None None None Human 5.2 pKd = 5.2 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 366 7 2 6 2.4 O[C@@H](CNCC1COc2ccccc2O1)COc1ccnc2ccccc12 10.1016/j.ejmech.2022.114961
CHEMBL5402516 387738 0 None None None Human 5.2 pKd = 5.2 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubationAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation
ChEMBL 366 7 2 6 2.4 O[C@@H](CNCC1COc2ccccc2O1)COc1ccnc2ccccc12 10.1016/j.ejmech.2022.114961
20554490 27607 0 None None None Rat 7.2 pKd = 7.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 364 13 3 5 1.5 CC(=O)NCCNCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192270 27607 0 None None None Rat 7.2 pKd = 7.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 364 13 3 5 1.5 CC(=O)NCCNCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
12733303 123160 0 None None None Guinea pig 6.2 pKd = 6.2 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 261 3 1 4 2.1 OC(CN1CCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL174882 123160 0 None None None Guinea pig 6.2 pKd = 6.2 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 261 3 1 4 2.1 OC(CN1CCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
54669764 137792 0 None None None Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830491 137792 0 None None None Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44264149 27736 0 None None None Rat 8.1 pKd = 8.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 397 11 2 5 3.0 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1193283 27736 0 None None None Rat 8.1 pKd = 8.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 397 11 2 5 3.0 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCCC2)cc1 10.1021/jm00389a008
54757232 137816 0 None None None Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830618 137816 0 None None None Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
157716 77360 22 None None None Guinea pig 8.1 pKd = 8.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@@H](O)CNC(C)C)cc1 10.1021/jm00350a009
CHEMBL148306 77360 22 None None None Guinea pig 8.1 pKd = 8.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@@H](O)CNC(C)C)cc1 10.1021/jm00350a009
44371389 26486 0 None None None Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 7 2 4 1.1 CC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1184362 26486 0 None None None Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 7 2 4 1.1 CC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
1786 5120 49 None None None Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
4171 5120 49 None None None Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
553 5120 49 None None None Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
CHEMBL13 5120 49 None None None Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
DB00264 5120 49 None None None Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
54757129 137794 0 None None None Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830493 137794 0 None None None Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
157717 116541 33 None None None Guinea pig 6.1 pKd = 6.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@H](O)CNC(C)C)cc1 10.1021/jm00350a009
CHEMBL1741004 116541 33 None None None Guinea pig 6.1 pKd = 6.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@H](O)CNC(C)C)cc1 10.1021/jm00350a009
54756929 137789 0 None None None Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830488 137789 0 None None None Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
54757331 137817 0 None None None Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830619 137817 0 None None None Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
20554484 469076 0 None None None Rat 7.1 pKd = 7.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 337 11 2 4 3.5 CC(C)NCC(O)COc1ccc(CCSCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL7043 469076 0 None None None Rat 7.1 pKd = 7.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 337 11 2 4 3.5 CC(C)NCC(O)COc1ccc(CCSCC2CCC2)cc1 10.1021/jm00389a008
44264171 197391 0 None None None Rat 5.1 pKd = 5.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 411 14 2 4 4.4 CC(CCc1ccccc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL267220 197391 0 None None None Rat 5.1 pKd = 5.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 411 14 2 4 4.4 CC(CCc1ccccc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
54756928 137788 0 None None None Human 6.1 pKd = 6.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830487 137788 0 None None None Human 6.1 pKd = 6.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44371561 102958 0 None None None Guinea pig 5.1 pKd = 5.1 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 4 1.9 CC(C)(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
CHEMBL156682 102958 0 None None None Guinea pig 5.1 pKd = 5.1 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 4 1.9 CC(C)(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
54758417 137786 0 None None None Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830485 137786 0 None None None Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
12733302 331171 0 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 249 3 2 4 2.0 CC(C)(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL427310 331171 0 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 249 3 2 4 2.0 CC(C)(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
2303 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
4946 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
564 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
63 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
91536 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
CHEMBL27 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
CHEMBL452861 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
DB00571 6476 48 None None None Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
12606702 26285 0 None None None Guinea pig 5.1 pKd = 5.1 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL1183312 26285 0 None None None Guinea pig 5.1 pKd = 5.1 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
3486 6418 47 None None None Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
4883 6418 47 None None None Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
555 6418 47 None None None Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
CHEMBL6995 6418 47 None None None Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
DB01297 6418 47 None None None Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
12606703 27838 0 None None None Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 276 8 2 4 2.5 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1194069 27838 0 None None None Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 276 8 2 4 2.5 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
3047492 468929 4 None None None Rat 8.0 pKd = 8.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
CHEMBL6939 468929 4 None None None Rat 8.0 pKd = 8.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
3047492 468929 4 None None None Rat 8.0 pKd = 8.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
CHEMBL6939 468929 4 None None None Rat 8.0 pKd = 8.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
54758417 137786 0 None None None Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830485 137786 0 None None None Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
110857 26488 52 None None None Guinea pig 4.0 pKd = 4.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 133 4 3 3 -0.7 CC(C)NCC(O)CO 10.1021/jm00180a007
CHEMBL1184370 26488 52 None None None Guinea pig 4.0 pKd = 4.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 133 4 3 3 -0.7 CC(C)NCC(O)CO 10.1021/jm00180a007
44264446 25357 0 None None None Rat 7.0 pKd = 7.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 12 2 4 3.2 CC(C)NCC(O)COc1ccc(CCCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1177932 25357 0 None None None Rat 7.0 pKd = 7.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 12 2 4 3.2 CC(C)NCC(O)COc1ccc(CCCOCC2CCC2)cc1 10.1021/jm00389a008
44287467 25503 0 None None None Guinea pig 6.0 pKd = 6.0 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 216 8 2 4 1.5 CCC(CC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
CHEMBL1178777 25503 0 None None None Guinea pig 6.0 pKd = 6.0 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 216 8 2 4 1.5 CCC(CC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
3047497 27654 4 None None None Guinea pig 6.0 pKd = 6.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192675 27654 4 None None None Guinea pig 6.0 pKd = 6.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
44276727 197624 0 None None None Guinea pig 7.0 pKd = 7.0 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
CHEMBL26917 197624 0 None None None Guinea pig 7.0 pKd = 7.0 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
12606685 25943 0 None None None Guinea pig 6.0 pKd = 6.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 7 2 3 1.0 CC(C)COCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1181117 25943 0 None None None Guinea pig 6.0 pKd = 6.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 7 2 3 1.0 CC(C)COCC(O)CNC(C)C 10.1021/jm00180a007
132 2632 14 None None None Rat 10.4 pKi = 10.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 2632 14 None None None Rat 10.4 pKi = 10.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 2632 14 None None None Rat 10.4 pKi = 10.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
132 2632 14 None None None Rat 10.3 pKi = 10.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 2632 14 None None None Rat 10.3 pKi = 10.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 2632 14 None None None Rat 10.3 pKi = 10.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
132 2632 14 None None None Rat 9.9 pKi = 9.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 2632 14 None None None Rat 9.9 pKi = 9.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 2632 14 None None None Rat 9.9 pKi = 9.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
132 2632 14 None None None Rat 9.5 pKi = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 2632 14 None None None Rat 9.5 pKi = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 2632 14 None None None Rat 9.5 pKi = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
2685 1837 22 None None None Rat 8.9 pKi = 8.9 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 1837 22 None None None Rat 8.9 pKi = 8.9 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 1837 22 None None None Rat 8.9 pKi = 8.9 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
2685 1837 22 None None None Rat 8.7 pKi = 8.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 1837 22 None None None Rat 8.7 pKi = 8.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 1837 22 None None None Rat 8.7 pKi = 8.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
2303 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 6476 48 None None None Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
5311116 4758 10 None None None Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 4758 10 None None None Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 4758 10 None None None Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
9909993 158925 0 None None None Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 158925 0 None None None Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
2685 1837 22 None None None Rat 5.0 pKi = 5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 1837 22 None None None Rat 5.0 pKi = 5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 1837 22 None None None Rat 5.0 pKi = 5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
9909993 158925 0 None None None Rat 4.9 pKi = 4.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 158925 0 None None None Rat 4.9 pKi = 4.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
33624 8322 24 None None None Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 8322 24 None None None Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 8322 24 None None None Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 8322 24 None None None Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 8322 24 None None None Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
2303 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 6476 48 None None None Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
1786 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
1786 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 5120 49 None None None Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
2303 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 6476 48 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
33624 8322 24 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 8322 24 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 8322 24 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 8322 24 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 8322 24 None None None Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
33624 8322 24 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 8322 24 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 8322 24 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 8322 24 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 8322 24 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
2303 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 6476 48 None None None Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
132 2632 14 None None None Rat 6.5 pKi = 6.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 2632 14 None None None Rat 6.5 pKi = 6.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 2632 14 None None None Rat 6.5 pKi = 6.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
2303 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 6476 48 None None None Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
1786 5120 49 None None None Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 5120 49 None None None Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 5120 49 None None None Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 5120 49 None None None Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 5120 49 None None None Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
9909993 158925 0 None None None Rat 7.3 pKi = 7.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 158925 0 None None None Rat 7.3 pKi = 7.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
1786 5120 49 None None None Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 5120 49 None None None Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 5120 49 None None None Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 5120 49 None None None Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 5120 49 None None None Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
5311116 4758 10 None None None Rat 7.2 pKi = 7.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 4758 10 None None None Rat 7.2 pKi = 7.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 4758 10 None None None Rat 7.2 pKi = 7.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
1786 5120 49 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 5120 49 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 5120 49 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 5120 49 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 5120 49 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
33624 8322 24 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 8322 24 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 8322 24 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 8322 24 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 8322 24 None None None Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
44331346 475209 0 None None None Human 5.2 pKi = 5.2 Functional
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
CHEMBL99599 475209 0 None None None Human 5.2 pKi = 5.2 Functional
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
2685 1837 22 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 1837 22 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 1837 22 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
33624 8322 24 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 8322 24 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 8322 24 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 8322 24 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 8322 24 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
5311116 4758 10 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 4758 10 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 4758 10 None None None Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
9909993 158925 0 None None None Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 158925 0 None None None Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
5311116 4758 10 None None None Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 4758 10 None None None Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 4758 10 None None None Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
2685 1837 22 None None None Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 1837 22 None None None Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 1837 22 None None None Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
9909993 158925 0 None None None Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 158925 0 None None None Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
5311116 4758 10 None None None Rat 4.1 pKi = 4.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 4758 10 None None None Rat 4.1 pKi = 4.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 4758 10 None None None Rat 4.1 pKi = 4.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
1658 509450 0 None None None Human 7.8 pA2 = 7.8 Functional
NoneNone
Drug Central 372 8 4 6 1.9 CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1 None
2249 1058 67 None None None Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
255 1058 67 None None None Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
548 1058 67 None None None Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
CHEMBL24 1058 67 None None None Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
DB00335 1058 67 None None None Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
2475 1528 0 None None None Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
433 1528 0 None None None Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
550 1528 0 None None None Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
CHEMBL305380 1528 0 None None None Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
DB08808 1528 0 None None None Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
36811 2998 34 None -4 2 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
535 2998 34 None -4 2 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
937 2998 34 None -4 2 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
CHEMBL926 2998 34 None -4 2 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
DB00841 2998 34 None -4 2 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
10184665 8655 40 None -44 3 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
4799 8655 40 None -44 3 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
7353 8655 40 None -44 3 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
CHEMBL1198857 8655 40 None -44 3 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
DB09082 8655 40 None -44 3 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
2723 123170 6 None -20 5 Guinea pig 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
65772 123170 6 None -20 5 Guinea pig 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL174984 123170 6 None -20 5 Guinea pig 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
DB13692 123170 6 None -20 5 Guinea pig 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
2388 18486 20 None -1 7 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
443372 18486 20 None -1 7 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
CHEMBL1160723 18486 20 None -1 7 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
1499 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 4274 42 None 2 31 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
12065 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 19875286
12065 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 33093660
45483813 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 19875286
45483813 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 33093660
CHEMBL579394 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 19875286
CHEMBL579394 1298 32 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 33093660
9512 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
9887812 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
CHEMBL208427 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
DB06190 7386 37 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
2598 8237 41 None -3 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
5403 8237 41 None -3 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
560 8237 41 None -3 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
CHEMBL1760 8237 41 None -3 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
DB00871 8237 41 None -3 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
123600 4712 0 None -2 2 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
1575 4712 0 None -2 2 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
9816 4712 0 None -2 2 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
CHEMBL1002 4712 0 None -2 2 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
DB13139 4712 0 None -2 2 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
567 1496 16 None -173 4 Human 6.5 pEC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
9841972 1496 16 None -173 4 Human 6.5 pEC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
CHEMBL284782 1496 16 None -173 4 Human 6.5 pEC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
36811 2998 34 None -4 2 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
535 2998 34 None -4 2 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
937 2998 34 None -4 2 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
CHEMBL926 2998 34 None -4 2 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
DB00841 2998 34 None -4 2 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
1155 3351 39 None -2 4 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
3343 3351 39 None -2 4 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
557 3351 39 None -2 4 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
CHEMBL32800 3351 39 None -2 4 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
DB01288 3351 39 None -2 4 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
1028 599 43 None -15 11 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
479 599 43 None -15 11 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
5816 599 43 None -15 11 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL679 599 43 None -15 11 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00668 599 43 None -15 11 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
5311064 2816 32 None None None Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
534 2816 32 None None None Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
806 2816 32 None None None Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
CHEMBL493682 2816 32 None None None Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
1960 5823 49 None -19 15 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
439260 5823 49 None -19 15 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
505 5823 49 None -19 15 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
6921840 5823 49 None -19 15 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL1437 5823 49 None -19 15 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00368 5823 49 None -19 15 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
1239 3447 41 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3410 3447 41 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3465 3447 41 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
CHEMBL1256786 3447 41 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
DB00983 3447 41 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
12578 1929 47 None 154 3 Human 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
2755 1929 47 None 154 3 Human 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
CHEMBL1374751 1929 47 None 154 3 Human 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
1499 4274 42 None 2 31 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
3779 4274 42 None 2 31 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
536 4274 42 None 2 31 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
CHEMBL434 4274 42 None 2 31 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
DB01064 4274 42 None 2 31 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
12582 1957 29 None 1 3 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
2783 1957 29 None 1 3 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
673 1957 29 None 1 3 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
CHEMBL49080 1957 29 None 1 3 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
DB01407 1957 29 None 1 3 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
4382 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
4382 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
7445 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
7445 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
9865528 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
9865528 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
CHEMBL2095212 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
CHEMBL2095212 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
DB08893 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
DB08893 5162 60 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
176 823 54 None -10 31 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2157 823 54 None -10 31 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2566 823 54 None -10 31 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
CHEMBL633 823 54 None -10 31 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
DB01118 823 54 None -10 31 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
1499 4274 42 None -269 5 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 4274 42 None -269 5 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 4274 42 None -269 5 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 4274 42 None -269 5 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 4274 42 None -269 5 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
321 2732 0 None -1 2 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
444031 2732 0 None -1 2 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
784 2732 0 None -1 2 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
CHEMBL1346 2732 0 None -1 2 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
DB00496 2732 0 None -1 2 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

9906822 309092 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 358 7 3 3 4.1 COc1cccc2c(CC(C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL416012 309092 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 358 7 3 3 4.1 COc1cccc2c(CC(C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1007/s00044-009-9257-x
44396736 139155 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL186271 139155 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
44396715 139734 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL189081 139734 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
2303 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
4946 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
564 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
63 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
91536 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
CHEMBL27 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
CHEMBL452861 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
DB00571 6476 48 None None None Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
9927453 197018 0 None None None Human 8.7 pEC50 = 8.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
CHEMBL26393 197018 0 None None None Human 8.7 pEC50 = 8.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
44392457 330819 0 None None None Human 8.0 pEC50 = 8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
CHEMBL425161 330819 0 None None None Human 8.0 pEC50 = 8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
44328703 24527 0 None None None Human 6.0 pEC50 = 6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 24527 0 None None None Human 6.0 pEC50 = 6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
10347461 215956 0 None None None Human 6.0 pEC50 = 6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1 10.1021/jm401532g
CHEMBL3139025 215956 0 None None None Human 6.0 pEC50 = 6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1 10.1021/jm401532g
146025803 346717 0 None None None Human 5.0 pEC50 = 5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 346717 0 None None None Human 5.0 pEC50 = 5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
76333795 176265 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 558 11 5 8 3.1 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1007/s00044-009-9257-x
CHEMBL2260985 176265 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 558 11 5 8 3.1 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1007/s00044-009-9257-x
10482960 216062 0 None None None Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.1 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1 10.1021/jm401532g
CHEMBL3139365 216062 0 None None None Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.1 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1 10.1021/jm401532g
567 1496 16 None None None Human 5.8 pEC50 = 5.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1007/s00044-009-9257-x
9841972 1496 16 None None None Human 5.8 pEC50 = 5.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1007/s00044-009-9257-x
CHEMBL284782 1496 16 None None None Human 5.8 pEC50 = 5.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1007/s00044-009-9257-x
2723 123170 6 None None None Guinea pig 6.8 pEC50 = 6.8 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
65772 123170 6 None None None Guinea pig 6.8 pEC50 = 6.8 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL174984 123170 6 None None None Guinea pig 6.8 pEC50 = 6.8 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
DB13692 123170 6 None None None Guinea pig 6.8 pEC50 = 6.8 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
11432806 138490 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL184407 138490 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
44396568 139569 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL188196 139569 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
76315638 176266 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
CHEMBL2260986 176266 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
2419 7043 56 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
5152 7043 56 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
559 7043 56 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
CHEMBL1263 7043 56 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
DB00938 7043 56 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
127046950 277339 0 None None None Human 5.7 pEC50 = 5.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 277339 0 None None None Human 5.7 pEC50 = 5.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
11318107 216061 0 None None None Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 505 16 4 7 3.4 O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
CHEMBL3139364 216061 0 None None None Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 505 16 4 7 3.4 O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
11318358 216102 0 None None None Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 519 16 4 7 3.8 O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
CHEMBL3139613 216102 0 None None None Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 519 16 4 7 3.8 O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
10393774 239376 0 None None None Human 5.7 pEC50 = 5.7 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 598 14 5 9 2.1 CCCCN(c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)S(=O)(=O)CC(=O)O 10.1021/jm000544b
CHEMBL35500 239376 0 None None None Human 5.7 pEC50 = 5.7 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 598 14 5 9 2.1 CCCCN(c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)S(=O)(=O)CC(=O)O 10.1021/jm000544b
44396532 139043 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL185836 139043 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
164612037 368668 0 None None None Human 4.7 pEC50 = 4.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 368668 0 None None None Human 4.7 pEC50 = 4.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
76315640 176268 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 575 12 3 7 5.8 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)cn(Cc3ccccc3)c12 10.1007/s00044-009-9257-x
CHEMBL2260988 176268 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 575 12 3 7 5.8 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)cn(Cc3ccccc3)c12 10.1007/s00044-009-9257-x
13720716 116571 0 None None None Guinea pig 6.6 pEC50 = 6.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL1788251 116571 0 None None None Guinea pig 6.6 pEC50 = 6.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2388 18486 20 None None None Human 7.6 pEC50 = 7.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
443372 18486 20 None None None Human 7.6 pEC50 = 7.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 18486 20 None None None Human 7.6 pEC50 = 7.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
10370605 216103 0 None None None Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.2 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1 10.1021/jm401532g
CHEMBL3139615 216103 0 None None None Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.2 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1 10.1021/jm401532g
146025803 346717 0 None None None Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 346717 0 None None None Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
146025803 346717 0 None None None Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 346717 0 None None None Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
15133335 78774 0 None None None Guinea pig 5.6 pEC50 = 5.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 413 5 3 6 3.6 COc1cc(CC2NCCc3c2cc(O)c(O)c3C(F)(F)F)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL143645 78774 0 None None None Guinea pig 5.6 pEC50 = 5.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 413 5 3 6 3.6 COc1cc(CC2NCCc3c2cc(O)c(O)c3C(F)(F)F)cc(OC)c1OC 10.1021/jm00081a007
15133334 237383 0 None None None Guinea pig 5.5 pEC50 = 5.5 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 471 5 3 6 3.2 COc1cc(CC2NCCc3cc(O)c(O)c(I)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL341654 237383 0 None None None Guinea pig 5.5 pEC50 = 5.5 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 471 5 3 6 3.2 COc1cc(CC2NCCc3cc(O)c(O)c(I)c32)cc(OC)c1OC 10.1021/jm00081a007
44583033 368819 0 None None None Human 8.5 pEC50 = 8.5 Binding
Binding affinity to beta-1 adrenoceptorBinding affinity to beta-1 adrenoceptor
ChEMBL 385 9 4 5 2.2 COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1021/jm900364m
CHEMBL486278 368819 0 None None None Human 8.5 pEC50 = 8.5 Binding
Binding affinity to beta-1 adrenoceptorBinding affinity to beta-1 adrenoceptor
ChEMBL 385 9 4 5 2.2 COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1021/jm900364m
44396779 139348 0 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL187209 139348 0 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
146025802 334148 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 334148 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44328703 24527 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 24527 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
146025802 334148 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 334148 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
3931 4582 43 None None None Human 6.5 pEC50 = 6.5 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
9829836 4582 43 None None None Human 6.5 pEC50 = 6.5 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
CHEMBL12998 4582 43 None None None Human 6.5 pEC50 = 6.5 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
44392558 137555 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
CHEMBL182770 137555 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
11962616 457 21 None None None Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
9326 457 21 None None None Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
CHEMBL3039530 457 21 None None None Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
DB12100 457 21 None None None Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
127045855 276971 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 276971 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
3083544 57618 28 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
4943 57618 28 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
CHEMBL1363 57618 28 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
DB00983 57618 28 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
DB01274 57618 28 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
146025802 334148 0 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 334148 0 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
146025802 334148 0 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 334148 0 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
10184665 8655 40 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
4799 8655 40 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
7353 8655 40 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
CHEMBL1198857 8655 40 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
DB09082 8655 40 None None None Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
9917962 332708 0 None None None Human 7.4 pEC50 = 7.4 Binding
Binding affinity towards human Beta-1 adrenergic receptorBinding affinity towards human Beta-1 adrenergic receptor
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL431678 332708 0 None None None Human 7.4 pEC50 = 7.4 Binding
Binding affinity towards human Beta-1 adrenergic receptorBinding affinity towards human Beta-1 adrenergic receptor
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
2388 18486 20 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
443372 18486 20 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 18486 20 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
76322965 176269 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 511 9 3 7 4.5 C[C@H](Cc1cn2c3c(cccc13)OCCC2)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL2260989 176269 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 511 9 3 7 4.5 C[C@H](Cc1cn2c3c(cccc13)OCCC2)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
11270071 199224 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
CHEMBL279931 199224 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
9803765 199841 0 None None None Human 4.3 pEC50 = 4.3 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 449 8 5 7 1.8 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL284311 199841 0 None None None Human 4.3 pEC50 = 4.3 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 449 8 5 7 1.8 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
168290235 385513 0 None None None Human 4.3 pEC50 = 4.3 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 385513 0 None None None Human 4.3 pEC50 = 4.3 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
44396531 139122 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL186135 139122 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
2388 18486 20 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
443372 18486 20 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 18486 20 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
127046950 277339 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 277339 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
10053159 215957 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 545 18 4 7 4.6 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1 10.1021/jm401532g
CHEMBL3139033 215957 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 545 18 4 7 4.6 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1 10.1021/jm401532g
10076176 216105 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1 10.1021/jm401532g
CHEMBL3139683 216105 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1 10.1021/jm401532g
10339796 240280 0 None None None Guinea pig 6.3 pEC50 = 6.3 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 381 5 3 6 2.8 COc1cc(CC2NCCc3c(F)c(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL358648 240280 0 None None None Guinea pig 6.3 pEC50 = 6.3 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 381 5 3 6 2.8 COc1cc(CC2NCCc3c(F)c(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2419 7043 56 None None None Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
5152 7043 56 None None None Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
559 7043 56 None None None Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
CHEMBL1263 7043 56 None None None Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
DB00938 7043 56 None None None Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
127045855 276971 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 276971 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
2388 18486 20 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
443372 18486 20 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 18486 20 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
155154344 405310 0 None None None Human 7.3 pEC50 = 7.3 Binding
cAMP Gs dynamic HTRF assay: Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD) containing 1 mM 3-Isobutyl-1-methylxanthene (IBMX; Cayman Chemical Company, catalog #13347). Serial dilutions were made in a 96 well V-bottom polypropylene compound microplate (Corning, catalog #3363) in stimulation buffer containing 1 mM IBMX, to 2× of the final desired concentration. Standard serial dilution curves were 10-point, 5-fold dilutions starting from a highest concentration of 10 μM. Controls present on every assay plate were 0.1% DMSO (vehicle control), 1 μM isoproterenol (full beta-adrenergic agonist control) and 15 μM xamoterol (partial beta-adrenergic agonist control). 5 μL from the 2× compound plate was stamped into a white 384 round well small volume HiBase assay plate (Greiner Bio-One; catalog #784075) to provide 4 technical replicates per concentration, per compound. Assay plates were centrifuged at 500×g for 10 seconds. Compounds and IBMX were prepared at 2× final dose to compensate for addition of cells.Cell preparation. 1× stimulation buffer, washing PBS (Dulbecco's phosphate-buffered saline, −Mg −Ca; Caisson Labs, catalog #PBL01), assay PBS (Dulbecco's phosphate-buffered saline, +Mg, +Ca; Caisson Labs, catalog #PBL02) and Versene (0.02% EDTA disodium salt solution in PBS without calcium or magnesium; Caisson Labs, catalog #EDL01) were pre-warmed to 37° C. Cells expressing beta-adrenergic receptor were washed in washing PBS to remove growth medium and then released from the surface by incubating with Versene for 5-10 minutes at 37° C. Cells were harvested using assay PBS, counted manually by hemocytometer or by an automated cell counter, pelleted by centrifugation (200×g, 5 minutes) and resuspended in 37° C. 1× stimulation buffer to a final density of 1.5×10{circumflex over ( )}6 cells/mL. 5 μL of the suspended cell solution (7500 cell total) were added to all wells of the 384 well assay plate, the assay plate was covered with an Axygen® plate seal (Corning PCR-SP) and incubated in a humidified 37° C. environment supplemented with 5% CO2 for 30 minutes.HTRF reagent addition, reading and data analysis. After 30 minutes of cell stimulation with test compound, the assay plates were centrifuged at 500×g for 10 seconds, and incubation was stopped with the addition of 5 μL cAMP-D2 acceptor, diluted 1:21 in detection and lysis buffer 2 (Cisbio 62CL2FDF) was added to all cells. Subsequently, 5 μL Anti-cAMP-Eu Donor, diluted 1:21 in detection and lysis buffer 2, was added to cells. Plates were sealed and reactions gently ‘vortexed’ at 900 rpm on a Heidolph Titramax 1000 for at least 30 minutes at room temperature. Plates were centrifuged again at 500×g for 10 seconds, and HTRF was measured using a Tecan Spark plate reader at 50 flashes per well. HTRF ratios (665 nm/620 nm×10,000) were determined and plotted in GraphPad Prism to generate a concentration-effect curve. Potency estimates (EC50) were derived from the four-parameter nonlinear regression of the concentration-effect curve and an estimate of relative efficacy was determined by comparing the magnitude of the test compound HTRF signal window (min−max dose) with the signal window of the full agonist control, isoproterenol.cAMP Gs dynamic HTRF assay: Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD) containing 1 mM 3-Isobutyl-1-methylxanthene (IBMX; Cayman Chemical Company, catalog #13347). Serial dilutions were made in a 96 well V-bottom polypropylene compound microplate (Corning, catalog #3363) in stimulation buffer containing 1 mM IBMX, to 2× of the final desired concentration. Standard serial dilution curves were 10-point, 5-fold dilutions starting from a highest concentration of 10 μM. Controls present on every assay plate were 0.1% DMSO (vehicle control), 1 μM isoproterenol (full beta-adrenergic agonist control) and 15 μM xamoterol (partial beta-adrenergic agonist control). 5 μL from the 2× compound plate was stamped into a white 384 round well small volume HiBase assay plate (Greiner Bio-One; catalog #784075) to provide 4 technical replicates per concentration, per compound. Assay plates were centrifuged at 500×g for 10 seconds. Compounds and IBMX were prepared at 2× final dose to compensate for addition of cells.Cell preparation. 1× stimulation buffer, washing PBS (Dulbecco's phosphate-buffered saline, −Mg −Ca; Caisson Labs, catalog #PBL01), assay PBS (Dulbecco's phosphate-buffered saline, +Mg, +Ca; Caisson Labs, catalog #PBL02) and Versene (0.02% EDTA disodium salt solution in PBS without calcium or magnesium; Caisson Labs, catalog #EDL01) were pre-warmed to 37° C. Cells expressing beta-adrenergic receptor were washed in washing PBS to remove growth medium and then released from the surface by incubating with Versene for 5-10 minutes at 37° C. Cells were harvested using assay PBS, counted manually by hemocytometer or by an automated cell counter, pelleted by centrifugation (200×g, 5 minutes) and resuspended in 37° C. 1× stimulation buffer to a final density of 1.5×10{circumflex over ( )}6 cells/mL. 5 μL of the suspended cell solution (7500 cell total) were added to all wells of the 384 well assay plate, the assay plate was covered with an Axygen® plate seal (Corning PCR-SP) and incubated in a humidified 37° C. environment supplemented with 5% CO2 for 30 minutes.HTRF reagent addition, reading and data analysis. After 30 minutes of cell stimulation with test compound, the assay plates were centrifuged at 500×g for 10 seconds, and incubation was stopped with the addition of 5 μL cAMP-D2 acceptor, diluted 1:21 in detection and lysis buffer 2 (Cisbio 62CL2FDF) was added to all cells. Subsequently, 5 μL Anti-cAMP-Eu Donor, diluted 1:21 in detection and lysis buffer 2, was added to cells. Plates were sealed and reactions gently ‘vortexed’ at 900 rpm on a Heidolph Titramax 1000 for at least 30 minutes at room temperature. Plates were centrifuged again at 500×g for 10 seconds, and HTRF was measured using a Tecan Spark plate reader at 50 flashes per well. HTRF ratios (665 nm/620 nm×10,000) were determined and plotted in GraphPad Prism to generate a concentration-effect curve. Potency estimates (EC50) were derived from the four-parameter nonlinear regression of the concentration-effect curve and an estimate of relative efficacy was determined by comparing the magnitude of the test compound HTRF signal window (min−max dose) with the signal window of the full agonist control, isoproterenol.
ChEMBL 262 3 2 3 2.5 CC(C)(C)NC[C@H](O)c1cccc(C(F)(F)F)n1 nan
CHEMBL5744358 405310 0 None None None Human 7.3 pEC50 = 7.3 Binding
cAMP Gs dynamic HTRF assay: Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD) containing 1 mM 3-Isobutyl-1-methylxanthene (IBMX; Cayman Chemical Company, catalog #13347). Serial dilutions were made in a 96 well V-bottom polypropylene compound microplate (Corning, catalog #3363) in stimulation buffer containing 1 mM IBMX, to 2× of the final desired concentration. Standard serial dilution curves were 10-point, 5-fold dilutions starting from a highest concentration of 10 μM. Controls present on every assay plate were 0.1% DMSO (vehicle control), 1 μM isoproterenol (full beta-adrenergic agonist control) and 15 μM xamoterol (partial beta-adrenergic agonist control). 5 μL from the 2× compound plate was stamped into a white 384 round well small volume HiBase assay plate (Greiner Bio-One; catalog #784075) to provide 4 technical replicates per concentration, per compound. Assay plates were centrifuged at 500×g for 10 seconds. Compounds and IBMX were prepared at 2× final dose to compensate for addition of cells.Cell preparation. 1× stimulation buffer, washing PBS (Dulbecco's phosphate-buffered saline, −Mg −Ca; Caisson Labs, catalog #PBL01), assay PBS (Dulbecco's phosphate-buffered saline, +Mg, +Ca; Caisson Labs, catalog #PBL02) and Versene (0.02% EDTA disodium salt solution in PBS without calcium or magnesium; Caisson Labs, catalog #EDL01) were pre-warmed to 37° C. Cells expressing beta-adrenergic receptor were washed in washing PBS to remove growth medium and then released from the surface by incubating with Versene for 5-10 minutes at 37° C. Cells were harvested using assay PBS, counted manually by hemocytometer or by an automated cell counter, pelleted by centrifugation (200×g, 5 minutes) and resuspended in 37° C. 1× stimulation buffer to a final density of 1.5×10{circumflex over ( )}6 cells/mL. 5 μL of the suspended cell solution (7500 cell total) were added to all wells of the 384 well assay plate, the assay plate was covered with an Axygen® plate seal (Corning PCR-SP) and incubated in a humidified 37° C. environment supplemented with 5% CO2 for 30 minutes.HTRF reagent addition, reading and data analysis. After 30 minutes of cell stimulation with test compound, the assay plates were centrifuged at 500×g for 10 seconds, and incubation was stopped with the addition of 5 μL cAMP-D2 acceptor, diluted 1:21 in detection and lysis buffer 2 (Cisbio 62CL2FDF) was added to all cells. Subsequently, 5 μL Anti-cAMP-Eu Donor, diluted 1:21 in detection and lysis buffer 2, was added to cells. Plates were sealed and reactions gently ‘vortexed’ at 900 rpm on a Heidolph Titramax 1000 for at least 30 minutes at room temperature. Plates were centrifuged again at 500×g for 10 seconds, and HTRF was measured using a Tecan Spark plate reader at 50 flashes per well. HTRF ratios (665 nm/620 nm×10,000) were determined and plotted in GraphPad Prism to generate a concentration-effect curve. Potency estimates (EC50) were derived from the four-parameter nonlinear regression of the concentration-effect curve and an estimate of relative efficacy was determined by comparing the magnitude of the test compound HTRF signal window (min−max dose) with the signal window of the full agonist control, isoproterenol.cAMP Gs dynamic HTRF assay: Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD) containing 1 mM 3-Isobutyl-1-methylxanthene (IBMX; Cayman Chemical Company, catalog #13347). Serial dilutions were made in a 96 well V-bottom polypropylene compound microplate (Corning, catalog #3363) in stimulation buffer containing 1 mM IBMX, to 2× of the final desired concentration. Standard serial dilution curves were 10-point, 5-fold dilutions starting from a highest concentration of 10 μM. Controls present on every assay plate were 0.1% DMSO (vehicle control), 1 μM isoproterenol (full beta-adrenergic agonist control) and 15 μM xamoterol (partial beta-adrenergic agonist control). 5 μL from the 2× compound plate was stamped into a white 384 round well small volume HiBase assay plate (Greiner Bio-One; catalog #784075) to provide 4 technical replicates per concentration, per compound. Assay plates were centrifuged at 500×g for 10 seconds. Compounds and IBMX were prepared at 2× final dose to compensate for addition of cells.Cell preparation. 1× stimulation buffer, washing PBS (Dulbecco's phosphate-buffered saline, −Mg −Ca; Caisson Labs, catalog #PBL01), assay PBS (Dulbecco's phosphate-buffered saline, +Mg, +Ca; Caisson Labs, catalog #PBL02) and Versene (0.02% EDTA disodium salt solution in PBS without calcium or magnesium; Caisson Labs, catalog #EDL01) were pre-warmed to 37° C. Cells expressing beta-adrenergic receptor were washed in washing PBS to remove growth medium and then released from the surface by incubating with Versene for 5-10 minutes at 37° C. Cells were harvested using assay PBS, counted manually by hemocytometer or by an automated cell counter, pelleted by centrifugation (200×g, 5 minutes) and resuspended in 37° C. 1× stimulation buffer to a final density of 1.5×10{circumflex over ( )}6 cells/mL. 5 μL of the suspended cell solution (7500 cell total) were added to all wells of the 384 well assay plate, the assay plate was covered with an Axygen® plate seal (Corning PCR-SP) and incubated in a humidified 37° C. environment supplemented with 5% CO2 for 30 minutes.HTRF reagent addition, reading and data analysis. After 30 minutes of cell stimulation with test compound, the assay plates were centrifuged at 500×g for 10 seconds, and incubation was stopped with the addition of 5 μL cAMP-D2 acceptor, diluted 1:21 in detection and lysis buffer 2 (Cisbio 62CL2FDF) was added to all cells. Subsequently, 5 μL Anti-cAMP-Eu Donor, diluted 1:21 in detection and lysis buffer 2, was added to cells. Plates were sealed and reactions gently ‘vortexed’ at 900 rpm on a Heidolph Titramax 1000 for at least 30 minutes at room temperature. Plates were centrifuged again at 500×g for 10 seconds, and HTRF was measured using a Tecan Spark plate reader at 50 flashes per well. HTRF ratios (665 nm/620 nm×10,000) were determined and plotted in GraphPad Prism to generate a concentration-effect curve. Potency estimates (EC50) were derived from the four-parameter nonlinear regression of the concentration-effect curve and an estimate of relative efficacy was determined by comparing the magnitude of the test compound HTRF signal window (min−max dose) with the signal window of the full agonist control, isoproterenol.
ChEMBL 262 3 2 3 2.5 CC(C)(C)NC[C@H](O)c1cccc(C(F)(F)F)n1 nan
44396513 139010 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL185660 139010 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
6916441 193726 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 402 9 4 4 3.5 CC(Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
CHEMBL282190 193726 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 402 9 4 4 3.5 CC(Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
44396577 139240 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL186676 139240 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
44396596 251381 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL361505 251381 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
76319327 176275 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 584 14 4 7 4.5 CCN(CC)C(=O)COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL2261203 176275 0 None None None Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 584 14 4 7 4.5 CCN(CC)C(=O)COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
13720717 155074 0 None None None Guinea pig 5.2 pEC50 = 5.2 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL2092996 155074 0 None None None Guinea pig 5.2 pEC50 = 5.2 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
127045855 276971 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 276971 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44328703 24527 0 None None None Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 24527 0 None None None Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44328703 24527 0 None None None Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 24527 0 None None None Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
76329060 216106 0 None None None Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 493 17 4 7 3.5 CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm401532g
CHEMBL3139685 216106 0 None None None Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 493 17 4 7 3.5 CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm401532g
76315639 176267 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(C(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
CHEMBL2260987 176267 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(C(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
76315637 176264 0 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 607 12 4 10 4.2 CCOC(=O)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL2260984 176264 0 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 607 12 4 10 4.2 CCOC(=O)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
44396530 139375 0 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL187317 139375 0 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
44392542 138156 0 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1007/s00044-009-9257-x
CHEMBL183552 138156 0 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1007/s00044-009-9257-x
2388 18486 20 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm401532g
443372 18486 20 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm401532g
CHEMBL1160723 18486 20 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm401532g
127045855 276971 0 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 276971 0 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
127046950 277339 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 277339 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
127046950 277339 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 277339 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
146025802 334148 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 334148 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
2419 7043 56 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
5152 7043 56 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
559 7043 56 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
CHEMBL1263 7043 56 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
DB00938 7043 56 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
146025803 346717 0 None None None Human 5.1 pEC50 = 5.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 346717 0 None None None Human 5.1 pEC50 = 5.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
44392575 136701 0 None None None Human 8.0 pEC50 = 8.0 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
CHEMBL181300 136701 0 None None None Human 8.0 pEC50 = 8.0 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
53494950 145309 0 None None None Human 10.4 pIC50 = 10.4 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cccc(OCCF)c1 10.1021/ml1002458
CHEMBL2011218 145309 0 None None None Human 10.4 pIC50 = 10.4 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cccc(OCCF)c1 10.1021/ml1002458
70683109 145317 0 None None None Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 481 9 4 6 1.7 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(I)nc1 10.1021/ml1002458
CHEMBL2011226 145317 0 None None None Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 481 9 4 6 1.7 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(I)nc1 10.1021/ml1002458
70693600 145318 0 None None None Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 433 9 4 6 1.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(Br)nc1 10.1021/ml1002458
CHEMBL2011227 145318 0 None None None Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 433 9 4 6 1.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(Br)nc1 10.1021/ml1002458
11546170 145307 0 None None None Human 10.1 pIC50 = 10.1 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)cc1 10.1021/ml1002458
CHEMBL2011216 145307 0 None None None Human 10.1 pIC50 = 10.1 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)cc1 10.1021/ml1002458
70691507 145306 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)cc1 10.1021/ml1002458
CHEMBL2011215 145306 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)cc1 10.1021/ml1002458
70683108 145315 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 417 12 4 7 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)nc1 10.1021/ml1002458
CHEMBL2011224 145315 0 None None None Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 417 12 4 7 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)nc1 10.1021/ml1002458
11523842 145304 0 None None None Human 10.0 pIC50 = 10.0 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 384 10 4 6 1.7 COc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
CHEMBL2011213 145304 0 None None None Human 10.0 pIC50 = 10.0 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 384 10 4 6 1.7 COc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
70680984 145325 0 None None None Human 9.9 pIC50 = 9.9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 371 10 3 5 1.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Cc1ccc(F)cc1 10.1021/ml1002458
CHEMBL2011235 145325 0 None None None Human 9.9 pIC50 = 9.9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 371 10 3 5 1.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Cc1ccc(F)cc1 10.1021/ml1002458
2585 1662 62 None None None Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 1662 62 None None None Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 1662 62 None None None Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 1662 62 None None None Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 1662 62 None None None Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
70687345 145305 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccccc1F 10.1021/ml1002458
CHEMBL2011214 145305 0 None None None Human 9.7 pIC50 = 9.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccccc1F 10.1021/ml1002458
70683106 145308 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 430 13 4 6 2.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCCF)cc1 10.1021/ml1002458
CHEMBL2011217 145308 0 None None None Human 9.6 pIC50 = 9.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 430 13 4 6 2.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCCF)cc1 10.1021/ml1002458
70680982 145316 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 373 9 4 6 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
CHEMBL2011225 145316 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 373 9 4 6 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
70693601 145319 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 434 9 4 7 1.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cnc(Br)cn1 10.1021/ml1002458
CHEMBL2011228 145319 0 None None None Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 434 9 4 7 1.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cnc(Br)cn1 10.1021/ml1002458
127 6360 38 None None None Human 9.1 pIC50 = 9.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
688095 6360 38 None None None Human 9.1 pIC50 = 9.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL117405 6360 38 None None None Human 9.1 pIC50 = 9.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
2176 6361 47 None None None Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
4828 6361 47 None None None Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
91 6361 47 None None None Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL500 6361 47 None None None Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
DB00960 6361 47 None None None Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
70689402 145313 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)c(F)c1 10.1021/ml1002458
CHEMBL2011222 145313 0 None None None Human 9.0 pIC50 = 9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)c(F)c1 10.1021/ml1002458
70680981 145310 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 429 12 5 6 2.5 CC(CF)Nc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
CHEMBL2011219 145310 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 429 12 5 6 2.5 CC(CF)Nc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
145990586 331653 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]-CGP-12177 from human beta1-adrenergic receptorDisplacement of [3H]-CGP-12177 from human beta1-adrenergic receptor
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 331653 0 None None None Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]-CGP-12177 from human beta1-adrenergic receptorDisplacement of [3H]-CGP-12177 from human beta1-adrenergic receptor
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
2249 1058 67 None None None Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
255 1058 67 None None None Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
548 1058 67 None None None Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
CHEMBL24 1058 67 None None None Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
DB00335 1058 67 None None None Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
2303 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 6476 48 None None None Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
24901416 142603 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945035 142603 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1 10.1016/j.bmcl.2011.10.049
44268305 193665 0 None None None Human 8.0 pIC50 = 8 Binding
Compound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligandCompound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligand
ChEMBL 345 10 3 5 2.8 COc1ccc(CC[C@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL274782 193665 0 None None None Human 8.0 pIC50 = 8 Binding
Compound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligandCompound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligand
ChEMBL 345 10 3 5 2.8 COc1ccc(CC[C@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
1531 4617 40 None None None Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 4617 40 None None None Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 4617 40 None None None Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 4617 40 None None None Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 4617 40 None None None Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
70685188 145321 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 392 11 4 9 -0.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nnn(CCF)n1 10.1021/ml1002458
CHEMBL2011230 145321 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 392 11 4 9 -0.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nnn(CCF)n1 10.1021/ml1002458
70687347 145323 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 358 9 3 6 0.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)c1ccc(F)nc1 10.1021/ml1002458
CHEMBL2011233 145323 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 358 9 3 6 0.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)c1ccc(F)nc1 10.1021/ml1002458
24901143 142609 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 483 10 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945041 142609 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 483 10 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
24900750 142623 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945289 142623 0 None None None Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1 10.1016/j.bmcl.2011.10.049
16049162 136424 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807826 136424 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1 10.1016/j.bmcl.2011.05.097
16049377 136430 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807832 136430 0 None None None Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24900751 142624 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.8 CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945290 142624 0 None None None Human 7.0 pIC50 = 7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.8 CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
44268277 46139 0 None None None Human 7.0 pIC50 = 7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 11 4 6 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13238 46139 0 None None None Human 7.0 pIC50 = 7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 11 4 6 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44281371 200295 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 655 14 3 10 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL287567 200295 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 655 14 3 10 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44377315 120171 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 14 3 6 5.4 O=C1N(CCCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL165177 120171 0 None None None Human 6.0 pIC50 = 6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 14 3 6 5.4 O=C1N(CCCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44313090 203219 0 None None None Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 568 12 6 7 4.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(OCC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308126 203219 0 None None None Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 568 12 6 7 4.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(OCC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
44312949 468753 0 None None None Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 602 11 6 6 6.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(CC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL67998 468753 0 None None None Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 602 11 6 6 6.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(CC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
3038500 23645 11 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting methodDisplacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting method
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/acs.jmedchem.5b01372
CHEMBL111201 23645 11 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting methodDisplacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting method
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/acs.jmedchem.5b01372
44307007 200922 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 469 12 3 6 3.6 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL292947 200922 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 469 12 3 6 3.6 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
10437614 201083 14 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 553 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL294042 201083 14 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 553 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
44303198 468200 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 7 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL64201 468200 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 7 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
44307065 468357 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 445 11 3 6 2.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(F)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64932 468357 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 445 11 3 6 2.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(F)cc1 10.1016/s0960-894x(98)00381-3
44307064 468360 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 461 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64936 468360 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 461 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00381-3
44307343 468606 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 457 12 3 7 2.5 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL66964 468606 0 None None None Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 457 12 3 7 2.5 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44268572 59355 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 572 16 6 8 2.9 COCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13521 59355 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 572 16 6 8 2.9 COCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268482 198394 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 499 12 5 7 2.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL273428 198394 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 499 12 5 7 2.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
12017016 200338 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 574 14 3 7 5.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL287947 200338 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 574 14 3 7 5.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
44298497 387179 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 464 11 1 5 5.9 CCCCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL53359 387179 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 464 11 1 5 5.9 CCCCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44298731 405177 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 429 10 2 3 4.9 CCCCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL57430 405177 0 None None None Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 429 10 2 3 4.9 CCCCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
9799092 100572 0 None None None Human 6.0 pIC50 = 6 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154419 100572 0 None None None Human 6.0 pIC50 = 6 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
44268281 40760 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 436 14 4 6 2.9 CCCCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12498 40760 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 436 14 4 6 2.9 CCCCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268275 43463 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 484 14 4 6 3.3 O=S(=O)(CCCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13003 43463 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 484 14 4 6 3.3 O=S(=O)(CCCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268254 43863 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 302 8 4 5 1.5 Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13034 43863 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 302 8 4 5 1.5 Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268295 198807 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 12 4 6 2.1 CCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL276480 198807 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 12 4 6 2.1 CCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268324 40668 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12450 40668 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
44268274 42709 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cccc(Cl)c1 10.1016/s0960-894x(98)00169-3
CHEMBL12813 42709 0 None None None Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cccc(Cl)c1 10.1016/s0960-894x(98)00169-3
44335572 19512 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 475 9 3 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL105968 19512 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 475 9 3 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00571-x
44335498 217176 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 447 9 3 5 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00571-x
CHEMBL318802 217176 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 447 9 3 5 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00571-x
44335562 218148 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 558 14 4 6 4.7 O=C(CCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL320138 218148 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 558 14 4 6 4.7 O=C(CCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44303192 468316 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 523 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL64697 468316 0 None None None Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 523 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00571-x
12049923 468665 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 12 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cc(F)cc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL67404 468665 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 12 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cc(F)cc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
44461468 215320 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 608 17 4 9 3.7 CCCCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL312364 215320 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 608 17 4 9 3.7 CCCCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44377412 238832 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 580 15 4 9 3.0 CCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL351467 238832 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 580 15 4 9 3.0 CCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44281037 232387 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 479 10 3 8 3.1 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33168 232387 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 479 10 3 8 3.1 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
12043158 328224 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CC(O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL418411 328224 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CC(O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44377677 119678 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 495 10 3 6 2.6 CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL164401 119678 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 495 10 3 6 2.6 CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44377517 120028 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 551 14 3 6 4.2 CCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL165015 120028 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 551 14 3 6 4.2 CCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44377957 120297 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 537 13 3 6 3.8 CCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL166013 120297 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 537 13 3 6 3.8 CCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44377650 238878 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 577 13 3 6 4.6 O=C1N(CCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL351967 238878 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 577 13 3 6 4.6 O=C1N(CCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44461489 470203 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 4.3 O=C1N(CCCC(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL79675 470203 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 4.3 O=C1N(CCCC(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44461719 470670 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 641 14 3 6 5.0 O=C1N(CCCC(F)(F)C(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL83754 470670 0 None None None Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 641 14 3 6 5.0 O=C1N(CCCC(F)(F)C(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44306992 468750 0 None None None Human 5.0 pIC50 = 5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 442 11 4 7 2.0 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67993 468750 0 None None None Human 5.0 pIC50 = 5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 442 11 4 7 2.0 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
44298767 201041 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 553 15 4 6 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
CHEMBL293818 201041 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 553 15 4 6 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
44298306 202101 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 6 1 3 4.1 CN(CCc1ccccc1)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL301594 202101 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 6 1 3 4.1 CN(CCc1ccccc1)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44298752 393946 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 415 8 1 3 4.5 CCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL56594 393946 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 415 8 1 3 4.5 CCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44298718 394182 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 386 8 1 3 4.3 CCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL56752 394182 0 None None None Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 386 8 1 3 4.3 CCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44335844 19210 0 None None None Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 5 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104377 19210 0 None None None Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 5 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
44335882 19243 0 None None None Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 425 11 3 5 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104551 19243 0 None None None Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 425 11 3 5 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
44335833 19913 0 None None None Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 448 9 3 6 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00571-x
CHEMBL107681 19913 0 None None None Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 448 9 3 6 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00571-x
44301881 200689 0 None None None Human 4.0 pIC50 = 4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 8 6.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4s3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL291306 200689 0 None None None Human 4.0 pIC50 = 4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 8 6.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4s3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44377755 238651 0 None None None Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 13 3 8 4.0 O=c1n(CCCC(F)(F)F)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL349689 238651 0 None None None Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 13 3 8 4.0 O=c1n(CCCC(F)(F)F)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44461488 470225 0 None None None Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 606 13 3 7 3.0 O=C(CCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O)N1CCCC1 10.1016/s0960-894x(99)00072-4
CHEMBL79915 470225 0 None None None Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 606 13 3 7 3.0 O=C(CCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O)N1CCCC1 10.1016/s0960-894x(99)00072-4
44298761 389560 0 None None None Human 4.0 pIC50 = 4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 331 3 2 3 2.2 CNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL54885 389560 0 None None None Human 4.0 pIC50 = 4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 331 3 2 3 2.2 CNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
145947241 332400 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
CHEMBL4301544 332400 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
44349588 235831 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 628 16 4 7 8.0 CCCCCCCCc1csc(N2CCc3cc(N/C(S)=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL338664 235831 0 None None None Human 7.0 pIC50 = 7.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 628 16 4 7 8.0 CCCCCCCCc1csc(N2CCc3cc(N/C(S)=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
9912580 41950 0 None None None Human 7.0 pIC50 = 7.0 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 470 13 4 6 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12674 41950 0 None None None Human 7.0 pIC50 = 7.0 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 470 13 4 6 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44301818 467788 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 572 11 4 8 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(O)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL61962 467788 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 572 11 4 8 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(O)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998855 118521 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 402 6 2 5 1.3 CN(c1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1)S(C)(=O)=O 10.1021/jm00082a016
CHEMBL162200 118521 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 402 6 2 5 1.3 CN(c1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1)S(C)(=O)=O 10.1021/jm00082a016
14998858 238736 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 422 6 3 5 1.9 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3cccc(Cl)c3)CCN2)cc1 10.1021/jm00082a016
CHEMBL350432 238736 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 422 6 3 5 1.9 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3cccc(Cl)c3)CCN2)cc1 10.1021/jm00082a016
44349378 42386 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 545 11 4 7 4.2 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(I)c1 10.1016/s0960-894x(00)00669-7
CHEMBL127428 42386 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 545 11 4 7 4.2 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(I)c1 10.1016/s0960-894x(00)00669-7
46881651 21190 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1nc(-c2ccccc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1084137 21190 0 None None None Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1nc(-c2ccccc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
46881753 21585 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 10 3 6 3.4 Cn1c(CCC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)nc2ccccc21 10.1016/j.bmcl.2010.01.130
CHEMBL1085929 21585 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 10 3 6 3.4 Cn1c(CCC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)nc2ccccc21 10.1016/j.bmcl.2010.01.130
2812 19119 69 None None None Human 5.0 pIC50 = 5.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
719 19119 69 None None None Human 5.0 pIC50 = 5.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 19119 69 None None None Human 5.0 pIC50 = 5.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
DB00257 19119 69 None None None Human 5.0 pIC50 = 5.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
5806 203226 13 None None None Rat 6.9 pIC50 = 6.9 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
CHEMBL30816 203226 13 None None None Rat 6.9 pIC50 = 6.9 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
DB12803 203226 13 None None None Rat 6.9 pIC50 = 6.9 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
5806 203226 13 None None None Guinea pig 6.9 pIC50 = 6.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
CHEMBL30816 203226 13 None None None Guinea pig 6.9 pIC50 = 6.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
DB12803 203226 13 None None None Guinea pig 6.9 pIC50 = 6.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
24901141 142782 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1947157 142782 0 None None None Human 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
12582 1957 29 None None None Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
2783 1957 29 None None None Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
673 1957 29 None None None Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
CHEMBL49080 1957 29 None None None Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
DB01407 1957 29 None None None Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
44338637 219094 0 None None None Guinea pig 5.9 pIC50 = 5.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 7 2 5 2.8 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
CHEMBL322130 219094 0 None None None Guinea pig 5.9 pIC50 = 5.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 7 2 5 2.8 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
10416656 42470 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3c(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL127656 42470 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3c(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cccc32)n1 10.1016/s0960-894x(00)00669-7
9831168 469590 0 None None None Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL74085 469590 0 None None None Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
12017012 200010 0 None None None Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 622 12 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL285520 200010 0 None None None Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 622 12 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
44338131 218257 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 6 2 5 3.2 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
CHEMBL320761 218257 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 6 2 5 3.2 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
83111 120170 49 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
CHEMBL165175 120170 49 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
415628 475032 52 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00082a016
CHEMBL9841 475032 52 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00082a016
46881981 20073 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 454 11 3 5 4.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCn1cccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078395 20073 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 454 11 3 5 4.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCn1cccc1 10.1016/j.bmcl.2010.01.130
46845698 20114 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(N2CCCC2)c(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078696 20114 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(N2CCCC2)c(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/j.bmcl.2010.01.130
10464801 25493 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178754 25493 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
16049160 136423 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 491 15 5 8 3.3 CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807825 136423 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 491 15 5 8 3.3 CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
16049234 136426 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807828 136426 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049374 136431 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807869 136431 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24900811 142608 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945040 142608 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
57401436 142645 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945504 142645 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
1800 473856 65 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
4189 473856 65 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 473856 65 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
DB01110 473856 65 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
3198 461850 54 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
983 461850 54 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 461850 54 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
DB01127 461850 54 None None None Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
10054896 233161 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33292 233161 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
12049918 202299 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 624 12 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL302893 202299 0 None None None Human 5.9 pIC50 = 5.9 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 624 12 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
44307379 468642 0 None None None Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 427 11 3 6 2.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00381-3
CHEMBL67251 468642 0 None None None Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 427 11 3 6 2.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00381-3
44307378 468783 0 None None None Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 478 11 3 7 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00381-3
CHEMBL68334 468783 0 None None None Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 478 11 3 7 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00381-3
44338562 23732 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 482 11 2 7 4.1 COc1cc(CCNCC(O)CO/N=C2/c3ccccc3C3CCCCCC23OC)cc(OC)c1 10.1021/jm00122a008
CHEMBL111706 23732 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 482 11 2 7 4.1 COc1cc(CCNCC(O)CO/N=C2/c3ccccc3C3CCCCCC23OC)cc(OC)c1 10.1021/jm00122a008
44301842 424250 0 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 11 3 7 6.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL58407 424250 0 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 11 3 7 6.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
80447 120024 66 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 207 2 1 4 1.0 O=[N+]([O-])c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL165012 120024 66 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 207 2 1 4 1.0 O=[N+]([O-])c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
46881899 22106 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089395 22106 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.01.130
2249 1058 67 None None None Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
255 1058 67 None None None Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
548 1058 67 None None None Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
CHEMBL24 1058 67 None None None Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
DB00335 1058 67 None None None Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
76332892 215601 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 528 7 3 6 5.4 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
CHEMBL3128185 215601 0 None None None Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 528 7 3 6 5.4 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
10375227 25497 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178761 25497 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
10012704 25501 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178768 25501 0 None None None Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
44268308 41974 0 None None None Human 6.9 pIC50 = 6.9 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 472 12 4 7 2.8 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12686 41974 0 None None None Human 6.9 pIC50 = 6.9 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 472 12 4 7 2.8 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
46881698 21490 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 5 2.9 O=C(CN1CC(c2ccccc2)CC1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1085444 21490 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 5 2.9 O=C(CN1CC(c2ccccc2)CC1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
44298288 201701 0 None None None Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 441 9 1 5 5.8 CCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL298594 201701 0 None None None Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 441 9 1 5 5.8 CCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44298515 392007 0 None None None Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 436 9 1 5 5.1 CCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL55852 392007 0 None None None Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 436 9 1 5 5.1 CCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44457929 175734 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
CHEMBL22318 175734 0 None None None Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
91965 474883 53 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccccc1N1CCNCC1 10.1021/jm00082a016
CHEMBL9746 474883 53 None None None Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccccc1N1CCNCC1 10.1021/jm00082a016
145946965 332366 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
CHEMBL4300897 332366 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
2464 7398 37 None None None Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
5253 7398 37 None None None Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
7297 7398 37 None None None Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
CHEMBL471 7398 37 None None None Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
DB00489 7398 37 None None None Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
44268249 43364 0 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 331 9 4 5 2.4 C[C@@H](CCc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12994 43364 0 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 331 9 4 5 2.4 C[C@@H](CCc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
44268495 58722 0 None None None Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 19 6 7 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13467 58722 0 None None None Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 19 6 7 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268496 198648 0 None None None Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 13 6 7 3.3 CC(C)NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL275291 198648 0 None None None Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 13 6 7 3.3 CC(C)NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268320 42286 0 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 456 11 4 6 3.1 Cc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12718 42286 0 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 456 11 4 6 3.1 Cc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
44301618 427760 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 574 11 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL58798 427760 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 574 11 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
46881618 22330 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1csc(-c2ccccc2)n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1090746 22330 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1csc(-c2ccccc2)n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
44298769 394202 0 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 457 12 1 5 6.6 CCCCCCCCc1csc(N(C)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL56767 394202 0 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 457 12 1 5 6.6 CCCCCCCCc1csc(N(C)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
97478 24232 53 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL114478 24232 53 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
10103956 25480 0 None None None Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178707 25480 0 None None None Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
9990035 26293 0 None None None Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183337 26293 0 None None None Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
16049450 136425 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807827 136425 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
56670158 136428 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807830 136428 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24901210 142572 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 11 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944690 142572 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 11 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
24900685 142601 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 464 11 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945033 142601 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 464 11 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
24901283 142626 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945292 142626 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
10282871 40435 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3cc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)ccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL123745 40435 0 None None None Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3cc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)ccc32)n1 10.1016/s0960-894x(00)00669-7
44335534 19165 0 None None None Human 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 559 13 5 6 4.1 O=C(NCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104193 19165 0 None None None Human 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 559 13 5 6 4.1 O=C(NCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44338543 20271 0 None None None Guinea pig 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 374 6 2 5 3.6 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
CHEMBL107981 20271 0 None None None Guinea pig 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 374 6 2 5 3.6 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
131847 118893 3 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL162513 118893 3 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
44301819 201199 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 7 6.8 CC(C)(C)c1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL294753 201199 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 7 6.8 CC(C)(C)c1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
208932 27811 6 None None None Human 5.8 pIC50 = 5.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL1193886 27811 6 None None None Human 5.8 pIC50 = 5.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44281531 200676 0 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 13 3 9 5.1 CSc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL291246 200676 0 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 13 3 9 5.1 CSc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
46881796 19930 0 None None None Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 3 6 2.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc2ccnn12 10.1016/j.bmcl.2010.01.130
CHEMBL1077273 19930 0 None None None Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 3 6 2.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc2ccnn12 10.1016/j.bmcl.2010.01.130
2249 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
255 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
548 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
CHEMBL24 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
DB00335 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
16118894 4572 6 None None None Human 6.8 pIC50 = 6.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00381-3
3467 4572 6 None None None Human 6.8 pIC50 = 6.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00381-3
CHEMBL276257 4572 6 None None None Human 6.8 pIC50 = 6.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00381-3
16118894 4572 6 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
3467 4572 6 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
CHEMBL276257 4572 6 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
11758172 201076 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL293994 201076 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998849 119314 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1cccc(N2CCNC(CNC(=O)c3ccc(NS(C)(=O)=O)cc3)C2)c1 10.1021/jm00082a016
CHEMBL163587 119314 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1cccc(N2CCNC(CNC(=O)c3ccc(NS(C)(=O)=O)cc3)C2)c1 10.1021/jm00082a016
11758172 201076 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL293994 201076 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
46881983 20099 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
CHEMBL1078575 20099 0 None None None Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
208932 27811 6 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL1193886 27811 6 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
71612644 270864 0 None None None Human 4.8 pIC50 = 4.8 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
CHEMBL3704833 270864 0 None None None Human 4.8 pIC50 = 4.8 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
1016 8173 46 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 8173 46 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 8173 46 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 8173 46 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 8173 46 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2247 1042 63 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 1042 63 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 1042 63 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 1042 63 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 1042 63 None None None Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2249 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
255 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
548 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
CHEMBL24 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
DB00335 1058 67 None None None Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
1786 5120 49 None None None Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
4171 5120 49 None None None Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
553 5120 49 None None None Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL13 5120 49 None None None Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00264 5120 49 None None None Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
145946488 332309 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4300195 332309 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
145947665 332451 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302144 332451 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
2303 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
4946 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
564 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
63 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
91536 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
CHEMBL27 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
CHEMBL452861 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
DB00571 6476 48 None None None Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
9933039 328052 0 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
CHEMBL417613 328052 0 None None None Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
44349356 235852 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc2ccccc12 10.1016/s0960-894x(00)00669-7
CHEMBL338748 235852 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc2ccccc12 10.1016/s0960-894x(00)00669-7
10627736 235862 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL338794 235862 0 None None None Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1 10.1021/jm000286i
44312924 329746 0 None None None Human 5.8 pIC50 = 5.8 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL421871 329746 0 None None None Human 5.8 pIC50 = 5.8 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
9826638 468328 1 None None None Human 5.8 pIC50 = 5.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 484 12 4 7 3.2 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64760 468328 1 None None None Human 5.8 pIC50 = 5.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 484 12 4 7 3.2 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44298695 201077 0 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 414 10 1 3 5.1 CCCCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL294008 201077 0 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 414 10 1 3 5.1 CCCCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44298843 393699 0 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1ccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)nc1 10.1016/s0960-894x(99)00277-2
CHEMBL56449 393699 0 None None None Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1ccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)nc1 10.1016/s0960-894x(99)00277-2
10347866 175961 1 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL22386 175961 1 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
10347866 175961 1 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
CHEMBL22386 175961 1 None None None Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
14664347 27884 0 None None None Human 4.8 pIC50 = 4.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 2 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(N(C)S(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
CHEMBL11944 27884 0 None None None Human 4.8 pIC50 = 4.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 2 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(N(C)S(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
44276727 197624 0 None None None Human 6.7 pIC50 = 6.7 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
CHEMBL26917 197624 0 None None None Human 6.7 pIC50 = 6.7 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
24900426 142605 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 12 5 6 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945037 142605 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 12 5 6 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1 10.1016/j.bmcl.2011.10.049
24901285 142631 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 11 5 6 5.2 CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2011.10.049
CHEMBL1945297 142631 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 11 5 6 5.2 CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2011.10.049
44268464 43264 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 585 17 5 8 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL12939 43264 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 585 17 5 8 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268520 45089 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 591 14 5 8 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)OCc1ccccc1 10.1016/s0960-894x(98)00170-x
CHEMBL13132 45089 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 591 14 5 8 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)OCc1ccccc1 10.1016/s0960-894x(98)00170-x
10746499 233469 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccc3C(F)(F)F)cs2)cc1 10.1021/jm000286i
CHEMBL333417 233469 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccc3C(F)(F)F)cs2)cc1 10.1021/jm000286i
46882084 20113 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(CCc2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078695 20113 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(CCc2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
46881901 22162 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089734 22162 0 None None None Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
12017007 314252 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL40898 314252 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
44338579 328292 0 None None None Guinea pig 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 364 7 2 5 3.0 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
CHEMBL418819 328292 0 None None None Guinea pig 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 364 7 2 5 3.0 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
44301979 201005 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cnc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL293577 201005 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cnc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
7096 474369 65 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL9434 474369 65 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
46845699 20135 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c(N2CCCC2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078876 20135 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c(N2CCCC2)c1 10.1016/j.bmcl.2010.01.130
46881573 22589 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1092502 22589 0 None None None Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
14739897 475161 0 None None None Human 4.7 pIC50 = 4.7 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1cccc(OCC(O)CN2CCN(c3ccc(NS(C)(=O)=O)cc3)CC2)c1 10.1021/jm00172a033
CHEMBL99331 475161 0 None None None Human 4.7 pIC50 = 4.7 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1cccc(OCC(O)CN2CCN(c3ccc(NS(C)(=O)=O)cc3)CC2)c1 10.1021/jm00172a033
36811 2998 34 None None None Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 2998 34 None None None Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 2998 34 None None None Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 2998 34 None None None Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 2998 34 None None None Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
1054 3263 41 None None None Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
59768 3263 41 None None None Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
7178 3263 41 None None None Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL768 3263 41 None None None Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00187 3263 41 None None None Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
12043157 235643 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 14 3 8 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
CHEMBL33755 235643 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 14 3 8 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
24900749 142625 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 11 4 7 3.8 COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945291 142625 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 11 4 7 3.8 COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
57400229 142632 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 12 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945298 142632 0 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 12 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
10346448 238543 0 None None None Human 5.7 pIC50 = 5.7 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL348501 238543 0 None None None Human 5.7 pIC50 = 5.7 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
70683107 145312 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccc(F)cc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
CHEMBL2011221 145312 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccc(F)cc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
70693599 145314 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 11 4 6 2.2 CCOc1ccc(NC(=O)NCCNC[C@H](O)COc2cccc(F)c2C#N)cc1 10.1021/ml1002458
CHEMBL2011223 145314 0 None None None Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 11 4 6 2.2 CCOc1ccc(NC(=O)NCCNC[C@H](O)COc2cccc(F)c2C#N)cc1 10.1021/ml1002458
2303 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
4946 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
564 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
63 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
91536 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL27 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL452861 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
DB00571 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
2303 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 6476 48 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
33624 8322 24 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
4061 8322 24 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
565 8322 24 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
CHEMBL499 8322 24 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
DB00373 8322 24 None None None Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
70680983 145322 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 348 8 3 6 -0.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)N1CCOCC1 10.1021/ml1002458
CHEMBL2011232 145322 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 348 8 3 6 -0.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)N1CCOCC1 10.1021/ml1002458
3931 4582 43 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1016/s0960-894x(98)00170-x
9829836 4582 43 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1016/s0960-894x(98)00170-x
CHEMBL12998 4582 43 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1016/s0960-894x(98)00170-x
44268604 80091 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 18 6 7 4.9 CCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL144870 80091 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 18 6 7 4.9 CCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44285529 297571 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 534 14 3 7 5.1 CCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL39577 297571 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 534 14 3 7 5.1 CCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44335618 19127 0 None None None Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 497 12 5 6 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104061 19127 0 None None None Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 497 12 5 6 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335560 19651 0 None None None Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 469 10 5 6 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL106746 19651 0 None None None Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 469 10 5 6 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335589 218961 0 None None None Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 540 15 4 7 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL321957 218961 0 None None None Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 540 15 4 7 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
1346 172 66 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
280 172 66 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
9899402 172 66 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
CHEMBL9666 172 66 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
1355 4109 38 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
142 4109 38 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
7153 4109 38 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
CHEMBL478 4109 38 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
DB12110 4109 38 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
10438390 468420 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL65513 468420 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44281344 200031 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 628 14 4 10 4.3 CC(=O)Nc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285704 200031 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 628 14 4 10 4.3 CC(=O)Nc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281255 234434 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(OC(F)(F)F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33515 234434 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(OC(F)(F)F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44281384 238076 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 14 3 10 4.4 COc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL34406 238076 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 14 3 10 4.4 COc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281467 238125 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 648 14 4 10 3.8 CS(=O)(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL34441 238125 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 648 14 4 10 3.8 CS(=O)(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281468 317392 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 623 12 3 8 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL415039 317392 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 623 12 3 8 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44377513 119309 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1ncn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL163531 119309 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1ncn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44461717 215371 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 577 15 3 8 4.6 CCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL312546 215371 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 577 15 3 8 4.6 CCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44461716 470165 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 605 17 3 8 5.4 CCCCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL79363 470165 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 605 17 3 8 5.4 CCCCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44281276 200006 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 15 3 8 4.9 CCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL285481 200006 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 15 3 8 4.9 CCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44281277 200350 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 563 16 3 8 5.3 CCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL288083 200350 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 563 16 3 8 5.3 CCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44377637 118356 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 633 14 3 6 5.3 O=C1N(CCCc2ccc(Cl)cc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL162043 118356 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 633 14 3 6 5.3 O=C1N(CCCc2ccc(Cl)cc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
10841426 235754 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 610 11 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc(F)c(F)c(F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL338216 235754 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 610 11 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc(F)c(F)c(F)c3)cs2)cc1 10.1021/jm000286i
9832011 215174 0 None None None Human 5.7 pIC50 = 5.7 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL312074 215174 0 None None None Human 5.7 pIC50 = 5.7 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
44307063 468359 0 None None None Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 505 11 3 6 3.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64935 468359 0 None None None Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 505 11 3 6 3.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00381-3
44306979 468688 0 None None None Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 476 11 4 7 2.7 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67534 468688 0 None None None Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 476 11 4 7 2.7 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
44306985 468709 0 None None None Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 460 11 4 7 2.2 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67672 468709 0 None None None Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 460 11 4 7 2.2 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
12017005 200438 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(CCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL288917 200438 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(CCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00277-8
12017014 200480 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 12 3 7 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3cc(F)c(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL289316 200480 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 12 3 7 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3cc(F)c(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
44285225 309681 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 562 13 3 7 5.8 CC(C)(C)CCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL39804 309681 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 562 13 3 7 5.8 CC(C)(C)CCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44268327 198581 0 None None None Human 5.7 pIC50 = 5.7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
CHEMBL274807 198581 0 None None None Human 5.7 pIC50 = 5.7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
44335497 19161 0 None None None Human 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 397 9 3 5 2.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00571-x
CHEMBL104180 19161 0 None None None Human 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 397 9 3 5 2.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00571-x
10416448 468411 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 622 12 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL65461 468411 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 622 12 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
70693598 145311 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1c(F)cccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
CHEMBL2011220 145311 0 None None None Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1c(F)cccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
2249 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
255 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
548 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
CHEMBL24 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
DB00335 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
2249 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
255 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
548 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
CHEMBL24 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
DB00335 1058 67 None None None Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
44280904 200141 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 632 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(-c4ccccn4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286438 200141 0 None None None Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 632 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(-c4ccccn4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
12017006 200559 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 11 3 7 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL290053 200559 0 None None None Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 11 3 7 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
10483845 468119 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 11 3 8 5.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63760 468119 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 11 3 8 5.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
14664345 27510 0 None None None Human 4.7 pIC50 = 4.7 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 2 8 1.7 CN(c1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1)S(C)(=O)=O 10.1021/jm00166a002
CHEMBL1191442 27510 0 None None None Human 4.7 pIC50 = 4.7 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 2 8 1.7 CN(c1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1)S(C)(=O)=O 10.1021/jm00166a002
44268534 43220 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 529 13 5 8 3.3 CCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL12911 43220 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 529 13 5 8 3.3 CCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268478 327846 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 561 13 5 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00170-x
CHEMBL417250 327846 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 561 13 5 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00170-x
44298851 200707 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 11 1 4 6.5 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL291467 200707 0 None None None Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 11 1 4 6.5 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
3054 315981 60 None None None Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
448537 315981 60 None None None Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
875 315981 60 None None None Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 315981 60 None None None Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
DB00255 315981 60 None None None Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
14998850 238688 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1ccccc1N1CCNC(CNC(=O)c2ccc(NS(C)(=O)=O)cc2)C1 10.1021/jm00082a016
CHEMBL349978 238688 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1ccccc1N1CCNC(CNC(=O)c2ccc(NS(C)(=O)=O)cc2)C1 10.1021/jm00082a016
9871525 40793 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1cccc(I)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL125168 40793 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1cccc(I)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
14998852 118499 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL162182 118499 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
9810596 40682 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 734 11 4 9 8.0 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc2cc(CCNC[C@H](O)c3cccnc3)ccc2c1 10.1016/s0960-894x(00)00669-7
CHEMBL124597 40682 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 734 11 4 9 8.0 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc2cc(CCNC[C@H](O)c3cccnc3)ccc2c1 10.1016/s0960-894x(00)00669-7
10371216 199936 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285001 199936 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
3038500 23645 11 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL111201 23645 11 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
3038500 23645 11 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL111201 23645 11 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.01.130
25020250 39327 22 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )
ChEMBL 388 4 2 6 3.8 c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1 10.1021/jm100075z
CHEMBL1214998 39327 22 None None None Human 5.6 pIC50 = 5.6 Binding
Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )
ChEMBL 388 4 2 6 3.8 c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1 10.1021/jm100075z
10206782 40737 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 492 10 4 6 4.9 N#CN/C(=N\c1cccc(Oc2ccccc2)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL124863 40737 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 492 10 4 6 4.9 N#CN/C(=N\c1cccc(Oc2ccccc2)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44268479 44738 0 None None None Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 543 13 5 8 3.7 CC(C)OC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13106 44738 0 None None None Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 543 13 5 8 3.7 CC(C)OC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
10054165 175733 1 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 14 3 6 5.0 O=C1N(CCCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL22317 175733 1 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 14 3 6 5.0 O=C1N(CCCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
31101 1504 27 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 1504 27 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 1504 27 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 1504 27 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 1504 27 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
46881982 20084 0 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCc1ccccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078465 20084 0 None None None Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCc1ccccc1 10.1016/j.bmcl.2010.01.130
130400 473157 6 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL99585 473157 6 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
12017011 200529 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL289689 200529 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
208932 27811 6 None None None Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL1193886 27811 6 None None None Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
14739889 474640 1 None None None Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 364 9 3 5 1.9 Cc1cccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)c1 10.1021/jm00172a033
CHEMBL95966 474640 1 None None None Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 364 9 3 5 1.9 Cc1cccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)c1 10.1021/jm00172a033
44281424 200474 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 12 3 9 4.2 O=C(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL289249 200474 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 12 3 9 4.2 O=C(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
44268367 44686 0 None None None Human 7.6 pIC50 = 7.6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 344 9 4 5 1.9 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13102 44686 0 None None None Human 7.6 pIC50 = 7.6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 344 9 4 5 1.9 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268556 57830 0 None None None Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 515 12 5 8 2.9 COC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13389 57830 0 None None None Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 515 12 5 8 2.9 COC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
11342656 466336 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 634 13 3 7 6.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cc2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL61429 466336 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 634 13 3 7 6.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cc2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
12049920 202692 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL304298 202692 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
10258518 202056 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 633 17 3 8 6.8 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL301231 202056 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 633 17 3 8 6.8 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
44281372 200293 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 621 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL287562 200293 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 621 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44461705 470661 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL83698 470661 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
10841171 235889 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3F)cs2)cc1 10.1021/jm000286i
CHEMBL338976 235889 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3F)cs2)cc1 10.1021/jm000286i
44298823 201409 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 462 11 1 3 7.1 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
CHEMBL296380 201409 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 462 11 1 3 7.1 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
44281074 234116 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CCC(=O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33438 234116 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CCC(=O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
16049090 136421 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 447 13 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807823 136421 0 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 447 13 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
24901211 142575 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1944693 142575 0 None None None Human 6.6 pIC50 = 6.6 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
2810 139881 42 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
714 139881 42 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
CHEMBL1902627 139881 42 None None None Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
70691508 145320 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 361 9 4 7 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nccs1 10.1021/ml1002458
CHEMBL2011229 145320 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 361 9 4 7 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nccs1 10.1021/ml1002458
2249 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
255 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
548 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
CHEMBL24 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
DB00335 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
44268571 58327 0 None None None Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 582 13 6 7 4.2 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)NC1CCCCC1 10.1016/s0960-894x(98)00170-x
CHEMBL13432 58327 0 None None None Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 582 13 6 7 4.2 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)NC1CCCCC1 10.1016/s0960-894x(98)00170-x
12049922 202801 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL304991 202801 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
12049916 468046 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 576 11 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63138 468046 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 576 11 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44281408 232363 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 646 13 4 10 4.4 COC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL33155 232363 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 646 13 4 10 4.4 COC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
10651078 41809 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(F)c3F)cs2)cc1 10.1021/jm000286i
CHEMBL125963 41809 0 None None None Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(F)c3F)cs2)cc1 10.1021/jm000286i
14664348 27114 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 3 8 2.4 CC(C)(COc1ccc(-n2ccnc2)cc1)NCC(O)COc1ccc(NS(C)(=O)=O)cc1 10.1021/jm00166a002
CHEMBL1188606 27114 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 3 8 2.4 CC(C)(COc1ccc(-n2ccnc2)cc1)NCC(O)COc1ccc(NS(C)(=O)=O)cc1 10.1021/jm00166a002
44298533 389547 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 469 11 1 5 6.5 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL54821 389547 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 469 11 1 5 6.5 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
14998853 238808 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
CHEMBL351183 238808 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
12043155 199931 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 8 4.8 CC(C)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL284965 199931 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 8 4.8 CC(C)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
10081581 25479 0 None None None Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178704 25479 0 None None None Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
10081581 25479 0 None None None Guinea pig 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178704 25479 0 None None None Guinea pig 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
44377753 238629 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 12 3 8 4.0 O=c1n(Cc2ccc(F)c(F)c2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL349505 238629 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 12 3 8 4.0 O=c1n(Cc2ccc(F)c(F)c2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
2249 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of Beta1 (unknown origin)Inhibition of Beta1 (unknown origin)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
255 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of Beta1 (unknown origin)Inhibition of Beta1 (unknown origin)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
548 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of Beta1 (unknown origin)Inhibition of Beta1 (unknown origin)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
CHEMBL24 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of Beta1 (unknown origin)Inhibition of Beta1 (unknown origin)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
DB00335 1058 67 None None None Human 6.6 pIC50 = 6.6 Binding
Inhibition of Beta1 (unknown origin)Inhibition of Beta1 (unknown origin)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
44338499 218228 0 None None None Guinea pig 5.6 pIC50 = 5.6 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 5 3 5 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12O 10.1021/jm00122a008
CHEMBL320704 218228 0 None None None Guinea pig 5.6 pIC50 = 5.6 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 5 3 5 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12O 10.1021/jm00122a008
14664343 25386 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 3 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
CHEMBL1178024 25386 0 None None None Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 3 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
12049921 468581 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cccc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL66789 468581 0 None None None Human 4.6 pIC50 = 4.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cccc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
2447484 193822 0 None None None Human 7.5 pIC50 = 7.5 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL305153 193822 0 None None None Human 7.5 pIC50 = 7.5 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
10205362 235825 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 468 8 4 5 4.4 N#CN/C(=N\c1cc(Cl)cc(Cl)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL338618 235825 0 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 468 8 4 5 4.4 N#CN/C(=N\c1cc(Cl)cc(Cl)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44306956 468371 0 None None None Human 6.5 pIC50 = 6.5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 495 11 3 6 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(98)00381-3
CHEMBL65042 468371 0 None None None Human 6.5 pIC50 = 6.5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 495 11 3 6 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(98)00381-3
72548703 317107 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysisDisplacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
CHEMBL4128926 317107 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysisDisplacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
70695718 145324 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 10 3 6 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCCC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
CHEMBL2011234 145324 0 None None None Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 10 3 6 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCCC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
16049026 136419 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 432 13 4 7 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807821 136419 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 432 13 4 7 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
16049029 136420 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 482 13 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807822 136420 0 None None None Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 482 13 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
16049028 136417 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807819 136417 0 None None None Human 8.4 pIC50 = 8.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
44268568 58628 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 570 16 6 7 4.1 CCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13459 58628 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 570 16 6 7 4.1 CCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44338529 218227 0 None None None Guinea pig 5.5 pIC50 = 5.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 7 2 5 3.2 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
CHEMBL320696 218227 0 None None None Guinea pig 5.5 pIC50 = 5.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 7 2 5 3.2 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
44301803 332568 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 588 12 3 7 5.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL430594 332568 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 588 12 3 7 5.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998846 119185 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 374 7 3 5 1.6 CS(=O)(=O)Nc1ccc(CNCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL163153 119185 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 374 7 3 5 1.6 CS(=O)(=O)Nc1ccc(CNCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
12049919 468145 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63963 468145 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44349323 40679 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 437 11 4 7 3.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(F)c1 10.1016/s0960-894x(00)00669-7
CHEMBL124584 40679 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 437 11 4 7 3.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(F)c1 10.1016/s0960-894x(00)00669-7
44281530 200008 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 609 12 3 8 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cc(F)c(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285499 200008 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 609 12 3 8 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cc(F)c(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
9938030 200204 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286859 200204 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44281425 200475 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 612 13 4 9 4.3 CC(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL289250 200475 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 612 13 4 9 4.3 CC(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44377687 120240 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 579 16 3 6 5.0 CCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL165513 120240 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 579 16 3 6 5.0 CCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
46881700 21192 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1c(=O)ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1084144 21192 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1c(=O)ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
46881529 21582 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 375 9 3 4 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1085898 21582 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 375 9 3 4 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
12017001 293743 0 None None None Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 540 11 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccccc3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL39269 293743 0 None None None Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 540 11 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccccc3)o2)cc1 10.1016/s0960-894x(00)00277-8
44298850 332907 0 None None None Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 461 8 1 4 6.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL433252 332907 0 None None None Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 461 8 1 4 6.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
44298281 387205 0 None None None Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 6 1 3 4.9 CN(C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21)C(C)(C)Cc1ccccc1 10.1016/s0960-894x(99)00277-2
CHEMBL53517 387205 0 None None None Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 6 1 3 4.9 CN(C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21)C(C)(C)Cc1ccccc1 10.1016/s0960-894x(99)00277-2
44335499 19331 0 None None None Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 439 10 3 5 3.9 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104981 19331 0 None None None Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 439 10 3 5 3.9 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335651 218165 0 None None None Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 431 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL320228 218165 0 None None None Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 431 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00571-x
44302005 200712 0 None None None Human 4.5 pIC50 = 4.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 595 11 4 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL291516 200712 0 None None None Human 4.5 pIC50 = 4.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 595 11 4 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1 10.1016/s0960-894x(00)00390-5
44280957 222033 0 None None None Human 4.5 pIC50 = 4.5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 590 13 3 9 3.4 O=C(CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1)N1CCCC1 10.1016/s0960-894x(00)00267-5
CHEMBL32996 222033 0 None None None Human 4.5 pIC50 = 4.5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 590 13 3 9 3.4 O=C(CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1)N1CCCC1 10.1016/s0960-894x(00)00267-5
11819522 26288 0 None None None Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183318 26288 0 None None None Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
46881574 22102 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1cc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089386 22102 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1cc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
14998847 118403 0 None None None Human 4.5 pIC50 = 4.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
CHEMBL162095 118403 0 None None None Human 4.5 pIC50 = 4.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
12017003 279114 0 None None None Human 4.5 pIC50 = 4.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38704 279114 0 None None None Human 4.5 pIC50 = 4.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
319 7908 34 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
444031 7908 34 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
784 7908 34 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
CHEMBL1346 7908 34 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
4183 4137 48 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
6918554 4137 48 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
7455 4137 48 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
CHEMBL1095777 4137 48 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
DB05039 4137 48 None None None Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
24901351 142576 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1944694 142576 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
24901413 142600 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12 10.1016/j.bmcl.2011.10.049
CHEMBL1945032 142600 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12 10.1016/j.bmcl.2011.10.049
24900937 142628 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 413 8 4 6 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945294 142628 0 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 413 8 4 6 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1 10.1016/j.bmcl.2011.10.049
57401435 142644 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 458 11 5 6 2.8 O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1 10.1016/j.bmcl.2011.10.049
CHEMBL1945503 142644 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 458 11 5 6 2.8 O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1 10.1016/j.bmcl.2011.10.049
44298314 201294 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 452 8 1 6 5.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1noc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL295502 201294 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 452 8 1 6 5.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1noc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
11556330 328209 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 620 12 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL418308 328209 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 620 12 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998851 238749 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 6 2 5 1.9 CS(=O)(=O)Nc1ccc(OCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL350581 238749 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 6 2 5 1.9 CS(=O)(=O)Nc1ccc(OCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
567 1496 16 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
9841972 1496 16 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
CHEMBL284782 1496 16 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
14739901 474609 0 None None None Human 5.5 pIC50 = 5.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1ccccc1OCC(O)CN1CCN(c2ccc(NS(C)(=O)=O)cc2)CC1 10.1021/jm00172a033
CHEMBL95754 474609 0 None None None Human 5.5 pIC50 = 5.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1ccccc1OCC(O)CN1CCN(c2ccc(NS(C)(=O)=O)cc2)CC1 10.1021/jm00172a033
14739893 18627 0 None None None Human 4.5 pIC50 = 4.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.8 CS(=O)(=O)Nc1ccc(OCC(O)CNCc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL100624 18627 0 None None None Human 4.5 pIC50 = 4.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.8 CS(=O)(=O)Nc1ccc(OCC(O)CNCc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
1499 4274 42 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779 4274 42 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
536 4274 42 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
CHEMBL434 4274 42 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
DB01064 4274 42 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
12828562 219267 0 None None None Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL322842 219267 0 None None None Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
2303 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
4946 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
564 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
63 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
91536 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
CHEMBL27 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
CHEMBL452861 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
DB00571 6476 48 None None None Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
44338613 220881 0 None None None Guinea pig 6.5 pIC50 = 6.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 5 3 5 2.9 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
CHEMBL327091 220881 0 None None None Guinea pig 6.5 pIC50 = 6.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 5 3 5 2.9 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
44268563 197500 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 569 17 5 7 4.7 CCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL268289 197500 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 569 17 5 7 4.7 CCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
46881699 19925 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1077238 19925 0 None None None Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
9873257 175899 15 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assay
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
CHEMBL22375 175899 15 None None None Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assay
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
44268632 57922 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 514 12 6 7 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13398 57922 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 514 12 6 7 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44285634 200568 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 17 3 7 6.3 CCCCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL290131 200568 0 None None None Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 17 3 7 6.3 CCCCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44281097 233737 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33384 233737 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
2291 6470 51 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 6470 51 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 6470 51 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 6470 51 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 6470 51 None None None Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
11811722 24366 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity against beta-1 adrenergic receptorBinding affinity against beta-1 adrenergic receptor
ChEMBL 413 5 1 4 4.4 O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2 10.1021/jm010878g
CHEMBL115280 24366 0 None None None Human 5.5 pIC50 = 5.5 Binding
Binding affinity against beta-1 adrenergic receptorBinding affinity against beta-1 adrenergic receptor
ChEMBL 413 5 1 4 4.4 O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2 10.1021/jm010878g
46881701 21193 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 3 8 3.0 Cc1sc2ncn(CC(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)c(=O)c2c1C 10.1016/j.bmcl.2010.01.130
CHEMBL1084145 21193 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 3 8 3.0 Cc1sc2ncn(CC(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)c(=O)c2c1C 10.1016/j.bmcl.2010.01.130
44281400 219894 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL32411 219894 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
2369 1284 48 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
356 1284 48 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
549 1284 48 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
CHEMBL423 1284 48 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
DB00195 1284 48 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
121848 251266 2 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL368457 251266 2 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
21138 193677 30 None None None Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
CHEMBL275742 193677 30 None None None Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
DB03322 193677 30 None None None Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
44301832 451654 1 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 17 3 7 6.8 CCCCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL60281 451654 1 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 17 3 7 6.8 CCCCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
44285692 274633 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)co1 10.1016/s0960-894x(00)00277-8
CHEMBL37512 274633 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)co1 10.1016/s0960-894x(00)00277-8
44267518 27581 0 None None None Human 4.4 pIC50 = 4.4 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL1192069 27581 0 None None None Human 4.4 pIC50 = 4.4 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44349367 40803 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 487 11 4 7 4.9 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cc(Cl)cc(Cl)c1 10.1016/s0960-894x(00)00669-7
CHEMBL125246 40803 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 487 11 4 7 4.9 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cc(Cl)cc(Cl)c1 10.1016/s0960-894x(00)00669-7
83113 120230 48 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL165462 120230 48 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
269722 444550 56 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL59517 444550 56 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
44267518 27581 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL1192069 27581 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
16049309 136432 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807870 136432 0 None None None Human 7.4 pIC50 = 7.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
56670092 136436 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807874 136436 0 None None None Human 6.4 pIC50 = 6.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
24901348 142571 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944689 142571 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1 10.1016/j.bmcl.2011.10.049
24901349 142574 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944692 142574 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1 10.1016/j.bmcl.2011.10.049
24901347 142577 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 463 11 5 6 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944695 142577 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 463 11 5 6 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1 10.1016/j.bmcl.2011.10.049
137 765 35 None None None Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
2119 765 35 None None None Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
563 765 35 None None None Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
66368 765 35 None None None Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
CHEMBL266195 765 35 None None None Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
DB00866 765 35 None None None Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
15483883 200401 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL288550 200401 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281219 221502 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 588 12 4 9 4.0 NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL32891 221502 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 588 12 4 9 4.0 NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
15523861 120320 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 599 14 3 6 4.6 O=C1N(CCCc2ccccc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL166188 120320 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 599 14 3 6 4.6 O=C1N(CCCc2ccccc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44377316 238751 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 5.0 O=C1N(CCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL350590 238751 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 5.0 O=C1N(CCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
46882031 20127 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCc2ccccc2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078749 20127 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCc2ccccc2)c1 10.1016/j.bmcl.2010.01.130
44298290 332925 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 371 4 1 5 3.9 Cc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL433454 332925 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 371 4 1 5 3.9 Cc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44298822 389539 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 460 8 1 3 6.7 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)c1 10.1016/s0960-894x(99)00277-2
CHEMBL54750 389539 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 460 8 1 3 6.7 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)c1 10.1016/s0960-894x(99)00277-2
44298516 390592 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 467 8 1 5 6.2 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1nc(CCCC2CCCC2)cs1 10.1016/s0960-894x(99)00277-2
CHEMBL55541 390592 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 467 8 1 5 6.2 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1nc(CCCC2CCCC2)cs1 10.1016/s0960-894x(99)00277-2
44301764 200780 0 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 564 15 3 7 6.0 CCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL291992 200780 0 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 564 15 3 7 6.0 CCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
12049915 202895 0 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL305558 202895 0 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
44298728 387258 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 401 8 2 3 4.1 CCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL53842 387258 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 401 8 2 3 4.1 CCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44190762 350837 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of radioligand from adrenergic beta-1 receptorDisplacement of radioligand from adrenergic beta-1 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 350837 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of radioligand from adrenergic beta-1 receptorDisplacement of radioligand from adrenergic beta-1 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
46882030 20100 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 427 9 4 5 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ncc[nH]2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078576 20100 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 427 9 4 5 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ncc[nH]2)c1 10.1016/j.bmcl.2010.01.130
1043 3255 6 None None None Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 3255 6 None None None Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 3255 6 None None None Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 3255 6 None None None Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 3255 6 None None None Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44298821 389538 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 453 11 1 5 6.1 CCCCCCCCc1cnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)o1 10.1016/s0960-894x(99)00277-2
CHEMBL54749 389538 0 None None None Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 453 11 1 5 6.1 CCCCCCCCc1cnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)o1 10.1016/s0960-894x(99)00277-2
12017018 279492 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 638 13 3 8 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38861 279492 0 None None None Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 638 13 3 8 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
145947927 332520 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302997 332520 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
2447486 125781 0 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL1788270 125781 0 None None None Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
76322045 215600 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 527 7 3 5 6.0 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
CHEMBL3128184 215600 0 None None None Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 527 7 3 5 6.0 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
176 823 54 None None None Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 823 54 None None None Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 823 54 None None None Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 823 54 None None None Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 823 54 None None None Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
44307340 202657 0 None None None Human 6.4 pIC50 = 6.4 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 470 12 4 7 2.6 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL304090 202657 0 None None None Human 6.4 pIC50 = 6.4 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 470 12 4 7 2.6 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44281218 311645 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 645 13 5 9 4.0 CNC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL405245 311645 0 None None None Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 645 13 5 9 4.0 CNC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
389 239896 36 None None None Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
44112 239896 36 None None None Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
CHEMBL357995 239896 36 None None None Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
DB08807 239896 36 None None None Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
44307196 468591 0 None None None Human 6.3 pIC50 = 6.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 510 11 4 7 3.3 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)c(Cl)c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL66859 468591 0 None None None Human 6.3 pIC50 = 6.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 510 11 4 7 3.3 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)c(Cl)c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
12017010 328200 0 None None None Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 572 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL418234 328200 0 None None None Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 572 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
10138809 333701 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL439794 333701 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
10099346 278319 0 None None None Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38254 278319 0 None None None Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
46881900 22107 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ccccc2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1089396 22107 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ccccc2)c1 10.1016/j.bmcl.2010.01.130
70687348 145326 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 393 10 3 6 1.0 N#Cc1ccccc1OC[C@@H](O)CNCCNS(=O)(=O)c1ccccc1F 10.1021/ml1002458
CHEMBL2011236 145326 0 None None None Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 393 10 3 6 1.0 N#Cc1ccccc1OC[C@@H](O)CNCCNS(=O)(=O)c1ccccc1F 10.1021/ml1002458
16049158 136422 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 475 14 5 7 3.4 CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807824 136422 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 475 14 5 7 3.4 CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
56673609 136435 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807873 136435 0 None None None Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
24900689 142607 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945039 142607 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
44268268 42512 1 None None None Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
CHEMBL12769 42512 1 None None None Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
567 1496 16 None None None Human 5.3 pIC50 = 5.3 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(98)00571-x
9841972 1496 16 None None None Human 5.3 pIC50 = 5.3 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(98)00571-x
CHEMBL284782 1496 16 None None None Human 5.3 pIC50 = 5.3 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(98)00571-x
15483880 199806 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL28405 199806 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281469 200292 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL287561 200292 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44308088 468601 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1CC(=O)N(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL66936 468601 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1CC(=O)N(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
10099459 470517 1 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL82296 470517 1 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
44377636 238784 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 607 12 3 6 4.5 O=C1N(Cc2ccc(F)c(F)c2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL350931 238784 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 607 12 3 6 4.5 O=C1N(Cc2ccc(F)c(F)c2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
10099459 470517 1 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL82296 470517 1 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
46881937 21093 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 494 9 3 6 5.5 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2s1 10.1016/j.bmcl.2010.01.130
CHEMBL1083831 21093 0 None None None Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 494 9 3 6 5.5 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2s1 10.1016/j.bmcl.2010.01.130
44458134 175789 0 None None None Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 565 15 3 10 3.1 CCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
CHEMBL22345 175789 0 None None None Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 565 15 3 10 3.1 CCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
44301886 201215 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 16 4 8 4.7 CC(=O)NCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL294849 201215 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 16 4 8 4.7 CC(=O)NCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
44377665 333036 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 567 15 3 7 3.4 COCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL434284 333036 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 567 15 3 7 3.4 COCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
2419 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
5152 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
559 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
CHEMBL1263 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
DB00938 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
2419 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
5152 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
559 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
CHEMBL1263 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
DB00938 7043 56 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
57398562 142604 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 11 5 6 4.1 CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945036 142604 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 11 5 6 4.1 CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1 10.1016/j.bmcl.2011.10.049
9984028 238447 0 None None None Human 5.3 pIC50 = 5.3 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2cccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c2)cc1 10.1021/jm0101500
CHEMBL347582 238447 0 None None None Human 5.3 pIC50 = 5.3 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2cccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c2)cc1 10.1021/jm0101500
44268498 198622 0 None None None Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 17 4 7 4.8 CCCCCCN(C)C(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL275114 198622 0 None None None Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 17 4 7 4.8 CCCCCCN(C)C(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
10075383 197425 0 None None None Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL267545 197425 0 None None None Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
44301617 412914 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 640 16 3 7 7.7 CCCCCCc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL58241 412914 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 640 16 3 7 7.7 CCCCCCc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
44268470 58563 0 None None None Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 14 5 7 3.5 CCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13453 58563 0 None None None Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 14 5 7 3.5 CCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44377754 238648 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 14 3 8 4.7 O=c1n(CCCC2CCCC2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL349651 238648 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 14 3 8 4.7 O=c1n(CCCC2CCCC2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44306959 468130 0 None None None Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 520 11 4 7 2.8 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL63842 468130 0 None None None Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 520 11 4 7 2.8 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
14998848 238774 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 5 2 5 2.1 O=C(NCC1CN(c2ccccc2)CCN1)c1ccc(-n2ccnc2)cc1 10.1021/jm00082a016
CHEMBL350847 238774 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 5 2 5 2.1 O=C(NCC1CN(c2ccccc2)CCN1)c1ccc(-n2ccnc2)cc1 10.1021/jm00082a016
44268605 198686 0 None None None Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 14 6 7 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL275511 198686 0 None None None Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 14 6 7 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44280903 200140 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 605 12 3 8 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286437 200140 0 None None None Human 6.3 pIC50 = 6.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 605 12 3 8 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44461718 470669 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL83753 470669 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
10007337 235598 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 535 14 3 8 4.5 CCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33725 235598 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 535 14 3 8 4.5 CCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
12043156 332873 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 575 14 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
CHEMBL433042 332873 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 575 14 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
44461718 470669 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
CHEMBL83753 470669 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
44307333 468668 0 None None None Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 472 12 4 8 2.0 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL67416 468668 0 None None None Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 472 12 4 8 2.0 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44280860 200096 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 521 13 3 8 4.1 CCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL286139 200096 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 521 13 3 8 4.1 CCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
1588 4738 26 None None None Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 4738 26 None None None Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 4738 26 None None None Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 4738 26 None None None Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 4738 26 None None None Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
12049917 468078 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 588 12 3 9 4.1 COc1ccc(-c2cnn(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1F 10.1016/s0960-894x(00)00422-4
CHEMBL63357 468078 0 None None None Human 5.3 pIC50 = 5.3 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 588 12 3 9 4.1 COc1ccc(-c2cnn(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1F 10.1016/s0960-894x(00)00422-4
44281073 237980 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CCC(O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL34328 237980 0 None None None Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CCC(O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
45482789 424681 0 None None None Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic beta-1 receptorInhibition of adrenergic beta-1 receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
CHEMBL584554 424681 0 None None None Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic beta-1 receptorInhibition of adrenergic beta-1 receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
15523859 470734 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL84190 470734 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
15523859 470734 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL84190 470734 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44298315 385818 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 454 11 1 6 5.5 CCCCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
CHEMBL52407 385818 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 454 11 1 6 5.5 CCCCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
14823035 270609 1 None None None Rat 7.2 pIC50 = 7.2 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
CHEMBL38486 270609 1 None None None Rat 7.2 pIC50 = 7.2 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
10112732 40695 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 418 8 4 5 3.3 N#CN/C(=N\c1cccc(F)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL124668 40695 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 418 8 4 5 3.3 N#CN/C(=N\c1cccc(F)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44307186 468756 0 None None None Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 455 12 3 6 3.0 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL68021 468756 0 None None None Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 455 12 3 6 3.0 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
24900813 142610 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 467 10 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945042 142610 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 467 10 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
44268365 198831 0 None None None Human 8.2 pIC50 = 8.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 406 10 4 5 3.2 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
CHEMBL276659 198831 0 None None None Human 8.2 pIC50 = 8.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 406 10 4 5 3.2 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
39468 37932 24 None None None Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
431 37932 24 None None None Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
CHEMBL1201237 37932 24 None None None Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
DB01210 37932 24 None None None Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
44268349 44425 0 None None None Human 7.2 pIC50 = 7.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 456 12 4 6 2.9 O=S(=O)(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13079 44425 0 None None None Human 7.2 pIC50 = 7.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 456 12 4 6 2.9 O=S(=O)(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
1499 4274 42 None None None Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
3779 4274 42 None None None Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
536 4274 42 None None None Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
CHEMBL434 4274 42 None None None Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
DB01064 4274 42 None None None Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
46881576 22161 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 6 3.3 O=C(Cc1nc2ccccc2o1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089725 22161 0 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 6 3.3 O=C(Cc1nc2ccccc2o1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
2249 1058 67 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
255 1058 67 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
548 1058 67 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
CHEMBL24 1058 67 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
DB00335 1058 67 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
44307144 468611 0 None None None Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 569 17 5 7 4.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL67015 468611 0 None None None Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 569 17 5 7 4.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44298256 394207 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 426 9 1 6 4.7 CCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
CHEMBL56768 394207 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 426 9 1 6 4.7 CCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
44301806 200866 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ncccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL292598 200866 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ncccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
46881938 21094 0 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 4 5.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1C1CCCCC1 10.1016/j.bmcl.2010.01.130
CHEMBL1083832 21094 0 None None None Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 4 5.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1C1CCCCC1 10.1016/j.bmcl.2010.01.130
44285226 200035 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 548 15 3 7 5.5 CCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL285713 200035 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 548 15 3 7 5.5 CCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44335628 19175 0 None None None Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 498 12 4 7 3.7 CCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104222 19175 0 None None None Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 498 12 4 7 3.7 CCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335588 19610 0 None None None Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 496 13 4 6 3.9 CCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL106487 19610 0 None None None Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 496 13 4 6 3.9 CCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44268273 197402 0 None None None Human 6.2 pIC50 = 6.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
CHEMBL267306 197402 0 None None None Human 6.2 pIC50 = 6.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
44349645 232560 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)N(c1nc(-c3ccc(OC(F)(F)F)cc3)cs1)CC2)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL332132 232560 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)N(c1nc(-c3ccc(OC(F)(F)F)cc3)cs1)CC2)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
12049926 468129 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 654 14 3 10 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63825 468129 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 654 14 3 10 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
56663238 136434 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807872 136434 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24901144 142573 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944691 142573 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
24900872 142606 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 478 12 5 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945038 142606 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 478 12 5 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
57391554 142612 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945044 142612 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1 10.1016/j.bmcl.2011.10.049
24900942 142633 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945299 142633 0 None None None Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
44306991 468676 0 None None None Human 5.2 pIC50 = 5.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 493 11 4 8 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3cnc4ccccc4c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67461 468676 0 None None None Human 5.2 pIC50 = 5.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 493 11 4 8 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3cnc4ccccc4c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
9917962 332708 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL431678 332708 0 None None None Human 7.2 pIC50 = 7.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44298787 387225 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 12 2 5 6.6 CCCCCCCCc1csc(Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL53679 387225 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 12 2 5 6.6 CCCCCCCCc1csc(Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
44301804 332905 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccn3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL433248 332905 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccn3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44313161 213498 0 None None None Human 5.2 pIC50 = 5.2 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308860 213498 0 None None None Human 5.2 pIC50 = 5.2 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
12017017 255435 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 606 13 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL36609 255435 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 606 13 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
12017013 273728 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 588 13 3 8 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL37335 273728 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 588 13 3 8 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
12017002 278900 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 558 11 3 7 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)cc3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38562 278900 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 558 11 3 7 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)cc3)o2)cc1 10.1016/s0960-894x(00)00277-8
44281470 232614 0 None None None Human 4.2 pIC50 = 4.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 12 4 9 4.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(C(O)c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33224 232614 0 None None None Human 4.2 pIC50 = 4.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 12 4 9 4.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(C(O)c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
13864381 475169 1 None None None Guinea pig 4.2 pIC50 = 4.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL99361 475169 1 None None None Guinea pig 4.2 pIC50 = 4.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
13864389 19405 0 None None None Guinea pig 5.2 pIC50 = 5.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL105383 19405 0 None None None Guinea pig 5.2 pIC50 = 5.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
15123375 120287 1 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 295 4 2 3 1.9 O=C(NCC1CN(c2ccccc2)CCN1)c1ccccc1 10.1021/jm00082a016
CHEMBL165901 120287 1 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 295 4 2 3 1.9 O=C(NCC1CN(c2ccccc2)CCN1)c1ccccc1 10.1021/jm00082a016
16049087 136415 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807817 136415 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
16049088 136416 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807818 136416 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
16049024 136418 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 498 13 4 7 4.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807820 136418 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 498 13 4 7 4.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
24901284 142630 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 12 5 6 5.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945296 142630 0 None None None Human 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 12 5 6 5.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
46881872 22066 1 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 411 10 4 7 2.6 CNc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
CHEMBL1089052 22066 1 None None None Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 411 10 4 7 2.6 CNc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
44298849 393286 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 434 9 1 3 6.3 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
CHEMBL56308 393286 0 None None None Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 434 9 1 3 6.3 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
44335663 19130 0 None None None Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 560 13 4 7 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1)OCCc1ccccc1 10.1016/s0960-894x(98)00571-x
CHEMBL104076 19130 0 None None None Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 560 13 4 7 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1)OCCc1ccccc1 10.1016/s0960-894x(98)00571-x
44335496 19140 0 None None None Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 335 8 3 5 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104127 19140 0 None None None Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 335 8 3 5 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
44301831 201103 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 590 14 3 7 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCCC3CCCC3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL294172 201103 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 590 14 3 7 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCCC3CCCC3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44301805 201154 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccnc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL294492 201154 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccnc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44281407 200473 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 666 14 4 10 3.6 CS(=O)(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL289248 200473 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 666 14 4 10 3.6 CS(=O)(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
44461706 470724 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 579 15 3 7 4.1 CCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL84117 470724 0 None None None Human 5.2 pIC50 = 5.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 579 15 3 7 4.1 CCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
44285685 200385 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL288418 200385 0 None None None Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
12043159 200192 0 None None None Human 4.2 pIC50 = 4.2 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CC(=O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL286800 200192 0 None None None Human 4.2 pIC50 = 4.2 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CC(=O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44281396 200139 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286435 200139 0 None None None Human 6.2 pIC50 = 6.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
10119061 41822 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1ccc(I)cc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL126055 41822 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1ccc(I)cc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44268539 44277 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 13 5 7 3.4 CC(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13068 44277 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 13 5 7 3.4 CC(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
14739891 474604 0 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 408 12 3 6 1.8 COCCc1ccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00172a033
CHEMBL95727 474604 0 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 408 12 3 6 1.8 COCCc1ccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00172a033
1978 515 40 None None None Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
40 515 40 None None None Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
7107 515 40 None None None Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
CHEMBL642 515 40 None None None Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
DB01193 515 40 None None None Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
44349646 40751 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3ccc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL124929 40751 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3ccc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cc32)n1 10.1016/s0960-894x(00)00669-7
44349629 42385 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL127422 42385 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44268569 198481 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL274143 198481 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
12017004 200328 0 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL287880 200328 0 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
46881575 22103 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 7 2.3 O=C(Cn1nc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089387 22103 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 7 2.3 O=C(Cn1nc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
9958539 203155 0 None None None Human 6.1 pIC50 = 6.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
CHEMBL307647 203155 0 None None None Human 6.1 pIC50 = 6.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
145947596 332468 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 355 5 2 5 3.4 Cc1cccc2c(=O)c3ccc(OCC(O)CNC(C)(C)C)cc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302343 332468 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 355 5 2 5 3.4 Cc1cccc2c(=O)c3ccc(OCC(O)CNC(C)(C)C)cc3oc12 10.1016/j.bmc.2018.04.038
16049448 136427 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807829 136427 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049376 136433 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807871 136433 0 None None None Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
24901209 142599 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12 10.1016/j.bmcl.2011.10.049
CHEMBL1945031 142599 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12 10.1016/j.bmcl.2011.10.049
24900812 142611 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 450 10 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945043 142611 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 450 10 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
44349379 42389 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 462 12 5 8 2.6 NC(=O)c1cccc(N/C(=C/[N+](=O)[O-])Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/s0960-894x(00)00669-7
CHEMBL127451 42389 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 462 12 5 8 2.6 NC(=O)c1cccc(N/C(=C/[N+](=O)[O-])Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/s0960-894x(00)00669-7
56673674 136429 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 513 13 5 8 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807831 136429 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 513 13 5 8 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24900874 142627 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945293 142627 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
44307113 333968 0 None None None Human 7.1 pIC50 = 7.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 552 11 3 5 3.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL442172 333968 0 None None None Human 7.1 pIC50 = 7.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 552 11 3 5 3.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
44268570 198482 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.8 CCCCCCN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL274144 198482 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.8 CCCCCCN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
14739892 475082 0 None None None Human 6.1 pIC50 = 6.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 337 8 2 5 2.7 Cc1ccccc1OCC(O)CNCc1ccc(-n2ccnc2)cc1 10.1021/jm00172a033
CHEMBL98773 475082 0 None None None Human 6.1 pIC50 = 6.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 337 8 2 5 2.7 Cc1ccccc1OCC(O)CNCc1ccc(-n2ccnc2)cc1 10.1021/jm00172a033
44335603 217051 0 None None None Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 538 16 4 6 5.0 CCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL318165 217051 0 None None None Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 538 16 4 6 5.0 CCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
9915238 405756 2 None None None Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL57486 405756 2 None None None Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
81430 445269 63 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
CHEMBL59597 445269 63 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
15483879 199971 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285240 199971 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281395 200110 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 13 4 10 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccccc3O)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286231 200110 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 13 4 10 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccccc3O)n2)cc1 10.1016/s0960-894x(00)00268-7
12017015 241652 0 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 546 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL36101 241652 0 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 546 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
9915238 405756 2 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
CHEMBL57486 405756 2 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
9896742 469811 0 None None None Human 4.1 pIC50 = 4.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL76403 469811 0 None None None Human 4.1 pIC50 = 4.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
44268266 41873 0 None None None Human 7.1 pIC50 = 7.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 317 8 4 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12633 41873 0 None None None Human 7.1 pIC50 = 7.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 317 8 4 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
44349357 315724 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1ccc2ccccc2c1 10.1016/s0960-894x(00)00669-7
CHEMBL410702 315724 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1ccc2ccccc2c1 10.1016/s0960-894x(00)00669-7
44338578 220100 0 None None None Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 378 6 2 5 3.4 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
CHEMBL325371 220100 0 None None None Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 378 6 2 5 3.4 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
44349237 328414 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 511 13 4 8 5.3 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(Oc2ccccc2)c1 10.1016/s0960-894x(00)00669-7
CHEMBL419787 328414 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 511 13 4 8 5.3 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(Oc2ccccc2)c1 10.1016/s0960-894x(00)00669-7
44268352 39432 0 None None None Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 380 10 4 6 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12188 39432 0 None None None Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 380 10 4 6 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
46881617 22260 1 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 397 9 4 7 2.2 Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
CHEMBL1090425 22260 1 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 397 9 4 7 2.2 Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
46901383 39328 27 None None None Human 5.1 pIC50 = 5.1 Binding
Inhibition of beta-1 adrenoceptorInhibition of beta-1 adrenoceptor
ChEMBL 380 5 3 6 2.4 NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1 10.1021/jm100076w
CHEMBL1214999 39328 27 None None None Human 5.1 pIC50 = 5.1 Binding
Inhibition of beta-1 adrenoceptorInhibition of beta-1 adrenoceptor
ChEMBL 380 5 3 6 2.4 NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1 10.1021/jm100076w
10012704 25501 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178768 25501 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
10442852 25494 0 None None None Guinea pig 5.1 pIC50 = 5.1 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178755 25494 0 None None None Guinea pig 5.1 pIC50 = 5.1 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
10076885 199972 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 14 3 9 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCOC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
CHEMBL285242 199972 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 14 3 9 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCOC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
46881752 21584 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 431 9 4 6 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)OCc1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
CHEMBL1085928 21584 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 431 9 4 6 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)OCc1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
10101116 38440 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1cccc2c1CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL120238 38440 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1cccc2c1CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
10722793 232396 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL331744 232396 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
44338127 21980 0 None None None Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 390 8 3 6 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12OCCO 10.1021/jm00122a008
CHEMBL108843 21980 0 None None None Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 390 8 3 6 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12OCCO 10.1021/jm00122a008
44301866 200726 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 18 3 7 6.7 CCCCCCCCc1csc(Cc2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL291593 200726 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 18 3 7 6.7 CCCCCCCCc1csc(Cc2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
44377514 119313 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL163579 119313 0 None None None Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44461486 470213 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 564 15 3 9 3.7 CCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL79806 470213 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 564 15 3 9 3.7 CCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44280795 222057 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 507 12 3 8 3.8 CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33013 222057 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 507 12 3 8 3.8 CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
15523860 238847 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 15 3 6 5.2 CCCCC(C)(C)CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL351596 238847 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 15 3 6 5.2 CCCCC(C)(C)CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44307396 468739 0 None None None Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 582 12 3 6 3.7 COc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL67886 468739 0 None None None Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 582 12 3 6 3.7 COc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
46881750 21544 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 4 5 3.1 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
CHEMBL1085693 21544 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 4 5 3.1 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
12049914 468597 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL66908 468597 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44268509 43273 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 513 13 5 7 3.1 CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL12943 43273 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 513 13 5 7 3.1 CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44338133 23537 0 None None None Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 6 3 5 2.6 CC(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
CHEMBL110659 23537 0 None None None Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 6 3 5 2.6 CC(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
2464 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
5253 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
7297 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
CHEMBL471 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
DB00489 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
44307205 468798 0 None None None Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 584 17 6 8 3.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL68408 468798 0 None None None Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 584 17 6 8 3.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44298852 201855 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL299719 201855 0 None None None Human 6.1 pIC50 = 6.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44268322 42829 0 None None None Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 303 8 4 5 1.7 Oc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12876 42829 0 None None None Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 303 8 4 5 1.7 Oc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44301843 432371 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 584 13 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCc3ccccc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL59270 432371 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 584 13 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCc3ccccc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
2464 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
5253 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
7297 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
CHEMBL471 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
DB00489 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
44281343 219904 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 14 3 13 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(C4N=NN=N4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL32418 219904 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 14 3 13 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(C4N=NN=N4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44280858 200001 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 17 3 8 5.7 CCCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL285458 200001 0 None None None Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 17 3 8 5.7 CCCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
2464 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
5253 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
7297 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
CHEMBL471 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
DB00489 7398 37 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
44298700 202051 0 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 345 3 1 3 2.5 CN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL301202 202051 0 None None None Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 345 3 1 3 2.5 CN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44268341 46586 0 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 492 11 4 6 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00169-3
CHEMBL13278 46586 0 None None None Human 5.1 pIC50 = 5.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 492 11 4 6 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00169-3
44301880 409916 0 None None None Human 4.1 pIC50 = 4.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 596 11 3 8 6.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4o3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL57908 409916 0 None None None Human 4.1 pIC50 = 4.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 596 11 3 8 6.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4o3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44307166 202781 0 None None None Human 6.0 pIC50 = 6.0 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 570 11 3 5 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(F)cc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL304878 202781 0 None None None Human 6.0 pIC50 = 6.0 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 570 11 3 5 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(F)cc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
12049925 198947 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL277613 198947 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
12049924 468780 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 606 13 3 9 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL68301 468780 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 606 13 3 9 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44301867 200727 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 613 12 4 8 5.5 CC(=O)Nc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL291594 200727 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 613 12 4 8 5.5 CC(=O)Nc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
46881531 21318 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 4 5 3.0 O=C(Cc1n[nH]c2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1084667 21318 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 4 5 3.0 O=C(Cc1n[nH]c2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
56645363 240095 21 None None None Human 5.0 pIC50 = 5.0 Binding
Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
CHEMBL3582478 240095 21 None None None Human 5.0 pIC50 = 5.0 Binding
Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
56645363 240095 21 None None None Human 5.0 pIC50 = 5.0 Binding
Panlabs assay (ADRB1)Panlabs assay (ADRB1)
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
CHEMBL3582478 240095 21 None None None Human 5.0 pIC50 = 5.0 Binding
Panlabs assay (ADRB1)Panlabs assay (ADRB1)
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
56645363 240095 21 None None None Human 5.0 pIC50 = 5.0 Binding
Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
CHEMBL3582478 240095 21 None None None Human 5.0 pIC50 = 5.0 Binding
Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
44335548 219324 0 None None None Human 6.0 pIC50 = 6.0 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 567 17 5 6 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL323113 219324 0 None None None Human 6.0 pIC50 = 6.0 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 567 17 5 6 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44298781 200841 0 None None None Human 6.0 pIC50 = 6.0 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 10 1 3 5.3 CCCCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL292407 200841 0 None None None Human 6.0 pIC50 = 6.0 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 10 1 3 5.3 CCCCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
10160636 232542 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 443 9 5 6 2.2 N#CN/C(=N\c1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(C(N)=O)c1 10.1016/s0960-894x(00)00669-7
CHEMBL332010 232542 0 None None None Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 443 9 5 6 2.2 N#CN/C(=N\c1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(C(N)=O)c1 10.1016/s0960-894x(00)00669-7
46882028 20090 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 467 11 3 5 4.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1COc1ccccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078495 20090 0 None None None Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 467 11 3 5 4.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1COc1ccccc1 10.1016/j.bmcl.2010.01.130
164612037 368668 0 None -1 14 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 368668 0 None -1 14 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 385513 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 385513 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 385564 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 385564 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 385575 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 385575 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
21595418 202699 0 None -2 2 Guinea pig 9.8 pKd = 9.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL304344 202699 0 None -2 2 Guinea pig 9.8 pKd = 9.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@@H]1CCCCN1 10.1021/jm00119a011
33624 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
4061 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
565 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
CHEMBL499 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
DB00373 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
33624 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
4061 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
565 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
CHEMBL499 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
DB00373 8322 24 None -2 2 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
12179890 195034 0 None 3 2 Human 9.4 pKd = 9.4 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
ChEMBL 223 6 2 3 1.7 Cc1cccc(OC[C@@H](O)CNC(C)C)c1 10.1021/jm800227h
CHEMBL252319 195034 0 None 3 2 Human 9.4 pKd = 9.4 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
ChEMBL 223 6 2 3 1.7 Cc1cccc(OC[C@@H](O)CNC(C)C)c1 10.1021/jm800227h
13157386 116578 3 None 138 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL1789879 116578 3 None 138 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
12878481 122765 0 None 169 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 OC(CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL173424 122765 0 None 169 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 OC(CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
135079 24789 0 None 9772 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11671 24789 0 None 9772 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
12878477 213263 0 None 10 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 6 3 4 3.2 CC(C)(C)NC[C@H](O)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL3085291 213263 0 None 10 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 6 3 4 3.2 CC(C)(C)NC[C@H](O)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
123686 4050 42 None -1 5 Guinea pig 9.0 pKd = 9.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm00156a028
12581 4050 42 None -1 5 Guinea pig 9.0 pKd = 9.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm00156a028
CHEMBL11268 4050 42 None -1 5 Guinea pig 9.0 pKd = 9.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm00156a028
25271869 308816 3 None -38 2 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 299 6 2 3 3.5 CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
CHEMBL4092412 308816 3 None -38 2 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 299 6 2 3 3.5 CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
2685 1837 22 None 724 3 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/acsmedchemlett.6b00363
541 1837 22 None 724 3 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/acsmedchemlett.6b00363
CHEMBL280822 1837 22 None 724 3 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/acsmedchemlett.6b00363
13157406 23734 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL11171 23734 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
13157406 23734 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11171 23734 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
13157406 23734 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00103a004
CHEMBL11171 23734 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00103a004
13621703 23687 0 None None None Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 6 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11145 23687 0 None None None Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 6 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13040879 47675 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
CHEMBL13365 47675 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
2369 1284 48 None 1 5 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
356 1284 48 None 1 5 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
549 1284 48 None 1 5 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
CHEMBL423 1284 48 None 1 5 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
DB00195 1284 48 None 1 5 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
12521601 256582 0 None 20 2 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 371 7 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL366769 256582 0 None 20 2 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 371 7 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
2685 1837 22 None 724 3 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
541 1837 22 None 724 3 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
CHEMBL280822 1837 22 None 724 3 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
3123920 5765 59 None 8 3 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10.1021/jm00119a011
546 5765 59 None 8 3 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10.1021/jm00119a011
CHEMBL7154 5765 59 None 8 3 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10.1021/jm00119a011
2369 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
356 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
549 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
CHEMBL423 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
DB00195 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
2303 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
4946 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
564 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
63 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
91536 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
CHEMBL27 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
DB00571 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
2369 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
356 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
549 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
CHEMBL423 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
DB00195 1284 48 None -10 5 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
2303 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
4946 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
564 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
63 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
91536 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
CHEMBL27 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
DB00571 6476 48 None -6 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
18047 461728 19 None 2 5 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00119a011
3616 461728 19 None 2 5 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00119a011
CHEMBL67096 461728 19 None 2 5 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00119a011
13267804 461767 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL69635 461767 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@H]1CCCCN1 10.1021/jm00119a011
123686 4050 42 None 1 5 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
12581 4050 42 None 1 5 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
CHEMBL11268 4050 42 None 1 5 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
13157364 155093 0 None 30 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 O[C@@H](CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL2096752 155093 0 None 30 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 O[C@@H](CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
13621676 23522 0 None 1122 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 475 11 3 6 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11051 23522 0 None 1122 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 475 11 3 6 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
2303 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
4946 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
564 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
63 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
91536 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
CHEMBL27 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
DB00571 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
2303 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
4946 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
564 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
63 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
91536 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
CHEMBL27 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
DB00571 6476 48 None -6 8 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
105110 200305 3 None -1 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 273 7 2 3 2.8 CC(C)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
62882 200305 3 None -1 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 273 7 2 3 2.8 CC(C)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL287651 200305 3 None -1 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 273 7 2 3 2.8 CC(C)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
13040919 215751 0 None -19 2 Guinea pig 8.0 pKd = 8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL31335 215751 0 None -19 2 Guinea pig 8.0 pKd = 8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
12462222 222119 0 None 39 2 Guinea pig 8.0 pKd = 8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1cc(C)ccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3302868 222119 0 None 39 2 Guinea pig 8.0 pKd = 8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1cc(C)ccc1C(O)CNC(C)C 10.1021/jm00208a015
235055 217044 3 None 3 2 Guinea pig 8.0 pKd = 8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 223 7 2 3 1.7 CC(C)CNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL31811 217044 3 None 3 2 Guinea pig 8.0 pKd = 8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 223 7 2 3 1.7 CC(C)CNCC(O)COc1ccccc1 10.1021/jm00354a002
13621706 23365 0 None 154 2 Guinea pig 8.0 pKd = 8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 8 3 4 2.9 CC(C)NCC(O)COc1ccc(-c2nc(C(C)C)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL10988 23365 0 None 154 2 Guinea pig 8.0 pKd = 8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 8 3 4 2.9 CC(C)NCC(O)COc1ccc(-c2nc(C(C)C)c[nH]2)cc1 10.1021/jm00156a028
5464103 174425 19 None 1 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 228 6 2 4 1.5 C/C(=N/OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL24045 174425 19 None 1 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 228 6 2 4 1.5 C/C(=N/OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
6917762 23629 5 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL111103 23629 5 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
6917762 23629 5 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
CHEMBL111103 23629 5 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
6917762 23629 5 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
CHEMBL111103 23629 5 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
13157371 122817 0 None 3235 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL173629 122817 0 None 3235 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
13621757 468454 0 None None None Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 13 3 7 2.8 COc1ccc(CCNC[C@H](O)COc2ccc(Cc3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL65774 468454 0 None None None Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 13 3 7 2.8 COc1ccc(CCNC[C@H](O)COc2ccc(Cc3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621651 23444 0 None None None Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL10998 23444 0 None None None Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
1054 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
59768 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
7178 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
CHEMBL768 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
DB00187 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
1054 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
59768 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
7178 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
CHEMBL768 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
DB00187 3263 41 None 6 2 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
44307782 468566 2 None 2 2 Guinea pig 7.0 pKd = 7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 1 3 1.8 CC(C)N(C)CC(O)COc1ccccc1 10.1021/jm00119a011
CHEMBL66662 468566 2 None 2 2 Guinea pig 7.0 pKd = 7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 1 3 1.8 CC(C)N(C)CC(O)COc1ccccc1 10.1021/jm00119a011
44279341 200275 0 None None None Guinea pig 7.0 pKd = 7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
CHEMBL287452 200275 0 None None None Guinea pig 7.0 pKd = 7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
3486 6418 47 None -6 6 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
4883 6418 47 None -6 6 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
555 6418 47 None -6 6 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
CHEMBL6995 6418 47 None -6 6 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
DB01297 6418 47 None -6 6 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
12484287 219276 0 None -2 2 Guinea pig 6.0 pKd = 6 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
CHEMBL3228930 219276 0 None -2 2 Guinea pig 6.0 pKd = 6 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
214809 220001 2 None 1 2 Rat 5.0 pKd = 5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 252 7 3 4 0.5 CC(C)NCC(O)COc1ccc(C(N)=O)cc1 10.1021/jm00207a025
CHEMBL3247302 220001 2 None 1 2 Rat 5.0 pKd = 5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 252 7 3 4 0.5 CC(C)NCC(O)COc1ccc(C(N)=O)cc1 10.1021/jm00207a025
44383643 330508 0 None -15 2 Guinea pig 4.0 pKd = 4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 238 7 1 3 3.0 CC(C)(C)NCCCON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL424369 330508 0 None -15 2 Guinea pig 4.0 pKd = 4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 238 7 1 3 3.0 CC(C)(C)NCCCON=C(C1CC1)C1CC1 10.1021/jm00145a008
56597178 179121 0 None 10 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1O 10.1021/jm400348g
CHEMBL2348209 179121 0 None 10 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1O 10.1021/jm400348g
13974078 23728 0 None None None Guinea pig 6.0 pKd = 6.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 388 7 4 6 2.5 CC(C)(C)NCC(O)COCC1CN=C(Nc2c(Cl)cccc2Cl)N1 10.1021/jm00115a008
CHEMBL111697 23728 0 None None None Guinea pig 6.0 pKd = 6.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 388 7 4 6 2.5 CC(C)(C)NCC(O)COCC1CN=C(Nc2c(Cl)cccc2Cl)N1 10.1021/jm00115a008
3486 6418 47 None -6 6 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
4883 6418 47 None -6 6 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
555 6418 47 None -6 6 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
CHEMBL6995 6418 47 None -6 6 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
DB01297 6418 47 None -6 6 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
551640 468528 19 None 1 2 Guinea pig 6.0 pKd = 6.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 7 2 3 1.6 CC(C)NCC(O)COCc1ccccc1 10.1021/jm00119a011
CHEMBL66331 468528 19 None 1 2 Guinea pig 6.0 pKd = 6.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 7 2 3 1.6 CC(C)NCC(O)COCc1ccccc1 10.1021/jm00119a011
137 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2119 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
563 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
66368 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
CHEMBL266195 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
DB00866 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
71662249 179114 0 None 109 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Cl)cc1 10.1021/jm400348g
CHEMBL2348202 179114 0 None 109 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Cl)cc1 10.1021/jm400348g
13621642 20535 1 None 2754 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 12 3 7 3.2 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)=O)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL10813 20535 1 None 2754 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 12 3 7 3.2 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)=O)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
13590033 24140 0 None 19 2 Guinea pig 6.0 pKd = 6.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 398 11 2 7 2.9 COc1ccc(CCNCC(O)COc2ccc(-c3ncco3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11401 24140 0 None 19 2 Guinea pig 6.0 pKd = 6.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 398 11 2 7 2.9 COc1ccc(CCNCC(O)COc2ccc(-c3ncco3)cc2)cc1OC 10.1021/jm00156a028
71662410 179118 0 None 12 2 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1C(F)(F)F 10.1021/jm400348g
CHEMBL2348206 179118 0 None 12 2 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1C(F)(F)F 10.1021/jm400348g
13621767 23634 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11112 23634 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
71662409 179116 0 None 85 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Br)c1 10.1021/jm400348g
CHEMBL2348204 179116 0 None 85 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Br)c1 10.1021/jm400348g
70695511 155080 0 None 1 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL2093060 155080 0 None 1 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
56598967 179123 0 None 275 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
CHEMBL2348211 179123 0 None 275 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
13040886 199924 0 None -1 2 Guinea pig 7.9 pKd = 7.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
CHEMBL284909 199924 0 None -1 2 Guinea pig 7.9 pKd = 7.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
66653395 179122 0 None 109 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(O)c1 10.1021/jm400348g
CHEMBL2348210 179122 0 None 109 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(O)c1 10.1021/jm400348g
13621715 19473 1 None 436 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL10574 19473 1 None 436 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
13621721 317625 1 None 2630 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 420 10 3 6 3.8 OC(CNCCc1ccncc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL416151 317625 1 None 2630 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 420 10 3 6 3.8 OC(CNCCc1ccncc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
9816183 200700 5 None -2 2 Human 6.9 pKd = 6.9 Binding
Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/s0960-894x(99)00205-x
CHEMBL29141 200700 5 None -2 2 Human 6.9 pKd = 6.9 Binding
Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/s0960-894x(99)00205-x
44459582 193975 0 None -13 2 Guinea pig 6.9 pKd = 6.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 312 8 2 5 2.5 CC(C)(C)NCC(O)CO/N=C(/CC(=O)C(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL24644 193975 0 None -13 2 Guinea pig 6.9 pKd = 6.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 312 8 2 5 2.5 CC(C)(C)NCC(O)CO/N=C(/CC(=O)C(C)(C)C)C1CC1 10.1021/jm00376a011
192962 219977 7 None 2 2 Guinea pig 6.9 pKd = 6.9 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1ccc(C(O)CNC(C)C)cc1 10.1021/jm00208a015
CHEMBL3246231 219977 7 None 2 2 Guinea pig 6.9 pKd = 6.9 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1ccc(C(O)CNC(C)C)cc1 10.1021/jm00208a015
2725073 199368 44 None 10 2 Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 167 4 2 3 0.4 NCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL281109 199368 44 None 10 2 Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 167 4 2 3 0.4 NCC(O)COc1ccccc1 10.1021/jm00354a002
15569840 328284 0 None None None Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL418770 328284 0 None None None Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
13040888 216527 0 None -1 2 Guinea pig 6.9 pKd = 6.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00354a003
CHEMBL31450 216527 0 None -1 2 Guinea pig 6.9 pKd = 6.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00354a003
13040905 216218 0 None 10 2 Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 343 10 2 5 2.3 COC(=O)CCc1ccc(OCC(O)CNCc2ccccc2)cc1 10.1021/jm00354a003
CHEMBL31416 216218 0 None 10 2 Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 343 10 2 5 2.3 COC(=O)CCc1ccc(OCC(O)CNCc2ccccc2)cc1 10.1021/jm00354a003
13040911 216871 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 353 12 2 7 1.1 CCOC(=O)CCNCC(O)COc1ccc(CCC(=O)OC)cc1 10.1021/jm00354a003
CHEMBL31677 216871 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 353 12 2 7 1.1 CCOC(=O)CCNCC(O)COc1ccc(CCC(=O)OC)cc1 10.1021/jm00354a003
15578602 199578 1 None -1 2 Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 CCOC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL282537 199578 1 None -1 2 Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 CCOC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
15578567 216627 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 339 10 2 7 0.8 CCOC(=O)C(NCC(O)COc1ccccc1C)C(=O)OCC 10.1021/jm00354a002
CHEMBL31508 216627 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 339 10 2 7 0.8 CCOC(=O)C(NCC(O)COc1ccccc1C)C(=O)OCC 10.1021/jm00354a002
15578620 216740 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig trachea
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL31591 216740 0 None None None Guinea pig 5.9 pKd = 5.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig trachea
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
44459632 196794 0 None -2 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 7 3 4 1.1 CC(NOCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL26224 196794 0 None -2 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 7 3 4 1.1 CC(NOCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
13621656 23597 0 None 1348 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 3.2 CCOCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL11093 23597 0 None 1348 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 3.2 CCOCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
5487795 184070 0 None -79 2 Guinea pig 5.9 pKd = 5.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 284 5 2 4 3.0 CC1C/C(=N/OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
CHEMBL24500 184070 0 None -79 2 Guinea pig 5.9 pKd = 5.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 284 5 2 4 3.0 CC1C/C(=N/OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
12606686 183668 0 None -31 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL24391 183668 0 None -31 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
5473526 314218 0 None -2 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 286 2 0 1 4.6 C[n+]1c(/C=C/c2ccccc2Cl)sc2ccccc21 10.1021/acsmedchemlett.6b00363
CHEMBL4089434 314218 0 None -2 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 286 2 0 1 4.6 C[n+]1c(/C=C/c2ccccc2Cl)sc2ccccc21 10.1021/acsmedchemlett.6b00363
2303 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
4946 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
564 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
63 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
91536 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL27 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL452861 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
DB00571 6476 48 None -6 8 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
1786 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
4171 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
553 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
CHEMBL13 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
DB00264 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
1786 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
4171 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
553 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
CHEMBL13 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
DB00264 5120 49 None -2 5 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
13621620 23297 0 None 1174 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL10983 23297 0 None 1174 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
15112598 23626 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 23626 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
12462220 222093 1 None -1 2 Guinea pig 5.8 pKd = 5.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1ccc(Br)cc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3302368 222093 1 None -1 2 Guinea pig 5.8 pKd = 5.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1ccc(Br)cc1C(O)CNC(C)C 10.1021/jm00208a015
15112598 23626 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 23626 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
71662248 179109 0 None 75 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1F 10.1021/jm400348g
CHEMBL2348197 179109 0 None 75 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1F 10.1021/jm400348g
1786 5120 49 None 1 5 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
4171 5120 49 None 1 5 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
553 5120 49 None 1 5 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
CHEMBL13 5120 49 None 1 5 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
DB00264 5120 49 None 1 5 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
56599097 179108 0 None 87 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
CHEMBL2348196 179108 0 None 87 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
15578610 221641 0 None 2 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 11 2 5 2.1 CCOC(=O)CCCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL32902 221641 0 None 2 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 11 2 5 2.1 CCOC(=O)CCCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
13621720 198584 1 None 407 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 9 3 5 3.5 CCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL274830 198584 1 None 407 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 9 3 5 3.5 CCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
2892936 196277 5 None -15 2 Guinea pig 5.8 pKd = 5.8 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 271 5 2 3 3.0 CC1CC(OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
CHEMBL25929 196277 5 None -15 2 Guinea pig 5.8 pKd = 5.8 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 271 5 2 3 3.0 CC1CC(OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
12238214 59162 14 None 19 2 Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL13504 59162 14 None 19 2 Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
13040900 216984 16 None None None Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 322 10 3 4 1.9 CC(C)NCC(O)COc1ccc(CCC(=O)NC(C)C)cc1 10.1021/jm00354a003
CHEMBL31768 216984 16 None None None Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 322 10 3 4 1.9 CC(C)NCC(O)COc1ccc(CCC(=O)NC(C)C)cc1 10.1021/jm00354a003
2249 1058 67 None 3 3 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
255 1058 67 None 3 3 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
548 1058 67 None 3 3 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
CHEMBL24 1058 67 None 3 3 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
DB00335 1058 67 None 3 3 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
62773144 219975 2 None 1 2 Guinea pig 6.8 pKd = 6.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1ccc(Br)cc1 10.1021/jm00208a015
CHEMBL3246227 219975 2 None 1 2 Guinea pig 6.8 pKd = 6.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1ccc(Br)cc1 10.1021/jm00208a015
14201557 468573 0 None -1 2 Guinea pig 6.8 pKd = 6.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
CHEMBL66724 468573 0 None -1 2 Guinea pig 6.8 pKd = 6.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
15578598 200400 1 None 7 2 Guinea pig 5.8 pKd = 5.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1ccc(OC)cc1 10.1021/jm00354a002
CHEMBL288546 200400 1 None 7 2 Guinea pig 5.8 pKd = 5.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1ccc(OC)cc1 10.1021/jm00354a002
3025067 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
65853 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
CHEMBL282614 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
DB12883 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
13621774 198746 0 None 208 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 427 13 3 7 2.6 COc1ccc(CCNCC(O)COc2ccc(OCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL275934 198746 0 None 208 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 427 13 3 7 2.6 COc1ccc(CCNCC(O)COc2ccc(OCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
56599231 179117 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Br)cc1 10.1021/jm400348g
CHEMBL2348205 179117 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Br)cc1 10.1021/jm400348g
56599232 179119 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm400348g
CHEMBL2348207 179119 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm400348g
13621653 155030 1 None 2238 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OC[C@@H](O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL2052004 155030 1 None 2238 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OC[C@@H](O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
3025067 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
65853 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
CHEMBL282614 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
DB12883 199589 36 None None None Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
54669764 137792 0 None -37 3 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830491 137792 0 None -37 3 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
56599099 179126 0 None 91 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
CHEMBL2348214 179126 0 None 91 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
71662247 179128 0 None 51 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
CHEMBL2348216 179128 0 None 51 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
13621700 468089 0 None 3630 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 7 2.9 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL63421 468089 0 None 3630 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 7 2.9 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
12398051 220064 0 None -43 2 Guinea pig 4.8 pKd = 4.8 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 245 2 2 2 2.8 CC1(C)NC1C(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00199a012
CHEMBL3251299 220064 0 None -43 2 Guinea pig 4.8 pKd = 4.8 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 245 2 2 2 2.8 CC1(C)NC1C(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00199a012
13621671 334007 0 None 234 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 496 13 3 8 2.5 COc1ccc(CCNCC(O)COc2ccc(-c3nc(CN4CCOCC4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL442522 334007 0 None 234 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 496 13 3 8 2.5 COc1ccc(CCNCC(O)COc2ccc(-c3nc(CN4CCOCC4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
44459891 196517 0 None -7 2 Guinea pig 6.7 pKd = 6.7 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 217 5 2 3 1.8 CC(C)(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL26059 196517 0 None -7 2 Guinea pig 6.7 pKd = 6.7 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 217 5 2 3 1.8 CC(C)(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
5484725 135902 13 None -741 2 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1ccc(OC[C@H](O)[C@H](C)NC(C)C)c2c1CCC2 10.1021/acsmedchemlett.6b00363
CHEMBL198059 135902 13 None -741 2 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1ccc(OC[C@H](O)[C@H](C)NC(C)C)c2c1CCC2 10.1021/acsmedchemlett.6b00363
90672832 220003 0 None 2 2 Rat 4.7 pKd = 4.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 294 6 3 5 0.5 CC(C)NCC(O)COc1ccc2c(c1)OCCNC2=O 10.1021/jm00207a025
CHEMBL3247304 220003 0 None 2 2 Rat 4.7 pKd = 4.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 294 6 3 5 0.5 CC(C)NCC(O)COc1ccc2c(c1)OCCNC2=O 10.1021/jm00207a025
54756928 137788 0 None -57 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830487 137788 0 None -57 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
13157407 123057 0 None 245 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 419 10 3 5 4.4 OC(CNCCc1ccccc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL174259 123057 0 None 245 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 419 10 3 5 4.4 OC(CNCCc1ccccc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
13621761 23672 0 None 10 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 385 8 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(Cc2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11135 23672 0 None 10 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 385 8 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(Cc2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
2769826 468801 37 None -1 2 Guinea pig 7.7 pKd = 7.7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 CC(C)NCC(O)COc1ccc2ccccc2c1 10.1021/jm00119a011
CHEMBL68419 468801 37 None -1 2 Guinea pig 7.7 pKd = 7.7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 CC(C)NCC(O)COc1ccc2ccccc2c1 10.1021/jm00119a011
56599102 179111 0 None 60 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(F)cc1 10.1021/jm400348g
CHEMBL2348199 179111 0 None 60 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(F)cc1 10.1021/jm400348g
56599233 179120 0 None 87 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm400348g
CHEMBL2348208 179120 0 None 87 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm400348g
13621712 155032 0 None 1288 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL2052006 155032 0 None 1288 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
54757027 137791 0 None -53 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830490 137791 0 None -53 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
157736 199201 5 None 31 2 Guinea pig 6.7 pKd = 6.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 CCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL279777 199201 5 None 31 2 Guinea pig 6.7 pKd = 6.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 CCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
90672835 220005 0 None -10 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C\c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
CHEMBL3247309 220005 0 None -10 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C\c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
15578594 216712 1 None 1 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1cccc(C)c1 10.1021/jm00354a002
CHEMBL31568 216712 1 None 1 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1cccc(C)c1 10.1021/jm00354a002
15569840 328284 0 None None None Guinea pig 6.7 pKd = 6.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig trachea
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL418770 328284 0 None None None Guinea pig 6.7 pKd = 6.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig trachea
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
15578618 202869 0 None None None Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 321 9 2 5 1.5 O=C(CCNCC(O)COc1ccccc1)OCC(F)(F)F 10.1021/jm00354a002
CHEMBL30538 202869 0 None None None Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 321 9 2 5 1.5 O=C(CCNCC(O)COc1ccccc1)OCC(F)(F)F 10.1021/jm00354a002
15578555 216024 2 None 1 2 Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 8 2 5 0.6 CCOC(=O)CNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL31392 216024 2 None 1 2 Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 8 2 5 0.6 CCOC(=O)CNCC(O)COc1ccccc1 10.1021/jm00354a002
15578616 214311 0 None None None Guinea pig 5.7 pKd = 5.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 333 9 2 5 2.2 O=C(CCNCC(O)COc1ccccc1)Oc1ccc(F)cc1 10.1021/jm00354a002
CHEMBL31047 214311 0 None None None Guinea pig 5.7 pKd = 5.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 333 9 2 5 2.2 O=C(CCNCC(O)COc1ccccc1)Oc1ccc(F)cc1 10.1021/jm00354a002
133620 469860 21 None None None Guinea pig 4.7 pKd = 4.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 9 3 4 1.4 CC(C)NCC(O)COc1ccc(CCC(=O)O)cc1 10.1021/jm00354a003
CHEMBL767 469860 21 None None None Guinea pig 4.7 pKd = 4.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 9 3 4 1.4 CC(C)NCC(O)COc1ccc(CCC(=O)O)cc1 10.1021/jm00354a003
13621680 317620 1 None 446 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 431 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Cl)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL416150 317620 1 None 446 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 431 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Cl)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
2303 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
4946 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
564 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
63 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
91536 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
CHEMBL27 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
DB00571 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
2303 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
4946 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
564 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
63 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
91536 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
CHEMBL27 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
DB00571 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
9904228 199501 2 None -1 2 Guinea pig 8.6 pKd = 8.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
CHEMBL281967 199501 2 None -1 2 Guinea pig 8.6 pKd = 8.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
2303 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
4946 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
564 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
63 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
91536 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
CHEMBL27 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
DB00571 6476 48 None -6 8 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
44279657 214094 1 None 2 2 Guinea pig 8.6 pKd = 8.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 237 7 2 3 2.0 Cc1ccccc1OCC(O)CNCC(C)C 10.1021/jm00354a002
CHEMBL31021 214094 1 None 2 2 Guinea pig 8.6 pKd = 8.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 237 7 2 3 2.0 Cc1ccccc1OCC(O)CNCC(C)C 10.1021/jm00354a002
2176 6361 47 None -4 4 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
4828 6361 47 None -4 4 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
91 6361 47 None -4 4 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
CHEMBL500 6361 47 None -4 4 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
DB00960 6361 47 None -4 4 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
13621767 23634 0 None None None Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11112 23634 0 None None None Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621749 23800 0 None None None Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 13 3 7 4.3 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11205 23800 0 None None None Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 13 3 7 4.3 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
2369 1284 48 None -3 5 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
356 1284 48 None -3 5 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
549 1284 48 None -3 5 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
CHEMBL423 1284 48 None -3 5 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
DB00195 1284 48 None -3 5 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
13157374 155092 0 None 1412 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNC[C@H](O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL2096751 155092 0 None 1412 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNC[C@H](O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
13621752 197661 0 None 144 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 12 3 6 2.9 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL269467 197661 0 None 144 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 12 3 6 2.9 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
3486 6418 47 None -6 6 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
4883 6418 47 None -6 6 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
555 6418 47 None -6 6 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
CHEMBL6995 6418 47 None -6 6 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
DB01297 6418 47 None -6 6 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
54757232 137816 0 None -30 3 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830618 137816 0 None -30 3 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
13621710 23604 0 None 478 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11097 23604 0 None 478 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
1786 5120 49 None -1 5 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
4171 5120 49 None -1 5 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
553 5120 49 None -1 5 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
CHEMBL13 5120 49 None -1 5 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
DB00264 5120 49 None -1 5 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
2030 7460 11 None -316 10 Human 6.7 pKd = 6.7 Binding
Binding affinity to human adrenergic beta-1 receptorBinding affinity to human adrenergic beta-1 receptor
ChEMBL 464 4 0 6 3.0 COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-] 10.1016/j.bmcl.2007.04.086
5311377 7460 11 None -316 10 Human 6.7 pKd = 6.7 Binding
Binding affinity to human adrenergic beta-1 receptorBinding affinity to human adrenergic beta-1 receptor
ChEMBL 464 4 0 6 3.0 COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-] 10.1016/j.bmcl.2007.04.086
CHEMBL251541 7460 11 None -316 10 Human 6.7 pKd = 6.7 Binding
Binding affinity to human adrenergic beta-1 receptorBinding affinity to human adrenergic beta-1 receptor
ChEMBL 464 4 0 6 3.0 COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-] 10.1016/j.bmcl.2007.04.086
6917762 23629 5 None -1 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL111103 23629 5 None -1 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
13621722 197631 2 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00156a028
CHEMBL269219 197631 2 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00156a028
2249 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
255 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
548 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
CHEMBL24 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
DB00335 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
13157412 123018 0 None None None Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 411 11 3 6 3.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL174106 123018 0 None None None Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 411 11 3 6 3.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
2249 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
255 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
548 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
CHEMBL24 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
DB00335 1058 67 None 3 3 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
3682 365954 13 None -316 4 Human 6.6 pKd = 6.6 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1021/jm400348g
CHEMBL513389 365954 13 None -316 4 Human 6.6 pKd = 6.6 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1021/jm400348g
13621638 24167 0 None 2137 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 13 3 7 3.1 COCc1[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)nc1C 10.1021/jm00156a028
CHEMBL11414 24167 0 None 2137 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 13 3 7 3.1 COCc1[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)nc1C 10.1021/jm00156a028
13621722 197631 2 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00103a004
CHEMBL269219 197631 2 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00103a004
2834366 222137 5 None 6 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 251 8 2 3 2.4 CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL3303501 222137 5 None 6 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 251 8 2 3 2.4 CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
3486 6418 47 None -6 6 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
4883 6418 47 None -6 6 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
555 6418 47 None -6 6 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
CHEMBL6995 6418 47 None -6 6 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
DB01297 6418 47 None -6 6 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
13040894 200208 0 None 12 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 COC(=O)CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL286894 200208 0 None 12 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 COC(=O)CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
13040915 202982 0 None 50 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL30622 202982 0 None 50 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
12797747 468544 2 None -2 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 251 9 2 3 2.0 CC(C)NCC(O)COCCCc1ccccc1 10.1021/jm00119a011
CHEMBL66449 468544 2 None -2 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 251 9 2 3 2.0 CC(C)NCC(O)COCCCc1ccccc1 10.1021/jm00119a011
15578575 199911 1 None 3 2 Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 10 2 5 1.4 CCOC(=O)CCCNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL284808 199911 1 None 3 2 Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 10 2 5 1.4 CCOC(=O)CCCNCC(O)COc1ccccc1 10.1021/jm00354a002
15578620 216740 0 None None None Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL31591 216740 0 None None None Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
44279341 200275 0 None None None Guinea pig 6.6 pKd = 6.6 Binding
The compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig trachea
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
CHEMBL287452 200275 0 None None None Guinea pig 6.6 pKd = 6.6 Binding
The compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig trachea
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
12462226 222117 0 None -1 2 Guinea pig 5.6 pKd = 5.6 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1ccc(C)cc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3302805 222117 0 None -1 2 Guinea pig 5.6 pKd = 5.6 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1ccc(C)cc1C(O)CNC(C)C 10.1021/jm00208a015
14348818 219332 0 None -5 3 Guinea pig 4.6 pKd = 4.6 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 219332 0 None -5 3 Guinea pig 4.6 pKd = 4.6 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
2303 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
4946 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
564 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
63 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
91536 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
CHEMBL27 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
CHEMBL452861 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
DB00571 6476 48 None -6 8 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
29057685 314696 11 None -1 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 394 4 1 6 3.1 COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
8056725 314696 11 None -1 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 394 4 1 6 3.1 COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
CHEMBL4094678 314696 11 None -1 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 394 4 1 6 3.1 COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
44383465 232250 2 None -2 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL355100 232250 2 None -2 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
21595423 461717 0 None -10 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL66324 461717 0 None -10 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
2297435 118428 4 None -10 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 253 7 1 2 3.5 C=CCNCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
CHEMBL1621144 118428 4 None -10 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 253 7 1 2 3.5 C=CCNCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
13157386 116578 3 None 138 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL1789879 116578 3 None 138 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621764 317520 0 None 1288 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 507 14 3 7 4.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL415970 317520 0 None 1288 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 507 14 3 7 4.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13040881 199395 0 None -1 2 Guinea pig 8.5 pKd = 8.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 7 2 5 2.0 CCOC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
CHEMBL281294 199395 0 None -1 2 Guinea pig 8.5 pKd = 8.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 7 2 5 2.0 CCOC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
56598832 179130 0 None 588 3 Human 8.5 pKd = 8.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348218 179130 0 None 588 3 Human 8.5 pKd = 8.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
15578565 216654 0 None 2 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 9 2 5 2.1 CCOC(=O)CC(C)(C)NCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31529 216654 0 None 2 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 9 2 5 2.1 CCOC(=O)CC(C)(C)NCC(O)COc1ccccc1C 10.1021/jm00354a002
13621770 23654 0 None 7 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.
ChEMBL 367 8 3 4 2.5 CC(C)NCC(O)COc1ccc(Cc2nc(Br)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11125 23654 0 None 7 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.
ChEMBL 367 8 3 4 2.5 CC(C)NCC(O)COc1ccc(Cc2nc(Br)c[nH]2)cc1 10.1021/jm00156a028
13621602 24132 0 None 1096 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 12 3 7 4.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2C)cc1OC 10.1021/jm00156a028
CHEMBL11396 24132 0 None 1096 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 12 3 7 4.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2C)cc1OC 10.1021/jm00156a028
2840793 468629 27 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00119a011
CHEMBL67151 468629 27 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00119a011
12484297 219277 0 None -15 2 Guinea pig 7.5 pKd = 7.5 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
CHEMBL3228931 219277 0 None -15 2 Guinea pig 7.5 pKd = 7.5 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
13621690 24188 0 None 1318 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 440 12 4 7 1.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(N)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11427 24188 0 None 1318 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 440 12 4 7 1.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(N)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621631 23995 0 None 169 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11307 23995 0 None 169 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
12606706 184036 0 None -13 2 Guinea pig 6.5 pKd = 6.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL24480 184036 0 None -13 2 Guinea pig 6.5 pKd = 6.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00376a011
3869259 313353 1 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
45052940 313353 1 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
5942882 313353 1 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
CHEMBL4079127 313353 1 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
21296271 197259 3 None -1 2 Guinea pig 4.5 pKd = 4.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 241 7 2 3 1.9 CC(C)(C)NCC(O)COC(C1CC1)C1CC1 10.1021/jm00376a011
CHEMBL26607 197259 3 None -1 2 Guinea pig 4.5 pKd = 4.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 241 7 2 3 1.9 CC(C)(C)NCC(O)COC(C1CC1)C1CC1 10.1021/jm00376a011
54757331 137817 0 None -39 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830619 137817 0 None -39 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
15578592 199701 1 None 1 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL283289 199701 1 None 1 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
15578606 217590 1 None 3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 COC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31938 217590 1 None 3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 COC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
559935 213519 5 None 12 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
CHEMBL30899 213519 5 None 12 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
11722868 214097 0 None 7 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
CHEMBL31025 214097 0 None 7 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
12238216 216766 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL31608 216766 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
13040909 216813 0 None 19 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 417 13 2 7 2.4 COC(=O)CCc1ccc(OCC(O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm00354a003
CHEMBL31638 216813 0 None 19 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 417 13 2 7 2.4 COC(=O)CCc1ccc(OCC(O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm00354a003
12238216 216766 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
CHEMBL31608 216766 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
159899 217190 31 None 1 2 Guinea pig 6.5 pKd = 6.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 217 4 2 3 1.5 NCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL31888 217190 31 None 1 2 Guinea pig 6.5 pKd = 6.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 217 4 2 3 1.5 NCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
13040917 199969 0 None None None Guinea pig 5.5 pKd = 5.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 383 11 2 9 0.3 CCOC(=O)C(NCC(O)COc1ccccc1C(=O)OC)C(=O)OCC 10.1021/jm00354a003
CHEMBL285233 199969 0 None None None Guinea pig 5.5 pKd = 5.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 383 11 2 9 0.3 CCOC(=O)C(NCC(O)COc1ccccc1C(=O)OC)C(=O)OCC 10.1021/jm00354a003
15578604 216748 1 None -1 2 Guinea pig 5.5 pKd = 5.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 7 2 5 0.5 COC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31598 216748 1 None -1 2 Guinea pig 5.5 pKd = 5.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 7 2 5 0.5 COC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
56598831 180000 0 None 295 2 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2365796 180000 0 None 295 2 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
54756927 137787 0 None -97 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830486 137787 0 None -97 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
54579961 125782 0 None -3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL1788274 125782 0 None -3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
3486 6418 47 None 3 6 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
4883 6418 47 None 3 6 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
555 6418 47 None 3 6 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
CHEMBL6995 6418 47 None 3 6 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
DB01297 6418 47 None 3 6 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
44274622 199980 0 None -3 2 Guinea pig 5.5 pKd = 5.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.6 CC(OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL285309 199980 0 None -3 2 Guinea pig 5.5 pKd = 5.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.6 CC(OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
29072430 315312 11 None -6 2 Human 4.5 pKd = 4.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 365 4 1 5 3.9 COc1cccc(/C=C2\Oc3c(CN4CCCC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
8071397 315312 11 None -6 2 Human 4.5 pKd = 4.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 365 4 1 5 3.9 COc1cccc(/C=C2\Oc3c(CN4CCCC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
CHEMBL4101524 315312 11 None -6 2 Human 4.5 pKd = 4.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 365 4 1 5 3.9 COc1cccc(/C=C2\Oc3c(CN4CCCC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
54758417 137786 0 None -38 3 Human 7.4 pKd = 7.4 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830485 137786 0 None -38 3 Human 7.4 pKd = 7.4 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
214004 220000 2 None None None Rat 5.4 pKd = 5.4 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 0.8 CNC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL3247301 220000 2 None None None Rat 5.4 pKd = 5.4 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 0.8 CNC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
3067050 193838 0 None -3 2 Guinea pig 4.4 pKd = 4.4 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.7 C=CC(C)(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL24586 193838 0 None -3 2 Guinea pig 4.4 pKd = 4.4 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.7 C=CC(C)(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
14201550 202254 0 None None None Guinea pig 6.4 pKd = 6.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL302605 202254 0 None None None Guinea pig 6.4 pKd = 6.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
16415941 314918 12 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 375 3 1 5 4.7 Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2 10.1021/acsmedchemlett.6b00363
16415942 314918 12 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 375 3 1 5 4.7 Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2 10.1021/acsmedchemlett.6b00363
CHEMBL4097144 314918 12 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 375 3 1 5 4.7 Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2 10.1021/acsmedchemlett.6b00363
12484297 219277 0 None -15 2 Guinea pig 7.4 pKd = 7.4 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
CHEMBL3228931 219277 0 None -15 2 Guinea pig 7.4 pKd = 7.4 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
2369 1284 48 None -10 5 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
356 1284 48 None -10 5 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
549 1284 48 None -10 5 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
CHEMBL423 1284 48 None -10 5 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
DB00195 1284 48 None -10 5 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
15578563 200249 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 317 9 2 5 2.1 CCOC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL287242 200249 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 317 9 2 5 2.1 CCOC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
15578588 213846 1 None 6 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccccc1Cl 10.1021/jm00354a002
CHEMBL30942 213846 1 None 6 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccccc1Cl 10.1021/jm00354a002
15578608 217128 1 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 295 10 2 5 1.7 CCOC(=O)CCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31857 217128 1 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 295 10 2 5 1.7 CCOC(=O)CCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
15578590 317549 1 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1cccc(Cl)c1 10.1021/jm00354a002
CHEMBL416030 317549 1 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1cccc(Cl)c1 10.1021/jm00354a002
12941056 202305 1 None 10 2 Guinea pig 6.4 pKd = 6.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.1 COC(=O)Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL30292 202305 1 None 10 2 Guinea pig 6.4 pKd = 6.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.1 COC(=O)Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
193122 3907 4 None None None Guinea pig 6.4 pKd = 6.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
542 3907 4 None None None Guinea pig 6.4 pKd = 6.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
CHEMBL142773 3907 4 None None None Guinea pig 6.4 pKd = 6.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
15569837 216212 1 None 6 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccc(Cl)cc1 10.1021/jm00354a002
CHEMBL31411 216212 1 None 6 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccc(Cl)cc1 10.1021/jm00354a002
15578596 220925 1 None -1 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1cccc(OC)c1 10.1021/jm00354a002
CHEMBL32736 220925 1 None -1 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1cccc(OC)c1 10.1021/jm00354a002
15578614 202900 0 None None None Guinea pig 6.4 pKd = 6.4 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 315 9 2 5 2.0 O=C(CCNCC(O)COc1ccccc1)Oc1ccccc1 10.1021/jm00354a002
CHEMBL30558 202900 0 None None None Guinea pig 6.4 pKd = 6.4 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 315 9 2 5 2.0 O=C(CCNCC(O)COc1ccccc1)Oc1ccccc1 10.1021/jm00354a002
13040902 214589 0 None 1 2 Guinea pig 5.4 pKd = 5.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 323 11 2 5 2.3 CCCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL31117 214589 0 None 1 2 Guinea pig 5.4 pKd = 5.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 323 11 2 5 2.3 CCCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
14348818 219332 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 219332 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
13162 7899 43 None -31622 4 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 ClC1=CC=CC(=C1NC2=NCCN2)Cl 10.1021/jm00115a008
2803 7899 43 None -31622 4 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 ClC1=CC=CC(=C1NC2=NCCN2)Cl 10.1021/jm00115a008
CHEMBL134 7899 43 None -31622 4 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 ClC1=CC=CC(=C1NC2=NCCN2)Cl 10.1021/jm00115a008
14348818 219332 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 219332 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
135079 24789 0 None 9772 2 Guinea pig 8.4 pKd = 8.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL11671 24789 0 None 9772 2 Guinea pig 8.4 pKd = 8.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
14201539 461719 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL66384 461719 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@H]1CCCCN1 10.1021/jm00119a011
2249 1058 67 None 3 3 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
255 1058 67 None 3 3 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
548 1058 67 None 3 3 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
CHEMBL24 1058 67 None 3 3 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
DB00335 1058 67 None 3 3 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
13621723 24255 0 None 1698 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 395 10 5 5 2.2 O=C(NCCNCC(O)COc1ccc(-c2ncc[nH]2)cc1)Nc1ccccc1 10.1021/jm00156a028
CHEMBL11467 24255 0 None 1698 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 395 10 5 5 2.2 O=C(NCCNCC(O)COc1ccc(-c2ncc[nH]2)cc1)Nc1ccccc1 10.1021/jm00156a028
13621665 198763 0 None 1412 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 2.9 COCCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL276029 198763 0 None 1412 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 2.9 COCCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
328583 220063 1 None -676 2 Guinea pig 4.4 pKd = 4.4 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 177 2 2 2 1.5 CC1(C)NC1C(O)c1ccccc1 10.1021/jm00199a012
CHEMBL3251298 220063 1 None -676 2 Guinea pig 4.4 pKd = 4.4 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 177 2 2 2 1.5 CC1(C)NC1C(O)c1ccccc1 10.1021/jm00199a012
29074692 315573 10 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 339 4 1 5 3.4 COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
8073977 315573 10 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 339 4 1 5 3.4 COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
CHEMBL4104850 315573 10 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 339 4 1 5 3.4 COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
2184756 118713 3 None -12 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 285 8 0 3 3.3 CN(C)CCOCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
CHEMBL1623548 118713 3 None -12 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 285 8 0 3 3.3 CN(C)CCOCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
71662246 179124 0 None 11 2 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
CHEMBL2348212 179124 0 None 11 2 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
29057664 314005 11 None -1 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 309 3 1 4 3.4 Cc1cc(O)c(CN(C)C)c2c1C(=O)/C(=C/c1ccccc1)O2 10.1021/acsmedchemlett.6b00363
8035384 314005 11 None -1 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 309 3 1 4 3.4 Cc1cc(O)c(CN(C)C)c2c1C(=O)/C(=C/c1ccccc1)O2 10.1021/acsmedchemlett.6b00363
CHEMBL4086982 314005 11 None -1 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 309 3 1 4 3.4 Cc1cc(O)c(CN(C)C)c2c1C(=O)/C(=C/c1ccccc1)O2 10.1021/acsmedchemlett.6b00363
44459922 197139 0 None 4 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 6 2 4 1.8 C/C(=N/OCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00376a011
CHEMBL26506 197139 0 None 4 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 6 2 4 1.8 C/C(=N/OCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00376a011
13302060 27099 0 None 112 2 Guinea pig 6.3 pKd = 6.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 411 11 2 7 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3nccn3C)cc2)cc1OC 10.1021/jm00156a028
CHEMBL1188509 27099 0 None 112 2 Guinea pig 6.3 pKd = 6.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 411 11 2 7 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3nccn3C)cc2)cc1OC 10.1021/jm00156a028
21595422 202307 0 None 2 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL302935 202307 0 None 2 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
12606684 196429 0 None -15 2 Guinea pig 6.3 pKd = 6.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL26003 196429 0 None -15 2 Guinea pig 6.3 pKd = 6.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
12548683 46671 0 None 2 2 Guinea pig 8.3 pKd = 8.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
CHEMBL13284 46671 0 None 2 2 Guinea pig 8.3 pKd = 8.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
10467512 193743 0 None -2 2 Guinea pig 8.3 pKd = 8.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00376a011
CHEMBL285972 193743 0 None -2 2 Guinea pig 8.3 pKd = 8.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00376a011
13621599 24200 0 None 3981 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 513 12 3 7 5.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
CHEMBL11431 24200 0 None 3981 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 513 12 3 7 5.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
13040884 47602 0 None 15 2 Guinea pig 8.3 pKd = 8.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 389 11 2 7 2.1 COC(=O)c1ccccc1OCC(O)CNCCc1ccc(OC)c(OC)c1 10.1021/jm00354a003
CHEMBL13358 47602 0 None 15 2 Guinea pig 8.3 pKd = 8.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 389 11 2 7 2.1 COC(=O)c1ccccc1OCC(O)CNCCc1ccc(OC)c(OC)c1 10.1021/jm00354a003
13621796 23752 0 None 1659 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 480 12 3 8 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cn2)cc1OC 10.1021/jm00156a028
CHEMBL11178 23752 0 None 1659 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 480 12 3 8 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cn2)cc1OC 10.1021/jm00156a028
13157365 255753 0 None 239 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 465 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL366389 255753 0 None 239 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 465 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
12462216 222145 0 None 2 2 Guinea pig 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1cc(Br)ccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3303705 222145 0 None 2 2 Guinea pig 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1cc(Br)ccc1C(O)CNC(C)C 10.1021/jm00208a015
13040883 199396 1 None -1 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 297 8 3 6 0.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)CO 10.1021/jm00354a003
CHEMBL281298 199396 1 None -1 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 297 8 3 6 0.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)CO 10.1021/jm00354a003
13040896 202297 4 None 15 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 293 8 2 5 1.6 COC(=O)/C=C/c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL30289 202297 4 None 15 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 293 8 2 5 1.6 COC(=O)/C=C/c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
9970852 220004 0 None 25 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C/c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
CHEMBL3247308 220004 0 None 25 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C/c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
15578573 216988 1 None 25 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 9 2 5 1.0 CCOC(=O)CCNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL31772 216988 1 None 25 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 9 2 5 1.0 CCOC(=O)CCNCC(O)COc1ccccc1 10.1021/jm00354a002
13621595 21914 0 None 575 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2Br)cc1OC 10.1021/jm00156a028
CHEMBL10879 21914 0 None 575 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2Br)cc1OC 10.1021/jm00156a028
13040890 214132 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
CHEMBL31036 214132 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
13040890 214132 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL31036 214132 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
14348818 219332 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 219332 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
14348819 23727 0 None None None Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 374 6 4 6 2.5 CC(C)(C)NCC(O)COc1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111694 23727 0 None None None Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 374 6 4 6 2.5 CC(C)(C)NCC(O)COc1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
14348818 219332 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 219332 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
13157384 155102 0 None None None Guinea pig 7.3 pKd = 7.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL2109975 155102 0 None None None Guinea pig 7.3 pKd = 7.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
54757229 137815 0 None -33 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830617 137815 0 None -33 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
44307572 468104 0 None 1 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
CHEMBL63582 468104 0 None 1 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
54757026 137790 0 None -74 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830489 137790 0 None -74 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
173 6634 59 None -2 2 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
5011 6634 59 None -2 2 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
CHEMBL18772 6634 59 None -2 2 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
173 6634 59 None -2 2 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
5011 6634 59 None -2 2 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
CHEMBL18772 6634 59 None -2 2 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
21595420 468703 0 None -1 2 Guinea pig 7.2 pKd = 7.2 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1ccc(OC[C@@H](O)[C@@H]2CCCCN2)cc1 10.1021/jm00119a011
CHEMBL67631 468703 0 None -1 2 Guinea pig 7.2 pKd = 7.2 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1ccc(OC[C@@H](O)[C@@H]2CCCCN2)cc1 10.1021/jm00119a011
13590031 23704 0 None None None Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 414 11 2 7 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nccs3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11155 23704 0 None None None Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 414 11 2 7 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nccs3)cc2)cc1OC 10.1021/jm00156a028
2303 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
4946 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
564 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
63 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
91536 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL27 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL452861 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
DB00571 6476 48 None -11 8 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
13157380 124887 0 None 2041 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 493 12 3 7 4.8 COc1ccc(CC(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL177765 124887 0 None 2041 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 493 12 3 7 4.8 COc1ccc(CC(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
13621686 24150 0 None 575 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 469 13 3 8 2.8 CCOC(=O)c1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL11406 24150 0 None 575 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 469 13 3 8 2.8 CCOC(=O)c1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
66653268 179113 0 None 426 3 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
CHEMBL2348201 179113 0 None 426 3 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
13157405 159547 0 None 141 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 O[C@@H](CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL2096750 159547 0 None 141 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 O[C@@H](CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
135817 333000 12 None None None Guinea pig 8.2 pKd = 8.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 391 13 2 5 3.2 CC(C)NCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1 10.1021/jm00103a004
CHEMBL43405 333000 12 None None None Guinea pig 8.2 pKd = 8.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 391 13 2 5 3.2 CC(C)NCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1 10.1021/jm00103a004
13157402 327723 0 None 398 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 OC(CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL434360 327723 0 None 398 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 OC(CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
13621716 155031 0 None 165 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNC[C@H](O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL2052005 155031 0 None 165 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNC[C@H](O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
56599101 179110 0 None 42 2 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(F)c1 10.1021/jm400348g
CHEMBL2348198 179110 0 None 42 2 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(F)c1 10.1021/jm400348g
10467512 193743 0 None -2 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL285972 193743 0 None -2 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
13621772 23568 0 None 301 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 14 3 7 2.7 COc1ccc(CCNCC(O)COc2ccc(COCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11080 23568 0 None 301 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 14 3 7 2.7 COc1ccc(CCNCC(O)COc2ccc(COCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
12521588 123148 0 None 10 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 289 6 3 4 2.2 CC(C)(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
CHEMBL174783 123148 0 None 10 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 289 6 3 4 2.2 CC(C)(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
13157410 256276 0 None 446 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 287 7 3 4 1.9 Cc1c[nH]c(-c2ccc(OCC(O)CNC3CC3)cc2)n1 10.1021/jm00361a004
CHEMBL366573 256276 0 None 446 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 287 7 3 4 1.9 Cc1c[nH]c(-c2ccc(OCC(O)CNC3CC3)cc2)n1 10.1021/jm00361a004
12521605 331167 0 None 9 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 303 6 3 4 2.5 Cc1c[nH]c(-c2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00361a004
CHEMBL427297 331167 0 None 9 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 303 6 3 4 2.5 Cc1c[nH]c(-c2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00361a004
13621758 24087 0 None 3 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 7 3 4 2.4 Cc1c[nH]c(Cc2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00156a028
CHEMBL11362 24087 0 None 3 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 7 3 4 2.4 Cc1c[nH]c(Cc2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00156a028
24208809 219974 18 None -5 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 209 5 2 3 1.7 COc1ccccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3246226 219974 18 None -5 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 209 5 2 3 1.7 COc1ccccc1C(O)CNC(C)C 10.1021/jm00208a015
2834364 78632 20 None -1 3 Guinea pig 7.2 pKd = 7.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
CHEMBL143467 78632 20 None -1 3 Guinea pig 7.2 pKd = 7.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
2834364 78632 20 None -1 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL143467 78632 20 None -1 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
60903220 219976 1 None 1 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1cccc(Br)c1 10.1021/jm00208a015
CHEMBL3246229 219976 1 None 1 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1cccc(Br)c1 10.1021/jm00208a015
15578561 214566 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 274 7 3 4 0.7 NC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL31099 214566 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 274 7 3 4 0.7 NC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
15578559 216775 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 CCOC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL31611 216775 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 CCOC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
15578570 200069 0 None None None Guinea pig 5.2 pKd = 5.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1cccc(NCC(O)COc2ccccc2C)c1 10.1021/jm00354a002
CHEMBL285958 200069 0 None None None Guinea pig 5.2 pKd = 5.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1cccc(NCC(O)COc2ccccc2C)c1 10.1021/jm00354a002
13162 7899 43 None -31622 4 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 ClC1=CC=CC(=C1NC2=NCCN2)Cl 10.1021/jm00115a008
2803 7899 43 None -31622 4 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 ClC1=CC=CC(=C1NC2=NCCN2)Cl 10.1021/jm00115a008
CHEMBL134 7899 43 None -31622 4 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 ClC1=CC=CC(=C1NC2=NCCN2)Cl 10.1021/jm00115a008
13157369 122509 0 None None None Guinea pig 6.2 pKd = 6.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 273 7 3 4 1.6 OC(CNC1CC1)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
CHEMBL172431 122509 0 None None None Guinea pig 6.2 pKd = 6.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 273 7 3 4 1.6 OC(CNC1CC1)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
56597179 179131 0 None 501 2 Human 8.1 pKd = 8.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348219 179131 0 None 501 2 Human 8.1 pKd = 8.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
13621593 23595 0 None 204 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 509 11 3 6 4.1 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
CHEMBL11092 23595 0 None 204 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 509 11 3 6 4.1 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
13621626 23837 0 None 741 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 445 11 3 6 3.6 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(Cl)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11224 23837 0 None 741 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 445 11 3 6 3.6 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(Cl)[nH]3)cc2)cc1OC 10.1021/jm00156a028
54757126 137793 0 None -57 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830492 137793 0 None -57 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
56599229 179112 0 None 37 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Cl 10.1021/jm400348g
CHEMBL2348200 179112 0 None 37 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Cl 10.1021/jm400348g
56599230 179115 0 None 10 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Br 10.1021/jm400348g
CHEMBL2348203 179115 0 None 10 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Br 10.1021/jm400348g
15578577 337087 0 None 1 2 Guinea pig 7.1 pKd = 7.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 COC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL448775 337087 0 None 1 2 Guinea pig 7.1 pKd = 7.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 COC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
13040907 216725 0 None 19 2 Guinea pig 6.1 pKd = 6.1 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 371 12 2 5 2.8 COC(=O)CCc1ccc(OCC(O)CNCCCc2ccccc2)cc1 10.1021/jm00354a003
CHEMBL31583 216725 0 None 19 2 Guinea pig 6.1 pKd = 6.1 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 371 12 2 5 2.8 COC(=O)CCc1ccc(OCC(O)CNCCCc2ccccc2)cc1 10.1021/jm00354a003
59373811 219978 9 None 2 2 Guinea pig 6.1 pKd = 6.1 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1cccc(C(O)CNC(C)C)c1 10.1021/jm00208a015
CHEMBL3246233 219978 9 None 2 2 Guinea pig 6.1 pKd = 6.1 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1cccc(C(O)CNC(C)C)c1 10.1021/jm00208a015
44279490 214362 0 None 1 2 Guinea pig 6.1 pKd = 6.1 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 297 9 2 5 1.8 CCOC(=O)CCNCC(O)COC1=CC=CCC1(C)C 10.1021/jm00354a002
CHEMBL31050 214362 0 None 1 2 Guinea pig 6.1 pKd = 6.1 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 297 9 2 5 1.8 CCOC(=O)CCNCC(O)COC1=CC=CCC1(C)C 10.1021/jm00354a002
15578569 220067 0 None None None Guinea pig 5.1 pKd = 5.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1ccc(NCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL32514 220067 0 None None None Guinea pig 5.1 pKd = 5.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1ccc(NCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
9576814 116529 3 None 2 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL171059 116529 3 None 2 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
21595419 202208 0 None 1 2 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL302339 202208 0 None 1 2 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@@H]1CCCCN1 10.1021/jm00119a011
14201547 461723 0 None -2 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL66702 461723 0 None -2 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
44274623 197142 1 None 7 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 201 6 2 3 1.2 CC(C)(C)NCC(O)COCC1CC1 10.1021/jm00376a011
CHEMBL26507 197142 1 None 7 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 201 6 2 3 1.2 CC(C)(C)NCC(O)COCC1CC1 10.1021/jm00376a011
155774 8875 30 None 8 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
2848 8875 30 None 8 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
538 8875 30 None 8 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
CHEMBL75753 8875 30 None 8 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
DB13781 8875 30 None 8 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
44459541 196497 0 None -1 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 242 7 2 4 1.9 C/C(CC1CC1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL26049 196497 0 None -1 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 242 7 2 4 1.9 C/C(CC1CC1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00376a011
12484287 219276 0 None -2 2 Guinea pig 6.1 pKd = 6.1 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
CHEMBL3228930 219276 0 None -2 2 Guinea pig 6.1 pKd = 6.1 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
54758320 137818 0 None -13 3 Human 6.1 pKd = 6.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830620 137818 0 None -13 3 Human 6.1 pKd = 6.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
54756929 137789 0 None -50 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830488 137789 0 None -50 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
5311116 4758 10 None 954 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
544 4758 10 None 954 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
CHEMBL207802 4758 10 None 954 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
56599098 179125 0 None 95 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
CHEMBL2348213 179125 0 None 95 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
13157382 124999 0 None 3981 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 507 12 3 7 5.2 COc1ccc(CC(C)(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL177860 124999 0 None 3981 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 507 12 3 7 5.2 COc1ccc(CC(C)(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
2303 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
4946 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
564 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
63 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
91536 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL27 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
DB00571 6476 48 None -6 8 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
44459890 200188 0 None 8 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 214 6 2 4 1.1 CC(C)(C)NCC(O)CO/N=C\C1CC1 10.1021/jm00376a011
CHEMBL286783 200188 0 None 8 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 214 6 2 4 1.1 CC(C)(C)NCC(O)CO/N=C\C1CC1 10.1021/jm00376a011
54757129 137794 0 None -29 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830493 137794 0 None -29 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
56598833 179129 0 None None None Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
CHEMBL2348217 179129 0 None None None Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
13621725 23826 1 None None None Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 389 12 5 5 1.8 CCCCNC(=O)NCCNCC(O)COc1ccc(-c2nc(C)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11219 23826 1 None None None Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 389 12 5 5 1.8 CCCCNC(=O)NCCNCC(O)COc1ccc(-c2nc(C)c[nH]2)cc1 10.1021/jm00156a028
21595421 328441 0 None -28 2 Guinea pig 7.0 pKd = 7.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1cccc(OC[C@@H](O)[C@@H]2CCCCN2)c1 10.1021/jm00119a011
CHEMBL419994 328441 0 None -28 2 Guinea pig 7.0 pKd = 7.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1cccc(OC[C@@H](O)[C@@H]2CCCCN2)c1 10.1021/jm00119a011
56599100 179127 0 None 12 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
CHEMBL2348215 179127 0 None 12 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
6917762 23629 5 None -1 2 Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL111103 23629 5 None -1 2 Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
54758415 137819 0 None -6 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830621 137819 0 None -6 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
20986823 312773 5 None -4 2 Human 4.0 pKd = 4.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 243 5 0 3 2.6 CN(C)CCOc1ccc2ccccc2c1C=O 10.1021/acsmedchemlett.6b00363
CHEMBL4071616 312773 5 None -4 2 Human 4.0 pKd = 4.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 243 5 0 3 2.6 CN(C)CCOc1ccc2ccccc2c1C=O 10.1021/acsmedchemlett.6b00363
9849699 145472 23 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
CHEMBL2012520 145472 23 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
DB12858 145472 23 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
487 1642 55 None -4 5 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
569 1642 55 None -4 5 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
71739 1642 55 None -4 5 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
CHEMBL324665 1642 55 None -4 5 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
46889772 21324 0 None 79 3 Human 10.0 pKi = 10 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 563 8 2 6 5.2 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC1)C2=O 10.1016/j.bmcl.2010.04.009
CHEMBL1084707 21324 0 None 79 3 Human 10.0 pKi = 10 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 563 8 2 6 5.2 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC1)C2=O 10.1016/j.bmcl.2010.04.009
2585 1662 62 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 1662 62 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 1662 62 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 1662 62 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 1662 62 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
2239 474203 48 None 3 2 Human 9.7 pKi = 9.7 Binding
Inhibition of beta-1 adrenoceptor (unknown origin)Inhibition of beta-1 adrenoceptor (unknown origin)
ChEMBL 371 7 3 7 2.8 CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1 10.1016/j.ejmech.2023.115172
CHEMBL93298 474203 48 None 3 2 Human 9.7 pKi = 9.7 Binding
Inhibition of beta-1 adrenoceptor (unknown origin)Inhibition of beta-1 adrenoceptor (unknown origin)
ChEMBL 371 7 3 7 2.8 CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1 10.1016/j.ejmech.2023.115172
DB09204 474203 48 None 3 2 Human 9.7 pKi = 9.7 Binding
Inhibition of beta-1 adrenoceptor (unknown origin)Inhibition of beta-1 adrenoceptor (unknown origin)
ChEMBL 371 7 3 7 2.8 CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1 10.1016/j.ejmech.2023.115172
185395 270561 40 None -6 3 Mouse 9.7 pKi = 9.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL3799125 270561 40 None -6 3 Mouse 9.7 pKi = 9.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
531 7893 1 None -2 2 Human 9.6 pKi = 9.6 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 279 5 4 4 1.0 O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm000544b
6603756 7893 1 None -2 2 Human 9.6 pKi = 9.6 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 279 5 4 4 1.0 O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm000544b
CHEMBL36060 7893 1 None -2 2 Human 9.6 pKi = 9.6 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 279 5 4 4 1.0 O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm000544b
127 6360 38 None 2 6 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
688095 6360 38 None 2 6 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL117405 6360 38 None 2 6 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
155548437 346646 0 None -3 2 Mouse 9.3 pKi = 9.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4537221 346646 0 None -3 2 Mouse 9.3 pKi = 9.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
2176 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
4828 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
91 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
CHEMBL500 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
DB00960 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
2176 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
4828 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
91 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL500 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
DB00960 6361 47 None -1 14 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
118710940 232778 0 None -1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 7 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3CCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323658 232778 0 None -1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 7 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3CCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
2585 1662 62 None -6 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
522 1662 62 None -6 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
551 1662 62 None -6 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
CHEMBL723 1662 62 None -6 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
DB01136 1662 62 None -6 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
49864395 39527 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221680 39527 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
46889812 20786 0 None -10 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 415 7 2 4 4.4 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2cccnc2)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1082501 20786 0 None -10 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 415 7 2 4 4.4 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2cccnc2)CC1 10.1016/j.bmcl.2010.04.009
155525244 335539 0 None -15 2 Mouse 9.0 pKi = 9.0 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4456301 335539 0 None -15 2 Mouse 9.0 pKi = 9.0 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
2303 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 6476 48 None -3 19 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
2685 1837 22 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
541 1837 22 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
CHEMBL280822 1837 22 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
2303 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
4946 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
564 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
63 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
91536 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL27 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL452861 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
DB00571 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
49864380 39524 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
CHEMBL1221637 39524 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
2303 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
4946 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
564 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
63 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
91536 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL27 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL452861 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
DB00571 6476 48 None -3 19 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
2685 1837 22 None 1 6 Mouse 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
541 1837 22 None 1 6 Mouse 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
CHEMBL280822 1837 22 None 1 6 Mouse 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
10075766 200580 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 532 11 5 8 0.2 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL290313 200580 0 None None None Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 532 11 5 8 0.2 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
2303 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 6476 48 None -3 19 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
49864333 39504 0 None -1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
CHEMBL1221541 39504 0 None -1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
33624 8322 24 None -4 7 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
4061 8322 24 None -4 7 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
565 8322 24 None -4 7 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
CHEMBL499 8322 24 None -4 7 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
DB00373 8322 24 None -4 7 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
49864460 39541 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 396 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSc3ccc(Cl)cc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221861 39541 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 396 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSc3ccc(Cl)cc3)c2s1 10.1016/j.bmcl.2010.06.136
11617407 39515 0 None -4 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 6 4 5 2.9 CC(C)(Cc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221590 39515 0 None -4 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 6 4 5 2.9 CC(C)(Cc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
11625619 159243 0 None -3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088201 159243 0 None -3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
2583 470697 25 None 2 2 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1021/jm00053a020
520 470697 25 None 2 2 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1021/jm00053a020
CHEMBL839 470697 25 None 2 2 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1021/jm00053a020
DB00521 470697 25 None 2 2 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1021/jm00053a020
145947665 332451 0 None None None Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302144 332451 0 None None None Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
52948805 41624 0 None -10 3 Human 7.0 pKi = 7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 502 9 2 7 5.5 CC(C)c1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258704 41624 0 None -10 3 Human 7.0 pKi = 7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 502 9 2 7 5.5 CC(C)c1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
10132882 194915 0 None 1 2 Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 8 2 6 3.2 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
CHEMBL251599 194915 0 None 1 2 Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 8 2 6 3.2 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
10201549 194916 0 None None None Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 8 2 6 3.9 O[C@@H](CNCCOc1ccc(-c2csc(C(F)(F)F)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL251600 194916 0 None None None Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 8 2 6 3.9 O[C@@H](CNCCOc1ccc(-c2csc(C(F)(F)F)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
155519891 334947 0 None -3 6 Human 6.0 pKi = 6 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 249 2 1 4 1.9 COc1cc(OC)c2c(c1)OC[C@@]1(C)NCC[C@@H]21 10.1021/acsmedchemlett.9b00225
CHEMBL4447975 334947 0 None -3 6 Human 6.0 pKi = 6 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 249 2 1 4 1.9 COc1cc(OC)c2c(c1)OC[C@@]1(C)NCC[C@@H]21 10.1021/acsmedchemlett.9b00225
3687256 21163 5 None -12 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1083994 21163 5 None -12 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
44444185 310783 0 None -112 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 514 13 4 7 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL400067 310783 0 None -112 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 514 13 4 7 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
681 3019 53 None -44 20 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
940 3019 53 None -44 20 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
947 3019 53 None -44 20 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
CHEMBL59 3019 53 None -44 20 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
DB00988 3019 53 None -44 20 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
9892481 142479 12 None -3162 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL1940832 142479 12 None -3162 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
59119466 221755 0 None -39 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 10 5 7 3.3 COC(=O)c1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290996 221755 0 None -39 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 10 5 7 3.3 COC(=O)c1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
72901200 238494 30 None -6918 33 Human 5.0 pKi = 5 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 322 7 2 4 3.8 Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1 10.6019/CHEMBL4507309
CHEMBL3480577 238494 30 None -6918 33 Human 5.0 pKi = 5 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 322 7 2 4 3.8 Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1 10.6019/CHEMBL4507309
2247 1042 63 None -95 37 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 1042 63 None -95 37 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 1042 63 None -95 37 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 1042 63 None -95 37 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 1042 63 None -95 37 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
16735274 308873 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL4108123 308873 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 nan
1786 5120 49 None -1 5 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
4171 5120 49 None -1 5 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
553 5120 49 None -1 5 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL13 5120 49 None -1 5 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00264 5120 49 None -1 5 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
44424578 327610 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL425658 327610 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
137640201 312873 2 None -8128 13 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4072818 312873 2 None -8128 13 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
44350012 41889 0 None -6 3 Guinea pig 5.0 pKi = 5.0 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
CHEMBL126394 41889 0 None -6 3 Guinea pig 5.0 pKi = 5.0 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
10464801 25493 0 None 3 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178754 25493 0 None 3 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
145946294 332276 0 None 3 2 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 302 8 3 5 0.3 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4299816 332276 0 None 3 2 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 302 8 3 5 0.3 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C)cc1 10.1021/acs.jmedchem.8b00625
24936882 41452 0 None -52 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 512 9 4 10 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1258143 41452 0 None -52 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 512 9 4 10 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
46889699 20978 0 None -26 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 470 8 1 5 4.1 C=CCc1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083364 20978 0 None -26 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 470 8 1 5 4.1 C=CCc1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
44444195 194942 0 None -87 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccc(Cl)cc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL251764 194942 0 None -87 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccc(Cl)cc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
49864413 39533 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221733 39533 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
10527469 312189 3 None -48977 15 Human 5.0 pKi = 5.0 Binding
Binding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligandBinding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 312189 3 None -48977 15 Human 5.0 pKi = 5.0 Binding
Binding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligandBinding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
11647002 39528 0 None -22 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221681 39528 0 None -22 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
851833 77531 52 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cccc(N2CCNCC2)c1Cl 10.1021/jm400140q
CHEMBL1424807 77531 52 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cccc(N2CCNCC2)c1Cl 10.1021/jm400140q
10012704 25501 0 None 1 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178768 25501 0 None 1 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
25242459 27005 0 None None None Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 391 7 3 6 2.7 CC(C)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1187782 27005 0 None None None Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 391 7 3 6 2.7 CC(C)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
2303 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
4946 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
564 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
63 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
91536 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL27 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL452861 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
DB00571 6476 48 None -3 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
44396532 139043 0 None -3 3 Human 7.0 pKi = 7.0 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL185836 139043 0 None -3 3 Human 7.0 pKi = 7.0 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
72544566 183936 0 None -5 5 Pig 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 375 10 0 6 3.1 COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443009 183936 0 None -5 5 Pig 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 375 10 0 6 3.1 COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
1028 599 43 None -66 18 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
479 599 43 None -66 18 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
5816 599 43 None -66 18 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL679 599 43 None -66 18 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00668 599 43 None -66 18 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
44423644 176354 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL226348 176354 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
49864377 39521 0 None -12 2 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221634 39521 0 None -12 2 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
36811 2998 34 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 2998 34 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 2998 34 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 2998 34 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 2998 34 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
1054 3263 41 None None None Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
59768 3263 41 None None None Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
7178 3263 41 None None None Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL768 3263 41 None None None Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00187 3263 41 None None None Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
567 1496 16 None -13 5 Human 6.0 pKi = 6.0 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/S0960-894X(97)00266-7
9841972 1496 16 None -13 5 Human 6.0 pKi = 6.0 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/S0960-894X(97)00266-7
CHEMBL284782 1496 16 None -13 5 Human 6.0 pKi = 6.0 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/S0960-894X(97)00266-7
567 1496 16 None -13 5 Human 5.0 pKi = 5.0 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/0960-894X(96)00417-9
9841972 1496 16 None -13 5 Human 5.0 pKi = 5.0 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/0960-894X(96)00417-9
CHEMBL284782 1496 16 None -13 5 Human 5.0 pKi = 5.0 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/0960-894X(96)00417-9
52948056 41389 0 None -6 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257915 41389 0 None -6 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
2769774 21047 18 None -16 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 277 7 1 4 1.5 C=CCc1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083667 21047 18 None -16 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 277 7 1 4 1.5 C=CCc1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
13720717 155074 0 None -3 2 Guinea pig 5.9 pKi = 5.9 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL2092996 155074 0 None -3 2 Guinea pig 5.9 pKi = 5.9 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
4080436 21048 3 None -10 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 279 6 1 4 1.9 CC(C)c1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083668 21048 3 None -10 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 279 6 1 4 1.9 CC(C)c1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
146025802 334148 0 None 1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 334148 0 None 1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
559926 197330 2 None None None Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
CHEMBL266619 197330 2 None None None Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
44444378 194665 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3cccnc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL250146 194665 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3cccnc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
72545011 183931 0 None -8 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 411 8 0 7 2.9 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443004 183931 0 None -8 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 411 8 0 7 2.9 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
72545239 183933 0 None -1 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 499 14 0 9 3.0 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443006 183933 0 None -1 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 499 14 0 9 3.0 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
155512924 334268 0 None -1 2 Mouse 5.9 pKi = 5.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 451 14 3 6 4.7 COc1cc(CCNCCCOc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4437939 334268 0 None -1 2 Mouse 5.9 pKi = 5.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 451 14 3 6 4.7 COc1cc(CCNCCCOc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
1028 599 43 None -66 18 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
479 599 43 None -66 18 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
5816 599 43 None -66 18 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
CHEMBL679 599 43 None -66 18 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
DB00668 599 43 None -66 18 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
49864416 39536 0 None -30 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221736 39536 0 None -30 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
9990035 26293 0 None 4 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183337 26293 0 None 4 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
44286965 316100 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 349 9 3 4 3.0 C[C@H](Cc1ccc(OCCO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL41113 316100 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 349 9 3 4 3.0 C[C@H](Cc1ccc(OCCO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
11178830 294814 0 None -794 9 Human 5.9 pKi = 5.9 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL393539 294814 0 None -794 9 Human 5.9 pKi = 5.9 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
770558 178401 39 None None None Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 298 1 1 2 3.1 FC(F)(F)c1cc(N2CCNCC2)cc(C(F)(F)F)c1 10.1021/jm400140q
CHEMBL2335162 178401 39 None None None Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 298 1 1 2 3.1 FC(F)(F)c1cc(N2CCNCC2)cc(C(F)(F)F)c1 10.1021/jm400140q
59119467 221741 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4ccccc4c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290983 221741 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4ccccc4c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
59119417 221745 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(-c4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290987 221745 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(-c4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
10310564 221746 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3cccc(-c4ccccc4)c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290988 221746 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3cccc(-c4ccccc4)c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
59119455 221749 0 None -19 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1cccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1 10.1016/j.bmcl.2014.04.069
CHEMBL3290990 221749 0 None -19 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1cccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1 10.1016/j.bmcl.2014.04.069
1960 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
439260 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
505 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
6921840 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
CHEMBL1437 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
DB00368 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
1960 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
439260 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
505 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
6921840 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
CHEMBL1437 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
DB00368 5823 49 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
3054 315981 60 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
448537 315981 60 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
875 315981 60 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 315981 60 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
DB00255 315981 60 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
24936492 41419 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258026 41419 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
46889853 20863 0 None -64 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 458 8 2 5 4.7 COc1ccc(C(=O)C2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
CHEMBL1082828 20863 0 None -64 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 458 8 2 5 4.7 COc1ccc(C(=O)C2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
118710949 232789 0 None -3 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323669 232789 0 None -3 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
10352428 201239 1 None -1 4 Rat 6.9 pKi = 6.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL295072 201239 1 None -1 4 Rat 6.9 pKi = 6.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
10136220 310844 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(C3CCCC3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL400392 310844 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(C3CCCC3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
72545238 183932 0 None -25 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 425 9 0 7 3.3 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443005 183932 0 None -25 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 425 9 0 7 3.3 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
1960 5823 49 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
439260 5823 49 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
505 5823 49 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
6921840 5823 49 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL1437 5823 49 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00368 5823 49 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
9821129 469345 0 None -1 3 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 378 12 3 6 2.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
CHEMBL72169 469345 0 None -1 3 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 378 12 3 6 2.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
72545008 183928 0 None -1 5 Pig 5.9 pKi = 5.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 451 15 0 9 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443001 183928 0 None -1 5 Pig 5.9 pKi = 5.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 451 15 0 9 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
247704 598 33 None -12 5 Rat 4.9 pKi = 4.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
4450 598 33 None -12 5 Rat 4.9 pKi = 4.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL42280 598 33 None -12 5 Rat 4.9 pKi = 4.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
155515982 334571 1 None -51286 17 Human 4.9 pKi = 4.9 Binding
Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 334571 1 None -51286 17 Human 4.9 pKi = 4.9 Binding
Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
2146 6309 49 None -3 10 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
485 6309 49 None -3 10 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
6041 6309 49 None -3 10 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
CHEMBL1215 6309 49 None -3 10 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
DB00388 6309 49 None -3 10 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
11188590 159244 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 4.2 CCC1=C(CC)CC2=C(C1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088202 159244 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 4.2 CCC1=C(CC)CC2=C(C1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
7096 474369 65 None -21 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm400140q
CHEMBL9434 474369 65 None -21 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm400140q
145946710 332328 0 None -2 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 7 3 5 0.7 CNCC(O)COc1ccc(S(=O)(=O)NC(C)(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4300393 332328 0 None -2 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 7 3 5 0.7 CNCC(O)COc1ccc(S(=O)(=O)NC(C)(C)C)cc1 10.1021/acs.jmedchem.8b00625
4143663 21221 13 None -1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(OC)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1084274 21221 13 None -1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(OC)c1 10.1016/j.bmcl.2010.04.009
31101 1504 27 None -32 28 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 1504 27 None -32 28 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 1504 27 None -32 28 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 1504 27 None -32 28 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 1504 27 None -32 28 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
46889810 21736 0 None -28 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 414 7 2 3 5.0 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2ccccc2)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086542 21736 0 None -28 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 414 7 2 3 5.0 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2ccccc2)CC1 10.1016/j.bmcl.2010.04.009
44328703 24527 0 None -1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 24527 0 None -1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
154 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
1621 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
17 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
5761 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
638252 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
CHEMBL263881 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
DB04829 4804 8 None -16 23 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
10291064 194886 0 None -14 2 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 341 8 2 6 2.9 O[C@@H](CNCCOc1ccc(-c2cscn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL251392 194886 0 None -14 2 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 341 8 2 6 2.9 O[C@@H](CNCCOc1ccc(-c2cscn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
10436455 311850 0 None None None Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 512 7 3 8 1.6 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4c3SCC(=O)N4)CC2)ccc1Cl 10.1021/jm00053a020
CHEMBL40609 311850 0 None None None Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 512 7 3 8 1.6 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4c3SCC(=O)N4)CC2)ccc1Cl 10.1021/jm00053a020
52946430 41693 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 3.7 CNC(=O)c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258940 41693 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 3.7 CNC(=O)c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
25266786 355543 0 None None None Rat 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
CHEMBL477672 355543 0 None None None Rat 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
4376990 385554 6 None -588 11 Human 5.8 pKi = 5.8 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 372 4 2 4 4.1 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(Cl)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
CHEMBL5222754 385554 6 None -588 11 Human 5.8 pKi = 5.8 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 372 4 2 4 4.1 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(Cl)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
688468 270650 5 None -398 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL388570 270650 5 None -398 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
11819522 26288 0 None 4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183318 26288 0 None 4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
24937014 41280 0 None -58 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1257554 41280 0 None -58 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
688468 270650 5 None -398 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL388570 270650 5 None -398 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
56677231 135976 0 None -234 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 367 7 4 5 3.5 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12 10.1016/j.bmc.2009.11.062
CHEMBL1800934 135976 0 None -234 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 367 7 4 5 3.5 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12 10.1016/j.bmc.2009.11.062
12828562 219267 0 None 3 2 Rat 5.8 pKi = 5.8 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL322842 219267 0 None 3 2 Rat 5.8 pKi = 5.8 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
2810 139881 42 None -1 2 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
714 139881 42 None -1 2 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
CHEMBL1902627 139881 42 None -1 2 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
2303 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
4946 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
564 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
63 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
91536 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
CHEMBL27 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
CHEMBL452861 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
DB00571 6476 48 None -27 19 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
49864379 39523 0 None -8 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 8 4 5 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221636 39523 0 None -8 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 8 4 5 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
10049403 311280 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 449 10 4 6 2.6 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
CHEMBL40297 311280 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 449 10 4 6 2.6 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
10082625 28042 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1195526 28042 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2249 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
255 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
548 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
CHEMBL24 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
DB00335 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
52943919 41590 0 None -25 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 10 2 7 5.1 C=CCc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258597 41590 0 None -25 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 10 2 7 5.1 C=CCc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
10273469 194664 0 None 3 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 417 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL250144 194664 0 None 3 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 417 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
155521165 335108 0 None 14 2 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 600 17 3 10 4.4 COc1cc(CCNC[C@H](O)COc2ccc(-c3nc(C(F)(F)F)cn3C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4450085 335108 0 None 14 2 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 600 17 3 10 4.4 COc1cc(CCNC[C@H](O)COc2ccc(-c3nc(C(F)(F)F)cn3C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
127046949 277209 0 None -23 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 472 12 3 5 4.6 COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3799455 277209 0 None -23 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 472 12 3 5 4.6 COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
14708665 193602 18 None -117 11 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
6603820 193602 18 None -117 11 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
CHEMBL25856 193602 18 None -117 11 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
CHEMBL43345 193602 18 None -117 11 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
DB16139 193602 18 None -117 11 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
44444179 194555 0 None -39 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 508 10 4 5 4.5 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(Cl)c(Cl)c2)ccc1O 10.1016/j.bmcl.2007.05.030
CHEMBL249359 194555 0 None -39 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 508 10 4 5 4.5 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(Cl)c(Cl)c2)ccc1O 10.1016/j.bmcl.2007.05.030
127047221 277230 0 None -6 6 Mouse 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
CHEMBL3799593 277230 0 None -6 6 Mouse 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
594115 43230 0 None 3 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1cc(O)c(O)c(F)c1 10.1021/jm00076a024
CHEMBL129190 43230 0 None 3 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1cc(O)c(O)c(F)c1 10.1021/jm00076a024
3042920 469875 7 None -1 2 Rat 4.8 pKi = 4.8 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 195 1 3 4 0.8 Oc1ccc(C2CNCCO2)cc1O 10.1021/jm00084a006
CHEMBL7681 469875 7 None -1 2 Rat 4.8 pKi = 4.8 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 195 1 3 4 0.8 Oc1ccc(C2CNCCO2)cc1O 10.1021/jm00084a006
49864414 39534 0 None -37 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
CHEMBL1221734 39534 0 None -37 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
2249 1058 67 None 1 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
255 1058 67 None 1 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
548 1058 67 None 1 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL24 1058 67 None 1 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
DB00335 1058 67 None 1 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
145946991 332380 0 None 1 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 330 9 3 5 1.0 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4301131 332380 0 None 1 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 330 9 3 5 1.0 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C(C)C)cc1 10.1021/acs.jmedchem.8b00625
44444393 331237 0 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 8 2 6 3.1 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)c(C)o1 10.1016/j.bmcl.2007.06.072
CHEMBL427711 331237 0 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 8 2 6 3.1 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)c(C)o1 10.1016/j.bmcl.2007.06.072
145947060 332387 0 None None None Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2cc(OCC(O)CN3CCN(c4ccccn4)CC3)ccc12 10.1016/j.bmc.2018.04.038
CHEMBL4301323 332387 0 None None None Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2cc(OCC(O)CN3CCN(c4ccccn4)CC3)ccc12 10.1016/j.bmc.2018.04.038
16735272 176730 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229614 176730 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
16735272 176730 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229614 176730 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
1499 4274 42 None -64 12 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
3779 4274 42 None -64 12 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
536 4274 42 None -64 12 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
CHEMBL434 4274 42 None -64 12 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
DB01064 4274 42 None -64 12 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
44439167 181378 0 None -158 10 Human 5.8 pKi = 5.8 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5c(c4)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL238732 181378 0 None -158 10 Human 5.8 pKi = 5.8 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5c(c4)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
2736205 178402 40 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 222 3 1 4 1.1 COc1cc(OC)cc(N2CCNCC2)c1 10.1021/jm400140q
CHEMBL2335163 178402 40 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 222 3 1 4 1.1 COc1cc(OC)cc(N2CCNCC2)c1 10.1021/jm400140q
702318 178404 55 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)c2ccccc2n1 10.1021/jm400140q
CHEMBL2335165 178404 55 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)c2ccccc2n1 10.1021/jm400140q
59119410 221752 0 None -158 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 11 5 6 4.3 CC(C)Oc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290993 221752 0 None -158 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 11 5 6 4.3 CC(C)Oc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
24885648 41012 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 460 8 2 7 4.4 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1255596 41012 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 460 8 2 7 4.4 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
46889852 20862 0 None -79 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 428 7 2 4 4.7 O=C(c1ccccc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1082827 20862 0 None -79 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 428 7 2 4 4.7 O=C(c1ccccc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
2249 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to Beta1 (unknown origin) assessed as inhibition constantBinding affinity to Beta1 (unknown origin) assessed as inhibition constant
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
255 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to Beta1 (unknown origin) assessed as inhibition constantBinding affinity to Beta1 (unknown origin) assessed as inhibition constant
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
548 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to Beta1 (unknown origin) assessed as inhibition constantBinding affinity to Beta1 (unknown origin) assessed as inhibition constant
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
CHEMBL24 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to Beta1 (unknown origin) assessed as inhibition constantBinding affinity to Beta1 (unknown origin) assessed as inhibition constant
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
DB00335 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to Beta1 (unknown origin) assessed as inhibition constantBinding affinity to Beta1 (unknown origin) assessed as inhibition constant
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acschembio.7b00481
127045855 276971 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 276971 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
127045855 276971 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
CHEMBL3797876 276971 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
10459124 332738 0 None None None Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 513 11 4 7 1.4 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
CHEMBL43196 332738 0 None None None Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 513 11 4 7 1.4 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
1960 5823 49 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
439260 5823 49 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
505 5823 49 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
6921840 5823 49 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
CHEMBL1437 5823 49 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
DB00368 5823 49 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
12578 1929 47 None -1 3 Human 6.8 pKi = 6.8 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.6019/CHEMBL5442175
2755 1929 47 None -1 3 Human 6.8 pKi = 6.8 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.6019/CHEMBL5442175
CHEMBL1374751 1929 47 None -1 3 Human 6.8 pKi = 6.8 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.6019/CHEMBL5442175
53379897 135983 0 None -40 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
CHEMBL1800961 135983 0 None -40 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
49864332 39503 0 None -6 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 310 7 4 5 2.4 CCC(CC)CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221540 39503 0 None -6 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 310 7 4 5 2.4 CCC(CC)CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
49864396 39529 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL1221682 39529 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
49864396 39529 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221682 39529 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
49864441 39539 0 None -4 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 346 7 4 6 2.0 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221803 39539 0 None -4 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 346 7 4 6 2.0 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
14823035 270609 1 None -52 3 Human 6.8 pKi = 6.8 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1016/S0960-894X(97)00266-7
CHEMBL38486 270609 1 None -52 3 Human 6.8 pKi = 6.8 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1016/S0960-894X(97)00266-7
10379016 40380 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL123566 40380 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
90469115 369125 7 None -56 17 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptorBinding affinity to human adrenergic beta1 receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
CHEMBL4867565 369125 7 None -56 17 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptorBinding affinity to human adrenergic beta1 receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
46889701 21403 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 9 2 6 4.0 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(O)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085014 21403 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 9 2 6 4.0 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(O)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
10131985 310673 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1ocnc1-c1ccc(OCCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2007.06.072
CHEMBL399440 310673 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1ocnc1-c1ccc(OCCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2007.06.072
2249 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
255 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
548 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
CHEMBL24 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
DB00335 1058 67 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
16736094 176707 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229391 176707 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
123133224 309011 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL4113713 309011 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
118710936 231966 0 None -29 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323654 231966 0 None -29 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
319 7908 34 None -190 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
444031 7908 34 None -190 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
784 7908 34 None -190 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
CHEMBL1346 7908 34 None -190 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
127045854 276873 0 None -13 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3797205 276873 0 None -13 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
10420352 327758 5 None -6 4 Guinea pig 5.8 pKi = 5.8 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 327758 5 None -6 4 Guinea pig 5.8 pKi = 5.8 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
10420352 327758 5 None -6 4 Rat 5.8 pKi = 5.8 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL43711 327758 5 None -6 4 Rat 5.8 pKi = 5.8 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
10420352 327758 5 None -6 4 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
CHEMBL43711 327758 5 None -6 4 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
10051943 40214 0 None -602 3 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
CHEMBL122757 40214 0 None -602 3 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
70684846 159238 17 None -4 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 3.2 CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3c1CCC(=O)N3)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088197 159238 17 None -4 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 3.2 CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3c1CCC(=O)N3)C2 10.1016/j.bmcl.2012.07.096
49864440 39538 0 None -29 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 434 7 4 7 2.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCN(CCN4CCCCCC4)CC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221802 39538 0 None -29 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 434 7 4 7 2.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCN(CCN4CCCCCC4)CC3)c2s1 10.1016/j.bmcl.2010.06.136
52916803 335526 28 None None None Human 5.7 pKi = 5.7 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL5212743
CHEMBL4456123 335526 28 None None None Human 5.7 pKi = 5.7 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL5212743
52916803 335526 28 None None None Human 5.7 pKi = 5.7 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL4507278
CHEMBL4456123 335526 28 None None None Human 5.7 pKi = 5.7 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL4507278
127035062 273890 0 None -72 19 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting methodDisplacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 273890 0 None -72 19 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting methodDisplacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
688467 174344 4 None -22 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229476 174344 4 None -22 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
688467 174344 4 None -22 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229476 174344 4 None -22 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
132060734 328128 0 None -6 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 391 5 0 4 4.0 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4177497 328128 0 None -6 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 391 5 0 4 4.0 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
145990586 331653 0 None -1 11 Human 7.7 pKi = 7.7 Binding
Binding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 331653 0 None -1 11 Human 7.7 pKi = 7.7 Binding
Binding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
46889729 21404 0 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 434 9 1 5 3.2 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085016 21404 0 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 434 9 1 5 3.2 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
205951 311217 10 None None None Rat 4.7 pKi = 4.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL40268 311217 10 None None None Rat 4.7 pKi = 4.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1ccc(O)c(O)c1F 10.1021/jm990599h
52916803 335526 28 None None None Human 5.7 pKi = 5.7 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL4507278
CHEMBL4456123 335526 28 None None None Human 5.7 pKi = 5.7 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL4507278
1499 4274 42 None -64 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779 4274 42 None -64 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
536 4274 42 None -64 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
CHEMBL434 4274 42 None -64 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
DB01064 4274 42 None -64 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
8029710 178405 8 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 320 2 1 6 2.7 CSc1nc(N2CCNCC2)c2sc3c(c2n1)CCCC3 10.1021/jm400140q
CHEMBL2335166 178405 8 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 320 2 1 6 2.7 CSc1nc(N2CCNCC2)c2sc3c(c2n1)CCCC3 10.1021/jm400140q
1239 3447 41 None -12 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3410 3447 41 None -12 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3465 3447 41 None -12 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
CHEMBL1256786 3447 41 None -12 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
DB00983 3447 41 None -12 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
10311070 221747 0 None -316 2 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 484 11 5 6 5.2 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290989 221747 0 None -316 2 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 484 11 5 6 5.2 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
25266787 355489 0 None None None Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
CHEMBL477466 355489 0 None None None Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
49864358 39514 0 None -1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 7 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221589 39514 0 None -1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 7 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
9871887 203248 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL308351 203248 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
2303 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
4946 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
564 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
63 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
91536 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
CHEMBL27 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
CHEMBL452861 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
DB00571 6476 48 None -3 19 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
9860739 294947 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 288 6 3 3 2.8 O[C@@H](CNC1CCCCC1)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
CHEMBL393648 294947 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 288 6 3 3 2.8 O[C@@H](CNC1CCCCC1)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
2303 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
4946 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
564 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
63 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
91536 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL27 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL452861 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
DB00571 6476 48 None -4 19 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
155512746 334241 0 None 19 2 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 568 22 3 10 3.9 COc1cc(CCNC[C@H](O)COc2ccc(COCCOC(C)C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4437569 334241 0 None 19 2 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 568 22 3 10 3.9 COc1cc(CCNC[C@H](O)COc2ccc(COCCOC(C)C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
131645 65779 3 None 1 2 Rat 7.7 pKi = 7.7 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 310 5 3 5 1.9 CC(C)(C)NCC(O)COc1cccc2c1SCC(=O)N2 10.1016/s0960-894x(00)00016-0
CHEMBL140908 65779 3 None 1 2 Rat 7.7 pKi = 7.7 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 310 5 3 5 1.9 CC(C)(C)NCC(O)COc1cccc2c1SCC(=O)N2 10.1016/s0960-894x(00)00016-0
2369 1284 48 None 11 2 Human 7.7 pKi = 7.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.6019/CHEMBL5442175
356 1284 48 None 11 2 Human 7.7 pKi = 7.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.6019/CHEMBL5442175
549 1284 48 None 11 2 Human 7.7 pKi = 7.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.6019/CHEMBL5442175
CHEMBL423 1284 48 None 11 2 Human 7.7 pKi = 7.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.6019/CHEMBL5442175
DB00195 1284 48 None 11 2 Human 7.7 pKi = 7.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.6019/CHEMBL5442175
9858463 194547 0 None -19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 325 8 2 6 2.4 O[C@@H](CNCCOc1ccc(-c2cocn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL249336 194547 0 None -19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 325 8 2 6 2.4 O[C@@H](CNCCOc1ccc(-c2cocn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
52943969 41663 0 None -23 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 4.3 CC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258825 41663 0 None -23 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 4.3 CC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
9901086 370865 25 None -676 15 Human 5.7 pKi = 5.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 304 4 1 5 2.1 Clc1cccc(COc2cncc(N3CCNCC3)n2)c1 10.6019/CHEMBL5442175
CHEMBL494947 370865 25 None -676 15 Human 5.7 pKi = 5.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 304 4 1 5 2.1 Clc1cccc(COc2cncc(N3CCNCC3)n2)c1 10.6019/CHEMBL5442175
2291 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
46889728 21046 0 None -5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 4.7 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3ccccc3C(C)C)CC1)C2=O 10.1016/j.bmcl.2010.04.009
CHEMBL1083666 21046 0 None -5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 4.7 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3ccccc3C(C)C)CC1)C2=O 10.1016/j.bmcl.2010.04.009
118710951 232791 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 358 6 4 5 2.8 Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1C 10.1016/j.bmcl.2014.06.014
CHEMBL3323671 232791 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 358 6 4 5 2.8 Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1C 10.1016/j.bmcl.2014.06.014
172745 200298 2 None -5 4 Rat 6.7 pKi = 6.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL287587 200298 2 None -5 4 Rat 6.7 pKi = 6.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
10155942 194723 0 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 10 2 7 2.6 COCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL250559 194723 0 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 10 2 7 2.6 COCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
72544787 183935 0 None -6 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 587 12 3 12 1.2 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443008 183935 0 None -6 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 587 12 3 12 1.2 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
72544789 183937 0 None -9 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 363 9 0 7 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443010 183937 0 None -9 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 363 9 0 7 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
1028 599 43 None -66 18 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
479 599 43 None -66 18 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
5816 599 43 None -66 18 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL679 599 43 None -66 18 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00668 599 43 None -66 18 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
145946965 332366 0 None None None Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
CHEMBL4300897 332366 0 None None None Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
93601 178397 57 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1ccc(N2CCNCC2)cc1Cl 10.1021/jm400140q
CHEMBL2335159 178397 57 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1ccc(N2CCNCC2)cc1Cl 10.1021/jm400140q
21138 193677 30 None -4 4 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
CHEMBL275742 193677 30 None -4 4 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
DB03322 193677 30 None -4 4 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
52949488 41416 0 None -19 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258023 41416 0 None -19 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
44423646 176189 0 None -4 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL225775 176189 0 None -4 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
16735257 176664 0 None -223 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
CHEMBL228992 176664 0 None -223 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
16735257 176664 0 None -223 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
CHEMBL228992 176664 0 None -223 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
155561031 346680 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4566666 346680 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
10465942 27799 0 None -1 3 Guinea pig 6.7 pKi = 6.7 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1193821 27799 0 None -1 3 Guinea pig 6.7 pKi = 6.7 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
598754 102126 42 None None None Human 6.7 pKi = 6.7 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400561w
CHEMBL1559535 102126 42 None None None Human 6.7 pKi = 6.7 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400561w
2388 18486 20 None -1 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
443372 18486 20 None -1 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 18486 20 None -1 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
155536406 336682 0 None 1 2 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4473272 336682 0 None 1 2 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
1499 4274 42 None -5 12 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
3779 4274 42 None -5 12 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
536 4274 42 None -5 12 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
CHEMBL434 4274 42 None -5 12 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
DB01064 4274 42 None -5 12 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
10103956 25480 0 None 2 2 Rat 5.7 pKi = 5.7 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178707 25480 0 None 2 2 Rat 5.7 pKi = 5.7 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
2389 6775 83 None -870 45 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 6775 83 None -870 45 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 6775 83 None -870 45 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 6775 83 None -870 45 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 6775 83 None -870 45 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
11154555 1656 51 None -794 24 Human 6.7 pKi = 6.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.6019/CHEMBL5442175
5037 1656 51 None -794 24 Human 6.7 pKi = 6.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.6019/CHEMBL5442175
7671 1656 51 None -794 24 Human 6.7 pKi = 6.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.6019/CHEMBL5442175
CHEMBL2028019 1656 51 None -794 24 Human 6.7 pKi = 6.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.6019/CHEMBL5442175
DB06016 1656 51 None -794 24 Human 6.7 pKi = 6.7 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.6019/CHEMBL5442175
598754 102126 42 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400140q
CHEMBL1559535 102126 42 None None None Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400140q
9866060 159237 0 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(NCC(O)c1ccc(O)c3[nH]c(=O)c(C)cc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088196 159237 0 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(NCC(O)c1ccc(O)c3[nH]c(=O)c(C)cc13)C2 10.1016/j.bmcl.2012.07.096
44423643 270641 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL387852 270641 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
44396659 139647 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 535 11 4 8 3.2 CS(=O)(=O)Oc1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
CHEMBL188622 139647 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 535 11 4 8 3.2 CS(=O)(=O)Oc1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
52947060 41453 0 None -2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 474 8 2 7 4.7 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258144 41453 0 None -2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 474 8 2 7 4.7 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
2419 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
5152 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
559 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
CHEMBL1263 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
DB00938 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
10431900 135977 0 None -10 2 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 413 16 4 4 5.3 OCc1cc(C(O)CNCCCCCCCCCCCc2ccccc2)ccc1O 10.1016/j.bmc.2009.11.062
CHEMBL1800935 135977 0 None -10 2 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 413 16 4 4 5.3 OCc1cc(C(O)CNCCCCCCCCCCCc2ccccc2)ccc1O 10.1016/j.bmc.2009.11.062
53387674 137463 0 None None None Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824265 137463 0 None None None Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
127046952 277394 0 None -190 6 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 421 12 3 5 4.5 COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800636 277394 0 None -190 6 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 421 12 3 5 4.5 COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
541614 41879 0 None -3 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 219 3 4 4 0.6 CNCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
CHEMBL126347 41879 0 None -3 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 219 3 4 4 0.6 CNCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
11218492 178394 41 None None None Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1ccnc(N2CCNCC2)c1 10.1021/jm400140q
CHEMBL2335156 178394 41 None None None Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1ccnc(N2CCNCC2)c1 10.1021/jm400140q
56645363 240095 21 None -5 6 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
CHEMBL3582478 240095 21 None -5 6 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
24937013 41320 0 None -33 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1257676 41320 0 None -33 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
56645363 240095 21 None -5 6 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
CHEMBL3582478 240095 21 None -5 6 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
56645363 240095 21 None -5 6 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
CHEMBL3582478 240095 21 None -5 6 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
1043 3255 6 None -257 33 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 3255 6 None -257 33 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 3255 6 None -257 33 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 3255 6 None -257 33 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 3255 6 None -257 33 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
15461453 346937 0 None -4 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 390 10 2 4 4.8 COc1ccccc1OCCNCCCOc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4513932 346937 0 None -4 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 390 10 2 4 4.8 COc1ccccc1OCCNCCCOc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
44288393 336186 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 310 5 3 5 2.7 CC(C)(C)Nc1cccc2c1SC(OCCCO)C(=O)N2 10.1021/jm00053a020
CHEMBL446609 336186 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 310 5 3 5 2.7 CC(C)(C)Nc1cccc2c1SC(OCCCO)C(=O)N2 10.1021/jm00053a020
10283146 216906 0 None -1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL317003 216906 0 None -1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
2557 97937 42 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
ChEMBL 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 10.1021/acsmedchemlett.9b00075
68770 97937 42 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
ChEMBL 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 10.1021/acsmedchemlett.9b00075
CHEMBL152067 97937 42 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
ChEMBL 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 10.1021/acsmedchemlett.9b00075
DB11770 97937 42 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
ChEMBL 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 10.1021/acsmedchemlett.9b00075
46889700 21402 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 472 7 1 5 4.5 CC(C)c1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085013 21402 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 472 7 1 5 4.5 CC(C)c1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
10082076 28108 0 None -10 3 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195953 28108 0 None -10 3 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
15580747 137462 0 None 2 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 397 8 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824264 137462 0 None 2 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 397 8 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
155526662 335727 0 None -3 2 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 333 9 4 6 1.7 COc1ccccc1OCCNC[C@@H](O)Cc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4459109 335727 0 None -3 2 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 333 9 4 6 1.7 COc1ccccc1OCCNC[C@@H](O)Cc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
6603724 308743 1 None 1 3 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1cc(O)c(O)cc1F 10.1021/jm990599h
CHEMBL40317 308743 1 None 1 3 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1cc(O)c(O)cc1F 10.1021/jm990599h
46889768 21401 0 None -27 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 402 8 1 5 2.8 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085010 21401 0 None -27 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 402 8 1 5 2.8 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
16737411 289687 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL389629 289687 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16737411 289687 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL389629 289687 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
24321330 21165 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 4.7 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083996 21165 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 4.7 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
46889771 21323 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084706 21323 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
72545010 183930 0 None -7 5 Pig 5.6 pKi = 5.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443003 183930 0 None -7 5 Pig 5.6 pKi = 5.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1 10.1016/j.bmcl.2013.09.026
172745 200298 2 None -5 4 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
CHEMBL287587 200298 2 None -5 4 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
24733400 178403 1 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 295 2 1 4 3.4 c1csc(-c2cccc3ccc(N4CCNCC4)nc23)c1 10.1021/jm400140q
CHEMBL2335164 178403 1 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 295 2 1 4 3.4 c1csc(-c2cccc3ccc(N4CCNCC4)nc23)c1 10.1021/jm400140q
10296414 7178 15 None -1995 9 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 431 6 1 5 4.2 O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C 10.1016/j.bmcl.2006.11.031
76 7178 15 None -1995 9 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 431 6 1 5 4.2 O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C 10.1016/j.bmcl.2006.11.031
CHEMBL183460 7178 15 None -1995 9 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 431 6 1 5 4.2 O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C 10.1016/j.bmcl.2006.11.031
44439165 292469 0 None -1000 8 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL391661 292469 0 None -1000 8 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
2419 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
5152 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
559 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
CHEMBL1263 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
DB00938 7043 56 None -204 15 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
2778334 178395 54 None None None Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 232 1 1 4 0.9 FC(F)(F)c1ccnc(N2CCNCC2)n1 10.1021/jm400140q
CHEMBL2335157 178395 54 None None None Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 232 1 1 4 0.9 FC(F)(F)c1ccnc(N2CCNCC2)n1 10.1021/jm400140q
59119472 221744 0 None -31 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 418 9 5 5 4.0 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4c(c3)CCC4)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290986 221744 0 None -31 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 418 9 5 5 4.0 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4c(c3)CCC4)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
176 823 54 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 823 54 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 823 54 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 823 54 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 823 54 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
52943968 41662 0 None -69 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258824 41662 0 None -69 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
70691181 159240 0 None -13 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 7 4 4 3.4 CCCCc1ccc2c(c1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088199 159240 0 None -13 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 7 4 4 3.4 CCCCc1ccc2c(c1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
46889769 21049 0 None -109 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 304 8 2 4 1.8 C=CCc1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083669 21049 0 None -109 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 304 8 2 4 1.8 C=CCc1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
72545240 183934 0 None -16 5 Pig 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 469 12 0 8 3.4 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443007 183934 0 None -16 5 Pig 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 469 12 0 8 3.4 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
9960584 308699 0 None -436 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL399329 308699 0 None -436 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
44571262 26843 0 None None None Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 341 7 2 5 3.1 CC(C)(CO)NCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186815 26843 0 None None None Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 341 7 2 5 3.1 CC(C)(CO)NCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
135398737 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
2818 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL253391 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 1973 61 None -144 61 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
1960 5823 49 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
439260 5823 49 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
505 5823 49 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
6921840 5823 49 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL1437 5823 49 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00368 5823 49 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
24886595 41515 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccc(F)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258370 41515 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccc(F)cc1 10.1016/j.bmcl.2010.08.039
145947253 332420 0 None 1 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 364 10 3 5 1.2 CNCC(O)COc1ccc(S(=O)(=O)NCCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4301724 332420 0 None 1 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 364 10 3 5 1.2 CNCC(O)COc1ccc(S(=O)(=O)NCCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
389 239896 36 None -2 7 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
44112 239896 36 None -2 7 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
CHEMBL357995 239896 36 None -2 7 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
DB08807 239896 36 None -2 7 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
46889643 20980 0 None 4 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]ccc23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083368 20980 0 None 4 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]ccc23)CC1 10.1016/j.bmcl.2010.04.009
155555687 346664 0 None 2 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4553747 346664 0 None 2 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
9924779 194846 0 None -8 2 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 9 3 7 1.9 OCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL251180 194846 0 None -8 2 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 9 3 7 1.9 OCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
44444191 336954 0 None -38 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccccc2Cl)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL447786 336954 0 None -38 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccccc2Cl)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
1960 5823 49 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
439260 5823 49 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
505 5823 49 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
6921840 5823 49 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL1437 5823 49 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00368 5823 49 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
42629372 135984 0 None -52 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
CHEMBL1800962 135984 0 None -52 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
10406968 232785 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323665 232785 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
10466448 222343 0 None -34 2 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
CHEMBL330994 222343 0 None -34 2 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
24936763 41485 0 None -30 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.9 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258260 41485 0 None -30 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.9 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
24936885 41354 0 None -32 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257797 41354 0 None -32 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
12828570 19413 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL105434 19413 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
52941476 41554 0 None -28 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258484 41554 0 None -28 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
155529446 335990 0 None -8 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4463246 335990 0 None -8 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
52941603 41172 0 None -21 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 573 9 2 9 3.8 O=C(c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1)N1CCOCC1 10.1016/j.bmcl.2010.08.039
CHEMBL1257204 41172 0 None -21 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 573 9 2 9 3.8 O=C(c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1)N1CCOCC1 10.1016/j.bmcl.2010.08.039
52947443 41483 0 None -17 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(F)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258258 41483 0 None -17 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(F)c1 10.1016/j.bmcl.2010.08.039
2770390 21051 10 None -1 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 499 10 1 6 3.2 C=CCc1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083672 21051 10 None -1 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 499 10 1 6 3.2 C=CCc1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
10083242 28082 1 None -8 3 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195814 28082 1 None -8 3 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
44582475 355488 0 None None None Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNCC(O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
CHEMBL477465 355488 0 None None None Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNCC(O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
2303 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
4946 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
564 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
63 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
91536 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
CHEMBL27 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
CHEMBL452861 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
DB00571 6476 48 None -27 19 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
46889811 20785 0 None -16 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 444 8 2 4 5.0 COc1ccc(CC2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
CHEMBL1082500 20785 0 None -16 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 444 8 2 4 5.0 COc1ccc(CC2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
185394 270560 41 None -3 5 Mouse 8.5 pKi = 8.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL3798017 270560 41 None -3 5 Mouse 8.5 pKi = 8.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
49864356 39512 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 330 6 4 5 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221587 39512 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 330 6 4 5 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
12147227 124742 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
142109147 124742 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
44386630 124742 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
69921317 124742 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
CHEMBL177442 124742 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
39468 37932 24 None -2 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
431 37932 24 None -2 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
CHEMBL1201237 37932 24 None -2 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
DB01210 37932 24 None -2 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O nan
52946537 41592 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3ccsc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258599 41592 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3ccsc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
118710941 232779 0 None -5 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 370 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3c3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323659 232779 0 None -5 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 370 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3c3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
164451 203225 8 None 1 3 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 361 12 3 6 1.6 O=C(O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1 10.1016/0960-894X(96)00417-9
CHEMBL308150 203225 8 None 1 3 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 361 12 3 6 1.6 O=C(O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1 10.1016/0960-894X(96)00417-9
46889727 20979 0 None -3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(OC)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083366 20979 0 None -3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(OC)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
127046948 277364 0 None -13 6 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800468 277364 0 None -13 6 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
15077955 311346 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 496 10 5 7 0.6 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL40343 311346 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 496 10 5 7 0.6 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
1028 599 43 None -23 18 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 599 43 None -23 18 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 599 43 None -23 18 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 599 43 None -23 18 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 599 43 None -23 18 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
53387673 137464 0 None None None Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OC[C@@H](O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824266 137464 0 None None None Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OC[C@@H](O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
16736091 176665 0 None -134 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
CHEMBL228996 176665 0 None -134 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
16736091 176665 0 None -134 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
CHEMBL228996 176665 0 None -134 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
25198751 26857 0 None None None Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2oc3ccccc3c(=O)c2c1 10.1016/j.bmc.2008.12.031
CHEMBL1186872 26857 0 None None None Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2oc3ccccc3c(=O)c2c1 10.1016/j.bmc.2008.12.031
10457669 316834 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 475 7 2 6 2.7 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4ccccc34)CC2)ccc1Cl 10.1021/jm00053a020
CHEMBL41214 316834 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 475 7 2 6 2.7 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4ccccc34)CC2)ccc1Cl 10.1021/jm00053a020
49864461 39542 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 381 12 4 6 2.8 CCCCN(CCCC)CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221862 39542 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 381 12 4 6 2.8 CCCCN(CCCC)CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
44287337 297807 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 378 9 4 5 2.5 C[C@H](Cc1ccc(OCC(=O)NO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL39596 297807 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 378 9 4 5 2.5 C[C@H](Cc1ccc(OCC(=O)NO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
11820657 27699 0 None -6 2 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL1193017 27699 0 None -6 2 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
155534529 336490 0 None -2 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4470694 336490 0 None -2 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
16737412 176705 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229388 176705 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
175 7426 39 None -676 24 Human 5.5 pKi = 5.5 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 383 6 1 4 3.0 Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.6019/CHEMBL5442175
68186 7426 39 None -676 24 Human 5.5 pKi = 5.5 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 383 6 1 4 3.0 Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.6019/CHEMBL5442175
CHEMBL79834 7426 39 None -676 24 Human 5.5 pKi = 5.5 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 383 6 1 4 3.0 Fc1ccc(cc1)OCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.6019/CHEMBL5442175
16737412 176705 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229388 176705 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
16736092 176706 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229390 176706 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16736092 176706 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229390 176706 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
1239 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
3410 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
3465 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
CHEMBL1256786 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
DB00983 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
153287553 335645 0 None -501 6 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 264 1 1 2 3.7 C[C@@]12CN(c3ccccc3)c3ccccc3[C@@H]1CCN2 10.1021/acsmedchemlett.9b00225
CHEMBL4457754 335645 0 None -501 6 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 264 1 1 2 3.7 C[C@@]12CN(c3ccccc3)c3ccccc3[C@@H]1CCN2 10.1021/acsmedchemlett.9b00225
10287658 221742 0 None -25 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290984 221742 0 None -25 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
90644154 221743 0 None -5 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3cccc4ccccc34)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290985 221743 0 None -5 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3cccc4ccccc34)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
10310047 221750 0 None -199 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 422 11 5 6 3.9 CCOc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290991 221750 0 None -199 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 422 11 5 6 3.9 CCOc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
1239 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
3410 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
3465 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
CHEMBL1256786 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
DB00983 3447 41 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
46889854 21628 0 None -104 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086077 21628 0 None -104 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
10140996 310925 0 None -398 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 486 11 5 7 3.0 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1O 10.1016/j.bmcl.2007.05.030
CHEMBL400947 310925 0 None -398 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 486 11 5 7 3.0 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1O 10.1016/j.bmcl.2007.05.030
1588 4738 26 None -169 28 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 4738 26 None -169 28 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 4738 26 None -169 28 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 4738 26 None -169 28 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 4738 26 None -169 28 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
2723 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm990012z
65772 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm990012z
CHEMBL174984 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm990012z
DB13692 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm990012z
2723 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
65772 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
CHEMBL174984 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
DB13692 123170 6 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
14925759 313920 6 None -11220 13 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4085780 313920 6 None -11220 13 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
52943362 41418 0 None -8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 466 8 2 8 4.4 OC(CNC1CCN(c2ncnc3scc(-c4cccs4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258025 41418 0 None -8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 466 8 2 8 4.4 OC(CNC1CCN(c2ncnc3scc(-c4cccs4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
118710945 232783 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 6 4 5 3.8 CCc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323663 232783 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 6 4 5 3.8 CCc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
155529870 336042 0 None -30 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4463925 336042 0 None -30 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
49864381 39525 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
CHEMBL1221638 39525 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
44361777 237378 0 None -3 2 Rat 6.5 pKi = 6.5 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 429 7 2 7 2.3 COc1ccccc1N1CCN(CC(O)COc2cccc3c2SCC(=O)N3)CC1 10.1016/s0960-894x(00)00016-0
CHEMBL341614 237378 0 None -3 2 Rat 6.5 pKi = 6.5 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 429 7 2 7 2.3 COc1ccccc1N1CCN(CC(O)COc2cccc3c2SCC(=O)N3)CC1 10.1016/s0960-894x(00)00016-0
155511898 334169 0 None -12 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 360 8 2 3 4.5 COc1ccccc1OCCNCCc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4436343 334169 0 None -12 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 360 8 2 3 4.5 COc1ccccc1OCCNCCc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
123133225 291555 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL3909417 291555 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
16735263 176715 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229442 176715 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
123133222 308877 0 None -6 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1cccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)c1 nan
CHEMBL4108239 308877 0 None -6 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1cccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)c1 nan
16735261 176666 0 None -47 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
CHEMBL228998 176666 0 None -47 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
16735495 176709 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229401 176709 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
16735495 176709 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229401 176709 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
44396798 333976 0 None -30 3 Human 7.5 pKi = 7.5 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL442225 333976 0 None -30 3 Human 7.5 pKi = 7.5 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
155521528 335155 0 None -1 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4450756 335155 0 None -1 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
118710944 232782 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323662 232782 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
15221053 469494 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 364 11 3 6 2.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
CHEMBL73220 469494 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 364 11 3 6 2.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
24937269 41516 0 None -1949 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258371 41516 0 None -1949 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
13864389 19405 0 None 8 2 Rat 5.5 pKi = 5.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL105383 19405 0 None 8 2 Rat 5.5 pKi = 5.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
16736096 270646 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL388177 270646 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16736096 270646 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL388177 270646 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 nan
49864355 39511 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 374 5 4 5 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC34CC5CC(CC(C5)C3)C4)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221586 39511 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 374 5 4 5 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC34CC5CC(CC(C5)C3)C4)c2s1 10.1016/j.bmcl.2010.06.136
172745 200298 2 None -2 4 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 200298 2 None -2 4 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
24936488 41518 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258373 41518 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
145947241 332400 0 None None None Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
CHEMBL4301544 332400 0 None None None Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
145947927 332520 0 None None None Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302997 332520 0 None None None Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
10376053 27394 0 None -2 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL1190547 27394 0 None -2 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
10292413 194689 0 None -7 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 367 9 2 6 3.6 CC(C)c1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL250352 194689 0 None -7 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 367 9 2 6 3.6 CC(C)c1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
10162297 309992 0 None -33 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1cccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
CHEMBL398322 309992 0 None -33 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1cccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
9947512 310737 0 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 9 2 6 3.5 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
CHEMBL399785 310737 0 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 9 2 6 3.5 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
1534 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
DB01446 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
1534 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
DB01446 193827 24 None -37 11 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
25032872 176297 0 None -102 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 397 6 1 6 0.9 O=C1C2C3C=CC(C3)C2C(=O)N1OCC(O)CN1CCN(c2ccccc2)CC1 10.1007/s00044-008-9094-3
CHEMBL2261429 176297 0 None -102 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 397 6 1 6 0.9 O=C1C2C3C=CC(C3)C2C(=O)N1OCC(O)CN1CCN(c2ccccc2)CC1 10.1007/s00044-008-9094-3
49864334 39505 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
CHEMBL1221542 39505 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
118710938 231968 0 None -6 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323656 231968 0 None -6 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
183812 470556 21 None -977 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 464 13 3 8 2.9 O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2012.07.096
CHEMBL82663 470556 21 None -977 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 464 13 3 8 2.9 O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2012.07.096
24937137 41627 0 None -23 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1258707 41627 0 None -23 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
11248705 181119 0 None -158 10 Human 6.4 pKi = 6.4 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL238519 181119 0 None -158 10 Human 6.4 pKi = 6.4 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
9512 7386 37 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
9887812 7386 37 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
CHEMBL208427 7386 37 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
DB06190 7386 37 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
90644140 221753 0 None -25 2 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 394 9 6 6 3.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(O)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290994 221753 0 None -25 2 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 394 9 6 6 3.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(O)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
135409453 8225 26 None -501 19 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.6019/CHEMBL5442175
226 8225 26 None -501 19 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.6019/CHEMBL5442175
2579 8225 26 None -501 19 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.6019/CHEMBL5442175
5362436 8225 26 None -501 19 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.6019/CHEMBL5442175
CHEMBL76370 8225 26 None -501 19 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.6019/CHEMBL5442175
DB01079 8225 26 None -501 19 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.6019/CHEMBL5442175
25242457 26866 0 None None None Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 373 8 4 7 1.0 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186915 26866 0 None None None Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 373 8 4 7 1.0 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
118710950 232790 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323670 232790 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
118710937 231967 0 None -19 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323655 231967 0 None -19 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
49864412 39532 0 None -5 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221732 39532 0 None -5 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
10947658 62361 0 None -363 16 Human 6.4 pKi = 6.4 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
CHEMBL137781 62361 0 None -363 16 Human 6.4 pKi = 6.4 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
1960 5823 49 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 5823 49 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 5823 49 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
6921840 5823 49 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 5823 49 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 5823 49 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
10376607 27617 0 None -1 2 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL1192423 27617 0 None -1 2 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
131268 222362 19 None -26 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL331036 222362 19 None -26 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
9967732 194576 0 None -19 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL249534 194576 0 None -19 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
9946573 310778 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 9 2 6 3.0 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL400049 310778 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 9 2 6 3.0 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
127901 202226 5 None None None Rat 5.4 pKi = 5.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 185 3 3 3 0.8 CNCC(O)c1cccc(O)c1F 10.1021/jm00076a024
CHEMBL302451 202226 5 None None None Rat 5.4 pKi = 5.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 185 3 3 3 0.8 CNCC(O)c1cccc(O)c1F 10.1021/jm00076a024
13864381 475169 1 None -39 4 Rat 4.4 pKi = 4.4 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL99361 475169 1 None -39 4 Rat 4.4 pKi = 4.4 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
122237 328190 6 None None None Rat 4.4 pKi = 4.4 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1cc(O)c(O)cc1F 10.1021/jm990599h
CHEMBL41818 328190 6 None None None Rat 4.4 pKi = 4.4 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1cc(O)c(O)cc1F 10.1021/jm990599h
1960 5823 49 None -33 26 Human 6.4 pKi = 6.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.6019/CHEMBL5442175
439260 5823 49 None -33 26 Human 6.4 pKi = 6.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.6019/CHEMBL5442175
505 5823 49 None -33 26 Human 6.4 pKi = 6.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.6019/CHEMBL5442175
6921840 5823 49 None -33 26 Human 6.4 pKi = 6.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.6019/CHEMBL5442175
CHEMBL1437 5823 49 None -33 26 Human 6.4 pKi = 6.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.6019/CHEMBL5442175
DB00368 5823 49 None -33 26 Human 6.4 pKi = 6.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.6019/CHEMBL5442175
44444193 309903 0 None -15 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2cccc(Cl)c2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL398241 309903 0 None -15 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2cccc(Cl)c2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
11625333 159242 0 None -2 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 4 4 4 3.3 Cc1c(C)c(C)c2c(c1C)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088200 159242 0 None -2 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 4 4 4 3.3 Cc1c(C)c(C)c2c(c1C)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
1978 515 40 None -15 3 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
40 515 40 None -15 3 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
7107 515 40 None -15 3 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
CHEMBL642 515 40 None -15 3 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
DB01193 515 40 None -15 3 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
16737588 176734 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 nan
CHEMBL229620 176734 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 nan
16737588 176734 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
CHEMBL229620 176734 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
44396596 251381 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL361505 251381 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
2249 1058 67 None 1 3 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
255 1058 67 None 1 3 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
548 1058 67 None 1 3 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
CHEMBL24 1058 67 None 1 3 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
DB00335 1058 67 None 1 3 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
52944986 41482 0 None -30 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
CHEMBL1258257 41482 0 None -30 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
118710946 232784 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 414 7 4 6 3.7 CCOc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323664 232784 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 414 7 4 6 3.7 CCOc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
44312421 328322 0 None -2 3 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 392 13 3 6 2.9 C[C@H](Cc1ncc(CCCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
CHEMBL419085 328322 0 None -2 3 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 392 13 3 6 2.9 C[C@H](Cc1ncc(CCCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
46889767 21399 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 400 9 1 5 2.4 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085009 21399 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 400 9 1 5 2.4 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
49783415 41547 0 None -5888 13 Rat 5.4 pKi = 5.4 Binding
Binding affinity to rat adrenergic beta-1 receptorBinding affinity to rat adrenergic beta-1 receptor
ChEMBL 320 7 1 5 2.9 CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1 10.1021/jm100668r
CHEMBL1258452 41547 0 None -5888 13 Rat 5.4 pKi = 5.4 Binding
Binding affinity to rat adrenergic beta-1 receptorBinding affinity to rat adrenergic beta-1 receptor
ChEMBL 320 7 1 5 2.9 CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1 10.1021/jm100668r
10381669 26856 0 None None None Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2c(=O)c3ccccc3oc2c1 10.1016/j.bmc.2008.12.031
CHEMBL1186871 26856 0 None None None Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2c(=O)c3ccccc3oc2c1 10.1016/j.bmc.2008.12.031
276 7142 30 None -3019 20 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 451 5 2 6 4.1 COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl 10.6019/CHEMBL5442175
5312149 7142 30 None -3019 20 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 451 5 2 6 4.1 COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl 10.6019/CHEMBL5442175
CHEMBL431298 7142 30 None -3019 20 Human 5.4 pKi = 5.4 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 451 5 2 6 4.1 COc1ccc(cc1N1CCNCC1)NS(=O)(=O)c1sc2c(c1C)cc(cc2)Cl 10.6019/CHEMBL5442175
52949934 41517 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 398 7 2 7 3.0 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258372 41517 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 398 7 2 7 3.0 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
49864415 39535 0 None -117 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
CHEMBL1221735 39535 0 None -117 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
1862 329 10 None -52 5 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00076a024
510 329 10 None -52 5 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00076a024
CHEMBL281232 329 10 None -52 5 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00076a024
46889642 21284 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2ccc3[nH]ccc3c2)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084527 21284 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2ccc3[nH]ccc3c2)CC1 10.1016/j.bmcl.2010.04.009
4806 8693 61 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
71768094 8693 61 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
7351 8693 61 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
9966051 8693 61 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
CHEMBL2104993 8693 61 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
DB09068 8693 61 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
52948792 41589 0 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258596 41589 0 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
25109291 366002 9 None -109647 12 Human 5.3 pKi = 5.3 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 327 1 2 6 1.7 Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1 10.6019/CHEMBL5442175
CHEMBL519240 366002 9 None -109647 12 Human 5.3 pKi = 5.3 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 327 1 2 6 1.7 Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1 10.6019/CHEMBL5442175
44571264 26860 0 None None None Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 407 8 4 7 1.7 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186886 26860 0 None None None Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 407 8 4 7 1.7 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
10207209 327790 0 None -309 3 Human 4.3 pKi = 4.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL440961 327790 0 None -309 3 Human 4.3 pKi = 4.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
10324985 158429 6 None -354 17 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic beta-1 receptorBinding affinity to adrenergic beta-1 receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL2068762 158429 6 None -354 17 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic beta-1 receptorBinding affinity to adrenergic beta-1 receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
16717791 159239 2 None -1 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 376 6 3 3 3.7 CCc1cc2c(cc1CC)CC(NCCc1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088198 159239 2 None -1 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 376 6 3 3 3.7 CCc1cc2c(cc1CC)CC(NCCc1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
10236758 234707 4 None -48977 13 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL3354065 234707 4 None -48977 13 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
44396568 139569 0 None -28 3 Human 6.3 pKi = 6.3 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL188196 139569 0 None -28 3 Human 6.3 pKi = 6.3 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
360400 197578 0 None -1 2 Rat 4.3 pKi = 4.3 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 237 2 2 4 1.9 CC(C)N1CCOC(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
CHEMBL268881 197578 0 None -1 2 Rat 4.3 pKi = 4.3 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 237 2 2 4 1.9 CC(C)N1CCOC(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
24937389 41319 0 None -478 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 10 3 9 4.2 COCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257675 41319 0 None -478 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 10 3 9 4.2 COCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
52948728 41318 0 None -8 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257674 41318 0 None -8 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
1786 5120 49 None 1 5 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
4171 5120 49 None 1 5 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
553 5120 49 None 1 5 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
CHEMBL13 5120 49 None 1 5 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
DB00264 5120 49 None 1 5 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
155516656 334686 0 None 40 2 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 629 18 4 11 3.3 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4443911 334686 0 None 40 2 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 629 18 4 11 3.3 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
44444189 194902 0 None -8 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 586 15 4 7 4.8 CS(=O)(=O)Nc1cc(C[C@@H](O)CN[C@@H](CCc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
CHEMBL251555 194902 0 None -8 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 586 15 4 7 4.8 CS(=O)(=O)Nc1cc(C[C@@H](O)CN[C@@H](CCc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
72545007 183927 0 None -3 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 407 12 0 8 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443000 183927 0 None -3 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 407 12 0 8 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
72545009 183929 0 None 1 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443002 183929 0 None 1 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1 10.1016/j.bmcl.2013.09.026
52946357 41591 0 None -11 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1258598 41591 0 None -11 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
127045853 277098 0 None -20 6 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3798748 277098 0 None -20 6 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
11757304 200488 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 550 11 5 9 0.3 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL289390 200488 0 None None None Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 550 11 5 9 0.3 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
9984829 78625 0 None -1 2 Rat 8.3 pKi = 8.3 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 542 11 2 8 3.5 COc1ccccc1N1CCN(CCCN2C(=O)CSc3c(OCC(O)CNC(C)(C)C)cccc32)CC1 10.1016/s0960-894x(00)00016-0
CHEMBL143463 78625 0 None -1 2 Rat 8.3 pKi = 8.3 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 542 11 2 8 3.5 COc1ccccc1N1CCN(CCCN2C(=O)CSc3c(OCC(O)CNC(C)(C)C)cccc32)CC1 10.1016/s0960-894x(00)00016-0
2405 1368 47 None -1 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
380 1368 47 None -1 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
7129 1368 47 None -1 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL645 1368 47 None -1 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
DB00612 1368 47 None -1 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
33624 8322 24 None -4 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
4061 8322 24 None -4 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
565 8322 24 None -4 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL499 8322 24 None -4 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
DB00373 8322 24 None -4 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
145948125 332508 0 None None None Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 341 5 2 5 3.1 CC(C)(C)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302853 332508 0 None None None Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 341 5 2 5 3.1 CC(C)(C)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
68807656 232786 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323666 232786 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
102262219 277353 0 None -12 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800400 277353 0 None -12 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
1531 4617 40 None -1 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 4617 40 None -1 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 4617 40 None -1 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 4617 40 None -1 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 4617 40 None -1 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
10297331 194773 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 445 12 2 7 4.2 O[C@@H](CNCCOc1ccc(-c2coc(COCc3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL250760 194773 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 445 12 2 7 4.2 O[C@@H](CNCCOc1ccc(-c2coc(COCc3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
10081581 25479 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178704 25479 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
10266538 235840 0 None -1 2 Guinea pig 6.3 pKi = 6.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
CHEMBL338704 235840 0 None -1 2 Guinea pig 6.3 pKi = 6.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
10081581 25479 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178704 25479 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
10059780 27221 0 None -9 3 Guinea pig 5.3 pKi = 5.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1189347 27221 0 None -9 3 Guinea pig 5.3 pKi = 5.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
127047996 276954 0 None -1122 6 Mouse 5.3 pKi = 5.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 303 8 3 5 2.3 COc1ccccc1OCCNCCc1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
CHEMBL3797758 276954 0 None -1122 6 Mouse 5.3 pKi = 5.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 303 8 3 5 2.3 COc1ccccc1OCCNCCc1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
23728722 251628 37 None -1 3 Human 5.3 pKi = 5.3 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL4507272
CHEMBL3617968 251628 37 None -1 3 Human 5.3 pKi = 5.3 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL4507272
5806 203226 13 None 2 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
CHEMBL30816 203226 13 None 2 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
DB12803 203226 13 None 2 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
5806 203226 13 None 2 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
CHEMBL30816 203226 13 None 2 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
DB12803 203226 13 None 2 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
10773922 308800 0 None -1 2 Rat 4.3 pKi = 4.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL40796 308800 0 None -1 2 Rat 4.3 pKi = 4.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
16736514 289692 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 nan
CHEMBL389902 289692 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 nan
16736514 289692 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
CHEMBL389902 289692 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
44424581 289690 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL389734 289690 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16735276 292695 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL3918348 292695 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
4276762 21283 9 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 530 8 1 6 4.9 COc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(C(C)(C)C)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1084526 21283 9 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 530 8 1 6 4.9 COc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(C(C)(C)C)c1 10.1016/j.bmcl.2010.04.009
127046951 277202 0 None -11 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3799427 277202 0 None -11 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
70541 178400 48 None None None Human 6.3 pKi = 6.3 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1cccc(N2CCNCC2)c1C 10.1021/jm400140q
CHEMBL2335161 178400 48 None None None Human 6.3 pKi = 6.3 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1cccc(N2CCNCC2)c1C 10.1021/jm400140q
23728722 251628 37 None -1 3 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL5212743
CHEMBL3617968 251628 37 None -1 3 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL5212743
23728722 251628 37 None -1 3 Human 5.3 pKi = 5.3 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL4507272
CHEMBL3617968 251628 37 None -1 3 Human 5.3 pKi = 5.3 Binding
GPCRScan assay: inhibition of Beta1GPCRScan assay: inhibition of Beta1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL4507272
1786 5120 49 None -1 5 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
4171 5120 49 None -1 5 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
553 5120 49 None -1 5 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
CHEMBL13 5120 49 None -1 5 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
DB00264 5120 49 None -1 5 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
2419 7043 56 None -23 15 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
5152 7043 56 None -23 15 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
559 7043 56 None -23 15 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
CHEMBL1263 7043 56 None -23 15 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
DB00938 7043 56 None -23 15 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
56645363 240095 21 None -5 6 Human 5.3 pKi = 5.3 Binding
Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
CHEMBL3582478 240095 21 None -5 6 Human 5.3 pKi = 5.3 Binding
Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)Inhibition of Adrenergic beta1 at compound concentration of 10.0 uM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_204010)
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL4507294
10512270 327589 5 None -5 2 Rat 6.3 pKi = 6.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL42370 327589 5 None -5 2 Rat 6.3 pKi = 6.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
24937390 41484 0 None -2 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 8 3 8 4.4 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258259 41484 0 None -2 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 8 3 8 4.4 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
10207208 308673 0 None -63 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL398557 308673 0 None -63 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
24937016 41626 0 None -5 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258706 41626 0 None -5 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
44351358 235814 5 None None None Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 205 2 4 4 0.4 NCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
CHEMBL338564 235814 5 None None None Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 205 2 4 4 0.4 NCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
44444188 194901 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1cccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
CHEMBL251554 194901 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1cccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
3931 4582 43 None -3 2 Human 6.2 pKi = 6.2 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
9829836 4582 43 None -3 2 Human 6.2 pKi = 6.2 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
CHEMBL12998 4582 43 None -3 2 Human 6.2 pKi = 6.2 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
118710942 232780 0 None -8 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccccc1[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
CHEMBL3323660 232780 0 None -8 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccccc1[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
49864378 39522 0 None -1 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221635 39522 0 None -1 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
15221055 469321 0 None -5 2 Human 4.2 pKi = 4.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 368 9 3 5 3.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
CHEMBL72060 469321 0 None -5 2 Human 4.2 pKi = 4.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 368 9 3 5 3.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
11978813 1488 62 None -69 28 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 10.6019/CHEMBL5442175
5014 1488 62 None -69 28 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 10.6019/CHEMBL5442175
7672 1488 62 None -69 28 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 10.6019/CHEMBL5442175
CHEMBL2105760 1488 62 None -69 28 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 10.6019/CHEMBL5442175
DB09128 1488 62 None -69 28 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 10.6019/CHEMBL5442175
44286983 278911 0 None -3 3 Human 6.2 pKi = 6.2 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 362 9 3 4 2.5 C[C@H](Cc1ccc(OCC(N)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL38569 278911 0 None -3 3 Human 6.2 pKi = 6.2 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 362 9 3 4 2.5 C[C@H](Cc1ccc(OCC(N)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
33624 8322 24 None -4 7 Human 8.2 pKi = 8.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.6019/CHEMBL5442175
4061 8322 24 None -4 7 Human 8.2 pKi = 8.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.6019/CHEMBL5442175
565 8322 24 None -4 7 Human 8.2 pKi = 8.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.6019/CHEMBL5442175
CHEMBL499 8322 24 None -4 7 Human 8.2 pKi = 8.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.6019/CHEMBL5442175
DB00373 8322 24 None -4 7 Human 8.2 pKi = 8.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.6019/CHEMBL5442175
118710947 232787 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 8 4 5 3.4 CC(C)Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323667 232787 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 8 4 5 3.4 CC(C)Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
146025803 346717 0 None 1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 346717 0 None 1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
146025801 335180 0 None -1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4451135 335180 0 None -1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
118710935 231965 0 None -9 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323653 231965 0 None -9 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
49864397 39530 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221683 39530 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
559929 19239 7 None None None Rat 7.2 pKi = 7.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
CHEMBL10453 19239 7 None None None Rat 7.2 pKi = 7.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
24936881 41387 0 None -10 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1257913 41387 0 None -10 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
9816183 200700 5 None -12 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL29141 200700 5 None -12 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2010.06.136
24936491 41390 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257916 41390 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
10140092 194911 0 None -114 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
CHEMBL251581 194911 0 None -114 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
13599050 197289 1 None 1 2 Rat 4.2 pKi = 4.2 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 251 2 3 4 1.8 CC(C)N1CCCC(O)(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
CHEMBL266290 197289 1 None 1 2 Rat 4.2 pKi = 4.2 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 251 2 3 4 1.8 CC(C)N1CCCC(O)(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
44423640 270640 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
CHEMBL387851 270640 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
16737587 308932 0 None None None Rat 4.2 pKi = 4.2 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL4110387 308932 0 None None None Rat 4.2 pKi = 4.2 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
44424580 176732 0 None 1 2 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229616 176732 0 None 1 2 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
10544781 469575 0 None -10 3 Human 5.2 pKi = 5.2 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 335 5 2 7 2.2 COc1cc(CC2NCCc3nc(N)sc32)cc(OC)c1OC 10.1021/jm990012z
CHEMBL73917 469575 0 None -10 3 Human 5.2 pKi = 5.2 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 335 5 2 7 2.2 COc1cc(CC2NCCc3nc(N)sc32)cc(OC)c1OC 10.1021/jm990012z
118710939 232777 0 None -14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 336 5 4 5 2.7 CC(C)[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
CHEMBL3323657 232777 0 None -14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 336 5 4 5 2.7 CC(C)[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
24936626 41281 0 None -87 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257555 41281 0 None -87 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
10316512 40749 0 None 18 2 Guinea pig 6.2 pKi = 6.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
CHEMBL124926 40749 0 None 18 2 Guinea pig 6.2 pKi = 6.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
11779308 42364 4 None -4 2 Guinea pig 5.2 pKi = 5.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
CHEMBL127318 42364 4 None -4 2 Guinea pig 5.2 pKi = 5.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
541604 327587 6 None -91 4 Guinea pig 4.2 pKi = 4.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 327587 6 None -91 4 Guinea pig 4.2 pKi = 4.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
1862 329 10 None -52 5 Rat 4.2 pKi = 4.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm990599h
510 329 10 None -52 5 Rat 4.2 pKi = 4.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm990599h
CHEMBL281232 329 10 None -52 5 Rat 4.2 pKi = 4.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm990599h
541604 327587 6 None -91 4 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00076a024
CHEMBL42359 327587 6 None -91 4 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00076a024
90644153 221740 0 None -19 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 470 11 5 6 5.3 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(Oc4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290982 221740 0 None -19 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 470 11 5 6 5.3 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(Oc4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
173 6634 59 None -79 11 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
5011 6634 59 None -79 11 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
CHEMBL18772 6634 59 None -79 11 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
150860015 387400 0 None -28 17 Human 5.2 pKi = 5.2 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 440 10 2 6 4.9 CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2ccc(Cl)c3cccnc23)cn1 10.1021/acs.jmedchem.2c01769
CHEMBL5395401 387400 0 None -28 17 Human 5.2 pKi = 5.2 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 440 10 2 6 4.9 CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2ccc(Cl)c3cccnc23)cn1 10.1021/acs.jmedchem.2c01769
44312269 469344 0 None 2 3 Human 5.2 pKi = 5.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 382 10 3 5 3.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
CHEMBL72168 469344 0 None 2 3 Human 5.2 pKi = 5.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 382 10 3 5 3.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
44423641 176342 0 None -12 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
CHEMBL226293 176342 0 None -12 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
2812 19119 69 None -38 34 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
719 19119 69 None -38 34 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 19119 69 None -38 34 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
DB00257 19119 69 None -38 34 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
11432806 138490 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL184407 138490 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
11432806 138490 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL184407 138490 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
118710935 231965 0 None -9 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323653 231965 0 None -9 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
44423645 176355 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL226349 176355 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
145946829 332340 0 None 4 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 380 11 3 6 1.0 CNCC(O)COc1ccc(S(=O)(=O)NCCOc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4300598 332340 0 None 4 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 380 11 3 6 1.0 CNCC(O)COc1ccc(S(=O)(=O)NCCOc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
49864439 39537 0 None -4 2 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 390 5 4 5 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221801 39537 0 None -4 2 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 390 5 4 5 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
594590 145062 47 None 39 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400140q
CHEMBL200234 145062 47 None 39 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400140q
1499 4274 42 None -33 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
3779 4274 42 None -33 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
536 4274 42 None -33 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
CHEMBL434 4274 42 None -33 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
DB01064 4274 42 None -33 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
44361634 78142 0 None None None Rat 5.2 pKi = 5.2 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 417 6 2 6 2.4 O=C1CSc2c(cccc2OCC(O)CN2CCN(c3ccc(F)cc3)CC2)N1 10.1016/s0960-894x(00)00016-0
CHEMBL142995 78142 0 None None None Rat 5.2 pKi = 5.2 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 417 6 2 6 2.4 O=C1CSc2c(cccc2OCC(O)CN2CCN(c3ccc(F)cc3)CC2)N1 10.1016/s0960-894x(00)00016-0
24936625 41355 0 None -1 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.8 O=C(O)c1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257798 41355 0 None -1 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.8 O=C(O)c1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
3207225 178406 7 None None None Human 6.2 pKi = 6.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 302 1 1 5 2.5 Cc1nc(N2CCNCC2)c2c3c(sc2n1)CC(C)CC3 10.1021/jm400140q
CHEMBL2335167 178406 7 None None None Human 6.2 pKi = 6.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 302 1 1 5 2.5 Cc1nc(N2CCNCC2)c2c3c(sc2n1)CC(C)CC3 10.1021/jm400140q
594590 145062 47 None 39 2 Human 7.2 pKi = 7.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400561w
CHEMBL200234 145062 47 None 39 2 Human 7.2 pKi = 7.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400561w
12582 1957 29 None -3 4 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
2783 1957 29 None -3 4 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
673 1957 29 None -3 4 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
CHEMBL49080 1957 29 None -3 4 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
DB01407 1957 29 None -3 4 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
10231679 194722 0 None -36 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 572 14 4 7 4.4 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
CHEMBL250553 194722 0 None -36 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 572 14 4 7 4.4 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
2419 7043 56 None -204 15 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442175
5152 7043 56 None -204 15 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442175
559 7043 56 None -204 15 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442175
CHEMBL1263 7043 56 None -204 15 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442175
DB00938 7043 56 None -204 15 Human 6.2 pKi = 6.2 Binding
PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.PDSP Secondary Binding target: ADRB1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442175
46889670 21341 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 533 7 2 5 5.2 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084772 21341 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 533 7 2 5 5.2 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
2303 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
4946 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
564 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
63 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
91536 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
CHEMBL27 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
CHEMBL452861 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
DB00571 6476 48 None -27 19 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
15077948 278851 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 514 10 5 8 0.8 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL38532 278851 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 514 10 5 8 0.8 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
9982903 333682 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 486 10 5 8 1.5 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL43968 333682 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 486 10 5 8 1.5 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
118710948 232788 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 9 4 5 3.5 CCCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323668 232788 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 9 4 5 3.5 CCCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
44433250 179934 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 340 6 3 3 3.5 O[C@@H](CNC12CC3CC(CC(C3)C1)C2)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
CHEMBL236514 179934 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 340 6 3 3 3.5 O[C@@H](CNC12CC3CC(CC(C3)C1)C2)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
11647002 39528 0 None -22 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL1221681 39528 0 None -22 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
52943932 41625 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 485 8 2 8 4.2 N#Cc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258705 41625 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 485 8 2 8 4.2 N#Cc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
155564274 349424 0 None 19 2 Mouse 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 643 19 4 11 3.7 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4576034 349424 0 None 19 2 Mouse 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 643 19 4 11 3.7 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
52947562 41556 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258486 41556 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
46889730 21452 0 None -42 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 436 8 1 5 3.6 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085270 21452 0 None -42 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 436 8 1 5 3.6 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
9958539 203155 0 None -1 3 Human 6.1 pKi = 6.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1021/jm990012z
CHEMBL307647 203155 0 None -1 3 Human 6.1 pKi = 6.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1021/jm990012z
1800 473856 65 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
4189 473856 65 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 473856 65 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
DB01110 473856 65 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
44444187 194873 0 None -23 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
CHEMBL251347 194873 0 None -23 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
5187268 20906 12 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 501 9 1 6 3.6 CC(C)c1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083053 20906 12 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 501 9 1 6 3.6 CC(C)c1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
155524756 335547 0 None 1 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4456505 335547 0 None 1 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
155540000 346619 0 None 1 2 Mouse 5.1 pKi = 5.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4515498 346619 0 None 1 2 Mouse 5.1 pKi = 5.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
3198 461850 54 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
983 461850 54 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 461850 54 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
DB01127 461850 54 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
2723782 178399 48 None None None Human 6.1 pKi = 6.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1ccc(N2CCNCC2)cc1C 10.1021/jm400140q
CHEMBL2335160 178399 48 None None None Human 6.1 pKi = 6.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1ccc(N2CCNCC2)cc1C 10.1021/jm400140q
13720716 116571 0 None -1 2 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL1788251 116571 0 None -1 2 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2249 1058 67 None 1 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
255 1058 67 None 1 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
548 1058 67 None 1 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
CHEMBL24 1058 67 None 1 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
DB00335 1058 67 None 1 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
10472143 232141 0 None -169 16 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
CHEMBL343755 232141 0 None -169 16 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
46889809 20977 0 None -1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 519 6 2 5 5.0 O=C1c2cccc3cccc(c23)C(=O)N1C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083363 20977 0 None -1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 519 6 2 5 5.0 O=C1c2cccc3cccc(c23)C(=O)N1C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
10375227 25497 0 None 2 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178761 25497 0 None 2 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
12353629 468892 0 None -23 3 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 237 2 4 4 1.4 CC(C)N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
CHEMBL6913 468892 0 None -23 3 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 237 2 4 4 1.4 CC(C)N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
9908924 278862 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 399 9 3 5 2.8 C[C@H](Cc1ccc(OCS(=O)(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL38538 278862 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 399 9 3 5 2.8 C[C@H](Cc1ccc(OCS(=O)(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
75201901 331247 26 None -562 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 331247 26 None -562 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
118710943 232781 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323661 232781 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
63180 158440 6 None None None Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranesDisplacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranes
ChEMBL 411 7 2 7 2.7 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL2068824 158440 6 None None None Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranesDisplacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranes
ChEMBL 411 7 2 7 2.7 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
44571260 27001 0 None None None Rat 5.1 pKi = 5.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 309 7 1 4 3.5 C=CCNCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1187740 27001 0 None None None Rat 5.1 pKi = 5.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 309 7 1 4 3.5 C=CCNCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
16735494 270637 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL387825 270637 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
16735494 270637 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL387825 270637 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
11776640 27800 0 None -16 3 Guinea pig 5.1 pKi = 5.1 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1193824 27800 0 None -16 3 Guinea pig 5.1 pKi = 5.1 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
49864394 39526 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 322 4 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221679 39526 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 322 4 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
2419 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
5152 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
559 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
CHEMBL1263 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
DB00938 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
127047859 277345 0 None -28 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 476 12 3 6 4.1 COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800341 277345 0 None -28 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 476 12 3 6 4.1 COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
9871887 203248 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm990012z
CHEMBL308351 203248 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm990012z
9871887 203248 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL308351 203248 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
9934284 181120 0 None -1995 10 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL238520 181120 0 None -1995 10 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
90644139 221751 0 None -100 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 424 10 5 6 4.2 CSc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290992 221751 0 None -100 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 424 10 5 6 4.2 CSc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
90644141 221754 0 None -6 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 396 9 5 5 3.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(F)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290995 221754 0 None -6 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 396 9 5 5 3.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(F)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
145946259 332295 0 None None None Human 4.1 pKi = 4.1 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 350 9 3 5 1.1 CNCC(O)COc1ccc(S(=O)(=O)NCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4300084 332295 0 None None None Human 4.1 pKi = 4.1 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 350 9 3 5 1.1 CNCC(O)COc1ccc(S(=O)(=O)NCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
90644146 221732 0 None -5 2 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 460 10 4 5 4.2 OCc1cc(C(O)CNCCc2ccc(N3CCC(Cc4ccccc4)CC3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290975 221732 0 None -5 2 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 460 10 4 5 4.2 OCc1cc(C(O)CNCCc2ccc(N3CCC(Cc4ccccc4)CC3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
49864442 39540 0 None -27 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 373 8 4 6 2.4 CN(CCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccccc1 10.1016/j.bmcl.2010.06.136
CHEMBL1221804 39540 0 None -27 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 373 8 4 6 2.4 CN(CCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccccc1 10.1016/j.bmcl.2010.06.136
1499 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
3779 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
536 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
CHEMBL434 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
DB01064 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
4421983 21599 5 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 484 9 1 5 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086005 21599 5 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 484 9 1 5 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
1499 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
3779 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
536 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
CHEMBL434 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
DB01064 4274 42 None -33 12 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
129896798 366054 45 None 1 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to beta1 adrenoceptor (unknown origin)Binding affinity to beta1 adrenoceptor (unknown origin)
ChEMBL 366 7 2 3 4.5 Cc1ccc(CN(CC(O)COc2cccc3[nH]ccc23)C(C)(C)C)cc1 10.1021/acs.jmedchem.0c01450
CHEMBL4789047 366054 45 None 1 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to beta1 adrenoceptor (unknown origin)Binding affinity to beta1 adrenoceptor (unknown origin)
ChEMBL 366 7 2 3 4.5 Cc1ccc(CN(CC(O)COc2cccc3[nH]ccc23)C(C)(C)C)cc1 10.1021/acs.jmedchem.0c01450
12353620 469261 1 None -66 2 Rat 5.1 pKi = 5.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 195 0 4 4 0.4 N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
CHEMBL7160 469261 1 None -66 2 Rat 5.1 pKi = 5.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 195 0 4 4 0.4 N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
2419 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
5152 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
559 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
CHEMBL1263 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
DB00938 7043 56 None -204 15 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
44351377 236639 0 None None None Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 203 3 3 3 0.9 CNCC(O)c1c(F)ccc(O)c1F 10.1021/jm00076a024
CHEMBL340189 236639 0 None None None Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 203 3 3 3 0.9 CNCC(O)c1c(F)ccc(O)c1F 10.1021/jm00076a024
15077956 333831 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 477 10 4 6 1.9 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
CHEMBL44097 333831 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 477 10 4 6 1.9 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
2464 7398 37 None -2 2 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
5253 7398 37 None -2 2 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
7297 7398 37 None -2 2 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
CHEMBL471 7398 37 None -2 2 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
DB00489 7398 37 None -2 2 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
9928332 197495 3 None -416 9 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assayCompound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assay
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/0960-894X(95)00398-D
CHEMBL268258 197495 3 None -416 9 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assayCompound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assay
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/0960-894X(95)00398-D
44570783 26865 0 None None None Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186914 26865 0 None None None Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
127046950 277339 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 277339 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
127046950 277339 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800303 277339 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
2736067 178396 47 None 93 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cc(Cl)cc(N2CCNCC2)c1 10.1021/jm400140q
CHEMBL2335158 178396 47 None 93 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cc(Cl)cc(N2CCNCC2)c1 10.1021/jm400140q
10442852 25494 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178755 25494 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
10012704 25501 0 None 1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178768 25501 0 None 1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
146025727 336217 0 None -316 27 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 336217 0 None -316 27 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
130442572 336435 0 None -181 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 336435 0 None -181 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
145946488 332309 0 None None None Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4300195 332309 0 None None None Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
52943770 41239 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 492 8 4 9 3.8 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257438 41239 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 492 8 4 9 3.8 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1O 10.1016/j.bmcl.2010.08.039
181743 346764 4 None -4265 22 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]Iodopindolol from human adrenergic beta-1 receptorDisplacement of [125I]Iodopindolol from human adrenergic beta-1 receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 346764 4 None -4265 22 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]Iodopindolol from human adrenergic beta-1 receptorDisplacement of [125I]Iodopindolol from human adrenergic beta-1 receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
155513731 327813 0 None -2 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4439238 327813 0 None -2 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
25120700 162678 0 None -5 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha1 adrenoceptorBinding affinity to alpha1 adrenoceptor
ChEMBL 369 7 1 5 3.0 COc1ccc(N2CCN(CC[C@@H](OC(N)=O)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2012.02.023
CHEMBL2158704 162678 0 None -5 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha1 adrenoceptorBinding affinity to alpha1 adrenoceptor
ChEMBL 369 7 1 5 3.0 COc1ccc(N2CCN(CC[C@@H](OC(N)=O)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2012.02.023
2723 123170 6 None -4 6 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
65772 123170 6 None -4 6 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL174984 123170 6 None -4 6 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
DB13692 123170 6 None -4 6 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
131487 19320 8 None None None Rat 4.1 pKi = 4.1 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
CHEMBL10494 19320 8 None None None Rat 4.1 pKi = 4.1 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
44396729 139149 0 None -34 3 Human 7.1 pKi = 7.1 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 528 10 5 7 2.8 CS(=O)(=O)c1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccc(N)c4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
CHEMBL186247 139149 0 None -34 3 Human 7.1 pKi = 7.1 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 528 10 5 7 2.8 CS(=O)(=O)c1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccc(N)c4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
46889770 21050 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 306 7 2 4 2.2 CC(C)c1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083670 21050 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 306 7 2 4 2.2 CC(C)c1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
49864335 39506 0 None -4 2 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 338 5 4 5 3.1 CC(C)(C)CC(C)(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221543 39506 0 None -4 2 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 338 5 4 5 3.1 CC(C)(C)CC(C)(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
49864357 39513 0 None -45 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 397 6 4 7 3.1 Cc1onc(-c2ccccc2)c1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221588 39513 0 None -45 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 397 6 4 7 3.1 Cc1onc(-c2ccccc2)c1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
4183 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
6918554 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
7455 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
CHEMBL1095777 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
DB05039 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
4183 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
6918554 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
7455 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
CHEMBL1095777 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
DB05039 4137 48 None -1 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
9894801 239370 0 None -4 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 592 11 5 10 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)N(CC(=O)O)C4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
CHEMBL354906 239370 0 None -4 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 592 11 5 10 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)N(CC(=O)O)C4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
24936627 41555 0 None -41 3 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 444 8 4 9 2.2 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258485 41555 0 None -41 3 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 444 8 4 9 2.2 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
52949489 41417 0 None -30 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258024 41417 0 None -30 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
9827999 258795 0 None 7 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 519 9 5 10 0.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(Cn4oc(=O)[nH]c4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
CHEMBL368584 258795 0 None 7 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 519 9 5 10 0.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(Cn4oc(=O)[nH]c4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
130442480 349282 0 None -117 24 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 349282 0 None -117 24 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
4407909 385410 0 None -16 10 Human 6.0 pKi = 6.0 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 356 4 2 4 3.6 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(F)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
CHEMBL5221893 385410 0 None -16 10 Human 6.0 pKi = 6.0 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 356 4 2 4 3.6 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(F)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
10112744 310688 0 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccncc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL399522 310688 0 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccncc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
128658 77466 4 None -1 2 Guinea pig 7.0 pKi = 7.0 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL142428 77466 4 None -1 2 Guinea pig 7.0 pKi = 7.0 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2303 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
4946 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
564 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
63 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
91536 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
CHEMBL27 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
CHEMBL452861 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
DB00571 6476 48 None -27 19 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
24936489 41388 0 None -12 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257914 41388 0 None -12 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
71612644 270864 0 None 2 2 Human 5.0 pKi = 5.0 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
CHEMBL3704833 270864 0 None 2 2 Human 5.0 pKi = 5.0 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
52943383 41451 0 None -16 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 544 9 2 8 5.3 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(OC(F)(F)F)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258142 41451 0 None -16 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 544 9 2 8 5.3 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(OC(F)(F)F)c1 10.1016/j.bmcl.2010.08.039
1016 8173 46 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 8173 46 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 8173 46 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 8173 46 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 8173 46 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
11962616 457 21 None None None Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
9326 457 21 None None None Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
CHEMBL3039530 457 21 None None None Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
DB12100 457 21 None None None Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
2803 1967 0 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 1967 0 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 1967 0 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 1967 0 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 1967 0 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3486 6418 47 None 3 6 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 6418 47 None 3 6 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 6418 47 None 3 6 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 6418 47 None 3 6 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 6418 47 None 3 6 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
3083544 57618 28 None 1 2 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
4943 57618 28 None 1 2 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1363 57618 28 None 1 2 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
DB00983 57618 28 None 1 2 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
DB01274 57618 28 None 1 2 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
3486 6418 47 None -6 6 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 6418 47 None -6 6 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 6418 47 None -6 6 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 6418 47 None -6 6 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 6418 47 None -6 6 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
1054 3263 41 None 6 2 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
59768 3263 41 None 6 2 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
7178 3263 41 None 6 2 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL768 3263 41 None 6 2 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
DB00187 3263 41 None 6 2 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
2249 1058 67 None 3 3 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 1058 67 None 3 3 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 1058 67 None 3 3 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 1058 67 None 3 3 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 1058 67 None 3 3 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
175540 232138 36 None -1 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
4702 232138 36 None -1 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
CHEMBL343633 232138 36 None -1 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
DB13443 232138 36 None -1 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
155774 8875 30 None 8 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
2848 8875 30 None 8 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
538 8875 30 None 8 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
CHEMBL75753 8875 30 None 8 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
DB13781 8875 30 None 8 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
1786 5120 49 None -2 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 5120 49 None -2 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 5120 49 None -2 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 5120 49 None -2 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 5120 49 None -2 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
2369 1284 48 None -3 5 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 1284 48 None -3 5 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 1284 48 None -3 5 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 1284 48 None -3 5 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 1284 48 None -3 5 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
18047 461728 19 None 2 5 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
3616 461728 19 None 2 5 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
CHEMBL67096 461728 19 None 2 5 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
2369 1284 48 None -10 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 1284 48 None -10 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 1284 48 None -10 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 1284 48 None -10 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 1284 48 None -10 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
2303 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 6476 48 None -6 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2369 1284 48 None 1 5 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 1284 48 None 1 5 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 1284 48 None 1 5 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 1284 48 None 1 5 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 1284 48 None 1 5 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
18047 461728 19 None -2 5 Human 8.0 pKd = 8.0 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
3616 461728 19 None -2 5 Human 8.0 pKd = 8.0 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
CHEMBL67096 461728 19 None -2 5 Human 8.0 pKd = 8.0 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
33624 8322 24 None -2 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
4061 8322 24 None -2 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
565 8322 24 None -2 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
CHEMBL499 8322 24 None -2 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
DB00373 8322 24 None -2 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
137 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2119 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
563 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
66368 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
CHEMBL266195 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
DB00866 765 35 None -15 3 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
13191 370 0 None 1 2 Human 10.4 pKd = 10.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 5 3 4 2.5 C(C)(C)(C)NC[C@@H](COC1=C2C=C(NC2=C(C=C1)C)C#N)O 26385885
91885640 370 0 None 1 2 Human 10.4 pKd = 10.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 5 3 4 2.5 C(C)(C)(C)NC[C@@H](COC1=C2C=C(NC2=C(C=C1)C)C#N)O 26385885
132 2632 14 None 19 2 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 20590599
132 2632 14 None 19 2 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 26385885
155346 2632 14 None 19 2 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 20590599
155346 2632 14 None 19 2 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 26385885
CHEMBL378501 2632 14 None 19 2 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 20590599
CHEMBL378501 2632 14 None 19 2 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 26385885
562 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 10079020
562 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 10531390
562 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 15037517
562 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 8982677
73754996 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 10079020
73754996 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 10531390
73754996 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 15037517
73754996 7687 0 None -2 5 Human 10.9 pKd = 10.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 397 6 3 4 2.4 OC(COc1cccc2c1c([125I])c([nH]2)C#N)CNC(C)C 8982677
12579 5620 0 None None None Rat 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 472 14 3 8 1.8 NC(=O)C1=CC=C(OCCNC[C@H](O)COC2=CC3=C(O[C@H](COCC4CC4)CO3)C=C2)C=C1 28400472
60151587 5620 0 None None None Rat 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 472 14 3 8 1.8 NC(=O)C1=CC=C(OCCNC[C@H](O)COC2=CC3=C(O[C@H](COCC4CC4)CO3)C=C2)C=C1 28400472
12580 5622 0 None None None Rat 8.4 pKd = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 13 3 8 1.9 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](COCC5CC5)CO4)C=C3 28400472
60150890 5622 0 None None None Rat 8.4 pKd = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 13 3 8 1.9 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](COCC5CC5)CO4)C=C3 28400472
531 7893 1 None None None Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
6603756 7893 1 None None None Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
CHEMBL36060 7893 1 None None None Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 O[C@H](COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
487 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
487 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
569 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
569 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
71739 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
71739 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
CHEMBL324665 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
CHEMBL324665 1642 55 None None None Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
487 1642 55 None -4 5 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
569 1642 55 None -4 5 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
71739 1642 55 None -4 5 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
CHEMBL324665 1642 55 None -4 5 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
135398737 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2818 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL253391 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 1973 61 None -144 61 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2389 6775 83 None -870 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 6775 83 None -870 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 6775 83 None -870 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 6775 83 None -870 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 6775 83 None -870 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
3054 315981 60 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
448537 315981 60 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
875 315981 60 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 315981 60 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
DB00255 315981 60 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
2146 6309 49 None -3 10 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 6309 49 None -3 10 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 6309 49 None -3 10 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 6309 49 None -3 10 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 6309 49 None -3 10 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
681 3019 53 None -44 20 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
940 3019 53 None -44 20 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
947 3019 53 None -44 20 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
CHEMBL59 3019 53 None -44 20 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
DB00988 3019 53 None -44 20 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
2247 1042 63 None -95 37 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 1042 63 None -95 37 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 1042 63 None -95 37 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 1042 63 None -95 37 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 1042 63 None -95 37 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
1016 8173 46 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 8173 46 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 8173 46 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 8173 46 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 8173 46 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
681 3019 53 None 1 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
940 3019 53 None 1 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
947 3019 53 None 1 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
CHEMBL59 3019 53 None 1 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
DB00988 3019 53 None 1 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
2068 370177 47 None -8 8 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
43815 370177 47 None -8 8 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
CHEMBL490 370177 47 None -8 8 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
DB00715 370177 47 None -8 8 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
3198 461850 54 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
983 461850 54 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 461850 54 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
DB01127 461850 54 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
1800 473856 65 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
4189 473856 65 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL91 473856 65 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
DB01110 473856 65 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
2812 19119 69 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
719 19119 69 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 19119 69 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
DB00257 19119 69 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
1209 3407 55 None 1 19 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 3407 55 None 1 19 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 3407 55 None 1 19 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 3407 55 None 1 19 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 3407 55 None 1 19 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
103 8980 49 None -2 31 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 8980 49 None -2 31 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 8980 49 None -2 31 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 8980 49 None -2 31 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 8980 49 None -2 31 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
1028 599 43 None -23 18 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 599 43 None -23 18 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 599 43 None -23 18 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 599 43 None -23 18 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 599 43 None -23 18 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
2865 8961 54 None -10 33 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 8961 54 None -10 33 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 8961 54 None -10 33 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 8961 54 None -10 33 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 8961 54 None -10 33 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
105 7039 60 None 64 2 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
2083 7039 60 None 64 2 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
558 7039 60 None 64 2 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
CHEMBL714 7039 60 None 64 2 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
DB01001 7039 60 None 64 2 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
1043 3255 6 None -257 33 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
149 3255 6 None -257 33 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
8223 3255 6 None -257 33 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL442 3255 6 None -257 33 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00696 3255 6 None -257 33 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
5311064 2816 32 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
534 2816 32 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
806 2816 32 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
CHEMBL493682 2816 32 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
2810 139881 42 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl None
714 139881 42 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl None
CHEMBL1902627 139881 42 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl None
31101 1504 27 None -32 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 1504 27 None -32 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 1504 27 None -32 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 1504 27 None -32 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 1504 27 None -32 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
1028 599 43 None -66 18 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 599 43 None -66 18 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 599 43 None -66 18 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 599 43 None -66 18 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 599 43 None -66 18 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
1960 5823 49 None -33 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 5823 49 None -33 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 5823 49 None -33 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
6921840 5823 49 None -33 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 5823 49 None -33 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 5823 49 None -33 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
66265 194428 9 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
832 194428 9 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 194428 9 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
DB01191 194428 9 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
2419 7043 56 None -204 15 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
5152 7043 56 None -204 15 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
559 7043 56 None -204 15 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
CHEMBL1263 7043 56 None -204 15 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
DB00938 7043 56 None -204 15 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
2464 7398 37 None -2 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
5253 7398 37 None -2 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
7297 7398 37 None -2 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
CHEMBL471 7398 37 None -2 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
DB00489 7398 37 None -2 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
1222 3419 44 None -1 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 3419 44 None -1 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 3419 44 None -1 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 3419 44 None -1 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 3419 44 None -1 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
2419 7043 56 None -23 15 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
5152 7043 56 None -23 15 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
559 7043 56 None -23 15 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
CHEMBL1263 7043 56 None -23 15 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
DB00938 7043 56 None -23 15 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
1960 5823 49 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 5823 49 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 5823 49 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
6921840 5823 49 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 5823 49 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 5823 49 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
1588 4738 26 None -169 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 4738 26 None -169 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 4738 26 None -169 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 4738 26 None -169 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 4738 26 None -169 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
1239 3447 41 None -12 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O None
3410 3447 41 None -12 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O None
3465 3447 41 None -12 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O None
CHEMBL1256786 3447 41 None -12 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O None
DB00983 3447 41 None -12 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O None
2258 6434 33 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
42396 6434 33 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
537 6434 33 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
CHEMBL1160714 6434 33 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
DB13777 6434 33 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
2557 97937 42 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
Drug Central 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 None
68770 97937 42 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
Drug Central 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 None
CHEMBL152067 97937 42 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
Drug Central 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 None
DB11770 97937 42 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
Drug Central 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 None
2388 18486 20 None -1 3 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
443372 18486 20 None -1 3 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
CHEMBL1160723 18486 20 None -1 3 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
1499 4274 42 None -5 12 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 4274 42 None -5 12 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 4274 42 None -5 12 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 4274 42 None -5 12 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 4274 42 None -5 12 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
2291 6470 51 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 6470 51 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 6470 51 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 6470 51 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 6470 51 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
3486 6418 47 None 5 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 6418 47 None 5 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 6418 47 None 5 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 6418 47 None 5 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 6418 47 None 5 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
175540 232138 36 None -1 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
4702 232138 36 None -1 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
CHEMBL343633 232138 36 None -1 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
DB13443 232138 36 None -1 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
154 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
1621 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
17 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
5761 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
638252 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL263881 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB04829 4804 8 None -16 23 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
242 971 74 None -3 38 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 971 74 None -3 38 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 971 74 None -3 38 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 971 74 None -3 38 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 971 74 None -3 38 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
1054 3263 41 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
59768 3263 41 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
7178 3263 41 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL768 3263 41 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
DB00187 3263 41 None None None Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
1865 384925 34 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
4411 384925 34 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
CHEMBL521606 384925 34 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
DB01203 384925 34 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
1960 5823 49 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 5823 49 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 5823 49 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
6921840 5823 49 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 5823 49 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 5823 49 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
4183 4137 48 None -1 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
6918554 4137 48 None -1 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
7455 4137 48 None -1 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
CHEMBL1095777 4137 48 None -1 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
DB05039 4137 48 None -1 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
12582 1957 29 None -3 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
2783 1957 29 None -3 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
673 1957 29 None -3 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
CHEMBL49080 1957 29 None -3 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
DB01407 1957 29 None -3 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
11978813 1488 62 None -69 28 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 1488 62 None -69 28 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 1488 62 None -69 28 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 1488 62 None -69 28 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 1488 62 None -69 28 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
1978 515 40 None -15 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
40 515 40 None -15 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
7107 515 40 None -15 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
CHEMBL642 515 40 None -15 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
DB01193 515 40 None -15 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
2249 1058 67 None 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 1058 67 None 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 1058 67 None 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 1058 67 None 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 1058 67 None 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
1786 5120 49 None 1 5 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 5120 49 None 1 5 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 5120 49 None 1 5 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 5120 49 None 1 5 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 5120 49 None 1 5 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
11504295 5953 40 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
4814 5953 40 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
7543 5953 40 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
CHEMBL605846 5953 40 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
DB09080 5953 40 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
4806 8693 61 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
71768094 8693 61 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
7351 8693 61 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
9966051 8693 61 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
CHEMBL2104993 8693 61 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
DB09068 8693 61 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
1786 5120 49 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 5120 49 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 5120 49 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 5120 49 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 5120 49 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
2405 1368 47 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
380 1368 47 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
7129 1368 47 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
CHEMBL645 1368 47 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
DB00612 1368 47 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
146294 1913 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
552 1913 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
637 1913 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
CHEMBL2110772 1913 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
2663 199008 20 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 None
569 199008 20 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 None
CHEMBL27810 199008 20 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 None
DB04846 199008 20 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 None
2027 389514 22 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
4631 389514 22 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
CHEMBL546 389514 22 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
DB01580 389514 22 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
424 496890 0 None 1 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 261 4 2 3 3.4 CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C None
71733 496890 0 None 1 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 261 4 2 3 3.4 CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C None
DB06726 496890 0 None 1 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 261 4 2 3 3.4 CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C None
1531 4617 40 None -1 9 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
3869 4617 40 None -1 9 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
7207 4617 40 None -1 9 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
CHEMBL429 4617 40 None -1 9 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
DB00598 4617 40 None -1 9 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
2405 1368 47 None -1 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
380 1368 47 None -1 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
7129 1368 47 None -1 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
CHEMBL645 1368 47 None -1 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
DB00612 1368 47 None -1 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
39468 37932 24 None -2 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O None
431 37932 24 None -2 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O None
CHEMBL1201237 37932 24 None -2 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O None
DB01210 37932 24 None -2 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O None
1887 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
189562 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
71301 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
7246 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
9844194 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
CHEMBL2365658 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
CHEMBL3526436 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
CHEMBL434394 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
DB04861 5630 45 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
2303 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 6476 48 None -27 19 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2303 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 6476 48 None -4 19 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2303 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 6476 48 None -3 19 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2078 43076 23 None -1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 None
37464 43076 23 None -1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 None
CHEMBL1290 43076 23 None -1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 None
DB01359 43076 23 None -1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 None
2475 1528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
433 1528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
550 1528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
CHEMBL305380 1528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
DB08808 1528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
33624 8322 24 None -4 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
4061 8322 24 None -4 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
565 8322 24 None -4 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
CHEMBL499 8322 24 None -4 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
DB00373 8322 24 None -4 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
2585 1662 62 None -6 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 1662 62 None -6 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 1662 62 None -6 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 1662 62 None -6 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 1662 62 None -6 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
4752 37934 24 None -1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 None
60657 37934 24 None -1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 None
CHEMBL1201274 37934 24 None -1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 None
DB09351 37934 24 None -1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 None
2583 470697 25 None 2 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 None
520 470697 25 None 2 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 None
CHEMBL839 470697 25 None 2 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 None
DB00521 470697 25 None 2 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 None
2176 6361 47 None -1 14 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 6361 47 None -1 14 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 6361 47 None -1 14 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 6361 47 None -1 14 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 6361 47 None -1 14 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
2585 1662 62 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 1662 62 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 1662 62 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 1662 62 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 1662 62 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
389 239896 36 None -2 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 None
44112 239896 36 None -2 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 None
CHEMBL357995 239896 36 None -2 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 None
DB08807 239896 36 None -2 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 None
1887 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
189562 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
71301 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
7246 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
9844194 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
CHEMBL2365658 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
CHEMBL3526436 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
CHEMBL434394 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
DB04861 5630 45 None 3 4 Human 9.2 pKi = 9.2 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
2598 8237 41 None -1000 2 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
5403 8237 41 None -1000 2 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
560 8237 41 None -1000 2 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
CHEMBL1760 8237 41 None -1000 2 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
DB00871 8237 41 None -1000 2 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
123600 4712 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
1575 4712 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
9816 4712 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
CHEMBL1002 4712 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
DB13139 4712 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
1155 3351 39 None -38 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
3343 3351 39 None -38 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
557 3351 39 None -38 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
CHEMBL32800 3351 39 None -38 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
DB01288 3351 39 None -38 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
567 1496 16 None -13 5 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
9841972 1496 16 None -13 5 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
CHEMBL284782 1496 16 None -13 5 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
36811 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
36811 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
535 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
535 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
937 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
937 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
CHEMBL926 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
CHEMBL926 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
DB00841 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
DB00841 2998 34 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
1028 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
1028 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
1028 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
479 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
479 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
479 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
5816 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
5816 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
5816 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
CHEMBL679 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
CHEMBL679 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL679 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
DB00668 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
DB00668 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00668 599 43 None -21 18 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
1960 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
1960 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
1960 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
439260 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
439260 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
439260 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
505 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
505 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
505 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
6921840 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
6921840 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
6921840 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
CHEMBL1437 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
CHEMBL1437 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL1437 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
DB00368 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
DB00368 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00368 5823 49 None -33 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
5311064 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
5311064 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
5311064 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
534 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
534 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
534 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
806 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
806 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
806 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
CHEMBL493682 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
CHEMBL493682 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
CHEMBL493682 2816 32 None None None Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
2464 7398 37 None -2 2 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
5253 7398 37 None -2 2 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
7297 7398 37 None -2 2 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
CHEMBL471 7398 37 None -2 2 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
DB00489 7398 37 None -2 2 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
484 5824 40 None 3 4 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O 2849109
951 5824 40 None 3 4 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O 2849109
CHEMBL432 5824 40 None 3 4 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O 2849109
4508 6384 62 None -199 9 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
509 6384 62 None -199 9 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
838 6384 62 None -199 9 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
CHEMBL1740 6384 62 None -199 9 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
DB11124 6384 62 None -199 9 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
1239 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
1239 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
3410 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3410 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
3465 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3465 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
CHEMBL1256786 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
CHEMBL1256786 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
DB00983 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
DB00983 3447 41 None -12 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
3486 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
3486 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
4883 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
4883 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
555 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
555 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
CHEMBL6995 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
CHEMBL6995 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
DB01297 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
DB01297 6418 47 None 5 2 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
1978 515 40 None -15 3 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
40 515 40 None -15 3 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
7107 515 40 None -15 3 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
CHEMBL642 515 40 None -15 3 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
DB01193 515 40 None -15 3 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
1499 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
1499 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
1499 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
3779 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
3779 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
3779 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
536 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
536 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
536 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
CHEMBL434 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
CHEMBL434 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
CHEMBL434 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
DB01064 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
DB01064 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
DB01064 4274 42 None -64 12 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
12578 1929 47 None -1 3 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
2755 1929 47 None -1 3 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
CHEMBL1374751 1929 47 None -1 3 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
2258 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
2258 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
42396 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
42396 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
537 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
537 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
CHEMBL1160714 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
CHEMBL1160714 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
DB13777 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
DB13777 6434 33 None None None Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
4183 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 16434564
4183 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
6918554 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 16434564
6918554 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
7455 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 16434564
7455 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
CHEMBL1095777 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 16434564
CHEMBL1095777 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
DB05039 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 16434564
DB05039 4137 48 None -1 8 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
2291 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 6470 51 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
1054 3263 41 None None None Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
59768 3263 41 None None None Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
7178 3263 41 None None None Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
CHEMBL768 3263 41 None None None Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
DB00187 3263 41 None None None Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
11823027 5529 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
39147 5529 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
554 5529 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
CHEMBL3246778 5529 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
CHEMBL649 5529 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
DB01203 5529 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
114905 4629 0 None None None Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
13192 4629 0 None None None Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
CHEMBL1742466 4629 0 None None None Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
DB12212 4629 0 None None None Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
155774 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
155774 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
2848 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
2848 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
538 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
538 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
CHEMBL75753 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
CHEMBL75753 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
DB13781 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
DB13781 8875 30 None None None Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
2249 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
2249 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
2249 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
255 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
255 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
255 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
548 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
548 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
548 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
CHEMBL24 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
CHEMBL24 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
CHEMBL24 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
DB00335 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
DB00335 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
DB00335 1058 67 None 1 3 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
1786 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
1786 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
1786 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
1786 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
1786 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
4171 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
4171 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
4171 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
4171 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
4171 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
553 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
553 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
553 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
553 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
553 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
CHEMBL13 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
CHEMBL13 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
CHEMBL13 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
CHEMBL13 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
CHEMBL13 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
DB00264 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
DB00264 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
DB00264 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
DB00264 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
DB00264 5120 49 None -1 5 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
12582 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
12582 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
2783 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
2783 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
673 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
673 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
CHEMBL49080 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
CHEMBL49080 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
DB01407 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
DB01407 1957 29 None -3 4 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
2405 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10372227
2405 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
2405 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 35762357
380 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10372227
380 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
380 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 35762357
7129 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10372227
7129 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
7129 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 35762357
CHEMBL645 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10372227
CHEMBL645 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
CHEMBL645 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 35762357
DB00612 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10372227
DB00612 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
DB00612 1368 47 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 35762357
1531 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
1531 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
3869 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
3869 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
7207 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
7207 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
CHEMBL429 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
CHEMBL429 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
DB00598 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
DB00598 4617 40 None -1 9 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
5311452 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10411574
5311452 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 15655528
5311452 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 20590599
547 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10411574
547 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 15655528
547 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 20590599
CHEMBL1326499 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10411574
CHEMBL1326499 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 15655528
CHEMBL1326499 7458 12 None -8 3 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 20590599
156297 6815 0 None None None Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 10 4 7 1.7 COc1cc(CCNCC(COc2ccc(c(c2)O)O)O)ccc1OC 9117106
5571 6815 0 None None None Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 10 4 7 1.7 COc1cc(CCNCC(COc2ccc(c(c2)O)O)O)ccc1OC 9117106
12579 5620 0 None None None Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 472 14 3 8 1.8 NC(=O)C1=CC=C(OCCNC[C@H](O)COC2=CC3=C(O[C@H](COCC4CC4)CO3)C=C2)C=C1 28400472
60151587 5620 0 None None None Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 472 14 3 8 1.8 NC(=O)C1=CC=C(OCCNC[C@H](O)COC2=CC3=C(O[C@H](COCC4CC4)CO3)C=C2)C=C1 28400472
2303 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
2303 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
2303 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
2303 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
4946 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
4946 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
4946 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
4946 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
564 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
564 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
564 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
564 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
63 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
63 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
63 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
63 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
91536 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
91536 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
91536 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
91536 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
CHEMBL27 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
CHEMBL27 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
CHEMBL27 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
CHEMBL27 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
CHEMBL452861 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
CHEMBL452861 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
CHEMBL452861 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
CHEMBL452861 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
DB00571 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
DB00571 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
DB00571 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
DB00571 6476 48 None -3 19 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
2475 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
2475 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
2475 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
433 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
433 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
433 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
550 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
550 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
550 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
CHEMBL305380 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
CHEMBL305380 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
CHEMBL305380 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
DB08808 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
DB08808 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
DB08808 1528 0 None -2 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
5311116 4758 10 None 44 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10079020
5311116 4758 10 None 44 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 28400472
544 4758 10 None 44 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10079020
544 4758 10 None 44 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 28400472
CHEMBL207802 4758 10 None 44 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10079020
CHEMBL207802 4758 10 None 44 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 28400472
3914 1526 0 None -7 5 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
570 1526 0 None -7 5 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
CHEMBL293030 1526 0 None -7 5 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
12580 5622 0 None None None Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 13 3 8 1.9 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](COCC5CC5)CO4)C=C3 28400472
60150890 5622 0 None None None Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 13 3 8 1.9 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](COCC5CC5)CO4)C=C3 28400472
33624 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
33624 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
33624 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
4061 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
4061 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
4061 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
565 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
565 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
565 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
CHEMBL499 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
CHEMBL499 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
CHEMBL499 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
DB00373 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
DB00373 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
DB00373 8322 24 None -4 7 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
2369 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
2369 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
2369 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
356 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
356 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
356 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
549 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
549 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
549 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
CHEMBL423 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
CHEMBL423 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
CHEMBL423 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
DB00195 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
DB00195 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
DB00195 1284 48 None 11 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
2685 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10079020
2685 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10411574
2685 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 15655528
2685 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 26385885
2685 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 27588207
541 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10079020
541 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10411574
541 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 15655528
541 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 26385885
541 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 27588207
CHEMBL280822 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10079020
CHEMBL280822 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10411574
CHEMBL280822 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 15655528
CHEMBL280822 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 26385885
CHEMBL280822 1837 22 None -1 6 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 27588207
123686 4050 42 None None None Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 23614528
12581 4050 42 None None None Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 23614528
CHEMBL11268 4050 42 None None None Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 23614528
2176 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
2176 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
4828 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
4828 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
91 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
91 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
CHEMBL500 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
CHEMBL500 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
DB00960 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
DB00960 6361 47 None -1 14 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
2687 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
2687 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
2687 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
532 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
532 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
532 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
CHEMBL420746 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
CHEMBL420746 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
CHEMBL420746 1835 0 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
2176 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
2176 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
2176 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
4828 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
4828 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
4828 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
91 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
91 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
91 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
CHEMBL500 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
CHEMBL500 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
CHEMBL500 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
DB00960 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
DB00960 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
DB00960 6361 47 None -1 14 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
2585 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
2585 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
522 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
522 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
551 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
551 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
CHEMBL723 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
CHEMBL723 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
DB01136 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
DB01136 1662 62 None -1 22 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
13193 1518 0 None None None Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
51045 1518 0 None None None Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
CHEMBL321582 1518 0 None None None Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
DB12752 1518 0 None None None Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
2687 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
2687 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
2687 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
532 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
532 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
532 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
CHEMBL420746 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
CHEMBL420746 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
CHEMBL420746 1835 0 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
135398737 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2818 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL253391 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 1973 61 None -2 61 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398745 5933 69 None -2 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1982 5933 69 None -2 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
4585 5933 69 None -2 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 5933 69 None -2 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 5933 69 None -2 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 5933 69 None -2 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
2181 6363 43 None -1 16 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 6363 43 None -1 16 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 6363 43 None -1 16 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 6363 43 None -1 16 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 6363 43 None -1 16 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2337 6622 53 None 1 36 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 6622 53 None 1 36 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 6622 53 None 1 36 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 6622 53 None 1 36 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 6622 53 None 1 36 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2389 6775 83 None -14 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 6775 83 None -14 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 6775 83 None -14 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 6775 83 None -14 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 6775 83 None -14 45 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2435 7298 64 None -4 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 7298 64 None -4 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 7298 64 None -4 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 7298 64 None -4 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 7298 64 None -4 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
115237 118408 70 None -1 26 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
4137 118408 70 None -1 26 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 118408 70 None -1 26 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
DB01267 118408 70 None -1 26 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
11954293 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
3036780 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
4115 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL504548 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
DB06216 212936 14 None -3 28 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
1028 599 43 None -21 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 599 43 None -21 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 599 43 None -21 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 599 43 None -21 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 599 43 None -21 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
1150 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
3337 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
DB00574 473039 11 None -1 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
2601 8241 23 None -3 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 8241 23 None -3 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 8241 23 None -3 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 8241 23 None -3 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 8241 23 None -3 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
2723 123170 6 None -2 6 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
65772 123170 6 None -2 6 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL174984 123170 6 None -2 6 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
DB13692 123170 6 None -2 6 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
173382 8114 0 None None None Human 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 333 8 4 6 2.0 COc1cc(CCNCC(c2ccc(c(c2)O)O)O)ccc1OC 8982677
533 8114 0 None None None Human 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 333 8 4 6 2.0 COc1cc(CCNCC(c2ccc(c(c2)O)O)O)ccc1OC 8982677
193122 3907 4 None None None Human 7.0 pKi None 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10079020
542 3907 4 None None None Human 7.0 pKi None 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10079020
CHEMBL142773 3907 4 None None None Human 7.0 pKi None 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10079020
10587912 5759 0 None 12 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 3 4 1.3 OCCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
545 5759 0 None 12 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 3 4 1.3 OCCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
146294 1913 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
552 1913 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
637 1913 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
CHEMBL2110772 1913 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
3123920 5765 59 None 7 3 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10079020
546 5765 59 None 7 3 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10079020
CHEMBL7154 5765 59 None 7 3 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10079020